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 Research in the Stoltz group is focused on the development of synthetic methods 
for the preparation of stereochemically rich molecules and the total synthesis of complex 
natural products.  One major theme of our group’s methods development is transition-metal 
catalyzed a-functionalization of carbonyl derivatives, with a particular focus on the 
development of allylic alkylation protocols. Although the a-functionalization of carbonyl 
derivatives such as enolates, has been extensively studied, the use of nitrogen and oxygen-
containing heterocycles, such as lactams and lactones, remains significantly under-
developed. These types of nucleophiles are significantly more reactive, and in the case of 
the g-butyrolactones and g-lactams, may be smaller in size. Because of these differences, 
the conditions that have been developed for the functionalization of carbonyl derivatives 
such as ketones does not translate well to these nucleophiles. Furthermore, within the 
context of enantioselective functionalization, the unique characteristics of these 
nucleophiles necessitates the development of large, bulky ligands that enable the formation 
of a very well-defined chiral environment around the transition metal catalyst.  This thesis 
mainly describes strategies that have been developed for the enantioselective a-
functionalization of nitrogen and oxygen-containing heterocycles, with a particular focus 
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Enantioselective Alkynylation of Trifluoromethyl Ketones  
Catalyzed by Cation-Binding Salen Nickel Complexes† 
 
1.1  INTRODUCTION, BACKGROUND, AND SYNTHETIC UTILITY 
 
Fluorinated organic compounds have proven to be exceptionally useful in many areas of 
organic chemistry, including materials, agrochemicals, and pharmaceuticals.1 In particular, the 
trifluoromethyl group has emerged as  a crucial motif in medicinal chemistry, as its incorporation 
may have a significant effect on the physicochemical and biological properties of drug targets 
through alteration of steric, electronic, lipophilic, and metabolic properties.  The trifluoromethyl 
group possesses a van der Waals volume of 39.8 Å3, and is an isostere of the isopropyl group.2a  It 
is also highly electron-withdrawing, affecting the reactivity of adjacent  functional groups, and in 
many cases increasing the molecule’s stability. In addition, the fluorine atoms may also participate 
in hydrogen bonding, which can be useful for the rational design of molecules that bind selectively 
to their specific target.2b   
 
† This research was performed in collaboration with the Hong lab at the Gwangju Institute of Science and 
Technology in Korea.  This research has been published and adapted with permission from Park, D.; Jette, C. I.;  
Kim, J.;  Jung, W. –O.; Lee, Y.;  Park, J.;   Kang, S.;  Han, M. S.;  Stoltz, B. M.;  Hong, S. Angew. Chem. Int. Ed. 
2020, 59, 775–779. Copyright 2020 Wiley-VCH. 




More specifically, chiral trifluoromethyl substituted tertiary alcohols and related derivatives are 
structural motifs present in numerous bioactive compounds (Figure 1.1.1, 1–3).  Of  particular 
importance is Efavirenz (1), a frequently prescribed HIV reverse transcriptase inhibitor.3 One 
attractive strategy for the enantioselective synthesis of these motifs is the asymmetric alkynylation 
of trifluoromethyl ketones. This  type of reaction may be catalytic in base, resulting in 
exceptionally mild reaction conditions, and the newly installed alkyne may be easily converted to 
Figure 1.1.2 Previous Reports of Asymmetric Alkynylation of Trifluoromethyl Ketones7  
 
 
KOt-Bu (20 mol %)
 66% yield, 52% ee
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a diverse array of functional groups (Figure 1.1.2). Since Carreira’s pioneering report,4a several 
catalysts have been developed for the enantioselective  alkynylation of aldehydes,4 imines,5 and 
alkyl ketones.6  In contrast, there are fewer reports on the enantioselective alkynylation of 
trifluoromethyl ketones,7,8 as the high reactivity of these electron-deficient electrophiles has led to 
significant challenges associated with facial selectivity.  Although there have been some reports 
on the enantioselective variant of this transformation, they all suffer from significant drawbacks, 
such as high temperatures,7a large excesses of expensive reagents,7b,d or the use of precious, 
second-row transition metals as  catalysts.7c,h-k   
In an effort to develop a more sustainable method for the enantioselective alkynylation of 
trifluoromethyl ketones, we turned our attention to the development of a bifunctional catalyst, in 
which two metals are held in place by the same ligand scaffold. One metal activates the nucleophile 
(a Brønsted base) and the other activates the electrophile (a Lewis acid). 9a  These types of  
bifunctional catalysts typically rely on a Salen-type framework to position both the Lewis Acid 
and the Brønsted base in the optimal geometry (Figure 1.1.3.A) . Previously reported catalysts of 
this type have been used for Michael additions, as well as Mannich and Aldol reactions.  In two of 
these examples, the Brønsted base is the metal phenoxide incorporated into the framework (Figure 
1.1.3. A, 7 and 9). One  characteristic of these catalysts is that they furnish the desired products in 
very high yields and selectivities,9a-h as the use of a single species to activate and bring together 
both the nucleophile and electrophile leads to a well-defined environment for the reactive 
intermediates.9a  For this reason, we envisioned that the use of a bifunctional catalyst  would enable 
efficient control over the facial selectivity of the highly reactive trifluoromethyl ketone.  The use 
of the salen ligand framework with a pendant crown ether10,11 which can interact with an alkali 
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metal cation would facilitate this form of cooperative catalysis, as the Lewis acid and Brønsted 
base could be held in close proximity by a very rigid and specific structure. In addition, the crown 
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4Å MS, THF


















































up to 45% yield,
90% ee
         Red = Lewis Acid, Blue = Brönsted Base.9a-h
7 8 9
A. Examples of previously reported bifunctional catalysts:
B. This research: Ni-catalyzed enantioselective alkynylation via bifunctional catalysis:
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1.2     CATALYST DEVELOPMENT AND OPTIMIZATION OF REACTION 
CONDITIONS 
To assess the efficacy of this type of cooperative catalyst we first synthesized and tested a 
number of ligand frameworks possessing oligo-ethers of varying length. We were pleased to find 
that ligand L2, with a binapthyl backbone and methoxyethane side chains, in combination with a 
Ni Lewis acid and KOt-Bu Brønsted base, furnished the desired product in excellent yields and ee 
(Table 1.2.1, entry 1). Interestingly, we found that although oligo-ether chain length did not have 
a significant effect on the ee, it did have an effect on the yield.  Switching to a ligand possessing 
methoxy substituents (L3), or extending the chain length (L4) resulted in less efficient catalysts 
(entries 2 and 3). It is also important to note that the presence of a coordinating ether moiety was 
critical for reactivity, as a tert-butyl substituent at this position completely shut down the reaction 
(entry 4, L5). In addition, we found NiII to be the optimal Lewis acid; switching to Co or Zn led to 
a significant drop in ee, and Pd led to complete loss of reactivity (entries 5-7). 
Next, we examined the importance of the counter-ion on the tert-butoxide base. The highest 
enantioselectivity and yield was observed with KOt-Bu; both LiOt-Bu and NaOt-Bu led to a slight 
reduction in yield and ee (entry 1 vs entries 8 and 9). When the reaction temperature was lowered 
from 50 °C to 25 °C, the ee was increased to 89% ee (entry 10). Lowering the temperature even 
further to –10 °C, however, led to the complete loss of reactivity (entry 11).Having investigated 
all other parameters, we returned to our ligand, focusing on examining the effect of different steric 
and electronic modifications on the backbone. We found that the binapthyl backbone was crucial 
for reactivity: when a ligand possessing a cyclohexyl backbone was used instead, no product was 
observed (L6, entry 12). In agreement with the work of Wang and co-workers12  we found that the  
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H Catalyst (5 mol %)
Base (20 mol %)
4Å MS, THF (0.48 M)




1 equiv 4 equiv
5 L2 KOt-Bu 50 91 49
6 L2 KOt-Bu 50 64 77
7 L2 KOt-Bu 50 – –
8 L2 LiOt-Bu 50 86 78
9 L2 NaOt-Bu 50 83 85
10 L2 KOt-Bu 25 93 89
11 L2 KOt-Bu –10 – –
13 L7 KOt-Bu 50 97 88
14 L1 KOt-Bu 50 95 91
















L2: R1 = O-CH2CH2O-CH3
L3: R1 = O-CH3
L4: R1 = O-[CH2CH2O]2-CH3









L7: R2 = Br, R3 = H








Entry Ligand Base Temp (°C) Yield (%)b % eec
1 L2 KOt-Bu 50 97 84
2 L3 KOt-Bu 50 48 82
3 L4 KOt-Bu 50 86 86
4 L5 KOt-Bu 50 – –
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introduction of bromide substituents on the salicyl arenes led to a slight improvement in the ee 
(entries 13 and 14). Using the 6-Bromo-Salen ligand (L1), the product was obtained in 93% yield 
and 93% ee at 25 °C under air (entry 15). 
 
1.3     ARYL TRIFLUOROMETHYL KETONE SUBSTRATE SCOPE 
With the optimized reaction conditions in hand, the substrate scope of the asymmetric alkynylation of 
aryl trifluoromethyl ketones was explored (Table 1.3.1).  Electrophiles possessing both electron-donating 
substituents (6aa, 6ea, 6fa) and electron-withdrawing substituents (6ba, 6ca, 6da) at the para-position of 
the arene were well-tolerated, resulting in the desired products in up to a 97% ee and 97% yield. Although 
substitution at the meta-position of the aryl ring was also tolerated (6ga), ortho-substitution did lead to a 
Table 1.3.1.  Scope with Aryl Trifluoromethyl Ketonesa 
 
 


















































L1-Ni (5 mol %)
KOt-Bu (20 mol %)
4Å MS, THF (0.48M)
25 °C, 24 h
1 equiv 4 equiv
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drop in yield (6ha). We noted that generally, the yields for electron-deficient trifluoromethyl ketones were 
slightly higher than with electron-rich substrates, with the latter requiring extended reaction times.  
However, we did note that the ee’s for electron-rich substrates were consistently higher than their electron-
deficient counter-parts. 
 We found that the nature of the alkyne had a less pronounced effect on the overall outcome of the 
reaction, and alkynes possessing both electron-withdrawing (6ab, 6ac, 6cb) and electron-donating 
substituents (6ad, 6ae, 6ee) at the para-position of the aryl substituent were well-tolerated. Furthermore, 




[a] Isolated yields on 0.242 mmol scale. Enantiomeric excess was determined by HPLC analysis. [b] Isolated yield after 
48 h.  
















































L1-Ni (5 mol %)
KOt-Bu (20 mol %)
4Å MS, THF (0.48M)
25 °C, 24 h
1 equiv 4 equiv
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we were pleased to observe that a bulky napthyl substituent (6af) and a cyclopropyl substituent (6eg and 
6eh) also led to product formation in good yields and ee. 
 
1.4  ALKYNYLATION OF UNSATURATED TRIFLUOROMETHYL KETONES  
In addition to the extensive scope with aryl trifluoromethyl ketones, Hong and coworkers 
found that phenylacetylene 5a could be added to unsaturated trifluoromethyl ketone 10a 
exclusively in a 1,2 fashion to form the vinyl trifluoromethyl carbinol  11aa in 65% yield and 92 
% ee (Scheme 1.4.1).13 The products of the alkynylation of these unsaturated ketones are especially 
useful synthetic intermediates, as they contain three functional handles: an alcohol, an alkene, and 
an alkyne.   
Examination of the literature showed that the synthesis of 11aa has been reported twice 
before. In 2011, Ma and coworkers showed that exclusive 1,2 addition of phenylacetylene  to 
unsaturated ketone 10a could be achieved in 68% yield and 66% ee using a system involving BaF2, 
Ti(Oi-Pr)4, Me2Zn, and a cinchona-derived ligand (Scheme 1.4.2.A).7b More recently, Michalak 
reported the formation of the alkenyl trifluoromethyl carbinol with a Cu-NHC catalyst and Et3N 
as the base (Scheme 1.4.2.B).7k Although the yields achieved in both of these systems are 
comparable to that reported by Hong and coworkers, the high ee achieved using the NiII salen 













L1-Ni (5 mol %)
KOt-Bu (20 mol %)
4 Å MS, THF
23 °C, 48 h
Hong. et. al: 65% yield, 92% ee
10a 5a 11aa
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catalyst makes the current system the best to date for the formation of these products.  
 
 
1.5 REACTION OPTIMIZATION FOR UNSATURATED TRIFLUOROMETHYL 
KETONES  
We initiated our studies by attempting to replicate the results reported by Hong and 
coworkers.13 Unfortunately, with the reported procedure, the product was obtained in no greater 
than a 20% yield and 88% ee (Table 1.5.1, entries 1 and 2). Analysis of the reported procedure 
showed that there were a few parameters that could be modified. The first is that a commercially 
available 1.0 M solution of KOt-Bu in THF was being used. By switching to solid KOt-Bu, 
possible errors in titration or fluctuations in concentration would be avoided, and variability in the 














BaF2 (20 mol %)
L (20 mol %)
Me2Zn (3 equiv)
















IPrCuCl (2 mol %)
Et3N (20 mol %)
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amount of base added would be reduced. Gratifyingly, we found that switching to solid KOt-Bu 
resulted in over a 22% boost in yield (entry 3).   
 
By switching to a glovebox reaction set-up, we were finally able to replicate the  65% yield 
reported by Hong and coworkers, although the ee was slightly lower than their reported 92% (entry 
4). In order to facilitate reaction screening at very low quantities, the reaction concentration was 
lowered to  0.1 M (entry 5), with no significant effect on the yield or ee. Finally, pre-stir of the Ni-
catalyst with the KOt-Bu base resulted in a slight improvement in yield (entry 6). 
 With these results in hand, two more reaction parameters were examined; the amount of 
KOt-Bu base and mol sieves used in the reaction. In the initial conditions developed by Hong and 
coworkers, 20 mol % KOt-Bu is used (entry 2, Table 1.5.2.). Increasing the amount of base to 40 
Table 1.5.1 Replication of Hong and Coworkers’ Results                   
 
                  
[a] Conversions and yields were determined by 1HNMR with trimethoxybenzene as an internal standard. [b] 
Enantiomeric excess (% ee) was determined by SFC. [c] With distilled alkyne, new bottle of KOt-Bu solution. [d] Pre-










L1-Ni (5 mol %)
KOt-Bu (20 mol %)
4 Å MS, THF
23 °C, 48 h
Hong. et. al: 65% yield, 92% ee












1.0 M in THF













6d glovebox 0.1 solid KOt-Bu
10a 5a 11aa
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mol % was detrimental to the reaction (entry 3), while decreasing the amount down to 10 mol % 
resulted in a modest boost in yield (entry 1).  
 To determine if these results were due to basic decomposition of the starting material or 
the product, both 10a and 11aa were stirred for 16 h with 10 mol % KOt-Bu (Scheme 1.5.1). The 
product was fully recovered, but only 68% of the starting material was recovered, suggesting that 







Hong and coworkers’ original reaction conditions did not involve a moisture-free reaction 
set-up, and we envisioned that this could be the reason that a large excess of 4 Å molecular sieves 
Table 1.5.2. Amount of KOt-Bu Base 
 
                               
[a] Conversions and yields were determined by 1HNMR with trimethoxybenzene as an internal standard. [b] 








Ni-cat (5 mol %)
KOt-Bu 
4 Å MS, THF,
23 °C, 48 h
91 72 90
100 68 88





















10 mol % KOt-Bu
THF, 23 °C, 16 h
10 mol % KOt-Bu
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was required.  Since we had switched to a glovebox set-up, the last parameter we decided to 
investigate was the quantity of molecular sieves in the reaction. Entry 2 (Table 1.5.3.) shows the 
initial amount of molecular sieves used for a 0.05 mmol scale reaction. Increasing the amount of 
molecular sieves does lead to a slight drop in yield (entry 1). As the amount of molecular sieves is 
decreased, the yield increases, up to 81% with 8 mg of mol sieves (entry 5). Decreasing the quantity 
of molecular sieves even further (entry 6), or excluding them altogether (entry 7) led to no 
improvements. These results indicate that the molecular sieves are beneficial but not critical for 
reactivity.  
 
Table 1.5.3. Effect of 4 Å Mol Sieves   
            
 
[a] Yields were determined by 1H NMR with trimethoxybenzene as an internal standard. [b] Enantiomeric excess (% 











4 Å mol sieves  











L1-Ni (5 mol %)
KOt-Bu (10 mol %)
4 Å MS, THF
23 °C, 48 h
10a 5a 11aa
82 78 884 18
84 81 905 8
82 77 906 5
0 73 907 0
84 888c 8 –
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1.6 SCOPE OF ENANTIOSELECTIVE ALKYNYLATION OF UNSATURATED 
TRIFLUOROMETHYL KETONES 





[a] Isolated yields on 0.2 mmol scale. Enantiomeric excess (% ee) was determined by SFC analysis.   
CF3
O
H L1-Ni (5 mol %)
KOt-Bu (10 mol %)
4Å MS, THF (0.1 M)





















































































 We next examined the scope of the enantioselective alkynylation of unsaturated trifluoromethyl 
ketones. Enones possessing aryl rings with substituents at the para (11ba, 11ca, 11da, 11ea), meta 
(11ga), and even ortho (11ha and 11ia) positions were all well-tolerated. We were also pleased to 
see that a tert-butyl ester-containing substrate (11fa) and a diene (11na) fared well under these 
mild reaction conditions. Even substrates possessing heteroaromatic substituents such as a furan 
(11aj), thiophene (11ak), and indole (11al) led to product formation in good yield and  excellent 
ee.  
 
1.7 PRELIMINARY MECHANISTIC INVESTIGATIONS 
 
 To investigate the binding behavior between L1-Ni and K+, we carried out metal ion titration studies, 
which were monitored by UV-vis absorption spectroscopy.14 Upon addition of KOt-Bu to a solution of L1-
Figure 1.7.1. Metal Ion Titration Studies via UV-Vis Absorption 
 
   
 
(a) UV-Vis spectra of L1-Ni (20 µM) in the presence of varying amounts of KOt-Bu (0 ~ 70 µM) in THF. Inset: Plot of 
absorbance at 403 nm versus concentration of KOt-Bu. (b) Job plot for binding mode between L1-Ni and K+ ions in THF. 
Aobs: Absorbance of L1-Ni at 403 nm with varying amounts of KOt-Bu; [L1-Ni] + [KOt-Bu] = 40 µM, Acon.: Absorbance 
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Ni, the UV-vis absorption spectrum exhibited characteristic peaks at 350, 403, and 350 nm with two clear 
isosbestic points at 376 and 460 nm (Figure 1.7.1.A). The absorbance at 403 nm for L1-Ni/K+ tended to 
proportionally increase with KOt-Bu concentration up to 20 µM, and then reached saturation region. Job 
plot analysis (Figure 1.7.1.B) was in good agreement with the titration study, clearly confirming that L1-
Ni binds to K+ with 1:1 binding stoichiometry. From the titration data based on the 1:1 binding model, the 
association constant (Ka) for binding of L1-Ni and K+ ions was calculated to be 6.6 × 105 M-1 using non-
linear regression analysis by DynaFit.15 
 A plausible catalytic cycle for the alkynylation reaction is shown in Figure 1.7.2. The mechanism 
is expected to begin with the deprotonation of the terminal alkyne to form  potassium acetylide A. Then, 
the trifluoromethyl ketone can coordinate to the Ni Lewis acid to form intermediate B. Once both the 
nucleophile and electrophile are bound to the catalyst, they are in close enough proximity for bond 
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formation to occur. The resulting propargyl alcohol can then bind to the potassium cation (C), and function 




 We have developed cation-binding salen Ni catalysts for enantioselective alkynylation of aryl and 
unsaturated trifluoromethyl ketones.  Critical to the improvement of the reaction conditions for the 
alkynylation of the unsaturated trifluoromethyl ketones was the use of a glove box set-up,  reduction in 
quantities of both KOt-Bu and molecular sieves, and slightly elevated temperatures. The cation-binding 
NiII/K+ heterobimetallic catalyst plays a key role in promoting the alkynylation with substoichiometric base 
and open to air in select cases,14 resulting in high enantioselectivity (up to 97% ee) and yield (up to 99%). 
Additionally, we confirmed a 1:1 binding stoichiometry of the designed catalyst with K+ by UV-vis 
absorption spectroscopy.  
 
1.9  EXPERIMENTAL SECTION 
 
1.9.1  MATERIALS AND METHODS 
Unless otherwise stated, all reactions were carried out under air atmosphere. Reaction 
progress was monitored by thin-layer chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC 
was performed using E. Merck silica gel 60 F254 precoated glass plates (0.25 mm) and visualized 
by UV fluorescence quenching, p-anisaldehyde, or KMnO4 staining.  Silicycle SiliaFlash® P60 
Academic Silica gel (particle size 40–63 nm) or 230-400 Mesh 60 Ǻ Silica Gel (Merck Inc.) was 
used for flash chromatography. All alkynylation reactions were performed in a 10 ml vial sealed 
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with a screw cap. At the Gwangju Institute of Science and Technology (GIST), all NMR spectra 
was recorded on a JEOL spectrometer, operating at 400 MHz or 300 MHz for 1H NMR and at 100 
MHz or 75 MHz for 13C NMR. At the California Institute of Technology (Caltech), 1H NMR 
spectra were recorded on Bruker 400 MHz or Varian Mercury 300 MHz spectrometers.  13C NMR 
spectra were recorded on Bruker 400 MHz spectrometer (101 MHz). 19F NMR spectra were 
recorded on Varian Mercury 300 MHz spectrometer (282 MHz). Data for 1H NMR are reported as 
follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration).  Multiplicities 
are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, 
m = multiplet, br s = broad singlet, br d = broad doublet, app = apparent.  Data for 13C NMR are 
reported in terms of chemical shifts (δ ppm).   All chemical shifts for 1H and 13C NMR were 
referenced to residual signals from CDCl3 (1H) 7.26 ppm and (13C) 77.16 ppm. High-resolution 
mass spectra (HRMS) were recorded on a JEOL JMS-700 MStation mass spectrometer.  At the 
GIST, Infrared (IR) spectra were obtained on a Nicolet iS10 FT-IR spectrometer with an ATR unit 
and recorded in wave numbers (cm-1). At Caltech, the IR spectra were obtained using Perkin Elmer 
Spectrum BXII spectrometer or Nicolet 6700 FTIR spectrometer using thin films deposited on 
NaCl plates and reported in frequency of absorption (cm–1). High-performance liquid 
chromatography (HPLC) was performed on an Agilent 1260 Infinity Series machine equipped with 
a variable wavelength detector and Daicel Chiralpak I Series columns (0.46 cm X 25 cm). 
Analytical SFC was performed with a Mettler SFC supercritical CO2 analytical chromatography 
system utilizing Chiralpak (AD-H, AS-H or IC) or Chiralcel (OD-H, OJ-H, or OB-H) columns 
(4.6 mm x 25 cm) obtained from Daicel Chemical Industries, Ltd. High resolution mass spectra 
(HRMS) were obtained from Agilent 6200 Series TOF with an Agilent G1978A Multimode source 
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in electrospray ionization (ESI+), atmospheric pressure chemical ionization (APCI+), or mixed 
ionization mode (MM: ESI-APCI+), or obtained from the Caltech Mass Spectrometry Laboratory. 
Specific optical rotations were measured with a Jasco P-2000 polarimeter operating on the sodium 
D-line (589 nm), using a 100 mm path-length cell and are reported as: [a]DT (concentration in 10 
mg/1 mL, solvent). Yields refer to the isolated yield of analytically pure material, unless otherwise 
noted.  
All chemicals were purchased from Aldrich, Acros, TCI, or Alfa-Aesar Chemical Co. and 
used as received unless otherwise noted.  At GIST, anhydrous tetrahydrofuran (THF), diethyl ether 
(Et2O), and dichloromethane (CH2Cl2) were dried using J.C. Meyer solvent purification system. 
Hexane was distilled from calcium hydride (CaH2). At Caltech, solvents were dried by passage 
through an activated alumina column under argon. Unless specified, all the other chemicals were 
purchased from Sigma-Aldrich Co., Acros Organics, TCI, Alfa Aesar, and Strem Chemicals Inc. 
and were used as received without further purification. 
 
1.9.2  EXPERIMENTAL PROCEDURES AND SPECTROSCOPIC DATA 
 
1.9.2.1        Synthesis and Spectroscopic Data for Salen-Crown Ether Ligands 
 
L3 and L5 are both known compounds, and were synthesized according to previously reported 
procedures.16,17  
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General Procedure for Aldehyde Synthesis  
 
 




6-bromo-2,3-dihydroxybenzaldehyde (SI1):   To a flame-dried round bottom flask under argon 
was added 6-bromo-2-hydroxy-3-methoxybenzaldehyde (5.74 g, 24.8 mmol, 1.0 equiv) and 
methylene chloride (50 mL). The solution was cooled to –78 °C and boron tribromide (7.1 mL, 
74.5 mmol, 3.0 equiv) in methylene chloride (68 mL) was added dropwise. The reaction was 
warmed to room temperature and stirred for 5 h. Upon reaction completion, the crude reaction 
mixture was poured into ice water and stirred for 1 h. The aqueous layer was extracted with 
methylene chloride three times. The combined extracts were washed with water and dried with 
sodium sulfate, and concentrated by rotary evaporator. The crude solid was then rinsed with 
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mmol, 85% yield). 1H NMR (300 MHz, CDCl3) δ 12.24 – 12.06 (m, 1H), 10.27 (s, 1H), 7.17 – 




6-bromo-2-hydroxy-3-(2-methoxyethoxy)benzaldehyde (SI2): Sodium hydride (1.17 g, 48.75 
mmol, 2.3 equiv) was added to a flame-dried flask under argon.  This flask was placed in an ice 
bath, and a solution of 6-bromo-2,3-dihydroxybenzaldehyde (SI1, 4.6 g, 21.2 mmol, 1.0 equiv) in 
DMSO (42 mL) was added dropwise. The resulting solution was stirred for 3 hours and then 2-
methoxyethyl 4-methylbenzenesulfonate19 (5.37 g, 23.22 mmol, 1.1 equiv) in DMSO (4.2 mL) 
was added dropwise. The reaction was stirred for 24 hours at room temperature. The reaction was 
quenched with water and the pH was checked and adjusted to pH = 7.  The aqueous layer was 
extracted with methylene chloride three times and the combined organic extracts were washed 
with 1M HCl, dried with Na2SO4, and then concentrated. The crude reaction mixture was filtered 
through a pad of silica and concentrated to afford 6-bromo-2-hydroxy-3-(2-
methoxyethoxy)benzaldehyde as an yellow solid (3.38 g, 12.3 mmol, 58% yield); 1H NMR (300 
MHz, CDCl3) δ 12.25 (s, 1H), 10.29 (s, 1H), 7.07 (d, J = 8.6 Hz, 1H), 6.99 (d, J = 8.6 Hz, 1H), 
4.23 – 4.15 (m, 2H), 3.82 – 3.75 (m, 2H), 3.45 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 198.5, 
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1641, 1579, 1467, 1454, 1438, 1388, 1370, 1332, 1317, 1285, 1274, 1250, 1211, 1202, 1127, 1102, 
1081, 898, 861, 822, 789, 749, 676; HRMS C10H12BrO4 (M+H)+: 274.9913, Found: 274.9921.  
 
The corresponding aldehydes for other ligands tested were synthesized according to the procedure 
described above. 
 
Synthesis of Salen Crown Ether Ligands: Imine Formation 
 
                 




methoxyethoxy)phenol)(L1):  6-bromo-2-hydroxy-3-(2-methoxyethoxy)benzaldehyde (2.38 g, 
8.67 mmol, 2.0 equiv) and (R)-(+)-1,1′-Binaphthyl-2,2′-diamine (1.7 g, 4.33 mmol, 1.0 equiv) 
were combined in EtOH (14 mL). The reaction mixture was heated to 120 °C and stirred for 6 h.  













77% yield O OSI2
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filtered solid was washed with EtOH, concentrated under reduced pressure, affording scarlet solids 
(2.69 g, 3.36 mmol, 77% yield); [α]D20 = –301.6 (c 0.652, CH2Cl2); 1H NMR (400 MHz, C6D6) δ 
13.84 (s, 1H), 9.08 (s, 1H), 7.65 (d, 12 Hz, 1H), 7.56 (d, 8 Hz, 1H), 7.30 (d, 12 Hz, 1H), 7.25 (d, 
8 Hz, 1H), 7.03 (t, 8 Hz, 1H), 6.87 (t, 8 Hz, 1H), 6.54 (d, 8 Hz, 1H), 6.12 (d, 8Hz, 1H), 3.55 (t, 6 
Hz, 2H), 3.21 (t, 4 Hz, 2H), 3.01 (s, 3H); 13C NMR (75 MHz, C6D6) δ 162.8, 155.0, 147.8, 143.6, 
133.5, 132.8, 130.3, 129.4, 128.4, 127.2, 126.5, 126.1, 121.7, 118.2, 117.6, 117.0, 116.8, 70.7, 
68.8, 58.5; IR (neat) 2925, 2876, 2817, 1600, 1586, 1440, 1338, 1246, 1224.50, 1125, 1085, 871, 





2-hydroxy-3-(2-methoxyethoxy)benzaldehyde (365 mg, 1.86 mmol, 2.0 equiv) and (R)-(+)-1,1′-
binaphthyl-2,2′-diamine (264.5 mg, 0.930 mmol, 1.0 equiv) were combined in EtOH (7 mL). The 
reaction mixture was stirred at room temperature for 48 h. The suspension was filtered. The filtered 
solid was washed with EtOH, concentrated under reduced pressure, affording orange solids (556.8 
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12.33 (s, 2H), 8.05, 8.02 (d, J = 12 Hz, 2H), 8.55 (s, 2H), 7.93, 7.91 (d, J = 8 Hz, 2H), 7.54, 7.51 
(d, J = 12 Hz, 2H), 7.40 – 7.44 (t, J = 8 Hz, 2H), 7.22 – 7.24 (d, J = 8 Hz, 2H), 7.19, 7.17 (d, J = 
8 Hz, 2H), 6.89, 6.88 (d, J = 4 Hz, 2H), 6.80, 6.79 (d, J = 4 Hz, 2H), 6.66 – 6.70 (t, J = 8 Hz, 2H), 
4.03 –4.06 (m, 4H), 3.65 – 3.68 (t, J = 6 Hz, 4H),  3.39 (s, 6H); HRMS (EI) Calcd. for C40H36N2O6: 








2-hydroxy-3-(2-(2-methoxyethoxy)ethoxy)benzaldehyde (191.3 mg, 0.797 mmol, 2.0 equiv) and 
(R)-(+)-1,1′-binaphthyl-2,2′-diamine (96.4 mg, 0.339 mmol, 1.0 equiv) were combined in EtOH 
(3 mL). The reaction mixture was stirred at room temperature for 48 h. The suspension was filtered. 
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orange solid (196.5 mg, 0.2697 mmol, 80% yield); [α]D20 = –352.1 (c 0.518, CH2Cl2); 1H NMR 
(400 MHz, CDCl3) δ 12.28 (s, 2H), 8.03 (d, J = 8 Hz, 2H ), 7.92 (d, J = 8 Hz, 2H), 7.52 (d, J = 8 
Hz, 2H), 7.44-7.40 (m, 2H), 7.26-7.22 (m, 2H), 7.18 (d, J = 8 Hz, 2H), 6.88 (d, J = 8 Hz, 2H), 6.79 
(d, J = 8 Hz, 2H), 6.70 – 6.66 (m, 2H), 4.09 – 4.06 (m, 4H), 3.79 – 3.76 (m, 4H), 3.67 – 3.65 (m, 
4H), 3.53 – 3.51 (m, 4H), 3.37 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 163.0, 151.7, 147.2, 144.4, 
133.3, 132.6, 130.2, 128.4, 127.0, 126.6, 125.8, 124.9, 119.7, 118.2, 118.0, 117.8, 72.0, 70.7, 69.7, 
69.1, 59.1; IR (neat) 3269, 3046, 2955, 2362, 1603, 1574, 1506, 1470, 1429, 1389, 1359, 1306, 
1261, 1194, 1143, 1087, 969, 856, 815, 744, 700; HRMS (EI) Calcd. for C44H44N2O8: 728.3098, 





  2-hydroxy-3-(2-methoxyethoxy)benzaldehyde (193 mg, 0.986 mmol, 2.0 equiv) and (1R,2R)-
cyclohexane-1,2-diamine (56.3 mg, 0.493 mmol, 1.0 equiv) were combined in EtOH (8 mL). The 
reaction mixture was stirred at room temperature for 48 h. The solvent was removed under reduced 
pressure. The residue was purified by column chromatography on silica-gel (n-hexane/EtOAc = 
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1H NMR (300 MHz, CDCl3) δ 13.83 (s, 2H), 8.21 (s, 2H), 6.88 – 6.90 (m, 2H), 6.77 – 6.80 (m, 
2H), 6.67 – 6.71 (t, J = 6 Hz, 2H), 4.13 – 4.16 (t, J = 4.5 Hz, 4H), 3.76 – 3.78 (t, J = 3 Hz, 4H), 
3.43 (s, 6H), 1.84 –1.93 (m, 4H), 1.66 –1.69 (d, J = 9 Hz, 2H), 1.42 – 1.47 (m, 2H) ppm; 13C NMR 
(75 MHz, CDCl3) δ 164.8, 152.2, 147.4, 124.0, 118.7, 117.9, 116.6, 72.5, 71.2, 68.6, 59.3, 33.1, 
24.1; IR (neat) 3315, 2929, 2856, 1625, 1578, 1477, 1450, 1376, 1338, 1289, 1233, 1022; HRMS 







(80 mg, 0.291 mmol) and (R)-(+)-1,1′-Binaphthyl-2,2′-diamine (41.232 mg, 0.145 mmol) were 
combined in EtOH (10 mL). The reaction mixture was stirred at room temperature for 48 h. The 
suspension was filtered. The filtered solid was washed with EtOH and concentrated under reduced 
pressure, affording scarlet solids (100 mg, 0.125 mmol, 86% yield); [α]D20 = –298.5 (c 0.5, 
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8 Hz, 2H), 7.48 (d, 12 Hz, 2H), 7.41 (m, 2H), 7.21 (m, 2H), 7.13 (d, 8 Hz, 2H), 6.96 (d, 4 Hz, 2H), 
6.91 (d, 4 Hz, 2H), 4.01 (m, 4H), 3.65 (t, 4Hz, 4H), .38 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 
161.6, 150.9, 148.2, 143.7, 133.2, 132.8, 130.4, 126.2, 120.4, 120.2, 117.5, 109.5, 77.5, 77.2, 76.9, 
70.8, 69.1, 59.2; IR (neat) 2875, 2360, 2342, 1605, 1569, 1450, 1398, 1363, 1332, 1250, 1199, 









Complexation Procedure (Ni-L Synthesis) 
 
 
Ni-Salen Complex (Ni-L1):  Ni(OAc)2•4H2O (1.17 g, 4.7 mmol, 1.4 equiv) and L1 (2.69 g, 3.36 
mmol, 1.0 equiv) were combined in EtOH and heated to 100 °C for 12 h. While still hot, the crude 
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vial was placed in the freezer for 12h. The crude mixture was then centrifuged down, and the EtOH 
was decanted. The mother liquor was then reduced via rotary evaporator, and the crude reaction 
mixture was allowed to rest in the freezer, and centrifuged a second time. The combined 
precipitates were washed with hexanes, and dried under vacuum to afford a yellow solid (2.2 g, 
2.58 mmol, 77% yield).  
 
All other metal complexes were prepared using this identical procedure. 
 
HRMS for the Catalysts with Nickel  
 
The normal spectral region could not be determined by 1H NMR, since Ni(II)-salen complexes are 
paramagnetic. High-resolution mass spectra (HRMS) shows desired Ni(II)-salen complexes 
bearing one nickel atom. Similar effects for Ni(II)-salen complexes have been reported before.20,21  
 
 
L2-Ni: HRMS (EI) Calcd. C40H34N2NiO6: 696.1770, Found: 696.1769 






L2: R1 = O-CH2CH2O-CH3
L3: R1 = O-CH3
L4: R1 = O-[CH2CH2O]2-CH3









L7: R2 = Br, R3 = H
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L4-Ni: HRMS (EI) Calcd. C44H42N2NiO8: 784.2295, Found: 784.2294 
L5-Ni: HRMS (EI) Calcd. C42H38N2NiO2: 660.2287, Found: 660.2286 
L6-Ni: HRMS (EI) Calcd. C26H32N2NiO6: 526.1614, Found: 526.1614  
L7-Ni: HRMS (EI) Calcd. C40H33Br2N2NiO6: 853.0059, Found: 853.0068 
L1-Ni: HRMS (EI) Calcd. C40H32Br2N2NiO6: 851.9980, Found: 851.9981  
 
1.9.2.3  Synthesis of Trifluoromethyl Ketones 
 
Aryl trifluoromethylketone 4h was prepared according to a previously reported procedure.22 All 
other aryl trifluoromethylketones were purchased from Alfa Aesar, Sigma-Aldrich, or TCI and 
used without further purification.  
 
Synthesis of Unsaturated Trifluoromethyl Ketones: 
 
Previously reported methods were used to prepare 10a23, 10b23, 10c24, 10d23, 10e23, 10i25, 10j25, 





General Procedure for the Synthesis of Unsaturated Trifluoromethyl ketones: 
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(E)-1,1,1-trifluoro-4-(m-tolyl)but-3-en-2-one (10g): 3-methylbenzaldehyde (601 mg, 5.0 mmol, 
1.0 equiv), piperidine (493 µL, 5.0 mmol, 1.0 equiv), and acetic acid ( 429 µL, 7.5 mmol, 1.5 
equiv) were all combined in dry toluene (5 mL) in a flame-dried flask under argon. The resultant 
solution was cooled to 0 °C, and then trifluoroacetone (1.8 mL, 20 mmol, 4 equiv) in toluene (5 
mL) was added slowly. The reaction was stirred at 0 °C for 2 hours and then allowed to stir at 
room temperature for 24 h. The reaction was quenched with saturated ammonium chloride solution 
and the aqueous layer was extracted three times with ethyl acetate. The combined organic extracts 
were washed with water, and dried with sodium sulfate. Product 10g was purified by column 
chromatography (5% EtOAc in hexanes) to provide a colorless oil (415 mg, 38% yield); 1H NMR 
(500 MHz, CDCl3) δ 7.95 (d, J = 15.9 Hz, 1H), 7.48 – 7.42 (m, 2H), 7.37 – 7.29 (m, 2H), 7.01 (dq, 
J = 16.0, 1.0 Hz, 1H), 2.41 (t, J = 0.7 Hz, 3H). All characterization data match those reported.26 
 
 
(E)-1,1,1-trifluoro-4-(o-tolyl)but-3-en-2-one (10h):  Product 10h was purified by column 
chromatography (8% EtOAc in hexanes) to provide a colorless oil (107 mg, 50% yield); 1H NMR 
(300 MHz, CDCl3) δ 8.31 (dt, J = 15.9, 0.6 Hz, 1H), 7.74 – 7.64 (m, 1H), 7.38 (td, J = 7.3, 1.4 Hz, 




















(E)-1,1,1-trifluoro-4-(1-methyl-1H-indol-3-yl)but-3-en-2-one (10l): Product 10l was purified 
by column chromatography (20% EtOAc in hexanes) to provide a yellow oil (192 mg, 15% yield); 
1H NMR (500 MHz, CDCl3) δ 8.21 (dd, J = 15.5, 0.7 Hz, 1H), 7.97 – 7.91 (m, 1H), 7.58 (s, 1H), 
7.44 – 7.32 (m, 3H), 6.97 (dt, J = 15.6, 1.0 Hz, 1H), 3.88 (s, 3H). 
All characterization data match those reported.27 
 
 
(E)-1,1,1-trifluoro-4-(naphthalen-2-yl)but-3-en-2-one (10m): Product 10m was purified by 
column chromatography (8% EtOAc in hexanes) to provide a light yellow oil (500 mg, 40% yield); 
1H NMR (500 MHz, CDCl3) δ 8.19 – 8.05 (m, 2H), 7.95 – 7.86 (m, 3H), 7.75 (dd, J = 8.6, 1.8 Hz, 




tert-butyl (E)-4-(4,4,4-trifluoro-3-oxobut-1-en-1-yl)benzoate (10f): Product 10f was prepared 
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provide a colorless oil (687 mg, 2.3 mmol, 46% yield); 1H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 
8.1 Hz, 2H), 7.97 (d, J = 16.0 Hz, 1H), 7.68 (d, J = 8.1 Hz, 2H), 7.07 (dt, J = 16.0, 1.0 Hz, 1H), 
1.61 (d, J = 0.9 Hz, 9H); 13C NMR (101 MHz, CDCl3) δ 164.8, 148.8, 136.9, 135.2, 130.3, 129.0, 
118.5, 82.0, 28.30; 19F NMR (282 MHz, CDCl3) δ –77.66; IR (Neat Film, NaCl) 3051, 2995, 1709, 
1613, 1568, 1417, 1392, 1368, 1305, 1265, 1189, 1141, 1063, 994, 896, 844, 772, 733, 705, 683 
cm–1.  
 




To a stirred solution of catalyst (0.012 mmol, 0.05 equiv) in THF (0.5 mL), alkyne (0.968 
mmol, 4 equiv), 4 Å molecular sieve (377 mg), and KOtBu (0.484 mmol, 0.2 equiv) were added 
at room temperature slowly. After the solution had been stirred at room temperature for 30 min to 
give a dark yellow mixture, ketone (0.242 mmol, 1.0 equiv) was added dropwise to a solution. 
After the resulting mixture was stirred at room temperature for 24 h, saturated ammonium chloride 
(2mL) was added to quench the reaction. The solution was extracted with ethyl acetate (3×15 mL). 
The combined organic layers were washed with brine, dried over anhydrous magnesium sulfate, 










L1-Ni (5 mol %)
KOt-Bu (20 mol %)
4Å MS, THF (0.48M)
25 °C, 24 h
1 equiv 4 equiv
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ethyl acetate/hexane. Enantiomeric excesses were determined by HPLC on chiral stationary phase 
(Daicel Chiralpak IB or ID column (0.46 cm × 25 cm)).  
 
 
1,1,1-trifluoro-2,4-diphenylbut-3-yn-2-ol (6aa) : Product 6aa was prepared using the  general 
procedure to provide a pale yellow oil (93% yield, 93% ee); [α]D24 = +26.8 (c = 0.5, CH2Cl2); The 
enantiomeric excess was determined by chiral HPLC analysis: Daicel Chiralpak IB column; 
Hexane/i-PrOH = 98:2; flow rate 1 mL/min, 254 nm wave length UV; minor tR = 11.081 min, 




Product 6ba was prepared using the general procedure to provide a pale yellow oil (93% yield, 
90% ee); [α]D24 = +25.2 (c = 0.5, CH2Cl2); The enantiomeric excess was determined by chiral 
HPLC analysis: Daicel Chiralpak ID column; Hexane/i-PrOH = 99:1; flow rate 0.5 mL/min, 254 
nm wave length UV; minor tR = 11.809 min, major tR = 11.014 min. All characterization data 













2-(4-chlorophenyl)-1,1,1-trifluoro-4-phenylbut-3-yn-2-ol (6ca): Product 6ca was prepared 
using the  general procedure to provide a pale yellow oil (94% yield, 89% ee); [α]D24 = +17.8 (c = 
0.5, CH2Cl2); The enantiomeric excess was determined by chiral HPLC analysis: Daicel Chiralpak 
ID column; Hexane/i-PrOH = 99:1; flow rate 0.5 mL/min, 254 nm wave length UV; minor tR = 
12.818 min, major tR = 11.254 min. All characterization data match those reported.29 
 
 
2-(4-bromophenyl)-1,1,1-trifluoro-4-phenylbut-3-yn-2-ol (6da): Product 6da was prepared 
using  the general procedure to provide a pale yellow oil (97% yield, 89% ee); [α]D24 = +14.2 (c = 
0.8, CH2Cl2); The enantiomeric excess was determined by chiral HPLC analysis: Daicel Chiralpak 
ID column; Hexane/i-PrOH = 99:1; flow rate 0.5 mL/min, 254 nm wave length UV; minor tR = 
14.004 min, major tR = 11.924 min. All characterization data match those reported.30 
 
 
(R)-1,1,1-trifluoro-2-(4-methoxyphenyl)-4-phenylbut-3-yn-2-ol (6ea): Product 6ea was 













The picture can't be displayed.
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+22.7 (c = 0.6, CH2Cl2); The enantiomeric excess was determined by chiral HPLC analysis: Daicel 
Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 mL/min, 254 nm wave length UV; minor 
tR = 12.240 min, major tR = 22.694 min. All characterization data match those reported.29 
 
 
1,1,1-trifluoro-4-phenyl-2-(p-tolyl)but-3-yn-2-ol (6fa): Product 6fa was prepared using the 
general procedure to provide a pale yellow oil (86% yield, 97% ee); [α]D24 = +22.4 (c = 0.6, 
CH2Cl2); The enantiomeric excess was determined by chiral HPLC analysis: Daicel Chiralpak ID 
column; Hexane/i-PrOH = 99:1; flow rate 1 mL/min, 254 nm wave length UV; minor tR = 8.663 
min, major tR = 7.225 min. All characterization data match those reported.29 
 
 
2-(3-bromophenyl)-1,1,1-trifluoro-4-phenylbut-3-yn-2-ol (6ga) : Product 6ga was prepared 
using the general procedure to provide a pale yellow oil (92% yield, 85% ee); [α]D24 = +23.0 (c = 
0.7, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.96 (s, 1H), 7.74 (d, 8 Hz, 1H), 7.53 (m, 3H), 7.35 
(m, 3H), 7.29 (t, 8 Hz, 1H), 3.25 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 137.6, 132.8, 132.2, 130.44, 
129.9, 128.6, 126.1, 125.2, 122.5, 121.4, 120.7, 88.7, 83.8, 73.1, 72.7; 19F NMR (282 MHz, CDCl3) 
δ –80.08; IR (Neat) 3547, 3066, 2233, 1594, 1570, 1490, 1473, 1444, 1423, 1348, 1246, 1168, 
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353.9867, Found: 353.9871. The enantiomeric excess was determined by chiral HPLC analysis: 
Daicel Chiralpak ID column; Hexane/i-PrOH = 99:1; flow rate 0.5 mL/min, 254 nm wave length 
UV; minor tR = 12.137 min, major tR = 11.398 min.  
 
 
1,1,1-trifluoro-2-(2-fluorophenyl)-4-phenylbut-3-yn-2-ol (6ha): Product 6ha was prepared 
using the general procedure to provide a pale yellow oil (70% yield, 87% ee); [α]D24 = +10.6 (c = 
0.2, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.83 (m, 1H), 7.53 (m, 2H), 7.32 (m, 4H), 7.11(m, 
2H), 3.55 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 162.4, 158.9, 132.2, 131.8, 131.7, 129.9, 129.6, 
128.5, 124.3, 124.2, 121.0, 117.0, 116.7, 88.2, 83.1, 72.4, 71.9; 19F NMR (282 MHz, CDCl3) δ –
80.24, –110.69; IR (neat) 3576, 2927, 2235, 1655, 1613, 1585, 1489, 1453, 1377, 1249, 1228, 
1174, 1153, 1120, 1000, 1010, 922, 823, 755, 740, 711, 689;  HRMS (EI) Calcd. for C16H10F4O: 
294.0668, Found: 294.0670; The enantiomeric excess was determined by chiral HPLC analysis: 
Daicel Chiralpak ID column; Hexane/i-PrOH = 99:1; flow rate 1 mL/min, 254 nm wave length 
UV; minor tR = 7.523 min, major tR = 6.467 min.  
 
 
(R)-1,1,1-trifluoro-2-phenyl-4-(p-tolyl)but-3-yn-2-ol (6ab) : Product 6ab was prepared using 
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CH2Cl2); The enantiomeric excess was determined by chiral HPLC analysis: Daicel Chiralpak IB 
column; Hexane/i-PrOH = 98:2; flow rate 1 mL/min, 254 nm wave length UV; minor tR = 12.079 
min, major tR = 8.448 min. All characterization data match those reported.30 
 
 
(R)-4-(4-bromophenyl)-1,1,1-trifluoro-2-phenylbut-3-yn-2-ol (6ac): Product 6ac was prepared 
using general procedure to provide a pale yellow oil (90% yield, 91% ee); [α]D24 = +29.9 (c = 0.7, 
CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.80 (m, 2H), 7.38(m, 7H), 3.19(s, 1H); 13C NMR (75 
MHz, CDCl3) δ 135.1, 133.6, 131.9, 129.7, 128.4, 127.2, 125.3, 124.2, 121.5, 119.9, 87.1, 85.6, 
73.7, 73.3; 19F NMR (282 MHz, CDCl3) δ –80.06; IR (neat) 3566, 2926, 2360, 2234, 1605, 1587, 
1452, 1394, 1361, 1248, 1166, 1116, 1098, 1064, 1012, 932, 906, 822, 761, 729, 696, 668; HRMS 
(EI) Calcd. for C16H10BrF3O: 353.9867, Found: 353.9868; The enantiomeric excess was 
determined by chiral HPLC analysis: Daicel Chiralpak IB column; Hexane/i-PrOH = 98:2; flow 
rate 1 mL/min, 254 nm wave length UV; minor tR = 13.405 min, major tR = 9.004 min. 
 
 
(R)-1,1,1-trifluoro-2-phenyl-4-(p-tolyl)but-3-yn-2-ol (6ae) : Product 6ae was prepared using 
general procedure to provide a pale yellow oil (94% yield, 90% ee); [α]D24 = +26.5 (c = 0.6, 
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column; Hexane/i-PrOH = 98:2; flow rate 1 mL/min, 254 nm wave length UV; minor tR = 10.213 
min, major tR = 7.287 min. All characterization data match those reported.30 
 
 
(R)-1,1,1-trifluoro-4-(4-methoxyphenyl)-2-phenylbut-3-yn-2-ol (6ad): Product 6ad was 
prepared using general procedure to provide a pale yellow oil (99% yield, 93% ee); [α]D24 = +26.7 
(c = 0.2, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 7.81 (m, 2H), 7.41 (m, 5H), 6.86 (m, 2H), 3.83 
(s, 3H), 3.12 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 160.6, 135.6, 133.7, 129.5, 128.3, 127.3, 114.2, 
113.0, 88.3, 83.3, 73.7, 73.2, 55.4, 29.7; 19F NMR (282 MHz, CDCl3) δ –80.19; IR (neat) 3428, 
2923, 2230, 1605, 1570, 1510, 1451, 1359, 1294, 1248, 1172, 1108, 1065, 1016, 933, 907, 832, 
764, 706; HRMS (EI) Calcd. for C17H13F3O2: 306.0868, Found: 306.0869; The enantiomeric 
excess was determined by chiral HPLC analysis: Daicel Chiralpak IB column; Hexane/i-PrOH = 
98:2; flow rate 1 mL/min, 254 nm wave length UV; minor tR = 17.337 min, major tR = 12.175 min.  
 
 
(R)-1,1,1-trifluoro-4-(naphthalen-2-yl)-2-phenylbut-3-yn-2-ol (6af): Product 6af was prepared 
using general procedure to provide a pale orange solid (89% yield, 89% ee); [α]D24 = +2.59 (c = 
0.6, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 8.09 (s, 1H), 7.81 (m, 5H), 7.47 (m, 6H), 3.23 (s, 
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127.9, 127.4, 127.3, 127.0, 125.5, 121.7, 118.3, 88.6, 84.8, 73.8, 73.4, 29.8; 19F NMR (282 MHz, 
CDCl3) δ –80.01; IR (neat) 3528, 3061, 2924, 2853, 2360, 2228, 1595, 1501, 1488, 1450, 1360, 
1226, 1168, 1097, 1063, 1005, 906, 868, 822, 767, 751, 700, 663; HRMS (EI) Calcd. for 
C20H13F3O: 326.0918, Found: 326.0918; The enantiomeric excess was determined by chiral HPLC 
analysis: Daicel Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 mL/min, 254 nm wave 
length UV; minor tR = 16.764 min, major tR = 11.734 min.  
 
 
(R)-2-(4-chlorophenyl)-1,1,1-trifluoro-4-(4-fluorophenyl)but-3-yn-2-ol (6cb) : Product 6cb 
was prepared using general procedure to provide a pale yellow oil (92% yield, 89% ee); [α]D24 = 
+14.6 (c = 0.7, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 7.71 (d, 9 Hz, 2H), 7.49 (m, 2H), 7.40 (m, 
2H), 7.03 (m, 2H), 3.10 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 165.1, 161.7, 135.9, 134.3, 134.2, 
133.8, 128.7, 128.6, 125.2, 121.4, 116.9, 116.2, 115.9, 87.4, 83.8, 73.3, 72.8; 19F NMR (282 MHz, 
CDCl3) δ –80.27, –108.15; IR (neat) 3453, 2928, 2235, 1706, 1652, 1601, 1507, 1491, 1406, 1359, 
1233, 1184, 1121, 1093, 1010, 949, 917, 765, 730, 717, 694; HRMS (EI) Calcd. for C16H9ClF4O: 
328.0278, Found: 328.0278; The enantiomeric excess was determined by HPLC through chiral 
HPLC analysis: Daicel Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 mL/min, 254 nm 










(R)-1,1,1-trifluoro-2-(4-methoxyphenyl)-4-(p-tolyl)but-3-yn-2-ol (6ee): Product 6ee was 
prepared using general procedure to provide a pale yellow oil (92% yield, 96% ee); [α]D24 = +17.5 
(c = 0.5, CH2Cl2); The enantiomeric excess was determined by chiral HPLC analysis: Daicel 
Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 mL/min, 254 nm wave length UV; minor 
tR = 28.064 min, major tR = 9.684 min.  All characterization data match those reported.30 
 
 
(R)-4-cyclopropyl-1,1,1-trifluoro-2-(4-methoxyphenyl)but-3-yn-2-ol (6eg): Product 6eg was 
prepared using general procedure to provide a pale yellow solid (93% yield, 96% ee); [α]D24 = 
+3.84 (c = 0.3, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 7.61 (d, 9 Hz, 2H), 6.89 (m, 2H), 3.82 (s, 
3H), 2.93 (s, 1H), 1.26 (m, 1H), 0.76 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 160.4, 128.6, 127.9, 
125.4, 121.6, 113.5, 92.5, 71.3, 55.4, 8.5; 19F NMR (282 MHz, CDCl3) δ –80.69; IR (neat) 2994, 
2931, 2828, 1605, 1573, 1505, 1458, 1431, 1396, 1345, 1249, 1204, 1078, 970, 923, 818, 781, 
733, 713, 687; HRMS (EI) Calcd. for C14H13F3O2: 270.0868, Found: 270.0868; The enantiomeric 
excess was determined by HPLC through chiral HPLC analysis: Daicel Chiralpak ID column; 
Hexane/i-PrOH = 99:1; flow rate 1 mL/min, 254 nm wave length UV; minor tR = 12.873 min, 













(R)-2-(3-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol (6eh): Product 6eh was 
prepared using general procedure to provide a pale yellow oil (95% yield, 80% ee); [α]D24 = +2.4 
(c = 0.3, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 7.70 (s, 1H), 7.58 (m, 1H), 7.30 (m, 2H), 2.95 
(s, 1H), 1.32 (m, 1H), 0.78 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 137.7, 134.2, 129.6, 129.4, 
127.6, 125.5, 93.2, 72.7, 72.1, 70.6, 29.8, 8.6, 0.6 19F NMR (282 MHz, CDCl3) δ –80.46; IR (neat) 
3458, 3016, 2441, 1597, 1578, 1475, 1428, 1364, 1261, 1165, 1106, 1076, 1027, 943, 925, 884, 
814, 787, 721, 688; HRMS (EI) Calcd. for C13H10ClF3O: 274.0323, Found: 274.0372; The 
enantiomeric excess was determined by chiral HPLC analysis: Daicel Chiralpak IB column; 
Hexane/i-PrOH = 99:1; flow rate 1 mL/min, 254 nm wave length UV; minor tR = 9.858 min, major 
tR = 9.287 min. 
 
1.9.2.5  PROCEDURE FOR ENANTIOSELECTIVE ALKYNYLATION OF VINYL 
TRIFLUOROMETHYL KETONES 
             
               
n = number of reactions. All reactions were set up in a N2-filled glovebox.   To a vial containing 
L1-Ni (8.6n mg, 0.01n mmol, 0.05 equiv) was added KOt-Bu (2.24n mg, 0.02 n mmol, 0.1 equiv) 






H L1-Ni (5 mol %)
KOt-Bu (10 mol %)
4Å MS, THF (0.1 M)
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new 4 dram vial was added 4 Å MS (32 mg) and phenylacetylene (88 µL, 0.8 mmol, 4.0 equiv). 
The L1-Ni + KOt-Bu solution (1.6 mL) was then added to this vial, and the solution was stirred 
for 30 min. The vinyl trifluoromethyl ketone (0.2 mmol, 1.0 equiv) in THF (0.8 mL) was then 
added and the reaction was stirred at 40 °C for 24 h. The reaction was then quenched with sat. 
NH4Cl solution and the aqueous layer was extracted three times with ethyl acetate. The combined 
organic extracts were dried with sodium sulfate and concentrated by rotary evaporator. The crude 
oil was then purified by column chromatography to afford the desired product.  
  
  
(R,E)-1,5-diphenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (11aa). Product 11aa was purified 
by column chromatography (8% EtOAc in hexanes) to provide a colorless oil (51.8 mg, 86% 
yield); 90% ee, [a]D25 +11.8 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.55 (dd, J = 8.0, 1.6 
Hz, 2H), 7.48 (dd, J = 8.3, 1.3 Hz, 2H), 7.45 – 7.27 (m, 6H), 7.21 (d, J = 15.8 Hz, 1H), 6.35 (d, J 
= 15.8 Hz, 1H), 2.91 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 135.8, 135.3, 132.2, 129.7, 129.0, 
128.9, 128.6, 127.4, 123.6 (d, J = 285.3 Hz), 122.4, 121.1, 88.7, 82.7, 72.4 (q, J = 32.9 Hz);19F 
NMR (282 MHz, CDCl3) δ 80.72 IR (Neat Film, NaCl) 3412, 3030, 2924, 1491, 1445, 1249, 1187, 
1130, 1056, 966, 753, 690 cm–1; HRMS (MM) m/z calc’d for C18H12F3 [M-OH]+: 285.0886 found 
285.0883; SFC Conditions: 15% IPA, 2.5 mL/min, Chiralpak OD-H column, λ = 254 nm, tR (min): 









(R,E)-5-phenyl-1-(p-tolyl)-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (11ba):  
Product (11ba) was prepared using general procedure and purified by column chromatography 
(10% EtOAc in hexanes) to provide a colorless oil (62.2 mg, 98% yield); 92% ee, [a]D25 +8.5 (c 
0.99, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.55 (dd, J = 8.0, 1.6 Hz, 2H), 7.46 – 7.32 (m, 5H), 
7.23 – 7.15 (m, 3H), 6.31 (d, J = 15.8 Hz, 1H), 2.96 (s, 1H), 2.38 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 139.1, 135.7, 132.5, 132.2, 129.63, 129.55, 128.6, 127.3, 123.6 (q, J = 285.3 Hz), 121.3, 
121.1, 88.7, 82.8, 72.5 (q, J = 32.8 Hz); 19F NMR (282 MHz, CDCl3) δ –80.72; IR (Neat Film, 
NaCl) 3412, 2924, 1654, 1515, 1491, 1444, 1361, 1249, 1186, 1131, 1054, 968, 797, 756, 727, 
689 cm–1; HRMS (MM) m/z calc’d for C19H14F3 [M-OH]+:  299.1042 found 299.1041; SFC 
Conditions: 6% IPA, 2.5 mL/min, Chiralpak OD-H column, λ = 254 nm, tR (min): major = 14.12, 
minor = 15.02. 
 
 
(R,E)-1-(4-methoxyphenyl)-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (11ca): Product 
(11ca) was prepared using general procedure and purified by column chromatography (10% 
EtOAc in hexanes) to provide a colorless oil (63.9 mg, 98% yield); 92% ee, [a]D25 +7.7 (c 0.97, 
CHCl3); 1H NMR (400 MHz, CDCl3 δ 7.58 – 7.50 (m, 2H), 7.46 – 7.32 (m, 5H), 7.15 (d, J = 15.8 
Hz, 1H), 6.94 – 6.85 (m, 2H), 6.20 (dd, J = 15.8, 0.7 Hz, 1H), 3.83 (s, 3H), 2.92 (s, 1H); 13C NMR 
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114.3, 88.6, 82.9, 72.5 (q, 32.8 Hz), 55.5; 19F NMR (282 MHz, CDCl3) δ –80.73; IR (Neat Film, 
NaCl) 3411, 2936, 2840, 1654, 1608, 1513, 1466, 1444, 1422, 1250, 1176, 1132, 1106, 1059, 967, 
850, 824, 803, 757, 728, 690 cm–1; HRMS (MM) m/z calc’d for C19H14F3O [M-OH]+: 315.0991 
found 315.0993; SFC Conditions: 15% IPA, 2.5 mL/min, Chiralpak OD-H column, λ = 254 nm, 
tR (min): major = 5.17, minor = 5.42. 
 
 
(R, E)-1-(4-fluorophenyl)-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (11da):  
Product 11da was prepared using general procedure and purified by column chromatography (8% 
EtOAc in hexanes) to provide a colorless oil (61.7 mg, 92% yield); 91% ee, [a]D25 +12.0 (c 1.0, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.54 (dd, J = 8.1, 1.6 Hz, 2H), 7.45 (dd, J = 8.7, 5.3 Hz, 
2H), 7.42 – 7.34 (m, 3H), 7.16 (d, J = 15.8 Hz, 1H), 7.06 (t, J = 8.7 Hz, 2H), 6.25 (d, J = 15.8 Hz, 
1H), 2.92 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 164.4, 161.9, 134.6, 132.2, 131.5 (q, J = 3.3 
Hz), 129.7, 129.1 (d, J = 8.2 Hz)  128.6, 125.0, 122.2, 121.0, 116.0, 115.8, 88.8, 82.7, 72.3 (q, J = 
32.9 Hz); 19F NMR (282 MHz, CDCl3) δ –80.76, –112.35; IR (Neat Film, NaCl) 3401, 3056, 2927, 
1602, 1510, 1492, 1444, 1362, 1234, 1187, 1159, 1130, 1094, 1055, 967, 854, 826, 808, 757, 728, 
690 cm–1; HRMS (MM) m/z calc’d for C18H11F4 [M-OH]+: 303.0791 found 303.0794; SFC 
Conditions: 20% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): major = 7.83, 










(R, E)-1-(4-bromophenyl)-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (11ea): 
Product 11ea was prepared using general procedure and purified by column chromatography (15% 
Et2O in hexanes) to provide a colorless oil (70.8 mg, 93% yield); 90% ee, [a]D25 –0.6 (c 0.98, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.59 – 7.46 (m, 4H), 7.45 – 7.31 (m, 5H), 7.13 (d, J = 15.8 
Hz, 1H), 6.32 (d, J = 15.8 Hz, 1H), 2.93 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 134.5, 134.2, 
132.2, 132.0, 129.8, 128.9, 128.6, 123.5 (q, J = 285.4 Hz), 123.1, 123.0, 120.9, 88.9, 82.5, 72.3 (q, 
J = 33.0 Hz); 19F NMR (282 MHz, CDCl3) δ –80.71; IR (Neat Film, NaCl) 3400, 1489, 1248, 
1187, 1130, 1056, 1010, 967, 816, 756, 690 cm–1; HRMS (MM) m/z calc’d for C18H11BrF3O [M-
OH]+: 362.9991 found 362.9984; SFC Conditions: 8% IPA, 2.5 mL/min, Chiralpak OD-H column, 




(11fa) Product 11fa was prepared using general procedure and purified by column 
chromatography (15% EtOAc in hexanes) to provide a colorless oil (65.9 mg, 82% yield); 89% 
ee, [a]D25 –10.4 (c 0.95, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.97 (d, J = 8.4 Hz, 2H), 7.58 – 
7.47 (m, 4H), 7.45 – 7.32 (m, 3H), 7.22 (d, J = 15.8 Hz, 1H), 6.41 (d, J = 15.8 Hz, 1H), 2.95 (s, 
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128.6, 127.1, 125.0, 124.8, 123.5 (q, J = 285.5 Hz), 88.7, 82.6, 81.6, 72.2 (q, J = 32.9 Hz), 28.3; 
19F NMR (282 MHz, CDCl3) δ –80.66 IR (Neat Film, NaCl) 3402, 2979, 1711, 1691, 1608, 1478, 
1492, 1445, 1394, 1370, 1317, 1299,1250, 1184, 1127, 1070, 1018, 972, 846, 757, 691, 613 cm–1; 
HRMS (MM) m/z calc’d for C23H20F3O2 [M-OH]+: 385.1410 found 385.1409; SFC Conditions: 




Product 11ga was prepared using general procedure and purified by column chromatography (8% 
EtOAc in hexanes) to provide a colorless oil (61.2 mg, 97% yield); 90% ee, [a]D25 +8.5 (c 0.88, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.53 (dd, J = 8.0, 1.6 Hz, 2H), 7.43 – 7.31 (m, 3H), 7.30 – 
7.21 (m, 3H), 7.17 (d, J = 15.8 Hz, 1H), 7.13 (d, J = 6.8 Hz, 1H), 6.32 (d, J = 15.8 Hz, 1H), 2.93 
(s, 1H), 2.36 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 138.5, 135.9, 135.2, 132.2, 129.8, 129.7, 
128.8, 128.6, 128.0, 126.1 (q, J = 229.9 Hz), 124.6, 122.2, 121.1, 88.7, 82.8, 72.5 (q, J = 32.8 Hz), 
21.5; 19F NMR (282 MHz, CDCl3) δ –80.7; IR (Neat Film, NaCl) 3407, 2924, 1490, 1444, 1379, 
1252, 1186, 1130, 1055, 1000, 966, 918, 844, 778, 756, 726, 689, 629 cm–1; HRMS (MM) m/z 
calc’d for C19H14F3 [M-OH]+: 299.1042 found 299.1045; SFC Conditions: 15% IPA, 2.5 mL/min, 










Product 11ha was prepared using general procedure and purified by column chromatography (8% 
EtOAc in hexanes) to provide a colorless oil (57.8 mg, 92% yield); 86% ee, [a]D25 +15.4 (c 0.87, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.57 – 7.46 (m, 4H), 7.45 – 7.33 (m, 3H), 7.25 – 7.16 (m, 
3H), 6.24 (d, J = 15.7 Hz, 1H), 2.93 (s, 1H), 2.42 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 136.4, 
134.5, 133.8, 132.2, 130.6, 129.7, 128.8, 128.6, 126.4, 126.3, 123.7, 123.6 (q, J = 285.3 Hz), 121.1, 
88.7, 82.9, 72.6 (q, J = 32.8 Hz), 19.9; 19F NMR (282 MHz, CDCl3) δ –80.73; IR (Neat Film, 
NaCl) 3411, 3061, 2926, 1600, 1490, 1462, 1444, 1381, 1261, 1248, 1185, 1133, 1098, 1058, 
1000, 967, 817, 753, 690, 628 cm–1; HRMS (MM) m/z calc’d for C19H14F3 [M-OH]+: 299.1042 
found 299.1043; SFC Conditions: 15% IPA, 2.5 mL/min, Chiralpak OD-H column, λ = 254 nm, 




Product 11ia was prepared using general procedure and purified by column chromatography (12% 
EtOAc in hexanes) to provide a colorless oil (59.6 mg, 92% yield); 86% ee, [a]D25 +19.5 (c 0.97, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.58 – 7.50 (m, 3H), 7.48 (d, J = 7.7 Hz, 1H), 7.43 – 7.33 
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Hz, 1H), 3.88 (s, 3H), 2.88 (s, 1H). 13C NMR (101 MHz, CDCl3) δ 157.5, 132.2, 131.0, 130.1, 
129.6, 128.6, 128.1, 123.6 (q, J = 285.2 Hz), 124.2, 123.0, 121.3, 120.8, 111.4, 111.2,  88.6, 83.0, 
72.8 (q, J = 32.7 Hz), 55.7; 19F NMR (282 MHz, CDCl3) δ –80.66; IR (Neat Film, NaCl) 3429, 
2940, 2360, 2237, 1599, 1490, 1465, 1248, 1185, 1136, 1103, 1048, 971, 754, 690 cm–1; HRMS 
(MM) m/z calc’d for C19H14F3O [M-OH]+: 315.09860 found 315.09993; SFC Conditions: 15% 
IPA, 2.5 mL/min, Chiralpak OD-H column, λ = 254 nm, tR (min): major = 4.95, minor = 5.67. 
 
 
(R,E)-1-(4-bromophenyl)-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (11ja):  
Product 11ja was prepared using general procedure and purified by column chromatography (15% 
Et2O in hexanes) to provide a colorless oil (52 mg, 89% yield); 90% ee, [a]D25 –7.42 (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 8.2 Hz, 2H), 7.45 – 7.32 (m, 4H), 6.99 (d, J = 15.6 Hz, 
1H), 6.42 (m, 2H), 6.29 (d, J = 15.6 Hz, 1H), 2.85 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 151.1, 
143.3, 132.2, 129.7, 128.6, 123.5 (q, J = 285.3 Hz), 123.5, 121.0, 120.6, 111.8, 111.2, 88.6, 82.6, 
72.2 (q, J = 33.1 Hz); 19F NMR (282 MHz, CDCl3) δ –80.78;  IR (Neat Film, NaCl) 3429, 3060, 
2926, 1661, 1600, 1564, 1491, 1445, 1400, 1300, 1266, 1249, 1188, 1154, 1127, 1056, 1016, 1000, 
960, 928, 884, 844, 804, 757, 742, 728, 690, 673, 654, 612 cm–1; HRMS (MM) m/z calc’d for 
C16H10F3O [M-OH]+: 275.0678 found 275.0668; SFC Conditions: 15% IPA, 2.5 mL/min, 










(R,E)-5-phenyl-1-(thiophen-2-yl)-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (11ka): Product 
11ka was prepared using general procedure and purified by column chromatography (8% EtOAc 
in hexanes) to provide a colorless oil (51.8 mg, 84% yield); 90% ee, [a]D25 +25.8 (c 0.88, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.54 (dd, J = 8.0, 1.5 Hz, 2H), 7.45 – 7.30 (m, 5H), 7.28 (dd, J = 
4.8, 1.5 Hz, 1H), 7.21 (d, J = 15.7 Hz, 1H), 6.20 (d, J = 15.7 Hz, 1H), 2.94 (s, 1H);13C NMR (101 
MHz, CDCl3) δ 137.9, 132.2, 129.8, 129.7, 128.6, 126.7, 125.2, 125.0, 122.1, 121.0, 88.7, 82.7, 
72.4 (q, J = 32.9 Hz); 19F NMR (282 MHz, CDCl3) δ –80.78; IR (Neat Film, NaCl) 3406, 2924, 
1656, 1491, 1444, 1358, 1308, 1249, 1186, 1126, 1054, 1000, 964, 868, 775, 757, 725, 690, 606 
cm–1; HRMS (MM) m/z calc’d for C16H10F3S [M-OH]+: 291.045 found 291.045; SFC Conditions: 





Product 11la was prepared using general procedure and purified by column chromatography (30% 
EtOAc in hexanes) to provide a yellow oil (32.2 mg, 63% yield); 96% ee, [a]D25 +4.2 (c 0.95 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 7.8 Hz, 1H), 7.48 (d, J = 8.1 Hz, 2H), 7.30 
(dd, J = 11.5, 4.2 Hz, 4H), 7.26 – 7.19 (m, 2H), 7.18 – 7.12 (m, 2H), 6.22 (d, J = 15.8 Hz, 1H), 
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121.4, 120.6, 120.3, 117.6, 111.9, 88.6, 83.3, 73.13 (q, J = 32.8 Hz), 33.1, 29.9; 19F NMR (282 
MHz, CDCl3) δ –80.83; IR (Neat Film, NaCl) 3382, 2922, 1651, 1535, 1491, 1444, 1378, 1333, 
1255, 1184, 1125, 1060, 960, 787, 758, 741, 691, 645 cm–1; HRMS (MM) m/z calc’d for 
C21H15F3N [M-OH]+: 338.1151 found 338.1151; SFC Conditions: 30% IPA, 2.5 mL/min, 
Chiralpak AD-H column, λ = 254 nm, tR (min): major = 6.29, minor = 7.80. 
 
 
(R, E)-1-(naphthalen-2-yl)-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (11ma): 
 Product 11ma was prepared using general procedure and purified by column chromatography 
(10% EtOAc in hexanes) to provide a colorless oil (67.7 mg, 96% yield); 92% ee, [a]D25 +13.8 (c 
1.0, CHCl3); 1H NMR (400 MHz, CDCl3)  δ 7.90 – 7.80 (m, 4H), 7.66 (dd, J = 8.7, 1.6 Hz, 1H), 
7.58 (d, J = 6.3 Hz, 2H), 7.50 (d, J = 9.4 Hz, 2H), 7.46 – 7.34 (m, 4H), 6.47 (d, J = 15.8 Hz, 1H), 
2.98 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 135.9, 133.7, 133.5, 132.7, 132.2, 129.7, 128.62, 
128.60, 128.3, 128.2, 127.9, 126.7, 126.6, 123.2 (q, J = 110.0 Hz), 88.8, 82.8, 72.5 (q, J = 32.9 
Hz); 19F NMR (282 MHz, CDCl3) δ –80.62; IR (Neat Film, NaCl) 3400, 3057, 1652, 1491, 1444, 
1361, 1252, 1186, 1126, 1054, 965, 894, 843, 810 cm–1; HRMS (MM) m/z calc’d for C18H11BrF3O 
[M-OH]+: 335.1042 found 335.1043; SFC Conditions: 8% IPA, 2.5 mL/min, Chiralpak IC column, 










(R,4E,6E)-1,7-diphenyl-3-(trifluoromethyl)hepta-4,6-dien-1-yn-3-ol (11na): Product 11na 
was prepared using general procedure and purified by column chromatography (8% EtOAc in 
hexanes) to provide a colorless oil (28.1 mg, 43% yield); 91% ee, [a]D25 +11.3 (c 0.67, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.54 (dd, J = 8.0, 1.6 Hz, 2H), 7.47 – 7.26 (m, 8H), 6.99 (dd, J = 
14.9, 10.4 Hz, 1H), 6.86 (dd, J = 15.4, 10.5 Hz, 1H), 6.74 (d, J = 15.5 Hz, 1H), 5.95 (d, J = 14.9 
Hz, 1H), 2.85 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 136.6, 136.5, 135.9, 132.2, 129.7, 128.9, 
128.6, 128.4, 126.9, 126.7, 125.6, 123.5 (q, J = 285.3 Hz), 121.1, 88.6, 82.7, 72.3 (q, J = 33.0 Hz); 
19F NMR (282 MHz, CDCl3) δ –80.78; IR (Neat Film, NaCl) 3396, 3027, 2922, 2850, 1644, 1491, 
1447, 1253, 1186, 1127, 1051, 990, 974, 828, 756, 726, 690 cm–1; HRMS (MM) m/z calc’d for 
C20H14F3 [M-OH]+: 311.1042 found 311.1037; SFC Conditions: 35% IPA, 2.5 mL/min, Chiralpak 
AD-H column, λ = 254 nm, tR (min): major = 3.3, minor =4.4. 
 
 
1.9.3  UV-VIS DATA FOR METAL TITRATION 
 
A sample solution containing L1-Ni (20 M) and different amounts of KOt-Bu (0, 1, 2, 5, 7, 10, 12, 
15, 17, 20, 25, 30, 35, 40, 45, 50, 60, and 70 M) prepared in dry THF, respectively. After incubation 
for 30 min at room temperature, UV-Vis spectra were recorded at 25 °C and each measurement 























 A solution of L1-Ni (40 M) in THF was mixed with solutions of KOtBu in THF (40 M) at varying 
ratios. After incubation for 30 min at room temperature, UV-Vis spectra were recorded at 25 °C 
and each measurement was repeated thrice. 
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Association constant for the binding of L1-Ni and K+ 
The program DynaFit was used for non-linear regression fitting of the titration data based on 
absorbance changes observed at 403 nm. From the result of Job plot, the fitting of titration data 
were performed as a 1:1 binding mode. The DynaFit scripts for the binding models used are 
provided below. 
[task] 
   task = fit 
   data = equilibria 
[mechanism] 
   L + M <==> LM : K1 association 
[constants] 
   K1 = 0.5? 
[concentrations] 
   L = 20 




   L = 0.0092? 
   LM = 0.0125 
[data] 
   variable M 
   file C:\./Users/skang/Desktop/dynafit4-win/DynaFit4/input/titration.txt     
[output] 













The association constant for the binding of L1-Ni and K+ ion. Ka = 6.6 × 105 M- 
 
 




1.10 NOTES AND REFERENCES 
1. Zhou, Y.; Wang, J.; Gu, Z.; Wang, S.; Zhu, W.; Aceña, J. L.; Soloshonok, V. A.; Izawa, 
K.; Liu, H. Chem. Rev. 2016, 116, 422–518. 
2. (a) Although both CF3 and iPr groups possess very different van der Waals radii (iPr = 56.2 
Å3), their A-values are nearly identical, which is why they are considered isosteric. For 
more information see: Tredwell, M.; Gouverneur, V. Fluorine in Medicinal Chemistry: 
Importance of Chirality. Comprehensive Chirality, Yamamoto, H.; Carreira, E., Eds.; 
Elsevier Ltd. 2012; Vol. 1, pp 70–85. (b) (a) Nie, J.; Guo. H.–C.; Cahard. D.; Ma, J. –A. 
Chem. Rev. 2011, 455–529. (b) Noda, H.; Kumagai, N.; Shibasaki, M. Asian J. Org. Chem. 
2018, 7, 599–612. 
3. Vrouenraets, S. M. E.; Wit, F. W. N. M.; Tongeren, J. V.; Lange, J. M. A. 2007, 8, 851–
871.   
4. For examples of enantioselective alkynylation of aldehydes, see: (a) Anand, N. K.; 
Carreira, E. M. J. Am. Chem. Soc. 2001, 123, 9687–9688.  (b) Li, X.; Lu, G.; Kwok, W. 
H.; Chan, A. S. C. J. Am. Chem. Soc. 2002, 124, 12636–12637. (c) Takita, R.; Yakura, K.; 
Ohshima, T.; Shibasaki, M. J. Am. Chem. Soc. 2005, 127, 13760–13761. (d) Wolf, C.; Liu, 
S. J. Am. Chem. Soc. 2006, 128, 10996–10997. (e) Trost, B. M.; Weiss, A. H. J. Am. Chem. 
Soc. 2006, 128, 8–9. (f) Asano, Y.; Hara, K.; Ito, H. Org. Lett. 2007, 9, 3901–3904. (g) Ito, 
J.–I.; Asai, R.; Nishiyama, H. Org. Lett. 2010, 12, 3860–3862. (h) Trost, B. M.; Quintard, 
A. Angew. Chem. Int. Ed. 2012, 51, 6704–6708, and Angew. Chem. 2012, 124, 6808–6812. 
(i) Trost, B. M.; Burns, A. C.; Bartlett, M. J.; Tautz, T.; Weiss, A. H. J. Am. Chem. Soc. 
Chapter 1: Enantioselective Alkynylation of Trifluoromethyl Ketones Catalyzed by Cation-Binding Salen 
Nickel Complexes 
56 
2012, 134, 1474–1477. (j) Trost, B. M.; Bartlett, M. J.; Weiss, A. H.; von Wangelin, A. J.; 
Chan, V. S. Chem.– Eur. J. 2012, 18, 16498–16509. (k) Song, T.; Zheng, L-S.; Ye, F.; 
Deng, W.–H.; Wei, Y.– L.; Jiang, K–Z.; Xu, L–W. Adv. Synth. Catal. 2014, 356, 1708–
1718. 
5. For examples of enantioselective alkynylation of imines, see: (a) Morisaki, K.; Sawa, M.; 
Nomaguchi, J.-Y.; Morimoto, H.; Takeuchi, Y.; Mashima, K.; Ohshima, T. Chem. Eur. J. 
2013, 19, 8417–8420. (b) de Armas, P.; Tejedor, D.; García–Tellado, F. Angew. Chem. Int. 
Ed. 2010, 49, 1013–1016 and Angew. Chem. 2010, 122, 1029–1032. (c) Morisaki, K.; 
Sawa, M.; Yonesaki, R.; Morimoto, H.; Mashima, K.; Ohshima, T. J. Am. Chem. Soc. 2016, 
138, 6194–6203. (d) Liu, R.–R.; Zhu, L.; Hu, J.–P.; Lu, C.–J.; Gao, J.–R.; Lan, Y.; Jia, Y.–
X. Chem. Commun. 2017, 53, 5890–5893.  
6. For examples of enantioselective alkynylation of ketones see: (a) Cozzi, P.G. Angew. 
Chem. Int. Ed. 2003, 42, 2895–2898 and Angew. Chem. 2003, 115, 3001–3004. (b) Zhou, 
Y.; Wang, R.; Xu, Z.; Yan, W.; Liu, L.; Kang, Y.; Han, Z. Org. Lett. 2004, 23, 4147–4149. 
(b) Lu, G.; Li, X.; Li, Y.-M.; Kwong, F. Y.; Chan, A. S. C. Adv. Synth. Catal. 2006, 348, 
1926–1933. (c) Lu, G.; Li, X.; Jia, X.; Chan, W. L.; Chan, A. S. C. Angew. Chem. Int. Ed. 
2003, 42, 5057–5058 and Angew. Chem. 2003, 115, 5211–5212. (d) Lu, G.; Li, Y.–M.; Li, 
X.–S.; Chan, A. S. C. Coord. Chem. Rev. 2005, 249, 1736–1744. (e) Liu, L.; Wang, R.; 
Kang, Y.–F.; Chen, C.; Xu, Z.–Q.; Zhou, Y.–F.; Ni, M.; Cai, H.–Q.; Gong, M.–Z. J. Org. 
Chem. 2005, 70, 1084–1086. (f) Chen, C.; Hong, L.; Xu, Z. Q.; Liu, L.; Wang, R. Org. 
Lett. 2006, 8, 2277–2280. 
Chapter 1: Enantioselective Alkynylation of Trifluoromethyl Ketones Catalyzed by Cation-Binding Salen 
Nickel Complexes 
57 
7. For alkynylation of trifluoromethyl ketones: (a) Motoki, R.; Kanai, M.; Shibasaki, M. Org. 
Lett. 2007, 9, 2997–3000. (b) Zhang, G.-W.; Meng, W.; Ma, H.; Nie, J.; Zhang, W.–Q.; 
Ma, J.–A. Angew. Chem. Int. Ed. 2011, 50, 3538–3542 and Angew. Chem. 2011, 123, 
3600–3604.  (c) Ohshima, T.; Kawabata, T.; Takeuchi, Y.; Kakinuma, T.; Iwasaki, T.; 
Yonezawa, T.; Murakami, H.; Nishiyama, H.; Mashima, K. Angew. Chem., Int. Ed. 2011, 
50, 6296–6300. (d) Dhayalan, V.; Murakami, R.; Hayashi, M. Asian J. Chem. 2013, 25, 
7505–7508.  (e) Cook, A. M.; Wolf, C. Angew. Chem. Int. Ed. 2016, 55, 2929–2933 and 
Angew. Chem. 2016, 128, 2982–2986. (f) Ito, J.–I.; Ubukata, S.; Muraoka, S.; Nishiyama, 
H. Chem. Eur. J. 2016, 22, 16801–16804. (g) Zheng, Y.; Harms, K.; Zhang, L.; Meggers, 
E. Chem. Eur. J. 2016, 22, 11977–11981. (h) Zheng, Y.; Zhang, L.; Meggers, E. Org. 
Process Res. Dev. 2018, 22, 103–107. (i) Chen, S.; Zheng, Y.; Cui, T.; Meggers, E.; Houk, 
K. N. J. Am. Chem. Soc. 2018, 140, 5146–5152. (j) Cui, T.; Qin, J.; Harms, K.; Meggers, 
E. Eur. J. Inorg. Chem. 2019, 195–198.  (k) For a racemic example, see: Czerwinski, P.; 
Molga, E.; Cavallo, L.; Poater, A.; Michalak, M. Chem. Eur. J. 2016, 22, 8089–8094. For 
alkenylation and phenylation of trifluoromethyl ketones: (l) Motoki, R.; Tomita, D.; Kanai, 
M.; Shibasaki, M. Tetrahedron Lett. 2006, 47, 8083–8086. 
8. For alkynylation of trifluoromethyl b-ketoesters: (a) Aikawa, K.; Hioki, Y.; Mikami, K. 
Org. Lett. 2010, 12, 5716-5719. (b) Wang, T.; Niu, J.–L.; Liu, S.L.; Huang, J.–J.; Gong, 
J.–F.; Song, M.–P. Adv. Synth. Catal. 2013, 355, 927–937. 
9. (a) Park, J.; Hong, S. Chem. Soc. Rev. 2012, 41, 6931-6943. (b) DiMauro, E. F.; Kozlowski, 
M. C. Org. Lett. 2001, 3, 1641-1644. (c) Handa, V.; Gnanadesikan, S.; Matsunaga, S.; 
Shibasaki, M. J. Am. Chem. Soc. 2007, 129, 4900-4901. (d) Chen, Z.; Morimoto, S.; 
Chapter 1: Enantioselective Alkynylation of Trifluoromethyl Ketones Catalyzed by Cation-Binding Salen 
Nickel Complexes 
58 
Matsunaga, S.; Shibasaki, M. J. Am. Chem. Soc. 2008, 130, 2170-2171. (e) Mitsunuma, 
H.; Matsunga, S. Chem. Commun. 2011, 47, 469-471. (f) Shepherd, N. E.; Tanabe, H.; Xu, 
Y.; Matsunaga, S.; Shibasaki, M. J. Am. Chem. Soc. 2010, 132, 3666-3667. (g) Yingjie, 
X.; Matsunaga, S.; Shibasaki, M. Org. Lett. 2010, 12, 3246-3249. (h) Matsunaga, S.; 
Shibasaki, M. Synlett, 2009, 10, 1635-1638. (i) Lang, K.; Park, J.; Hong, S. Angew. Chem. 
Int. Ed. 2012, 51, 1620–1624 and Angew. Chem. 2012, 124, 1652–1656. (j) Park, J.; Lang, 
K.; Abboud, K. A.; Hong, S. Chem.–Eur. J. 2011, 17, 2236–2245. (k) Park, J.; Lang, K.; 
Abboud, K. A.; Hong, S. J. Am. Chem. Soc. 2008, 130, 16484–16485. (l) Shibasaki, M.; 
Sasai, H.; Arai, T. Angew. Chem. Int. Ed. 1997, 36, 1236–1256.  
10. For the use of chiral crown-ether type catalysts, see: (a) Cram, D. J.; Sogah, G. D. Y. J. 
Chem. Soc., Chem. Commun. 1981, 625–628. (b) Brak, K.; Jacobsen, E. N. Angew. Chem. 
Int. Ed. 2013, 52, 534–561 and Angew. Chem. 2013, 125, 558–588. (c) Oliveira, M. T.; 
Lee, J.–W. Chem. Cat. Chem. 2017, 9, 377–384. (d) Akiyama, T.; Hara, M.; Fuchibe, K.; 
Sakamoto, S.; Yamaguchi, K. Chem. Commun. 2003, 1734–1735. (e) Yan, H.; Jang, H. B.; 
Lee, J.–W.; Kim, H. K.; Lee, S. W.; Yang, J. W.; Song, C. E. Angew. Chem., Int. Ed. 2010, 
49, 8915−8917 and Angew. Chem. 2010, 122, 9099–9101. (f) Yan, H.; Oh, J. S.; Lee, J.–
W.; Song, C. E. Nat. Commun. 2012, 3, 1212. (g) Park, S. Y.; Lee, J.–W.; Song, C. E. Nat. 
Commun. 2015, 6, 7512. (h) Li, L.; Liu, Y.; Peng, Y.; Yu, L.; Wu, X.; Yan, H. Angew. 
Chem. Int. Ed. 2016, 55, 331–335 and Angew. Chem. 2016, 128, 339–343. (i) Liu, Y.; Ao, 
J.; Paladhi, S.; Song, C. E.; Yan, H. J. Am. Chem. Soc. 2016, 138, 16486–16492. (j) 
Vaithiyanathan, V.; Kim, M. J.; Liu, Y.; Yan, H.; Song, C. E. Chem. –Eur. J. 2017, 23, 
1268−1272. (k) Kim, M. J.; Xue, L.; Liu, Y.; Paladhi, S.; Park, S. J.; Yan, H.; Song, C. E. 
Chapter 1: Enantioselective Alkynylation of Trifluoromethyl Ketones Catalyzed by Cation-Binding Salen 
Nickel Complexes 
59 
Adv. Synth. Catal. 2017, 359, 811−823. (l) Yu, L.; Wu, X.; Kim, M. J.; Vaithiyanathan, V.; 
Liu, Y.; Tan, Y.; Qin, W.; Song, C. E.; Yan, H. Adv. Synth. Catal. 2017, 359, 1879–1891. 
(m) Park, S. Y.; Hwang, I.–S.; Lee, H.–J.; Song, C. E. Nat. Commun. 2017, 8, 14877. (n) 
Tan, Y.; Luo, S.; Li, D.; Zhang, N.; Jia, S.; Liu, Y.; Qin, W.; Song, C. E.; Yan, H. J. Am. 
Chem. Soc. 2017, 139, 6431–6436. (o) Duan, M.; Liu, Y.; Ao, J.; Xue, L.; Luo, S.; Tan, 
Y.; Qin, W.; Song, C. E.; Yan, H. Org. Lett. 2017, 19, 2298−2301. (p) Paladhi, S.; Liu, Y.; 
Kumar, B. S.; Jung, M.-J.; Park, S. Y.; Yan, H.; Song, C. E. Org. Lett. 2017, 19, 
3279−3282. (q) Paladhi, S.; Park, S. Y.; Yang, J. W.; Song, C. E. Org. Lett. 2017, 19, 
5336–5339. (r) Paladhi, S.; Hwang, I.–S.; Yoo, E. J.; Ryu, D. H.; Song, C. E. Org. Lett. 
2018, 20, 2003−2006. (s) Liu, Y.; Liu, S.; Li, D.; Zhang, N.; Peng, L.; Ao, J.; Song, C. E.; 
Lan, Y.; Yan, H. J. Am. Chem. Soc. 2019, 141, 1150−1159. 
11.  For the use of ligands with pendant crown ethers in transition metal-catalysis, see: (a) 
Sawamura, M.; Nagata, H.; Sakamoto, H.; Ito, Y. J. Am. Chem. Soc. 1992, 114, 2586–
2592.  (b) Trost, B. M.; Radinov, R. J. Am. Chem. Soc. 1997, 119, 5962–5963. (c) 
Dinuclear Schiff-base catalysts: (d) Matsunaga, S.; Shibasaki, M. Chem. Commun., 2014, 
50, 1044–1057. (e) Chen. Z.; Morimoto, H.; Matsunaga, S.; Shibasaki, M. J. Am. Chem. 
Soc. 2008, 130, 2170–2171. (f) Xu, Y.; Lin, L.; Kanai, M.; Matsunaga, S.; Shibasaki, M. 
J. Am. Chem. Soc. 2011, 133, 5791–5793.   
12. Yang, D.; Wang, L.; Han, F.; Zhao, D.; Zhang, B.; Wang, R. Angew. Chem. Int. Ed. 2013, 
52, 6739–6742 and Angew. Chem. 2013, 125, 6871–6874.  
13. Personal communication 
14. Cai, Z.; Xiao, D.; Do, L. H. J. Am. Chem. Soc. 2015, 137, 15501–15510.  
Chapter 1: Enantioselective Alkynylation of Trifluoromethyl Ketones Catalyzed by Cation-Binding Salen 
Nickel Complexes 
60 
15. See Materials and Methods Section for more details. 
16. Bi, W.-Y.; Lü, X.-Q.; Chai, W.-L.; Song, J.-R.; Wong, W.-Y.; Wong, W.-K.; Jones, R. A. 
Journal of Molecular Structure 2008, 891, 450-455. 
17. Pärssinen, A.; Luhtanen, T.; Pakkanen, T.; Leskelä, M.; Repo, T. European Journal of In
organic Chemistry 2010, 2010, 266-274. 
18.  Moreno, M.; Elgaher, W. A.; Herrmann, J.; Schläger, N.; Hamed, M. M.; Baumann, S.; M
üller, R.; Hartmann, R. W.; Kirschning, A. Synlett, 2015, 26, 1175–1178.   
19. Vazquez-Molina, D.; Pope, G. M.; Ezazi, A. A.; Mendoza-Cortes, J. L.; Harper, J. H.; Uri
be-Romo, F. J. Chem. Commun. 2018, 54, 6947–6950.   
20. Zhang, H-C.; Huang, W-S.; Pu, L. J. Org. Chem. 2001, 66, 481-487. 
21. Mechler, M.; Latendorf, K.; Frey, W.; Peters, R. Organometallics 2013, 32, 112-130. 
22. Kelly, CB.; Mercadante, MA.; Hamlin, TA.; Fletcher, MH. J. Org. Chem. 2012, 77, 8131
-814. 
23. Zheng, C.; Li, Y.; Yang. Y.; Wang, H.; Cui, H.; Zhang, J.; Zhao, G. Adv. Synth. and Cata
l. 2009, 351, 1685–1691.  
24. Ortega, A.; Manzano, R.; Uria, U.; Carrillo, L.; Reyes, E.; Tejero, T.; Merino, P.; Vicario, 
J. L. Angew. Chem. Int. Ed. 2018, 57, 8225–8229. 
25. Wang, Y.; Han, J.; Chen, J.; Weiguo, C. Tetrahedron, 2015, 71, 8256–8262. 
26. Sasaki, S.; Yamauchi, T.; Higashiyama, K. Tetrahedron Lett. 2010, 51, 2326–2328. 
27. Nenajdenko, V. G.; Krasovsky, A. L.; Lebedev, M. V.; Balenkova, E. S. Synlett, 1997, 12
, 1349–1350. 
28. Sanz-Marco, A.; Blay, G.; Muñoz, M. C.; Pedro, J. R. Chem. Commun. 2015, 51, 8958–8
961.  
29. Motoki, R.; Kanai, M.; Shibasaki, M. Org. Lett. 2007, 9, 2997-3000. 
30. Zhang, G.-W.; Meng, W.; Ma, H.; Nie, J.; Zhang, W.-Q.; Ma, J.-A. Angew. Chem. Int. E. 











Spectra Relevant to Chapter 1: 
Enantioselective Alkynylation of Trifluoromethyl Ketones Catalyzed by 




















































A1.3  13C NMR (101 MHz, CDCl3) of compound SI2. 
 
 
A1.2 Infrared spectrum (Thin Film, NaCl) of compound SI2. 
 
























































A1.6 13C NMR (101 MHz, CDCl3) of compound 10f. 
 
 
A1.5 Infrared spectrum (Thin Film, NaCl) of compound 10f. 
 







             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
     

















A1.7 19F NMR (282 MHz, CDCl3) of compound 10f. 
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A1.10  13C NMR (101 MHz, CDCl3) of compound 11aa. 
 
 
A1.9 Infrared spectrum (Thin Film, NaCl) of compound 11aa. 
 
 





A1.11  19F NMR (282 MHz, CDCl3) of compound 11aa. 
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A1.14 13C NMR (101 MHz, CDCl3) of compound 11ba. 
 
 
A1.13 Infrared spectrum (Thin Film, NaCl) of compound 11ba. 
 









A1.15 19F NMR (282 MHz, CDCl3) of compound 11ba. 
 




















































































































   
A1.17 Infrared spectrum (Thin Film, NaCl) of compound 11ca. 
 
A1.18 13C NMR (101 MHz, CDCl3) of compound 11ca. 
 
 




A1.19 19F NMR (282 MHz, CDCl3) of compound 11ca. 
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A1.22 13C NMR (101 MHz, CDCl3) of compound 11da. 
 
 
A1.21 Infrared spectrum (Thin Film, NaCl) of compound 11da. 
 








A1.23 19F NMR (282 MHz, CDCl3) of compound 11da. 
 














































A1.26 13C NMR (101 MHz, CDCl3) of compound 11ea. 
 
 
A1.25 Infrared spectrum (Thin Film, NaCl) of compound 11ea. 





A1.27 19F NMR (282 MHz, CDCl3) of compound 11ea. 
 
















































A1.30 13C NMR (101 MHz, CDCl3) of compound 11fa. 
 
 
A1.29 Infrared spectrum (Thin Film, NaCl) of compound 11fa. 
 





A1.31 19F NMR (282 MHz, CDCl3) of compound 11fa. 
 
















































A1.34 13C NMR (101 MHz, CDCl3) of compound 11ga. 
 
 
A1.33 Infrared spectrum (Thin Film, NaCl) of compound 11ga. 
 





A1.35  19F NMR (282 MHz, CDCl3) of compound 11ga. 
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A1.38 13C NMR (101 MHz, CDCl3) of compound 11ha. 
 
 
A1.37 Infrared spectrum (Thin Film, NaCl) of compound 11ha. 
 




             
             











































A1.39 19F NMR (282 MHz, CDCl3) of compound 11ha. 
 




























































































A1.41 Infrared spectrum (Thin Film, NaCl) of compound 11ia. 
 
A1.42 13C NMR (101 MHz, CDCl3) of compound 11ia. 
 
 






A1.43 19F NMR (282 MHz, CDCl3) of compound 11ia. 














































A1.46 13C NMR (101 MHz, CDCl3) of compound 11ja. 
 
 
A1.45 Infrared spectrum (Thin Film, NaCl) of compound 11ja. 
 





A1.47 19F NMR (282 MHz, CDCl3) of compound 11ja. 














































A1.50 13C NMR (101 MHz, CDCl3) of compound 11ka. 
 
 
A1.49 Infrared spectrum (Thin Film, NaCl) of compound 11ka. 
 





A1.51 19F NMR (282 MHz, CDCl3) of compound 11ka. 
















































A1.53 Infrared spectrum (Thin Film, NaCl) of compound 11la. 
 
A1.54 13C NMR (101 MHz, CDCl3) of compound 11la. 
 
 




A1.55 19F NMR (282 MHz, CDCl3) of compound 11la. 
 
















































A1.58 13C NMR (101 MHz, CDCl3) of compound 11ma. 
 
 
A1.57 Infrared spectrum (Thin Film, NaCl) of compound 11ma. 
 





A1.59 19F NMR (282 MHz, CDCl3) of compound 11ma. 
 














































A1.62 13C NMR (101 MHz, CDCl3) of compound 11na. 
 
 
A1.61 Infrared spectrum (Thin Film, NaCl) of compound 11na. 
 




             
             
             
             


























The spectra for compounds L1, L2, L4, L6, L7, 6ga, 6ha, 6ac, 6ad, 6af, 6cb, 6eg, 6eh can 
all be found in: Park, D.; Jette, C. I.;  Kim, J.;  Jung, W. –O.; Lee, Y.;  Park, J.;   Kang, S.;  Han, 
M. S.;  Stoltz, B. M.;  Hong, S. Angew. Chem. Int. Ed. 2020, 59, 775–779.  
A1.63 19F NMR (282 MHz, CDCl3) of compound 11na. 




Palladium-Catalyzed Enantioselective Arylation of g-Lactams with Aryl 
Chlorides and Bromides† 
 
2.1   INTRODUCTION AND BACKGROUND 
 
Nitrogen heterocycles are ubiquitous structural motifs that can be found across all areas and 
applications of organic chemistry. A particularly important subgroup of this class are the 
pyrrolidinones, which along with their saturated counterparts, the pyrrolidines, occur widely in 
nature,1,2 possess a wide range of biological and pharmacological properties,3 and are commonly 
employed in materials4 and catalysis.5  For these reasons, the development of stereoselective 
approaches to functionalized five-membered nitrogen-containing heterocycles is of great interest 
in the synthesis of small molecules and natural products.   
 Our group has a long-standing interest in the stereoselective synthesis of five-membered  
N-heterocyclic building blocks, having developed methods for both enantioselective allylic 
alkylation6 and enantioselective a-acylation of g-lactams.7  The a-aryl pyrrolidinone building 
block is of special interest, as it would enable access to the phenethylbenzylamine structural motif, 
which is prevalent in a number of biologically active natural products and drug-like molecules 
 
† This work was performed in collaboration with Irina Geibel and Shoshana Bachman, both alumni in the Stoltz group, 
visiting researchers Masaki Hayashi, Hideki Shimizu, and Jeremy B. Morgan, as well as visiting graduate student 
Shunya Sakurai.  This  work has been published and adapted with permission from Jette, C. I. Geibel, I.; Bachman, 
S.; Hayashi, M.; Sakurai, S.; Shimizu, H.; Morgan, J. B.; Stoltz, B. M.  Angew. Chem. Int. Ed. 2019, 58, 4297–4301. 
Copyright 2019 Wiley-VCH. 
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(Figure 2.1.1).8 Nevertheless, methods describing the asymmetric a-arylation of substituted 
pyrrolidinones to produce a-quaternary g-lactams have remained elusive.  
2.2   OVERVIEW ON a-ARYLATION 
Over the past 20 years, transition metal-catalyzed a-arylation of carbonyl derivatives has 
emerged as a powerful method for C–C bond formation as it enables the efficient construction of 
sp3–sp2 bonds a- to a carbonyl derivative. Although the first report of a transition-metal catalyzed 
a-arylation dates back to 1973,9 it was not until the concomitant reports from Miura10, Hartwig,11 
and Buchwald,12 in which an enolate formed in-situ could be used with a catalytic amount of Pd, 
that the value of this reaction was truly appreciated. Since then, a number of transition metal 
catalysts have been developed for this transformation, and although transition metals such as Ni 
and Cu have been used previously in this transformation, the  most developed systems involve the 
use of a Pd catalyst. 





























up to 91% yield
and  97% ee
or
Ar Br







RL9: R = Et
L10: R = Me
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 The Pd-catalyzed a-arylation reaction is believed to proceed via a Pd(0)-Pd(II) cycle as 
outlined in Figure 2.2.1.13 Initially, a starting Pd(0) species A undergoes oxidative addition into an 
aryl halide or pseudohalide to afford a Pd(II) aryl species (B). This Pd(II) species can then undergo 
transmetalation to afford either the C-bound (C) or the O-bound (D) enolate. If the O-bound 
enolate is generated, a potentially rate-determining isomerization to the C-bound enolate must 
precede reductive elimination. Finally, reductive elimination results in the desired product and the 
regeneration of the starting Pd (0) species A.   
Although the efficiency of the reaction depends on many factors,  the nature of the carbonyl 
compound employed has the greatest impact on the reaction conditions. The acidity of the a-proton 
and the subsequent reactivity of the enolate generated will dictate which types of bases must be 
used or whether a less reactive silyl or zinc enolate is required. Furthermore, the steric 
encumbrance and reactivity of the enolate generated will in turn determine which types of aryl 
halides, ligands, solvents, and reaction temperatures will be needed to generate the product in 
synthetically useful quantities. It is for these reasons that reaction conditions tend to be very unique 
and specific to each new class of nucleophile.  Some of the carbonyl derivatives that have already 
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been used in this chemistry include ketones, amides, esters, aldehydes, nitriles, sulfones, and nitro-
alkanes.13   
There are a number of subtle challenges that have potentially precluded a-substituted g-
lactams from being successfully implemented in Pd-catalyzed asymmetric a-arylation chemistry.  
One of the challenges is the necessity for enolization by strong base, which may lead to the 
generation of unwanted aryne intermediates from the aryl halide14,15 in addition to catalyst 
decomposition.  As a result, prior reports are limited to either a-unsubstituted piperidinones, which 
require pre-formation of a basicity-tempered zinc enolate to generate the desired product (Figure 
2.2.2.A),16 or oxindoles (Figure 2.2.2.B),17i which are a special case that do not require high 
temperatures or strongly basic conditions.  Taking these considerations into account, we sought to 
develop the first method for the direct transition metal-catalyzed enantioselective a-arylation of 
a-substituted g-lactams to generate all-carbon quaternary stereocenters. 
 
2.3   REACTION OPTIMIZATION WITH ARYL CHLORIDES 









1. LiHMDS (2 equiv)
    ZnCl2 (2.2 equiv), –20 °C
2. Ar–Br (1 equiv)
   Pd(dba)2 (5 mol %)





TMEDA•PdMe2 (4 mol %)
L (4 mol %)
NaOt-Bu (2 equiv)
Ar–Br (1 equiv)
















up to 98% yield




Table 2.3.1. Preliminary Ligand Screen 
 
 
[a] Determined by GC using 1,3,5-trimethoxybenzene as an internal standard. [b]Determined by 1HNMR using 
1,3,5-trimethoxybenzene as an internal standard. [c] Determined by SFC, AD column, 40% IPA, 2.5 mL/min 
method. 
 
Entry Ligand Conversion (%)a Yield (%)b 33 (%)a ee (%)c
1 SL-J004-1 61 27 5 45
2 SL-J502-1 37 < 5 28 –
3 SL-J002-1 88 8 40 –
4 SL-J004-1 62 16 6 18
5 SL-J009-1 41 < 5 25 –
6 SL-J015-1 24 20 5 –10
7 SL-J404-2 66 24 19 –8
8 SL-M004-1 65 47 12 –34
9 SL-M009-1 59 43 12 –48
10 SL-M003-1 14 8 19 –55
11 SL-M012-1 59 < 5 35 –
12 SL-M001-1 35 13 13 54
13 SL-W002-1 4 < 5 4 –
14 SL-W003-1 45 18 13 2
15 SL-W008-1 7 < 5 4 –
16 SL-T001-1 46 21 19 16
17 SL-T002-1 75 38 9 –12
18 (R)-SEGPHOS < 5 < 5 5 –
19 (S)-t-Bu-Phox < 5 < 5 < 5 –
20 (R)-Diop 8 7 < 5 –























SL-J004-1: Alkyl = Cy




SL-J002-1: Alkyl = t-Bu





SL-J015-2: Ar1 = 2-furyl, 
Ar2 = 3,5-xylyl







SL-M004-1: Ar = 4-
methoxy-3,-5- dimethylphenyl
SL-M009-1: Ar = 3,-5-dixylyl









SL-W002-1: R = Ph













SL-M012-2: Ar = 2-tolyl
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 In the first round of screening, a number of commercially available ligands were tested in 
the Pd-catalyzed arylation of p-methoxyphenyl-protected lactam 30a using 3-methoxylphenyl 
chloride 31i. With 10 mol% Pd(OAc)2, 1.0 equiv of LiHMDS, in toluene at 80 °C, over 20 
commercially available ligands were tested (Table 2.3.1).  
The ferrocene ligands  (entries 1–17) generally resulted in the highest levels of reactivity; 
other aryl and alkyl phosphines such as (R)-Segphos, (S)-t-Bu-Phox, (R)-Diop, or (S,R)-Tangphos 
resulted in very low conversions and negligible amounts of product (entries 18-21).  The ferrocene 
ligand classes examined include Josiphos (entries 1–7), Mandyphos (entries 8–12), Walphos 
(entries 13–15), and Taniaphos (entries 16 and 17) ligands.  The Josiphos ligand class (entries 1–
7) generally led to low yields (less than 30% in all cases), and with the exception of ligand J004-




[a] Conditions: 0.1 mmol scale. Yields determined by LC-MS analysis of the crude reaction mixture using 1,3,5–
trimethoxybenzene as a standard. [b] Determined by chiral SFC analysis of the isolated product. [c] 1.0 equiv 30a, 
1.5 equiv LiHMDS, 2.0 equiv 31a.  [d] 100% fresh toluene, complete setup in glovebox, run for 36 h. PMP = p-













PMP Me Ph Cl
Pd source (10 mol %)
ligand (12 mol %)
LiHMDS (1.1 equiv)













L9: R = Et
L10: R = Me









4 L11 17 <5












L8: Ar = 3,-5-dixylyl (SL-M009-1)
Pd(dba)2









1.3 equiv 1.0 equiv
31a
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1 (entry 1), very low ee’s. In a number of cases, a large amount of the dechlorinated product 33 
(entries 2, 3, 5, and 7) was observed. Generally, where the yields of the desired product were high, 
the amount of dechlorinated product 33 was low, and vice versa. These results could be indicating 
that the slow step in this reaction is not oxidative addition, but could be transmetalation, or O–
bound to C–bound enolate isomerization, as a slow  reductive elimination is unlikely given the 
large bite angle of these ligands.19 The very similar Walphos (entries 13–15)  class also led to low 
yields. The Taniaphos ligands (entries 16, 17)  did lead to slightly higher product yields, but the 
ee’s were very low. With the Mandyphos class of ligands, however, the highest yields and ee’s 
were obtained. With M004-1 and M009-1 (entries 8 and 9), the product yields were over 40%, and 
with M003-1, the product was obtained in  55% ee.  
 Intrigued by the results obtained with Mandyphos ligand M009-1, we initiated a brief 
investigation into the Pd source with this ligand (Table 2.3.2).  Interestingly, we noted that 
switching to Pd(dba)2 led to  a significant reduction in reactivity (Table 2.3.2, entry 1 versus Table 
2.3.1, entry 9). Upon examination of other ligands in combination with this Pd source, we found 
that Et-ferrocelane (L9) led to the formation of 32aa in very high ee, albeit in only moderate yield. 
Table 2.3.3. Additional Pd and Solvent Screena 
 
 
[a] 0.1 mmol scale. Yields determined by LC-MS analysis of the crude reaction mixture using 1,3,5–
trimethoxybenzene as a standard. [b] Determined by chiral SFC analysis of the isolated product. PMP = p-
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Pd source (10 mol %)
L9 (12 mol %)
LiHMDS (1.2 equiv)
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It should be noted that these results were unique and specific to this ligand,  as other ligands in this 
class (L10, L11, and L12) resulted in very low conversion. Concerned about consumption of the 
starting material via formation of the lactam-dba adduct, a product which proved difficult to 
separate from 32aa, we chose to examine a few more Pd sources in combination with L9.  We 
found that  in contrast to what was observed with  M009-1, Pd(0) sources resulted in greater 
reactivity and selectivity with L9, and with both Pd2(dm-bda)3 (entry 8) and Pd2(pm-dba)3 (Table 
2.3.3, entry 1), the product was obtained in significantly higher quantities but in similar ee to 
Pd(dba)2.  
 Using Pd2(pm-dba)3 as the Pd source, the effect of the solvent on the reaction outcome was 
tested next. We noted that dioxane led to a significantly better reaction outcome as compared to 
toluene and benzene (entry 3 versus entries 1 and 2). Interestingly, upon examination of other Pd 
 




[a] Conditions: 0.1 mmol scale. Yields determined by LC-MS analysis of the crude reaction mixture using 1,3,5–
trimethoxybenzene as a standard. [b] Determined by chiral SFC analysis of the isolated product. [c] 14 hour. [d] 
Isolated yield = 58%. [d] >95% conversion. [e] With 2.5 mol% Pd2(pm-dba)3, 7.5 mol % L9, 6 h.  




PMP Me Ph Cl
Pd (dm-dba)2(10 mol %)
ligand (12 mol %)
base 







3 LiOt-Bu (2) 0 –
4 NaOt-Bu (2) 0 –







































LiHMDS (1.5)1.5 65 931 1 100
LiHMDS (1.5)1.5 69 949 1 100
L9: R = Et
L10: R = Me











LiHMDS (1.5)1.5 19 < 510 1 100L11
LiHMDS (1.5)1.5 65 9411e 1 100L9
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sources in dioxane, we noted that Pd(dm-dba)2 still performed similarly (entry 6) to Pd2(pm-dba)3, 
but other Pd sources did lead to significant drops in reactivity (entries 7 and 8). Having identified 
two Pd sources that could be used interchangeably under these conditions,18 as well as the 
appropriate solvent, we next turned our attention to the nature and equivalents of the base, the 
nucleophile and electrophile stoichiometry, and the reaction temperature (Table 2.3.4). Increasing 
the reaction temperature to 100 °C  led to a slight boost in yield (entry 1).  We noted that inverting 
the stoichiometry did not lead to significant changes in the reaction outcome (entry 2).  
 Upon examination of a number of different bases, we found that the hexamethyldisilazide bases 
proved to be optimal for this transformation. Unsurprisingly, the weaker t-butoxide bases led to no 
product formation even at elevated temperatures (entries 3–5). Notably, employing LDA, a 
significantly stronger base than the hexamethyldisilazides, did not lead to any significant 
improvements in reactivity (entry 9).  One possible explanation for this could be that LiHMDS, 
which has a pKa of 26 in THF,31  may not be strong enough to fully deprotonate the g-lactam,  thus 
limiting the amount of reactive enolate present throughout the course of the reaction. When LDA 
is used, quantitative enolization is anticipated, which may lead to decomposition of the lactam 
enolate via other undesirable pathways.  Finally, the nature of the cation on the HMDS also had an 
effect; LiHMDS seemed to be the best base for this reaction, as switching to Na or KHMDS led to 
significant drops in yield and ee (entries 6 and 7).  
 With these slightly modified conditions, we re-tested the remaining ferrocelane ligands once 
again. In contrast to the initial set of conditions (Table 2.3.2, entries 2 and 3), with these new 
conditions, L9 and L10 both led to equally high levels of reactivity and selectivity. The use of the 
bulkier L11,  however, still led to both diminished yield and enantioselectivity.  We believe there 
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may be a number of reasons why L9 and L10 are optimal ligands for this transformation: these 
highly electron-rich dialkylphosphine ligands should undergo rapid oxidative addition to the aryl 
halide, while the large bite angle should encourage facile reductive elimination.19 Additionally, 
since alkyl phosphines are less susceptible to P–C cleavage,20 we believe that these ligands might 
form a Pd/ligand complex that is more stable at high temperatures. Finally, although we found both 
Pd(dm-dba)2 and Pd2(pm-dba)3 to be equally effective Pd(0) sources at 10 mol% catalyst loading, 
we did find that  Pd2(pm-dba)3 led to a more active pre-catalyst, which also allowed us to lower 
the catalyst loadings and shorten the reaction time  (entry 11).21  
 
2.4   REACTION OPTIMIZATION WITH ARYL BROMIDES 
Although  the use of electrophiles such as iodobenzene (entries 1 and 2, Table 2.4.1) and 
phenyl triflate resulted in no product formation, we were pleased to see that bromobenzene did 
lead to the a-aryl g-lactam in moderate yield and selectivity (entry 3). Interestingly, we noted that  
Table 2.4.1. Optimization with Aryl Bromidesa 
 
                     
 
 
[a] Conditions: 0.1 mmol scale. [b] Yield determined by LCMS analysis of the crude reaction mixture using 1,3,5–
trimethoxybenzene as a standard. [c] Determined by chiral SFC analysis of the isolated product. [d] Reaction 




4 L10 12 86 92
5 L10 15 31 72
6d L10 15 84 92
7e L10 15 72 92
3d L9 16 64 96
L91 20 – –















entry Ph–X base ligand time (h) yield (%)b ee (%)c
N
O
PMP Me Ph X
Pd2(pm-dba)3 (2.5 mol %)
L9 or L10 (7.5 mol %)
base (1.5 equiv)






















RL9: R = Et
L10: R = Me
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L10 was the best ligand when bromobenzene was used, and in contrast to what was observed with 
chlorobenzene (Table 2.3.4),   NaHMDS proved optimal (entries 4 and 5).  With this new set of 
conditions, the reaction proceeds at a lower temperature; the desired product is obtained in 84% 
yield and 92% ee (entry 6) after 15 h at 80 °C. Moreover, at 54 °C the product is still obtained in 
good yield and high enantiomeric excess (entry 7). 
 
2.5   REACTION SCOPE 
 With optimized conditions for aryl chlorides and aryl bromides in hand, the effect of the N-
protecting group on the reaction was examined (Table 2.5.1).  We were pleased to find that a 
number of different N-protecting groups were tolerated in our reaction.  Bis-methoxyphenyl lactam 
30b performs just as well as 30a with Method B, but a slight decrease in yield and 
Table 2.5.1. Scope of the N-Protecting Groupa 
 
 
[a] Conditions for each method are as follows: Method A: lactam (1.5 equiv), Ph–Cl (1.0 equiv), Pd2(pmdba)3 (2.5 
mol%), L9 (7.5 mol %), LiHMDS (1.5 equiv), dioxane (0.2 M), 100 °C, 20h. Method B: lactam (1.5 equiv), Ph–
Br (1.0 equiv), Pd2(pmdba)3 (2.5 mol%), L10 (7.5 mol%), NaHMDS (1.5 equiv), dioxane (0.2 M), 80 °C, 20 h. [b] 












Method A: 53% yield, 89% ee
Method B: 85% yield, 92% ee
Method A: 40% yield, 73% ee
Method B: 64% yield, 56% ee
Method A: 58% yield, 90% ee
Method B: 91% yield, 93% ee
Method A: 43% yield, 95% ee









Method A: 65% yield, 94% eeb





Method A: 33% yield, 79% ee








Pd2(pm-dba)3 (2.5 mol %)
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enantioselectivity is observed when subjected to Method A (32ba).  Switching to ortho-methoxy 
phenyl substituted 30c or electron-deficient trifluoromethylphenyl 30e led to diminished yield and 
enantioselectivity (32ca and 32ea).  Although N-phenyl 30d does not outperform 30a in Method 
A, it does exhibit higher reactivity and enantioselectivity when exposed to Method B, furnishing 
Table 2.5.2. Scope of the Aryl Halidea 
 
[a] Conditions for each method are as follows: Method A: 30a (1.5 equiv), Ar–Cl (1.0 equiv), Pd2(pmdba)3 (2.5 mol 
%),  L9 (7.5 mol %), LiHMDS (1.5 equiv), dioxane (0.2 M), 100 °C, 6 h. Method B: lactam (1.5 equiv), Ar–Br (1.0 
equiv), Pd2(pmdba)3 (2.5 mol %), L10 (7.5 mol %) NaHMDS (1.5 equiv), dioxane (0.2 M), 80 °C, 15 h. [b] Absolute 

















































Method A: 65% yield, 94% ee 
Method B: 83% yield, 92% ee
Method A: 83% yield, 95% ee 
Method B: 75% yield, 93% ee
Method A: 88% yield, 94% ee
Method A: 33% yield, 93% ee Method A: 78% yield, 97% ee Method A: 49% yield, 91% ee 
Method B: 57% yield, 95% ee
Method A: 60% yield, 91% ee Method A: 87% yield, 81% ee Method A: 69% yield, 86% ee









Pd2(pm-dba)3 (2.5 mol %)
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the desired product in 91% yield and 93% ee (32da).  Benzyl-protected lactam 30f affords a-
quaternary lactam 32fa in high levels of enantiomeric excess across both methods.  
Next, we examined the substrate scope of the enantioselective a-arylation (Table 2.5.2).  We 
found that aryl bromides and aryl chlorides with a variety of substitution patterns are 
accommodated in the arylation.  Aryl halides possessing electron-deficient (see products 32ab, 
32ad, 32ah,22 32ae) and electron-rich (32af, 32ag) substituents at the para-position led to products 
with excellent enantioselectivities using Method A and B, respectively.  Aryl halides possessing 
Table 2.5.3. Scope of the Lactama 
 
 
[a] Conditions for each method are as follows: Method A: lactam (1.5 equiv), Ar–Cl (1.0 equiv), Pd2(pmdba)3 (2.5 
mol %), L9 (7.5 mol %) LiHMDS (1.5 equiv), dioxane (0.2 M), 100 °C, 20 h. Method B: lactam (1.5 equiv), Ar–Br 
(1.0 equiv), Pd2(pmdba)3 (2.5 mol %), L10 (7.5 mol %) NaHMDS (1.5 equiv), dioxane (0.2 M), 80 °C, 20 h. PMP = 

















Method B: 41% yield, 90% ee
Method A: 59% yield, 91% ee
Method B: 50% yield, 89% ee Method A: 46% yield, 93% ee
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substituents at the meta-position are also permissible in both Method A and B, although slightly 
diminished enantioselectivity is observed when 3-chloroanisole is used as the electrophile (32ai).  
Unfortunately, only trace product is observed when ortho-substituted aryl halides are exposed to 
our reaction conditions.23  Gratifiyingly, an N-methyl indole was also tolerated, as we obtained 5-
indolyl lactam 32al in moderate yield and excellent enantioselectivity. 
 The scope of substitution at the lactam a-carbon was then examined (Table 2.5.3).  We found 
that sterically demanding a-substituents are well tolerated in both methods.  Although the yields 
are slightly diminished, the high levels of enantioselectivity are retained.  Examples having ethyl 
(32ha, 32hb), benzyl (32ga, 32gb), propyl (32ia), phenethyl (32ja), and 2-naphthylmethyl (32ka) 
substitution all furnish the a-arylated products in good enantioselectivity.  a-Benzyl substituted 
lactam 30g was also employed in the reaction with a number of different electrophilic coupling 
partners using both methods.  Even with a more hindered substrate, similar patterns of reactivity 
and selectivity to a-methyl substituted 30a were observed.  When an electron-deficient aryl 
chloride coupling partner is used in Method A or m-bromotoluene is used in Method B with 1g, 
the desired product is formed in high enantioselectivity and good yield (32gc and  32gd). 
 
2.6   PRODUCT TRANSFORMATIONS 
 
Recognizing the potential value of these enantioenriched, quaternary center-containing 
heterocycles to the synthetic and pharmaceutical communities, we sought to utilize this new 
transformation in the preparation of differentially substituted five-membered heterocycles 
(Scheme 2.5.1).  a-Quaternary lactam 32aa can be swiftly deprotected with ceric ammonium 
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nitrate (CAN) providing unprotected lactam 34 in 73% yield.  Reduction of the lactam carbonyl 
with lithium aluminum hydride provides the corresponding medicinally valuable pyrrolidine 
(35).24  Partial reduction of the lactam with lithium triethylborohydride and trapping of the 
resulting iminium ion with potassium cyanide yields chiral aminonitrile 36 in moderate yield but 
with high diastereoselectivity. 
 
2.7   CONCLUSION 
In conclusion, we have developed a protocol for the first transition metal-catalyzed 
enantioselective a-arylation of g-lactams.  Two related procedures were developed for this 
transformation, allowing for the use of either aryl chlorides or bromides as electrophiles.  We are 
able to construct a-quaternary stereocenters in good yield and high enantiomeric excess (up to 
91% yield and 97% ee).  Asymmetry is induced through the use of a chiral, dialkyl bisphosphine 
ligand that generates a Pd/ligand complex that is stable under strongly basic conditions and 
elevated temperatures.  Critical to the development of these conditions was also the identification 




[a] Conditions: (a) CAN, MeCN/H2O, 0 °C, 30 min, 73% yield; (b) LAH, Et2O, 0 °C to 23 °C, 16 h, 93% yield; (c) 
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of an appropriate base and electrophile combination.  We found that a broad range of substitution 
is tolerated on either coupling partner. We also demonstrated that these a-quaternary g-lactams 
can be efficiently converted to a number of different enantioenriched nitrogen containing 
heterocyclic building blocks via product derivatizations.   
 
2.8  EXPERIMENTAL SECTION 
2.8.1  MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under an argon or 
nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried by passage through 
an activated alumina column under argon. Reaction progress was monitored by thin-layer 
chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC was performed using E. Merck silica 
gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence quenching, p-
anisaldehyde, or KMnO4 staining.  Silicycle SiliaFlash® P60 Academic Silica gel (particle size 
40–63 nm) was used for flash chromatography. 1H NMR spectra were recorded on a Bruker 
Avance HD 400 MHz or Varian Mercury 300 MHz spectrometers and are reported relative to 
residual CHCl3 (δ 7.26 ppm). 13C NMR spectra were recorded on a Bruker Avance HD 400 MHz 
spectrometer (100 MHz) and are reported relative to residual CHCl3 (δ 77.36 ppm). 19F NMR 
spectra were recorded on a Varian Mercury 300 MHz spectrometer (282 MHz). Data for 1H NMR 
are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration).  
Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, 
sept = septuplet, m = multiplet, br s = broad singlet, br d = broad doublet, app = apparent.  Data 
for 13C NMR are reported in terms of chemical shifts (δ ppm). IR spectra were obtained using a 
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Perkin Elmer Spectrum BXII spectrometer or Nicolet 6700 FTIR spectrometer using thin films 
deposited on NaCl plates and reported in frequency of absorption (cm–1).  Optical rotations were 
measured with a Jasco P-2000 polarimeter operating on the sodium D-line (589 nm), using a 100 
mm path-length cell and are reported as: [a]DT (concentration in 10 mg/1 mL, solvent). Analytical 
SFC was performed with a Mettler SFC supercritical CO2 analytical chromatography system 
utilizing Chiralpak (AD-H) or Chiralcel (OD-H) columns (4.6 mm x 25 cm) obtained from Daicel 
Chemical Industries, Ltd. High resolution mass spectra (HRMS) were obtained from Agilent 6200 
Series TOF with an Agilent G1978A Multimode source in electrospray ionization (ESI+), 
atmospheric pressure chemical ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+). 
Reagents were purchased from Sigma-Aldrich, Acros Organics, Strem, or Alfa Aesar and used as 
received unless otherwise stated.  
 
2.8.2  EXPERIMENTAL PROCEDURES 
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Synthesis of N-substituted lactam starting material 
 
1-(4-methoxyphenyl)pyrrolidin-2-one (SI3):25 To a solution of CuI (1.904 g, 10 mmol, 0.1 
equiv) in toluene (100 mL, 1.0 M) was added DMEDA (2.15 mL, 20 mmol, 0.2 equiv), 4-
iodoanisole (23.4 g, 100 mmol, 1 equiv), 2-pyrrolidinone (9.11 mL, 120 mmol, 1.2 equiv), and 
anhydrous K3PO4 (42.5 g, 200 mmol, 2 equiv). The resultant mixture was heated to 100 °C and 
allowed to stir for 14 hours. The reaction was cooled, diluted with EtOAc, and filtered through 
celite. The filtrate was concentrated and recrystallized from 20% EtOAc in hexanes to afford SI3 
as a colorless solid (16.0 g, 83.7 mmol, 84% yield); 1H NMR (300 MHz, CDCl3) δ 7.55 – 7.43 (m, 
2H), 6.96 – 6.84 (m, 2H), 3.92 – 3.73 (m, 5H), 2.59 (dd, J = 8.5, 7.7 Hz, 2H), 2.25 – 2.07 (m, 2H). 
All characterization data match those reported.25 
 
1-(2-methoxyphenyl)pyrrolidin-2-one (SI4):25 Compound SI4 was prepared from 2-
pyrrolidinone using a previously reported procedure; 1H NMR (300 MHz, CDCl3) δ 7.26 (m, 2H), 
7.04 – 6.90 (m, 2H), 3.84 (s, 3H), 3.76 (t, J = 7.1 Hz, 2H), 2.56 (dd, J = 8.5, 7.7 Hz, 2H), 2.19 (tt, 






















Chapter 2- Palladium-Catalyzed Enantioselective Arylation of g-Lactams with Aryl Chlorides and 
Bromides 
127  
1-(3,5-dimethoxyphenyl)pyrrolidin-2-one (SI5):25 Compound SI5 was prepared from 2-
pyrrolidinone using a previously reported procedure; 1H NMR (500 MHz, CDCl3) δ 6.86 (d, J = 
2.2 Hz, 2H), 6.27 (t, J = 2.2 Hz, 1H), 3.83 (t, J = 7.0 Hz, 2H), 3.80 (s, 6H), 2.61 (dd, J = 8.5, 7.7 
Hz, 2H), 2.15 (tt, J = 7.8, 7.0 Hz, 2H). All characterization data match those reported.25 
 
1-phenylpyrrolidin-2-one (SI6):26 Compound SI6 was prepared from 2-pyrrolidinone using a 
previously reported procedure. All characterization data match those reported.26 
 
1-(4-(trifluoromethyl)phenyl)pyrrolidin-2-one (SI7): 2-pyrrolidinone (23.5 mmol, 2.0 g), 
Cs2CO3 (1.07 g, 32.9 mmol, 1.4 equiv), Xantphos (460 mg, 0.80 mmol, 3.3 mol%), Pd(OAc)2 (106 
mg, 0.47 mmol, 2.0 mol%), and 4-bromobenzotrifluoride (4.22 mL, 30.6 mmol, 1.3 equiv) in 
dioxane (70 mL) under inert atmosphere were heated to 100 °C for 24 h. The reaction was then 
cooled to ambient temperature, filtered through a plug of silica, and concentrated. The filtrate was 
recrystallized from 20% EtOAc in hexanes to afford SI7 as a colorless solid (4.52 g, 19.7 mmol, 
84% yield); 1H NMR (500 MHz, CDCl3) δ 7.79 – 7.74 (m, 2H), 7.64 – 7.59 (m, 2H), 3.90 (t, J = 
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1-benzylpyrrolidin-2-one (SI8): To a flame-dried round-bottom flask under argon was added 2-
pyrrolidinone (3.38 g, 39.7 mmol, 1.0 equiv), DMAP (243 mg, 1.39 mmol, 0.05 equiv), 
dichloromethane (60 mL), and triethylamine (8.30 mL, 60 mmol, 1.5 equiv). The resulting solution 
was cooled to 0 °C and benzyl chloride (5.54 mL, 47.7 mmol, 1.2 equiv) was added dropwise. The 
reaction was allowed to warm to ambient temperature and stirred for one hour. The crude reaction 
mixture was quenched with saturated NH4Cl solution, extracted three times, then the combined 
organic layers were washed with saturated NaHCO3 solution. The organic layer was dried over 
Na2SO4 and concentrated. The filtrate was recrystallized from 25% EtOAc in hexanes to afford 
SI8 as a colorless solid (3.64 g, 20.8 mmol, 48% yield); 1H NMR (300 MHz, CDCl3) δ 7.26 (m, 
5H), 4.45 (s, 2H), 3.26 (dd, J = 7.5, 6.7 Hz, 2H), 2.45 (dd, J = 8.6, 7.6 Hz, 2H), 2.07 – 1.90 (m, 
2H). All characterization data match those reported.28 
2.8.2.2  Synthesis of a-Substituted g-Lactams 
 
General Procedure 1: a-alkylation of N-substituted lactams with alkyl halides:  
 
 
1-(4-methoxyphenyl)-3-methylpyrrolidin-2-one (30a): To a solution of i-Pr2NH (3.45 mL, 24.7 
mmol, 1.1 equiv) in THF (22.5 mL) at 0 °C was added a solution n-BuLi (2.57 M in hexanes, 9.63 
mL, 24.7 mmol, 1.1 equiv) dropwise. The resulting mixture was stirred at 0 °C for 20 min, then 
cooled to –78 °C. A solution of 1-(4-methoxyphenyl)pyrrolidin-2-one (4.30 g, 22.5 mmol, 1.0 
equiv) in THF (60 mL) was added dropwise via cannula. The reaction was allowed to stir for 1 h 
at –78 °C, then a solution of MeI (2.10 mL, 33.75 mmol, 1.5 equiv) in MTBE (17 mL) was added 




1. LDA (1.1 equiv), –78 °C, THF, 1 h
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quenched with a saturated aqueous NH4Cl solution and allowed to warm to ambient temperature. 
The aqueous layer was extracted four times with EtOAc, and the resulting organic layers were 
dried over Na2SO4 and concentrated. The resulting crude oil was purified by column 
chromatography (40% EtOAc in hexanes) to afford 30a as a colorless solid (4.0 g, 19.5 mmol, 
89% yield); 1H NMR (500 MHz, CDCl3) δ 7.53 (d, J = 9.1 Hz, 2H), 6.90 (d, J = 9.1 Hz, 1H), 3.80 
(s, 3H), 3.78 – 3.68 (m, 1H), 2.74 – 2.57 (m, 1H), 2.36 (dddd, J = 12.3, 8.5, 6.7, 3.6 Hz, 1H), 1.76 
(ddt, J = 12.5, 9.4, 8.6 Hz, 1H), 1.30 (d, J = 7.1 Hz, 3H). All characterization data match those 
reported.25 
 
1-(3,5-dimethoxyphenyl)-3-methylpyrrolidin-2-one (30b): Compound 30b was prepared from 
SI5 using a previously reported procedure;1 1H NMR (500 MHz, CDCl3) δ 6.91 (d, J = 2.2 Hz, 
2H), 6.26 (t, J = 2.2 Hz, 1H), 3.80 (s, 6H), 3.74 (dd, J = 8.8, 5.0 Hz, 2H), 2.67 (ddq, J = 9.7, 8.2, 
7.0 Hz, 1H), 2.35 (ddt, J = 12.3, 8.4, 5.0 Hz, 1H), 1.75 (ddt, J = 12.4, 9.6, 8.8 Hz, 1H), 1.30 (d, J 
= 7.1 Hz, 3H). All characterization data match those reported.25 
 
1-(2-methoxyphenyl)-3-methylpyrrolidin-2-one (30c): Compound 30c was prepared from SI4 
using a previously reported procedure;1 1H NMR (500 MHz, CDCl3) δ 7.26 (m, 2H), 7.08 – 6.89 
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7.3, 3.5 Hz, 1H), 1.81 (dq, J = 12.4, 8.5 Hz, 1H), 1.31 (d, J = 7.2 Hz, 3H). All characterization 
data match those reported.25 
 
3-methyl-1-phenylpyrrolidin-2-one (30d): Compound 30d was prepared from SI6 and 
iodomethane using General Procedure 1. The filtrate was recrystallized from 25% EtOAc in 
hexanes to afford 30d as a colorless solid (3.2 g, 18.3 mmol, 74% yield); 1H NMR (500 MHz, 
CDCl3) δ 7.67 – 7.61 (m, 2H), 7.41 – 7.33 (m, 2H), 7.14 (tt, J = 7.4, 1.1 Hz, 1H), 3.85 – 3.72 (m, 
2H), 2.68 (ddq, J = 9.5, 8.5, 7.1 Hz, 1H), 2.38 (dddd, J = 12.2, 8.5, 6.6, 3.5 Hz, 1H), 1.78 (ddt, J 
= 12.4, 9.5, 8.6 Hz, 1H), 1.32 (d, J = 7.1 Hz, 3H). All characterization data match those reported.29  
 
1-benzyl-3-methylpyrrolidin-2-one (30f): Compound 30f was prepared from SI8 and 
iodomethane using General Procedure 1. The resulting crude oil was purified by column 
chromatography (5% MeOH in CH2Cl2) to afford 1f as a yellow oil (4.1 g, 21.7 mmol, 70% yield); 
1H NMR (300 MHz, CDCl3) δ 7.26 (s, 5H), 4.45 (d, J = 3.7 Hz, 2H), 3.23 – 3.09 (m, 2H), 2.52 
(ddt, J = 15.8, 8.7, 7.1 Hz, 1H), 2.21 (dddd, J = 12.6, 8.7, 6.0, 4.8 Hz, 1H), 1.68 – 1.50 (m, 1H), 
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1-(4-methoxyphenyl)-3-phenethylpyrrolidin-2-one (30j): Compound 30j was prepared from 
SI3 and  (2-iodoethyl)benzene using General Procedure 1. The resulting crude oil was purified by 
column chromatography (40% EtOAc in hexanes) to afford 1j as a colorless solid (487 mg, 1.65 
mmol, 33% yield); 1H NMR (300 MHz, CDCl3) δ 7.58 – 7.47 (m, 2H), 7.36 – 7.14 (m, 5H), 6.96 
– 6.83 (m, 2H), 3.80 (s, 3H), 3.78 – 3.69 (m, 2H), 2.93 – 2.66 (m, 2H), 2.59 (qd, J = 9.1, 4.7 Hz, 
1H), 2.40 – 2.24 (m, 2H), 1.91 – 1.68 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 175.8, 156.8, 141.9, 
133.2, 128.8, 126.3, 121.9, 114.3, 55.8, 47.5, 42.8, 33.7, 33.3, 25.4; IR (Neat Film, NaCl) 2930, 
2855, 1677, 1518, 1456, 1393, 1318, 1255, 1224, 1181, 1121, 1034, 825, 752, 717, 699 cm–1; 
HRMS (MM) m/z calc’d for C19H22NO2+ [M+H]+: 296.1645, found 296.1646. 
 
1-(4-methoxyphenyl)-3-(naphthalen-2-ylmethyl)pyrrolidin-2-one (30k): Product 30k was 
prepared from SI3 2-(bromomethyl)naphthalene using General Procedure 1 and purified by 
column chromatography (33% EtOAc in hexanes) to provide 30k as a colorless solid (430 mg, 
1.30 mmol, 52% yield); 1H NMR (500 MHz, CDCl3) δ 7.80 – 7.83 (m, 1H), 7.77 – 7.80 (m, 2H), 
7.68 – 7.69 (m, 1H), 7.48 – 7.51 (m, 2H), 7.42 – 7.47 (m, 2H), 7.39 (dd, J = 8.4, 1.7 Hz, 1H), 6.89 
– 6.92 (m, 2H), 3.81 (s, 3H), 3.68 (dt, J = 9.5, 7.8 Hz, 1H), 3.56 (ddd, J = 9.6, 8.7, 3.4 Hz, 1H), 
3.47 (dd, J = 13.0, 3.4 Hz, 1H), 2.95 – 3.05 (m, 2H), 2.17 (dddd, J = 12.7, 8.4, 7.5, 3.3 Hz, 1H), 
1.91 (dq, J = 12.7, 8.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 174.9, 156.7, 137.0, 133.7, 132.8, 
132.4, 128.3, 127.8, 127.7, 127.6, 127.5, 126.2, 125.6, 121.9, 114.2, 55.6, 47.3, 45.0, 37.4, 24.3; 
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900, 824, 739 cm–1; HRMS (MM) m/z calc’d for C22H22NO2+ [M+H]+: 332.1645, found 
332.1648. 
General Procedure 2: a-alkylation of N-substituted lactams with alkyl iodides: 
 
3-methyl-1-(4-(trifluoromethyl)phenyl)pyrrolidin-2-one (30e): To a solution of LiHMDS (1.61 
g, 9.60 mmol, 1.1 equiv) in THF (44 mL) at –78 °C was added a solution of 1-(4-
(trifluoromethyl)phenyl)pyrrolidin-2-one (2.0 g, 8.93 mmol, 1.0 equiv) in THF (4 mL) dropwise. 
The solution was stirred –78°C for 30 minutes, then iodomethane (1.11 mL, 17.86 mmol, 2 equiv) 
was added dropwise. The reaction was stirred at –48 °C for 30 minutes, then allowed to warm to 
ambient temperature overnight. The reaction mixture was quenched with a saturated NH4Cl 
solution, and extracted with EtOAc three times. The combined organic extracts were washed with 
saturated NaHCO3 solution, dried over Na2SO4, and concentrated. The resulting crude oil was 
purified by column chromatography (10% EtOAc in hexanes) to afford 30e as a colorless solid 
(1.30 g, 5.34 mmol, 61% yield); 1H NMR (500 MHz, CDCl3) δ 7.82 – 7.77 (m, 2H), 7.64 – 7.59 
(m, 2H), 3.85 – 3.77 (m, 2H), 2.71 (ddq, J = 9.8, 8.5, 7.1 Hz, 1H), 2.42 (dddd, J = 12.7, 8.5, 5.7, 
4.3 Hz, 1H), 1.81 (ddt, J = 12.5, 9.8, 8.7 Hz, 1H), 1.33 (d, J = 7.1 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 177.10, 142.53, 125.96 (q, J = 3.7 Hz), 118.93, 46.31, 38.38, 26.86, 16.06; 19F NMR 
(282 MHz, CDCl3) δ –62.1; (Neat Film, NaCl) 2977, 1697, 1393, 1329, 1221, 1195, 1164, 1113, 
1070, 908, 859, 842, 821, 731, 715 cm–1; HRMS (MM) m/z calc’d for C12H13F3NO+ [M+H]+: 
244.0944, found 244.0947. 
N
OCF3 1. LiHMDS (1.1 equiv), –78°C, THF, 30 min








3-ethyl-1-(4-methoxyphenyl)pyrrolidin-2-one (30h): Compound 30h was prepared from 
iodoethane using General Procedure 2. The resulting crude oil was purified by column 
chromatography (20% EtOAc in hexanes) to afford 30h as a colorless solid (1.18 g, 5.38 mmol, 
54% yield); 1H NMR (500 MHz, CDCl3) δ 7.55 – 7.49 (m, 2H), 6.93 – 6.80 (m, 2H), 3.80 (s, 3H), 
3.78 – 3.71 (m, 2H), 2.54 (qd, J = 8.9, 4.3 Hz, 1H), 2.32 (dddd, J = 12.5, 8.7, 7.1, 3.7 Hz, 1H), 
1.98 (dqd, J = 13.6, 7.5, 4.3 Hz, 1H), 1.81 (dq, J = 12.5, 8.6 Hz, 1H), 1.58 – 1.47 (m, 1H), 1.02 (t, 
J = 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 176.0, 156.7, 133.2, 121.8, 114.3, 55.8, 44.9, 24.6, 
24.5, 11.8; (Neat Film, NaCl) 3054, 2957, 2935, 2875, 2837, 1682, 1613, 1514, 1486, 1464, 1430, 
1398, 1326, 1288, 1252, 1225, 1181, 1121, 1100, 1032, 829, 736, 704, 612 cm–1; HRMS (MM) 
m/z calc’d for C13H18NO2+ [M+H]+: 220.1332, found 220.1322. 
General Procedure 3: a-alkylation of PMP-pyrrolidinone with alkyl bromides:  
 
1-(4-methoxyphenyl)-3-propylpyrrolidin-2-one (30i): To a solution of i-Pr2NH (0.77 mL, 5.5 
mmol, 1.1 equiv) in THF (5.0 mL) at 0 °C was added a solution n-BuLi (2.57 M in hexanes, 2.2 
mL, 5.5 mmol, 1.1 equiv) dropwise. The resulting mixture was stirred at 0 °C for 20 min, then 
cooled to –78 °C. A solution of 1-(4-methoxyphenyl)pyrrolidin-2-one SI3 (956 mg, 5.0 mmol, 1.0 
equiv) in THF (12.5 mL) was added dropwise via cannula. The reaction was allowed to stir for 1 
h at –78 °C, then a solution of 1-bromopropane (0.68 mL, 7.5 mmol, 1.5 equiv) in MTBE (4 mL) 







1. LDA (1.1 equiv), –78°C, THF, 30 min
2. 1-bromopropane (1.5 equiv)
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was then quenched with saturated NH4Cl solution and allowed to warm to ambient temperature. 
The aqueous layer was extracted four times with EtOAc, and the resulting organic layers were 
dried over Na2SO4 and concentrated. The resulting crude oil was purified by column 
chromatography (40% EtOAc in hexanes) to afford 30i as a colorless solid (210 mg, 0.90 mmol, 
20% yield); 1H NMR (300 MHz, CDCl3) δ 7.56 – 7.46 (m, 2H), 6.94 – 6.86 (m, 2H), 3.80 (s, 3H), 
3.78 – 3.70 (m, 2H), 2.59 (qd, J = 8.8, 4.1 Hz, 1H), 2.31 (dddd, J = 12.7, 8.7, 6.6, 4.1 Hz, 1H), 
1.94 (qd, J = 5.9, 4.9, 3.4 Hz, 1H), 1.79 (dq, J = 12.5, 8.6 Hz, 1H), 1.52 – 1.34 (m, 3H), 0.97 (t, J 
= 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 176.2, 156.7, 133.3, 121.8, 114.3, 55.8, 47.5, 43.4, 
33.8, 25.2, 20.8, 14.4; IR (Neat Film, NaCl) 2955, 2927, 2859, 2837, 1681, 1613, 1517, 1480, 
1464, 1398, 1324, 1291, 1252, 1223, 1181, 1123, 1099, 1032, 909, 828, 732, 646, 614 cm–1; 
HRMS (MM) m/z calc’d for C14H20NO2+ [M+H]+: 234.1489, found 234.1494. 
 
3-benzyl-1-(4-methoxyphenyl)pyrrolidin-2-one (30g): Compound 30g was prepared from 
benzyl bromide using General Procedure 3. The resulting crude oil was purified by column 
chromatography (20% EtOAc in hexanes) to afford 30g as a colorless solid (2.25 g, 8.00 mmol, 
80% yield); 1H NMR (500 MHz, CDCl3) δ 1H NMR (500 MHz, CDCl3) δ 7.55 – 7.44 (m, 2H), 
7.33 – 7.28 (m, 2H), 7.26 – 7.21 (m, 3H), 6.95 – 6.86 (m, 2H), 3.81 (s, 3H), 3.68 (dt, J = 9.5, 7.7 
Hz, 1H), 3.55 (ddd, J = 9.5, 8.6, 3.5 Hz, 1H), 3.31 (dd, J = 13.6, 4.0 Hz, 1H), 2.96 – 2.88 (m, 1H), 
2.80 (dd, J = 13.7, 9.4 Hz, 1H), 2.17 (dddd, J = 12.3, 8.6, 7.5, 3.5 Hz, 1H), 1.86 (dq, J = 12.7, 8.5 
Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 175.1, 156.9, 139.7, 133.1, 129.4, 128.8, 126.7, 122.0, 
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1514, 1494, 1455, 1443, 1396, 1324, 1284, 1256, 1226, 1180, 1125, 1088, 1032, 824, 748, 733, 
701, 618 cm–1; HRMS (MM) m/z calc’d for C18H20NO2+ [M+H]+: 282.1489, found 282.1500. 
2.8.2.3  General Procedures for Pd-Catalyzed a-arylation of g-lactams 
Method A: In a nitrogen-filled glovebox, to an oven-dried 4 mL vial equipped with a stir bar was 
added 1,1′-Bis[(2S,5S)-2,5-diethylphospholano]ferrocene L9 (7.06 mg, 15 µmol, 0.075 equiv), 
Pd2(pmdba)3 (5.5 mg, 5 µmol, 0.025 equiv), and dioxane (0.4 mL). The vial was capped with a 
PTFE-lined septum cap and stirred at 40 °C. After 20 minutes, the mixture was cooled to ambient 
temperature and the corresponding aryl chloride 31 (1.0 equiv) was added. A solution of protected-
lactam 30 (1.5 equiv) and LiHMDS (50.2 mg, 0.3 mmol, 1.5 equiv) was then added to the resulting 
mixture, and the reaction was sealed with electrical tape and stirred at 100 °C for 6 h, unless 
otherwise noted. The solution was cooled to ambient temperature, quenched with saturated NH4Cl 
solution, and extracted with EtOAc five times. The combined organic layers were dried over 
Na2SO4 and concentrated. The crude reaction mixture was purified by silica gel flash 
chromatography to furnish the product.  
Method B:  In a nitrogen-filled glovebox, to an oven-dried 4 mL vial equipped with a stir bar was 
added 1,1′-Bis[(2S,5S)-2,5-dimethylphospholano]ferrocene L10 (7.06 mg, 15 µmol, 0.075 equiv), 
Pd2(pmdba)3 (5.5 mg, 5 µmol, 0.025 equiv), and dioxane (0.4 mL). The vial was capped with a 
PTFE-lined septum cap and stirred at 40 °C. After 20 minutes, the mixture was cooled to ambient 
temperature and the corresponding aryl bromide 2 (1.0 equiv) was added. A solution of protected-
lactam 30 (1.5 equiv) and NaHMDS (55.0 mg, 0.3 mmol, 1.5 equiv) was added to the resulting 
mixture, and the reaction was sealed with electrical tape and stirred at 80 °C for 15 h, unless 
otherwise noted. The solution was cooled to ambient temperature, quenched with saturated NH4Cl 
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solution, and extracted with EtOAc five times. The combined organic layers were dried over 
Na2SO4 and concentrated. The crude reaction mixture was purified by silica gel flash 
chromatography to furnish the product.  
2.8.2.4 Spectroscopic Data for Products from Catalytic Reactions 
The absolute configuration of 32ab was determined via x-ray crystallographic analysis. The 
absolute configuration for all other products has been inferred by analogy. See Appendix 4.   
 
(S)-1-(4-methoxyphenyl)-3-methyl-3-phenylpyrrolidin-2-one (32aa): Product 32aa was 
prepared using Method A and purified by column chromatography (25% EtOAc in hexanes) to 
provide a colorless oil (34.9 mg, 0.124 mmol, 65% yield); 94% ee; [a]D25 –284.5 (c 0.98, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.56 – 7.42 (m, 2H), 7.40 – 7.30 (m, 2H), 7.32 – 7.12 (m, 3H), 6.91 
– 6.79 (m, 2H), 3.73 (s, 3H), 3.64 (qdd, J = 9.6, 8.0, 5.3 Hz, 2H), 2.50 (ddd, J = 12.7, 6.7, 3.9 Hz, 
1H), 2.20 (dt, J = 12.7, 8.0 Hz, 1H), 1.56 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 176.6, 156.9, 
143.6, 133.3, 128.9, 127.2, 126.4, 121.8, 114.3, 55.8, 50.3, 45.9, 35.2, 25.8; IR (Neat Film, NaCl) 
3057, 2932, 2963, 2874, 1690, 1511, 1429, 1463, 1396, 1321, 1299, 1248, 1181, 1088, 1070, 1032, 
881, 829, 768, 699, 634 cm–1; HRMS (MM) m/z calc’d for C18H20NO2+ [M+H]+: 282.1489, found 
282.1490; SFC Conditions: 20% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): 
minor = 5.69, major = 6.73. 
Method B: Product 32aa was prepared using Method B. The crude product was purified by 
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[a]D25 –284.0 (c 0.70, CHCl3); SFC Conditions: 20% IPA, 2.5 mL/min, Chiralcel OD-H column, 
λ = 254 nm, tR (min): minor = 5.70, major = 6.70. 
 
(S)-1-(3,5-dimethoxyphenyl)-3-methyl-3-phenylpyrrolidin-2-one (32ba): Product 32ba was 
prepared using general Method A, allowing the reaction to stir for 20 h.  The crude product was 
purified by column chromatography (33% EtOAc in hexanes) to provide a colorless oil (33.1 mg, 
0.106 mmol, 53% yield); 89% ee; [a]D25 –123.4 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
7.41 – 7.43 (m, 2H), 7.32 – 7.36 (m, 2H), 7.25 (ddt, J = 8.0, 6.6, 1.2 Hz, 1H), 6.98 (d, J = 2.2 Hz, 
2H), 6.29 (t, J = 2.2 Hz, 1H), 3.80 (s, 6H), 3.75 (ddd, J = 9.6, 8.1, 3.7 Hz, 1H), 3.70 (ddd, J = 9.6, 
8.1, 6.9 Hz, 1H), 2.58 (ddd, J = 12.7, 6.9, 3.7 Hz, 1H), 2.26 (dt, J = 12.7, 8.1 Hz, 1H), 1.64 (s, 3H); 
13C NMR (125 MHz, CDCl3) δ 177.3, 161.2, 143.2, 141.8, 129.0, 127.2, 126.4, 98.3, 97.0, 55.7, 
50.9, 45.7, 34.8, 25.7; IR (Neat Film, NaCl) 3057, 2962, 2934, 2841, 1699, 1598, 1479, 1459, 
1447, 1391, 1275, 1249, 1208, 1155, 1067, 835, 701 cm–1; HRMS (MM) m/z calc’d for 
C19H22NO3+ [M+H]+: 312.1594, found 312.1594; SFC Conditions: 20% IPA, 2.5 mL/min, 
Chiralcel OD-H column, λ = 254 nm, tR (min): minor = 5.29, major= 6.47. 
Method B: Product 32ba was prepared using Method B, allowing the reaction to stir for 20 h.  The 
crude reaction was purified by column chromatography to provide a yellow solid (52.9 mg, 0.170 
mmol, 85% yield); 92% ee; [a]D25 –141.0 (c 1.00, CHCl3); SFC Conditions: 20% IPA, 2.5 mL/min, 











(S)-1-(2-methoxyphenyl)-3-methyl-3-phenylpyrrolidin-2-one (32ca): Product 32ca was 
prepared using general Method A, allowing the reaction to stir for 20 h. The crude product was 
purified by column chromatography (33% EtOAc in hexanes) to provide a colorless oil (18.3 mg, 
65 µmol, 33% yield); 79% ee; [a]D25 – 44.7 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.53 
– 7.55 (m, 2H), 7.34 – 7.38 (m, 2H), 7.24 – 7.30 (m, 3H), 6.95 – 7.01 (m, 2H), 3.83 (s, 3H), 3.63 
– 3.71 (m, 2H), 2.56 (ddd, J = 12.6, 6.9, 4.5 Hz, 1H), 2.34 (dt, J = 12.5, 7.7 Hz, 1H), 1.66 (s, 3H); 
13C NMR (125 MHz, CDCl3) δ 177.8, 155.3, 144.2, 129.1, 129.0, 128.7, 127.9, 126.9, 126.7, 
121.2, 112.4, 55.9, 49.1, 46.9, 36.7, 25.6; IR (Neat Film, NaCl) 3060, 2964, 2927, 1698, 1597, 
1504, 1461, 1406, 1304, 1280, 1252, 1122, 1025, 752, 700 cm–1; HRMS (MM) m/z calc’d for 
C18H20NO2+ [M+H]+: 282.1489, found 282.1492; SFC Conditions: 20% IPA, 2.5 mL/min, 
Chiralcel OD-H column, λ = 210 nm, tR (min): minor = 4.85, major = 6.04. 
Method B: Product 32ba was prepared using Method B, allowing the reaction to stir for 20 h.  The 
crude reaction was purified by column chromatography to provide a yellow solid (26.7 mg, 0.1 
mmol, 47% yield); 90% ee; [a]D25 –64.5 (c 0.84, CHCl3); SFC Conditions: 20% IPA, 2.5 mL/min, 
Chiralcel OD-H column, λ = 210 nm, tR (min): minor = 4.80, major= 5.83. 
 
(S)-3-methyl-1,3-diphenylpyrrolidin-2-one (32da): Product 32da was prepared using general 
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chromatography (33% EtOAc in hexanes) to provide a yellow oil (29.3 mg, 0.117 mmol, 58% 
yield); 90% ee; [a]D25 –87.2 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.69 – 7.72 (m, 2H), 
7.44 – 7.46 (m, 2H), 7.37 – 7.41 (m, 2H), 7.33 – 7.37 (m, 2H), 7.24 – 7.28 (m, 1H), 7.15 – 7.18 
(m, 1H), 3.79 (ddd, J = 9.6, 8.0, 3.7 Hz, 1H), 3.74 (ddd, J = 9.6, 8.1, 6.9 Hz, 1H), 2.60 (ddd, J = 
12.6, 6.8, 3.7 Hz, 1H), 2.29 (dt, J = 12.7, 8.0 Hz, 1H), 1.65 (s, 3H); 13C NMR (125 MHz, CDCl3) 
δ 177.0, 143.4, 139.9, 129.1, 128.9, 127.2, 126.4, 124.8, 120.1, 50.5, 45.5, 35.0, 25.7; IR (Neat 
Film, NaCl) 3061, 3030, 2967, 2928, 2875, 1710, 1694, 1597, 1494, 1458, 1445, 1393, 1304, 1225, 
1091, 1072, 1031, 901, 878, 759, 699 cm–1; HRMS (MM) m/z calc’d for C17H18NO+ [M+H]+: 
252.1383, found 252.1385; SFC Conditions: 10% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 
254 nm, tR (min): minor = 9.96, major = 10.52. 
Method B: Product 32da was prepared using Method B, allowing the reaction to stir for 20 h. The 
crude reaction mixture was purified by column chromatography to provide a yellow oil (45.8 mg, 
0.182 mmol, 91% yield); 93% ee; [a]D25 –82.6 (c 1.00, CHCl3); SFC Conditions: 10% IPA, 2.5 
mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): minor = 10.51, major = 11.01. 
 
(S)-3-methyl-3-phenyl-1-(4-(trifluoromethyl)phenyl)pyrrolidin-2-one (32ea): Product 32ea 
was prepared using general Method A, allowing the reaction to stir for 20 h. The crude product 
was purified by column chromatography (33% EtOAc in hexanes) to provide a yellow oil (25.3 
mg, 79 µmol, 40% yield); 73% ee; [a]D25 –92.0 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 
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(m, 1H), 3.81 (ddd, J = 9.5, 8.0, 3.6 Hz, 1H), 3.75 (ddd, J = 9.5, 8.2, 6.9 Hz, 1H), 2.65 (ddd, J = 
12.8, 6.9, 3.6 Hz, 1H), 2.31 (dt, J = 12.8, 8.1 Hz, 1H), 1.65 (s, 3H); 13C NMR (125 MHz, CDCl3) 
δ 177.6, 142.9, 129.1, 127.4, 126.6 – 126.2 (m), 125.5, 123.4, 119.4, 50.7, 45.3, 34.7, 25.8; 19F 
(282 MHz, CDCl3) δ –62.1; IR (Neat Film, NaCl) 2925, 1700, 1614, 1520, 1490, 1457, 1387, 
1321, 1222, 1163, 1117, 1064, 1012, 839, 765, 698 cm–1; HRMS (MM) m/z calc’d for 
C18H17F3NO+ [M+H]+: 320.1257, found 320.1260; SFC Conditions: 20% IPA, 2.5 mL/min, 
Chiralcel OD-H column, λ = 254 nm, tR (min): minor = 3.03, major = 3.23. 
Method B: Product 32ea was prepared using Method B, allowing the reaction to stir for 20 h. The 
crude product was  purified by column chromatography to provide a yellow oil (40.9 mg, 0.128 
mmol, 64% yield); 56% ee; [a]D25 –16.9 (c 1.00, CHCl3); SFC Conditions: 20% IPA, 2.5 mL/min, 
Chiralcel OD-H column, λ = 254 nm, tR (min): minor = 2.95, major = 3.14. 
 
(S)-1-benzyl-3-methyl-3-phenylpyrrolidin-2-one (32fa): Product 32fa was prepared using 
Method A, allowing the reaction to stir for 20 h. The crude product was purified by column 
chromatography (33% EtOAc in hexanes) to provide a yellow oil (23.0 mg, 87 µmol, 43% yield); 
95% ee; [a]D25 –21.4 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.43 (m, 2H), 7.30 – 
7.31 (m, 4H), 7.27 – 7.30 (m, 1H), 7.22 – 7.26 (m, 3H), 4.55 (d, J = 14.7 Hz, 1H), 4.52 (d, J = 14.9 
Hz, 1H), 3.15 – 3.22 (m, 2H), 2.41 (ddd, J = 12.8, 6.7, 5.2 Hz, 1H), 2.12 (ddd, J = 12.8, 7.9, 7.1 
Hz, 1H), 1.58 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 177.7, 144.1, 136.9, 129.0, 128.8, 128.5, 
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2868, 1686, 1494, 1425, 1269, 1078, 1029, 766, 747, 699 cm–1; HRMS (MM) m/z calc’d for 
C18H20NO+ [M+H]+: 266.1539, found 266.1541; SFC Conditions: 20% IPA, 2.5 mL/min, Chiralcel 
OD-H column, λ = 210 nm, tR (min): minor = 6.24, major = 6.48. 
Method B: Product 32fa was prepared using Method B, allowing the reaction to stir for 20 h.  The 
crude product was purified by column chromatography to provide a yellow oil (29.1 mg, 0.110 
mmol, 55% yield); 92% ee; [a]D25 –17.7 (c 1.00, CHCl3); SFC Conditions: 20% IPA, 2.5 mL/min, 
Chiralcel OD-H column, λ = 210 nm, tR (min): minor = 6.14, major = 6.47. 
 
 
(S)-1-(4-methoxyphenyl)-3-methyl-3-(naphthalen-2-yl)pyrrolidin-2-one (32ab): Product 32ab 
was prepared using Method A and purified by column chromatography (25% EtOAc in hexanes) 
to provide a colorless oil (54.8 mg, 0.165 mmol, 83% yield); 94% ee; [a]D25 –159.0 (c 0.70, 
CHCl3); 1H NMR (400 MHz, CDCl3)  δ 7.86 – 7.83 (m, 2H), 7.82 – 7.78 (m, 2H), 7.63 – 7.58 (m, 
3H), 7.50 – 7.41 (m, 2H), 6.96 – 6.90 (m, 2H), 3.81 (s, 3H), 3.78 – 3.70 (m, 2H), 2.70 (ddd, J = 
12.6, 6.6, 4.0 Hz, 1H), 2.35 (dt, J = 12.7, 8.0 Hz, 1H), 1.73 (s, 3H); 13C NMR (100 MHz, CDCl3) 
δ 176.5, 156.9, 140.9, 133.5, 133.2, 132.6, 128.8, 128.4, 127.8, 126.5, 126.2, 125.0, 124.9, 122.0, 
114.4, 55.8, 50.6, 46.0, 35.2, 25.8; IR (Neat Film, NaCl) 3054, 2964, 2834, 1689, 1512, 1396, 
1290, 1299, 1248, 1182, 1093, 1033, 951, 859, 827, 751, 639 cm–1; HRMS (MM) m/z calc’d for 
C22H22NO2+ [M+H]+: 332.1645, found 332.1649; SFC Conditions: SFC Conditions: 30% IPA, 2.5 
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Method B: Product 32ab was prepared using Method B.  The crude product was purified by 
column chromatography to provide a colorless oil (50 mg, 0.151 mmol, 75% yield); 93% ee; [a]D25 
–176.0 (c 0.70, CHCl3); SFC Conditions: 30% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 254 
nm, tR (min): minor = 5.69, major = 7.12. 
 
(S)-1-(4-methoxyphenyl)-3-methyl-3-(4-(trifluoromethyl)phenyl)pyrrolidin-2-one (32ac): 
Product 32ac was prepared using Method A and purified by column chromatography (25% EtOAc 
in hexanes) to provide a colorless oil (61.5 mg, 0.176 mmol, 88% yield); 94% ee; [a]D25 –109.8 (c 
0.70, CHCl3); 1H NMR (400 MHz, CDCl3)  δ 7.65 – 7.49 (m, 6H), 7.03 – 6.80 (m, 2H), 3.81 (s, 
3H), 3.80 (m, 2H), 2.57 (ddd, J = 12.8, 7.1, 4.4 Hz, 1H), 2.32 (ddd, J = 12.8, 7.9, 7.2 Hz, 1H), 1.65 
(s, 3H); 13C NMR (100 MHz, CDCl3) δ 175.8, 157.1 147.8, 132.9, 129.5 (q, J = 32.5 Hz), 127.0, 
125.9 (q, J = 3.8 Hz), 122.0, 114.4, 55.8, 50.3, 45.8, 34.9, 25.6; 19F NMR (282 MHz, CDCl3) δ –
62.5; IR (Neat Film, NaCl) 2965, 2935, 1691, 1618, 1513, 1455, 1444, 1398, 1328, 1300, 1250, 
1165, 1121, 1078, 1068, 1035, 1016, 829, 708, 618 cm–1; HRMS (MM) m/z calc’d for 
C19H19F3NO2+ [M+H]+: 350.1362, found 350.1367; SFC Conditions: 30% IPA, 2.5 mL/min, 












Chapter 2- Palladium-Catalyzed Enantioselective Arylation of g-Lactams with Aryl Chlorides and 
Bromides 
143  
(S)-3-(4-fluorophenyl)-1-(4-methoxyphenyl)-3-methylpyrrolidin-2-one (32ad): Product 32ad 
was prepared using Method A and purified by column chromatography (25% EtOAc in hexanes) 
to provide a colorless oil (19.5 mg, 65 µmol, 33% yield); 93% ee; [a]D25 –109.9 (c 0.6, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.64 – 7.50 (m, 2H), 7.47 – 7.34 (m, 2H), 7.07 – 6.96 (m, 2H), 6.96 
– 6.87 (m, 2H), 3.81 (s, 3H), 3.85 – 3.63 (m, 2H), 2.59 – 2.48 (m, 1H), 2.28 (dt, J = 12.7, 7.8 Hz, 
1H), 1.61 (s, 3H);  13C NMR (100 MHz, CDCl3) δ 176.4, 163.2, 160.8, 157.0, 139.4 (d, J = 3.2 
Hz), 128.1 (d, J = 8.0 Hz), 121.9, 115.7 (d, J = 21.2 Hz), 114.4, 55.8, 49.8, 45.8, 35.2, 25.9; 19F 
NMR (282 MHz, CDCl3) δ –116.2; IR (Neat Film, NaCl) 2959, 2926, 1689, 1602, 1509, 
1463,1454, 1443, 1397, 1299, 1290, 1248, 1181, 1165, 1085, 1072, 1034, 1015, 830, 750, 621 cm–
1; HRMS (MM) m/z calc’d for C18H19FNO2+ [M+H]+: 300.1394, found 300.1404; SFC Conditions: 
30% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 210 nm, tR (min): minor = 2.78, major = 3.11. 
 
(S)-3-([1,1'-biphenyl]-4-yl)-1-(4-methoxyphenyl)-3-methylpyrrolidin-2-one (32ae): Product 
32ae was prepared using Method A and purified by column chromatography (25% EtOAc in 
hexanes) to provide a colorless oil (55.4 mg, 0.155 mmol, 78% yield); 97% ee; [a]D25 –129.1 (c 
0.94, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.66 – 7.53 (m, 6H), 7.54 – 7.48 (m, 2H), 7.47 – 7.40 
(m, 2H), 7.37 – 7.30 (m, 1H), 6.95 – 6.88 (m, 2H), 3.81 (s, 3H), 3.79 – 3.70 (m, 2H), 2.63 (ddd, J 
= 12.7, 6.5, 4.3 Hz, 1H), 2.31 (d, J = 12.7 Hz, 1H), 1.67 (s, 3H); 13C NMR (100 MHz, CDCl3) 
δ176.6, 156.9, 142.7, 141.0, 140.1, 133.2, 129.1, 127.6, 127.4, 126.9, 121.9, 114.4, 55.8, 53.8, 
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1299, 1248, 1181, 1086, 1034, 1007, 829, 768, 733 cm–1; HRMS (MM) m/z calc’d for C24H24NO2+ 
[M+H]+: 358.1802, found 358.1808; SFC Conditions: 30% IPA, 2.5 mL/min, Chiralcel OD-H 
column, λ = 254 nm, tR (min):, minor = 7.40, major = 8.83. 
 
(S)-1-(4-methoxyphenyl)-3-methyl-3-(p-tolyl)pyrrolidin-2-one (32af): Product 32af was 
prepared using Method A and purified by column chromatography (25% EtOAc in hexanes) to 
provide a colorless oil (28.8 mg, 98 µmol, 49% yield); 91% ee; [a]D25 –64.6 (c 0.50, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 7.67 – 7.52 (m, 2H), 7.35 – 7.29 (m, 2H), 7.20 – 7.11 (m, 2H), 6.96 – 
6.87 (m, 2H), 3.81 (s, 3H), 3.76 – 3.63 (m, 2H), 2.56 (ddd, J = 12.7, 6.5, 3.9 Hz, 1H), 2.32 (s, 3H), 
2.26 (dt, J = 12.6, 8.1 Hz, 1H), 1.61 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 176.8, 156.8, 140.6, 
136.8, 133.3, 129.6, 126.3, 121.8, 114.3, 55.8, 50.0, 45.9, 35.2, 25.8, 21.3; IR (Neat Film, NaCl) 
2960, 1689, 1511, 1452, 1395, 1289, 1249, 1182, 1086, 1031, 828, 749 cm–1; HRMS (MM) m/z 
calc’d for C19H22NO2+ [M+H]+: 296.1645, found 296.1650; SFC Conditions: 30% IPA, 2.5 
mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): minor = 3.29, major = 3.63. 
Method B: Product 32af was prepared using Method B. The crude product was purified by column 
chromatography to provide a colorless oil (33.6 mg, 0.114 mmol, 57% yield); 95% ee; [a]D25 –
125.8 (c 0.70, CHCl3); SFC Conditions: 30% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 254 










(S)-3-(4-(tert-butyl)phenyl)-1-(4-methoxyphenyl)-3-methylpyrrolidin-2-one (32ag): Product 
32ag was prepared using Method A and purified by column chromatography (25% EtOAc in 
hexanes) to provide a colorless oil (39.9 mg, 0.118 mmol, 60% yield); 91% ee; [a]D25 –121.0 (c 
0.93, CHCl3); 1H NMR (400 MHz, CDCl3)  δ 7.62 – 7.55 (m, 2H), 7.35 (d, J = 0.6 Hz, 4H), 6.97 
– 6.84 (m, 2H), 3.80 (s, 3H), 3.73 (ddd, J = 8.2, 5.4, 3.1 Hz, 2H), 2.58 (ddd, J = 12.6, 6.4, 4.3 Hz, 
1H), 2.26 (dt, J = 12.7, 7.9 Hz, 1H), 1.62 (s, 3H), 1.30 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 
176.9, 156.8, 149.9, 140.5, 133.4, 126.1, 125.8, 121.8, 114.3, 55.8, 49.9, 45.9, 35.1, 34.7, 31.6, 
25.7; IR (Neat Film, NaCl) 2962, 2869, 1693, 1512, 1396, 1363, 1321, 1290, 1299, 1249, 1182, 
1121, 1086, 1034, 829, 796, 758, 618 cm–1; HRMS (MM) m/z calc’d for C22H28NO2+ [M+H]+: 
338.2115, found 338.2120; SFC Conditions: 30% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 
254 nm, tR (min): major = 3.35, minor = 4.06. 
 
(S)-1-(4-methoxyphenyl)-3-methyl-3-(4-(pyrrolidine-1 carbonyl)phenyl)pyrrolidin-2-one 
(32ah): Product 32ah was prepared using Method B and purified by column chromatography (25% 
EtOAc in hexanes) to provide a colorless oil (65.9 mg, 0.174 mmol, 87% yield); 81% ee; [a]D25 –
89.2 (c 0.70, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.63 – 7.54 (m, 2H), 7.51 – 7.43 (m, 4H), 
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2H), 2.54 (ddd, J = 12.7, 6.9, 3.9 Hz, 1H), 2.28 (dt, J = 12.7, 7.9 Hz, 1H), 2.00 – 1.92 (m, 2H), 
1.91 – 1.79 (m, 2H), 1.63 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 176.3, 169.7, 157.0, 145.4, 136.1, 
133.0, 127.7, 126.4, 121.9, 114.4, 55.8, 50.3, 50.0, 46.5, 45.9, 35.1, 26.7, 25.6, 24.8; IR (Neat 
Film, NaCl) 2968, 2876, 1689, 1623, 1562, 1512, 1426, 1398, 1298, 1249, 1182, 1116, 1085, 1033, 
933, 830, 749, 707, 663 cm–1; HRMS (MM) m/z calc’d for C23H27N2O3+ [M+H]+: 379.2016, found 
379.2011; SFC Conditions: 30% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): 
minor = 9.00, major =10.34. 
 
(S)-3-(3-methoxyphenyl)-1-(4-methoxyphenyl)-3-methylpyrrolidin-2-one (32ai): 
Product 32ai was prepared using Method A and purified by column chromatography (25% EtOAc 
in hexanes) to provide a colorless oil (43.0 mg, 0.138 mmol, 69% yield); 86% ee; [a]D25 –109.9 (c 
0.70, CHCl3); 1H NMR (300 MHz, CDCl3) δ 7.62 – 7.53 (m, 2H), 7.30 – 7.21 (m, 1H), 7.05 – 6.98 
(m, 2H), 6.95 – 6.86 (m, 2H), 6.79 (ddd, J = 8.2, 2.3, 1.1 Hz, 1H), 3.80 (s, 3H), 3.79 (s, 3H),  3.77 
– 3.67 (m, 2H), 2.57 (ddd, J = 12.7, 6.5, 4.2 Hz, 1H), 2.26 (dt, J = 12.7, 8.0 Hz, 1H), 1.62 (s, 3H); 
13C NMR (100 MHz, CDCl3)  δ 176.5, 160.1, 156.9, 145.3, 133.2, 129.9, 121.9, 118.8, 114.4, 
112.8, 112.1, 55.8, 55.6, 50.3, 45.9, 35.2, 25.8; IR (Neat Film, NaCl) 3052, 2962, 2935, 2836, 
1693, 1682, 1600, 1582, 1513, 1488, 1456, 1464, 1430, 1395, 1320, 1290, 1247, 1181, 1124, 1089, 
1036, 932, 914, 882, 829, 792, 751, 701, 667, 637 cm–1; HRMS (MM) m/z calc’d for C19H22NO3+ 
[M+H]+: 312.1594, found 312.1590; SFC Conditions: 30% IPA, 4.0 mL/min, Chiralpak AD-H 











Product 32aj was prepared using Method A and purified by column chromatography (20% EtOAc 
in hexanes) to provide a colorless oil (53.3 mg, 0.153 mmol, 75% yield); 96% ee; [a]D25 –105.7 (c 
0.93, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.74 – 7.70 (m, 1H), 7.67 (dddd, J = 7.8, 1.9, 1.3, 0.6 
Hz, 1H), 7.61 – 7.40 (m, 4H), 6.97 – 6.89 (m, 2H), 3.81 (s, 4H), 3.75 –  3.69 (m, 1H), 2.58 (ddd, 
J = 12.8, 7.3, 4.7 Hz, 1H), 2.33 (ddd, J = 12.9, 7.9, 6.9 Hz, 1H), 1.65 (d, J = 1.6 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 175.9, 157.1, 144.8, 132.9, 131.2 (q, J = 32.0 Hz), 130.2, 129.4, 127.0, 126.2 
– 125.6 (m), 124.3 – 124.0 (m), 123.2 (q, J = 3.8 Hz), 122.0, 114.4, 55.8, 50.1, 45.9, 34.9, 25.7; 
19F NMR (282 MHz, CDCl3) δ –62.5; IR (Neat Film, NaCl) 2932, 2962, 2838, 1721, 1692, 1681, 
1512, 1504, 1493, 1442, 1400, 1329, 1299, 1249, 1163, 1119, 1075, 1034, 829, 802, 702 cm–1; 
HRMS (MM) m/z calc’d for C19H19F3NO2+ [M+H]+: 350.1362, found 350.1359; SFC Conditions: 
30% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): minor = 2.52, major = 2.97. 
 
(S)-1-(4-methoxyphenyl)-3-methyl-3-(m-tolyl)pyrrolidin-2-one (32ak): Product 32ak was 
prepared using Method B and purified by column chromatography (25% EtOAc in hexanes) to 
provide a colorless oil (41.4 mg, 0.140 mmol, 70% yield); 97% ee; [a]D25 –209.3 (c 0.79, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 9.2 Hz, 2H), 7.31 – 7.18 (m, 3H), 7.06 (t, J = 5.5 Hz, 
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2.26 (dt, J = 12.7, 8.0 Hz, 1H), 1.62 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 176.7, 156.8, 143.5, 
138.5, 133.3, 128.8, 127.9, 127.2, 123.4, 121.8, 114.3, 55.8, 50.2, 45.9, 35.3, 25.8, 22.0; IR (Neat 
Film, NaCl) 2962, 2962, 1690, 1606, 1586, 1512, 1488, 1444, 1429, 1396, 1321, 1299, 1249, 1182, 
1124, 1086, 1034, 932, 882, 829, 788, 750, 704, 641, 612; HRMS (MM) m/z calc’d for C19H22NO2+ 
[M+H]+: 296.1645, found 296.1645; SFC Conditions: 30% IPA, 2.5 mL/min, Chiralpak AD-H 
column, λ = 254 nm, tR (min): major = 5.47, minor = 7.72. 
 
(S)-1-(4-methoxyphenyl)-3-methyl-3-(1-methyl-1H-indol-6-yl)pyrrolidin-2-one (32al): 
Product 32al was prepared using Method B and purified by column chromatography (25% EtOAc 
in hexanes) to provide a colorless oil (29.2 mg, 87 µmol, 44% yield); 92% ee; [a]D25 –94.5 (c 0.70, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.67 (dd, J = 1.9, 0.8 Hz, 1H), 7.64 – 7.56 (m, 2H), 7.38 – 
7.27 (m, 2H), 7.03 (d, J = 3.1 Hz, 1H), 6.95 – 6.88 (m, 2H), 6.44 (dd, J = 3.1, 0.8 Hz, 1H), 3.81 
(s, 3H), 3.77 (s, 3H), 3.71 (dd, J = 8.3, 4.9 Hz, 2H), 2.67 (dt, J = 12.6, 5.0 Hz, 1H), 2.31 (dt, J = 
12.6, 8.3 Hz, 1H), 1.69 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 177.3, 156.7, 135.9, 134.3, 133.5, 
129.5, 128.7, 121.8, 120.5, 118.3, 114.3, 109.7, 101.4, 55.8, 50.4, 46.0, 35.8, 33.2, 26.5; IR (Neat 
Film, NaCl) 2961, 1688, 1614, 1511, 1490, 1394, 1294, 1248, 1181, 1124, 1089, 1034, 884, 827, 
798, 730, 654 cm–1; HRMS (MM) m/z calc’d for C21H23N2O2+ [M+H]+: 335.1754, found 335.1752; 
SFC Conditions: 30% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): minor = 










(S)-3-benzyl-1-(4-methoxyphenyl)-3-(naphthalen-2-yl)pyrrolidin-2-one (32gb):  
Product 32gb was prepared using general Method A, allowing the reaction to stir for 20 h. The 
crude product was purified by column chromatography (33% EtOAc in hexanes) to provide a 
colorless solid (47.7 mg, 0.117 mmol, 59% yield); 91% ee; [a]D25 –172.6 (c 1.00, CHCl3); 1H 
NMR (500 MHz, CDCl3) δ 7.96 (d, J = 2.0 Hz, 1H), 7.86 (d, J = 8.8 Hz, 1H), 7.80 – 7.85 (m, 2H), 
7.72 (dd, J = 8.7, 2.0 Hz, 1H), 7.46 – 7.49 (m, 2H), 7.41 – 7.45 (m, 2H), 7.21 – 7.23 (m, 3H), 7.15 
– 7.17 (m, 2H), 6.87 – 6.90 (m, 2H), 3.79 (s, 3H), 3.51 – 3.56 (m, 2H), 3.24 – 3.29 (m, 2H), 2.60 
(ddd, J = 12.9, 7.1, 3.7 Hz, 1H), 2.48 (dt, J = 13.0, 7.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ  
175.1, 157.0, 139.4, 137.6, 133.5, 133.0, 132.7, 130.8, 128.6, 128.6, 128.5, 127.7, 127.0, 126.4, 
126.3, 125.6, 125.6, 122.3, 114.3, 55.8, 55.2, 46.1, 45.7, 30.2; IR (Neat Film, NaCl) 3058, 2951, 
2929, 2836, 1687, 1600, 1512, 1454, 1397, 1321, 1299, 1249, 1181, 1036, 828, 749, 703 cm–1; 
HRMS (MM) m/z calc’d for C28H26NO2+ [M+H]+: 408.1958, found 408.1962; SFC Conditions: 
30% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): major = 8.16, minor = 9.63. 
 
(S)-3-ethyl-1-(4-methoxyphenyl)-3-(naphthalen-2-yl)pyrrolidin-2-one (32hb). Product 32hb 
was prepared using Method A, allowing the reaction to stir for 20 h. The crude product was purified 









Chapter 2- Palladium-Catalyzed Enantioselective Arylation of g-Lactams with Aryl Chlorides and 
Bromides 
150  
46% yield); 93% ee; [a]D25 –167.2 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.91 – 7.93 (br 
s, 1H), 7.80 – 7.85 (m, 3H), 7.70 (dd, J = 8.5, 1.9 Hz, 1H), 7.54 – 7.57 (m, 2H), 7.44 – 7.49 (m, 
2H), 6.88 – 6.92 (m, 2H), 3.80 (s, 3H), 3.74 – 3.77 (m, 2H), 2.74 (ddd, J = 12.8, 5.6, 4.0 Hz, 1H), 
2.41 (dt, J = 12.7, 8.5 Hz, 1H), 2.18 – 2.25 (m, 1H), 2.03 – 2.10 (m, 1H), 0.93 (t, J = 7.4 Hz, 3H); 
13C NMR (125 MHz, CDCl3) δ 175.8, 156.8, 138.8, 133.5, 133.2, 132.6, 128.6, 128.4, 127.7, 
126.4, 126.2, 125.6 – 125.3 (m), 122.0, 114.3, 55.8, 54.3, 46.1, 32.3, 30.5, 9.5; IR (Neat Film, 
NaCl) 3055, 2963, 2932, 2877, 1687, 1512, 1464, 1396, 1298, 1249, 1181, 1035, 828, 750 cm–1; 
HRMS (MM) m/z calc’d for C23H24NO2+ [M+H]+: 346.1802, found 346.1805; SFC Conditions: 
30% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 210 nm, tR (min): minor = 5.01, major = 6.05. 
 
(S)-3-benzyl-1-(4-methoxyphenyl)-3-phenylpyrrolidin-2-one (32ga): Product 32ga was 
prepared using Method B, allowing the reaction to stir for 20 h. The crude product was purified by 
column chromatography (33% EtOAc in hexanes) to provide a colorless oil (29.0 mg, 81 µmol, 
41% yield); 90% ee; [a]D25 –90.0  (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.53 – 7.56 (m, 
2H), 7.40 – 7.43 (m, 2H), 7.33 – 7.37 (m, 2H), 7.25 – 7.28 (m, 1H), 7.20 – 7.24 (m, 3H), 7.11 – 
7.13 (m, 2H), 6.85 – 6.89 (m, 2H), 3.79 (s, 3H), 3.49 (dt, J = 9.4, 7.4 Hz, 1H), 3.44 (d, J = 13.4 
Hz, 1H), 3.23 (ddd, J = 9.3, 8.1, 3.9 Hz, 1H), 3.14 (d, J = 13.5 Hz, 1H), 2.48 (ddd, J = 12.9, 7.1, 
3.9 Hz, 1H), 2.39 (dt, J = 13.0, 7.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 175.2, 156.9, 142.2, 
137.7, 133.0, 130.7, 128.8, 128.5, 127.4, 127.1, 127.0, 122.2, 114.3, 55.8, 55.0, 46.0, 45.8, 30.1; 
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828, 701 cm–1;  HRMS (MM) m/z calc’d for C24H24NO2+ [M+H]+: 358.1802, found 358.1805; SFC 
Conditions: 25% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): major = 6.45, 
minor = 7.11. 
 
(S)-3-ethyl-1-(4-methoxyphenyl)-3-phenylpyrrolidin-2-one (32ha): Product 32ha was 
prepared using Method B, allowing the reaction to stir for 20 h. The crude product was purified by 
column chromatography (33% EtOAc in hexanes) to provide a light yellow oil (29.5 mg, 0.100 
mmol, 50% yield) 89% ee; [a]D25 –77.2 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.52 – 
7.56 (m, 2H), 7.43 – 7.52 (m, 2H), 7.31 – 7.36 (m, 2H), 7.22 – 7.27 (m, 1H), 6.87 – 6.91 (m, 2H), 
3.79 (s, 3H), 3.65 – 3.75 (m, 2H), 2.60 (ddd, J = 12.9, 6.5, 3.2 Hz, 1H), 2.33 (dt, J = 12.9, 8.5 Hz, 
1H), 2.05 – 2.13 (m, 1H), 1.93 – 2.00 (m, 1H), 0.88 (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 175.9, 156.8, 141.5, 133.3, 128.8, 127.2, 126.9, 121.9, 114.3, 55.8, 54.1, 46.1, 32.4, 30.5, 
9.5; IR (Neat Film, NaCl) 3056, 2962, 2931, 1687, 1512, 1444, 1396, 1322, 1296, 1249, 1181, 
1118, 1097, 1034, 829, 764, 700 cm–1; HRMS (MM) m/z calc’d for C19H22NO2+ [M+H]+: 
296.1645, found 296.1638; SFC Conditions: 20% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 
254 nm, tR (min): major = 5.32, minor = 6.46. 
 
(S)-1-(4-methoxyphenyl)-3-phenyl-3-propylpyrrolidin-2-one (32ia): Product 32ia was 
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column chromatography (15% EtOAc in hexanes) to provide a colorless oil (27.6 mg, 89 µmol, 
45% yield); 90% ee; [a]D25 –120.0 (c 0.70, CHCl3); 1H NMR (400 MHz, CDCl3) 7.57 – 7.48 (m, 
4H), 7.37 – 7.30 (m, 2H), 7.26 – 7.21 (m, 1H), 6.93 – 6.85 (m, 2H), 3.79 (s, 3H), 3.75 – 3.65 (m, 
2H), 2.62 (ddd, J = 12.9, 6.3, 3.4 Hz, 1H), 2.33 (dt, J = 12.9, 8.5 Hz, 1H), 2.04 (ddd, J = 13.7, 
11.1, 5.9 Hz, 1H), 1.93 – 1.82 (m, 1H), 1.34 – 1.20 (m, 2H), 0.90 (t, J = 7.3 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ 175.9, 156.8, 141.7, 133.3, 128.8, 127.1, 126.8, 121.8, 114.3, 55.8, 53.7, 
46.1, 42.0, 31.0, 18.4, 14.8; IR (Neat Film, NaCl) 2957, 2932, 2872, 1687, 1512, 1463, 1444, 1430, 
1396, 1322, 1298, 1249, 1181, 1098, 1034, 883, 829, 964, 731, 700, 638 cm–1; HRMS (MM) m/z 
calc’d for C20H24NO2+ [M+H]+: 310.1802, found 310.1807; SFC Conditions: 40% IPA, 2.5 
mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 2.94 , major = 3.47. 
 
(S)-1-(4-methoxyphenyl)-3-phenethyl-3-phenylpyrrolidin-2-one (32ja): Product 32ja was 
prepared using Method B, allowing the reaction to stir for 20 h. The crude product was purified by 
column chromatography (25% EtOAc in hexanes) to provide a colorless oil (39.9 mg, 0.107 mmol, 
54% yield); 78% ee; [a]D25 –95.7 (c 0.70, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.62 – 7.49 (m, 
4H), 7.41 – 7.31 (m, 2H), 7.29 – 7.23 (m, 3H),  7.20 – 7.09 (m, 3H), 6.96 – 6.84 (m, 2H), 3.80 (s, 
3H), 3.79 – 3.67 (m, 2H), 2.71 – 2.60 (m, 2H), 2.51 (td, J = 12.7, 4.7 Hz, 1H), 2.44 – 2.34 (m, 2H), 
2.21 (ddd, J = 13.5, 12.2, 4.7 Hz, 1H).13C NMR (100 MHz, CDCl3) δ 175.6, 156.9, 142.3, 141.2, 
133.2, 129.0, 128.7, 127.4, 126.9, 126.1, 121.9, 114.3, 55.8, 53.7, 46.1, 41.5, 31.4; IR (Neat Film, 
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730, 654 cm–1; HRMS (MM) m/z calc’d for C25H26NO2+ [M+H]+: 372.1958, found 372.1961; SFC 
Conditions: 30% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): minor = 5.03, 
major = 5.40. 
 
(S)-1-(4-methoxyphenyl)-3-(naphthalen-2-ylmethyl)-3-phenylpyrrolidin-2-one (32ka). 
Product 32ka was prepared using Method B, allowing the reaction to stir for 20 h. The crude 
product was purified by column chromatography (33% EtOAc in hexanes) to provide a colorless 
oil (48.0 mg, 0.118 mmol, 59% yield); 94% ee; [a]D25 –128.4 (c 1.00, CHCl3); 1H NMR (500 MHz, 
CDCl3) δ 7.77 – 7.81 (m, 1H), 7.72 – 7.75 (m, 1H), 7.68 (d, J = 8.4 Hz, 1H), 7.60 (br s, 1H), 7.56 
– 7.59 (m, 2H), 7.42 – 7.46 (m, 2H), 7.34 – 7.41 (m, 4H), 7.27 – 7.30 (m, 1H), 7.22 (dd, J = 8.4, 
1.8 Hz, 1H), 6.84 – 6.87 (m, 2H), 3.79 (s, 3H), 3.62 (d, J = 13.5 Hz, 1H), 3.50 (ddd, J = 9.4, 8.0, 
7.0 Hz, 1H), 3.31 (d, J = 13.5 Hz, 1H), 3.24 (ddd, J = 9.4, 8.0, 3.6 Hz, 1H), 2.50 (ddd, J = 12.9, 
7.0, 3.6 Hz, 1H), 2.44 (dt, J = 12.9, 8.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 175.2, 156.9, 
142.0, 135.4, 133.6, 133.0, 132.6, 129.4, 129.1, 128.9, 128.0, 127.9, 127.9, 127.4, 127.1, 126.2, 
125.9, 122.2, 114.3, 55.8, 55.2, 46.1, 45.9, 30.0; IR (Neat Film, NaCl) 3054, 2952, 2836, 1688, 
1511, 1463, 1397, 1321, 1299, 1249, 1181, 1034, 909, 828, 729, 699 cm–1; HRMS (MM) m/z 
calc’d for C28H26NO2+ [M+H]+: 408.1958, found 408.1954; SFC Conditions: 10% IPA, 2.5 









Product 32gc was prepared using general Method A, allowing the reaction to stir for 20 h. The 
crude product was purified by column chromatography (25% EtOAc in hexanes) to provide a 
colorless oil (60.3 mg, 0.142 mmol, 71% yield); 94% ee; [a]D25 –188.3 (c 1.00, CHCl3); 1H NMR 
(500 MHz, CDCl3) δ 7.69 – 7.72 (m, 2H), 7.59 – 7.63 (m, 2H), 7.37 – 7.41 (m, 2H), 7.22 – 7.25 
(m, 3H), 7.11 – 7.13 (m, 2H), 6.87 – 6.90 (m, 2H), 3.80 (s, 3H), 3.49 (t, J = 7.2 Hz, 1H), 3.45 (d, 
J = 11.3 Hz, 1H), 3.22 (ddd, J = 9.4, 7.2, 5.4 Hz, 1H), 3.13 (d, J = 13.4 Hz, 1H), 2.45 – 2.53 (m, 
2H); 13C NMR (125 MHz, CDCl3) δ 174.5, 157.1, 146.5, 136.9, 132.6, 130.6, 129.5 (q, J = 32.5 
Hz), 128.6, 127.5, 127.3, 125.7 (q, J = 3.8 Hz), 123.4, 122.3, 114.3, 55.8, 54.9, 45.9, 45.9, 30.0; 
19F NMR (282 MHz, CDCl3) δ –62.5; IR (Neat Film, NaCl) 3062, 2954, 2926, 2838, 1687, 1616, 
1513, 1442, 1400, 1327, 1300, 1251, 1167, 1123, 1072, 1037, 1018, 829, 703 cm–1; HRMS (MM) 
m/z calc’d for C25H23F3NO2+ [M+H]+: 426.1675, found 426.1677; SFC Conditions: 15% IPA, 2.5 
mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): major = 5.17, minor = 5.93. 
 
(S)-3-benzyl-1-(4-methoxyphenyl)-3-(m-tolyl)pyrrolidin-2-one (32gd): Product 32gd was 
prepared using Method B, allowing the reaction to stir for 20 h. The crude product was purified by 
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64% yield); 93% ee; [a]D25 –179.0 (c 1.00, CHCl3); 1H NMR (500 MHz, CDCl3) δ 7.41 (d, J = 
16.1 Hz, 2H), 7.39 (s, 1H), 7.32 (s, 1H), 7.25 (m, 4H), 7.16 (m, 2H), 7.10 (s, 1H), 6.87 (d, J = 16.1 
Hz, 2H), 3.80 (s, 3H), 3.50 (dt, J = 9.3, 7.4 Hz, 1H), 3.45 (d, J = 13.4 Hz, 1H), 3.21 (ddd, J = 9.2, 
8.1, 3.8 Hz, 1H), 3.12 (d, J = 13.4 Hz, 1H), 2.47 (ddd, J = 12.9, 7.1, 3.8 Hz, 1H), 2.41 (s, 1H), 2.37 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 175.2, 156.9, 142.2, 138.4, 137.8, 133.1, 130.8, 128.6, 
128.4, 128.1, 127.8, 127.0, 124.0, 122.2, 114.3, 55.8, 55.0, 46.0, 45.8, 30.1, 22.0; IR (Neat Film, 
NaCl) 2923, 1686, 1604, 1584, 1511, 1453, 1299, 1249, 1180, 1119, 1099, 1036, 890, 828, 787, 
738, 703, 613 cm-1; HRMS (MM) m/z calc’d for C25H26NO2+ [M+H]+: 372.1958, found 372.1960; 
SFC Conditions: 15% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): major = 
8.44, minor = 7.00. 
Product Transformations 
 
(S)-3-methyl-3-phenylpyrrolidin-2-one (34): To a solution of 32aa (30.2 mg, 93% ee; 0.107 
mmol, 1.0 equiv) in acetonitrile (2.2 mL) at 0 °C was added a solution of ceric ammonium nitrate 
(88 mg, 0.161 mmol, 1.5 equiv) in de-ionized water (2.2 mL) dropwise. The resulting mixture was 
stirred for 30 minutes at 0 °C. Upon consumption of the starting material, the reaction was diluted 
with water and extracted with EtOAc three times. The combined organic extracts were dried over 
Na2SO4 and the product was purified by column chromatography (5% MeOH in CH2Cl2) to afford 
34 as a yellow solid (13.6 mg, 78 µmol, 73% yield).  [a]D25 –80.8 (c 0.665, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 7.47 – 7.39 (m, 2H), 7.39 – 7.30 (m, 2H), 7.26 (s, 1H), 6.88 (d, J = 22.5 Hz, 1H), 
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1.56 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 181.8, 143.7, 128.9, 127.1, 126.4, 48.2, 39.4, 38.3, 
24.8, 19.4; IR (Neat Film, NaCl) 3056, 3026, 2960, 2931, 2830, 1619, 1601, 1515, 1488, 1496, 
1464, 1445, 1366, 1281, 1240, 1180, 1081, 1042, 967, 811, 764, 700 cm–1; HRMS (MM) m/z 
calc’d for C11H14NO+ [M+H]+: 176.1070, found 176.1068. 
 
(S)-1-(4-methoxyphenyl)-3-methyl-3-phenylpyrrolidine (35): To a solution of 32aa (46.3 mg, 
93% ee, 0.170 mmol, 1.0 equiv) in diethyl ether (1.65 mL) at 0 °C was added LiAlH4 (31.2 mg, 
0.820 mmol, 5 equiv). The reaction was stirred at 0 °C for 5 min, then allowed to warm to ambient 
temperature. After 15 h, the reaction was quenched with H2O and extracted with EtOAc seven 
times. The combined organic layers were dried over Na2SO4 and concentrated in vacuo. The crude 
product was purified by column chromatography (10% EtOAc in hexanes) to afford 5 as a light 
grey solid (41.1 mg, 0.154 mmol, 93% yield); [a]D25 –85.2 (c 0.70, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ δ 7.40 – 7.30 (m, 5H), 7.26 – 7.21 (m, 1H), 6.88 (d, J = 9.0 Hz, 2H), 6.56 (d, J = 8.1 Hz, 
2H), 3.78 (s, 3H), 3.60 – 3.42 (m, 3H), 3.38 (t, J = 10.5 Hz, 1H), 2.38 – 2.25 (m, 1H), 2.24 – 2.14 
(m, 1H), 1.44 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 148.4, 143.1, 128.7, 126.5, 126.1, 115.5, 
112.3, 60.4, 56.4, 47.6, 46.1, 38.5, 28.6; IR (Neat Film, NaCl) 3056, 3026, 2960, 2931, 2830, 1619, 
1601, 1515, 1488, 1496, 1464, 1445, 1366, 1281, 1240, 1180, 1081, 1042, 967, 811, 764, 700 cm–
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(2S,3S)-1-(4-methoxyphenyl)-3-methyl-3-phenylpyrrolidine-2-carbonitrile (36): To a solution 
of 32aa (38.5 mg, 93% ee, 0.137 mmol, 1 equiv) in THF (14 mL) was added a solution of LiBEt3H 
(1 M in THF, 0.42 mL, 3 equiv) dropwise at –78 °C. The resulting solution was stirred at –78 °C 
for 2 hours, then warmed to ambient temperature and allowed to stir for 8 hours. The reaction was 
cooled to 0 °C and acetic acid (164 µL, 2.9 mmol, 21 equiv) was added dropwise. After 10 min, 
KCN (171 µL, 4.8 M solution, 0.82 mmol, 6.0 equiv), celite, and Na2SO4	were added successively. 
The reaction was stirred at 0 °C for 5 hours, quenched with anhydrous K2CO3, and filtered through 
celite. The solvent was removed and the crude product was purified by column chromatography 
(20% EtOAc in hexanes) to afford 6 as a colorless solid (17.5 mg, 60 µmol, 43% yield, 93:7 dr); 
[a]D25 –233.7 (c 0.70, CHCl3); δ 1H NMR (400 MHz, CD2Cl2) δ 7.35 – 7.30 (m, 4H), 7.28 – 7.20 
(m, 1H), 6.88 – 6.82 (m, 2H), 6.66 – 6.59 (m, 2H), 4.67 (s, 1H), 3.72 (s, 3H), 3.49 (td, J = 8.6, 4.1 
Hz, 1H), 3.34 (dt, J = 8.8, 7.5 Hz, 1H), 2.51 (dddd, J = 12.3, 7.5, 4.2, 0.8 Hz, 1H), 2.31 (ddd, J = 
13.0, 8.4, 7.6 Hz, 1H), 1.71 (s, 3H); 13C NMR (100 MHz, CD2Cl2) δ 152.6, 144.5, 139.7, 128.8, 
127.1, 125.3, 117.9, 114.9, 113.6, 60.4, 55.7, 49.5, 47.3, 37.0, 25.7; IR (Neat Film, NaCl) 3048, 
2929, 2860, 1514, 1456, 146 cm–1; HRMS (MM) m/z calc’d for C19H21N2O+ [M+H]+: 293.1648, 
found 293.1642; Please note that the NMR data listed is for the major diastereomer. 
 Stereochemical Assignment:  
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APPENDIX 2 
Challenging Substrates in the Palladium-Catalyzed Enantioselective Arylation 
of g-Lactams with Aryl Chlorides and Bromides† 
 
 
A2.1   INTRODUCTION  
 Although we found that the conditions  developed for the Pd-catalyzed a-arylation of g-
lactams were fairly robust and tolerant of a wide range of reactivity, some substrates proved to be 
very challenging and could not withstand the high temperatures and strongly basic conditions 
required for efficient and selective product formation. Below are both lactams and aryl halides that 
resulted in  low reactivity, selectivity, or both.  
 
A2.2  LIMITATIONS IN THE  PROTECTING GROUP AND a-SUBSTITUENT ON 
THE g-LACTAM  
 Although the optimized conditions for the lactam arylation were highly tolerant of a 
number of aryl protected lactams, there were a number of limitations.  The use of a bulky 2,4-
dimethoxyphenyl protecting group led to significantly diminished yields and ee’s in Method A, 
 
† This work was performed in collaboration with Irina Geibel and Shoshana Bachman, both alumni in the Stoltz group, 
visiting researchers Masaki Hayashi, Hideki Shimizu, and Jeremy B. Morgan, as well as visiting graduate student 
Shunya Sakurai.  This  work has been published and adapted with permission from Jette, C. I. Geibel, I.; Bachman, 
S.; Hayashi, M.; Sakurai, S.; Shimizu, H.; Morgan, J. B.; Stoltz, B. M.  Angew. Chem. Int. Ed. 2019, 58, 4297–4301. 
Copyright 2019 Wiley-VCH. 
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and with Method B, no product was observed (32na, Table A2.2.1). Switching to lactams 
possessing alkyl protecting groups other than benzyl resulted in diminished yields in both Method 























We also found that our reaction conditions were intolerant of N-protecting groups such as Cbz 
(30o) and tosyl (30p), and were specific to the g-lactams, as the larger d-valerolactam 
nucleophile led to no product formation (30q).   




[a] Conditions for each method are as follows: Method A: lactam (1.5 equiv), Ph–Cl (1.0 equiv), Pd2(pm-dba)3 
(2.5 mol%), L9 (7.5 mol %), LiHMDS (1.5 equiv), dioxane (0.2 M), 100 °C, 20h. Method B: lactam (1.5 equiv), 
Ph–Br (1.0 equiv), Pd2(pm-dba)3 (2.5 mol%), L10 (7.5 mol%), NaHMDS (1.5 equiv), dioxane (0.2 M), 80 °C, 20 
















Method A: 21% yield, 92% ee
Method B: 22% yield, 94% ee
32ma
Method A: 18% yield, 92% ee





Method A: 28% yield, ee NA
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As is noted in Chapter 2.4, we found that generally, as we increased the size of the a-
substituent on the lactam, significantly lower reactivities were observed. a-Substituents that 
resulted in no reaction include allyl (30r) and isoprenyl (30s), as well as  electron-deficient 
benzylic (30t) and trifluoroethyl substituents (30u).  
   
A2.3 LIMITATIONS IN FUNCTIONAL GROUP TOLERANCE ON THE 
ELECTROPHILE 
 A number of additional aryl chlorides and bromides that were not included in Table 2.4.2 
were also tested (Table A2.3.1). Electrophiles that resulted in good reactivities but poor 
enantioselectivities include those with highly electron-withdrawing groups at the para-position  
(32am, 32an, and 32ao), or 2-chloropyridine (32ap), as these may undergo  competing SNAr.  
 We also observed that Method B works best for electron-neutral substrates: both electron-
rich (32ac) and electron-poor substrates (32ai) resulted in only moderate enantioselectivities. It 
should be noted, however that these products could both be synthesized in high enantioselectivity 
with Method A (see Table 2.4.2).  
 Appendix 2 – Challenging Substrates in Palladium-Catalyzed Enantioselective Arylation of g-Lactams 
with Aryl Chlorides and Bromides 
165 
  





[a] Conditions for each method are as follows: Method A: 1a (1.5 equiv), Ar–Cl (1.0 equiv), Pd2(pm-dba)3 (2.5 mol %),  
L9 (7.5 mol %), LiHMDS (1.5 equiv), dioxane (0.2 M), 100 °C, 6 h. Method B: lactam (1.5 equiv), Ar–Br (1.0 equiv), 
Pd2(pm-dba)3 (2.5 mol %), L10 (7.5 mol %) NaHMDS (1.5 equiv), dioxane (0.2 M), 80 °C, 15 h. [b] Absolute configuration  




































Method A: 64% yield, 6% ee












Pd2(pm-dba)3 (2.5 mol %)
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Ortho-substituted electrophiles did not fare well in either of our methods, and the 
corresponding products were generated in very low yields and only moderate enantioselectivities 
(32aq, 32ar, and 32as). In addition, our reaction conditions were intolerant of electrophiles 
possessing ketone (31t), styrene (31s), amide-NH (31o),  methyl ester (31q), carboxylic acid (31p), 
nitro (31n), or phthalimide (31m) functional groups. Although we were able to successfully use a 
methyl-protected indole electrophile (32al, Table 2.4.2), we found that a number of additional 
heteroaromatic electrophiles such as  thiophene (31r), pyridine (31u), tosyl-protected indole (31v), 
and benzofuran (31w) resulted in no product formation.  
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A3.2 Infrared spectrum (Thin Film, NaCl) of compound 30e. 
 





A3.4 19F NMR (282 MHz, CDCl3) of compound 30e. 
 


























































































            
            
            
















































A3.6 Infrared spectrum (Thin Film, NaCl) of compound 30g. 
 







            






































































































































A3.9 Infrared spectrum (Thin Film, NaCl) of compound 30h. 
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A3.12 Infrared spectrum (Thin Film, NaCl) of compound 30j. 
 
Appendix 3 – Spectra Relevant to Chapter 2 
 
177 
            
            
            
            
            
            
            
            
            
            
            
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
            
            
            
            
            
            
            
            
            
            





































Appendix 3 – Spectra Relevant to Chapter 2 
 
178 
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            




            
            
            
            
            























A3.15 Infrared spectrum (Thin Film, NaCl) of compound 30i. 
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A3.18 Infrared spectrum (Thin Film, NaCl) of compound 30k. 
 






            
            
            






















































































            
            
            
            
            







































A3.22  13C NMR (125 MHz, CDCl3) of compound 32aa. 
 
A3.21 Infrared spectrum (Thin Film, NaCl) of compound 32aa. 
 


















































































































































A3.24 Infrared spectrum (Thin Film, NaCl) of compound 32ba. 
 
















































































































































A3.27 Infrared spectrum (Thin Film, NaCl) of compound 32ca. 
 













































































































































A3.30 Infrared spectrum (Thin Film, NaCl) of compound 32da. 
 
















































































































































A3.33 Infrared spectrum (Thin Film, NaCl) of compound 32ea. 
 








     
  
A3.35  19F NMR (282 MHz, CDCl3) of compound 32ea. 
 













































































































































A3.37 Infrared spectrum (Thin Film, NaCl) of compound 32fa. 
 




























           



































































            


















A3.41 13C NMR (100 MHz, CDCl3) of compound 32ab. 
 
A3.40 Infrared spectrum (Thin Film, NaCl) of compound 32ab. 
 












































































            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
A3.43 Infrared spectrum (Thin Film, NaCl) of compound 32ac. 
 
A3.44 13C NMR (100 MHz, CDCl3) of compound 32ac. 
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A3.45  19F NMR (282 MHz, CDCl3) of compound 32ac. 
 
            
   
 
  





            
























































































            
            
            
            
            
            
            
            
            
            

































A3.48  13C NMR (100 MHz, CDCl3) of compound 32ad. 
 
 
A3.47 Infrared spectrum (Thin Film, NaCl) of compound 32ad. 
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  A3.49 19F NMR (282 MHz, CDCl3) of compound 32ad. 
 








            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            





















































            
            
            
            
            
            
            
            
            
            
            
            
            
            




            
       
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            




A3.51 Infrared spectrum (Thin Film, NaCl) of compound 32ae. 
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A3.54 Infrared spectrum (Thin Film, NaCl) of compound 32af. 
 



























































































































            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            




A3.57 Infrared spectrum (Thin Film, NaCl) of compound 32ag. 
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A3.60  Infrared spectrum (Thin Film, NaCl) of compound 32ah. 
 

















































































































































A3.63 Infrared spectrum (Thin Film, NaCl) of compound 32ai. 
 
















































































































































A3.66 Infrared spectrum (Thin Film, NaCl) of compound 32aj. 
 











A3.68  19F NMR (282 MHz, CDCl3) of compound 32aj. 
 

















































































































































A3.70 Infrared spectrum (Thin Film, NaCl) of compound 32ak. 
 

















































































































































A3.73 Infrared spectrum (Thin Film, NaCl) of compound 32al. 
 














































































































































A3.76 Infrared spectrum (Thin Film, NaCl) of compound 32gb. 
 















































































































































A3.79 Infrared spectrum (Thin Film, NaCl) of compound 32hb. 
 






            
            
            
            
            



































































































































A3.82 Infrared spectrum (Thin Film, NaCl) of compound 32ga. 
 
 
















































































































































A3.85 Infrared spectrum (Thin Film, NaCl) of compound 32ha. 
 




































































































            
            
            
            
            
            
            
            
            
            
            
            
  
  
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            





A3.88 Infrared spectrum (Thin Film, NaCl) of compound 32ia. 
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A3.91 Infrared spectrum (Thin Film, NaCl) of compound 32ja. 
 






















































A3.94 Infrared spectrum (Thin Film, NaCl) of compound 32ka. 
 
























































A3.97 Infrared spectrum (Thin Film, NaCl) of compound 32gc. 
 




A3.99  19F NMR (282 MHz, CDCl3) of compound 32gc. 
























































A3.101 Infrared spectrum (Thin Film, NaCl) of compound 32gk. 
 







            





































































































































A3.104 Infrared spectrum (Thin Film, NaCl) of compound 34. 
 






























































































            
            
            
            
            
            
            
            
            
            
            
            
            
            
            




























A3.107 Infrared spectrum (Thin Film, NaCl) of compound 35. 






































































A3.110 Infrared spectrum (Thin Film, NaCl) of compound 36. 
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X-Ray Crystallography Reports Relevant to Chapter 2: 
Palladium-Catalyzed Enantioselective Arylation of g-Lactams with Aryl 
Chlorides and Bromides 
  





A4.1  GENERAL EXPERIMENTAL 
 
For crystal structure determination of 3ab: Low-temperature diffraction data (f-and w-
scans) were collected on a Bruker AXS D8 VENTURE KAPPA diffractometer coupled to 
a PHOTON 100 CMOS detector with Cu Ka radiation (l = 1.54178 Å) from an IμS micro-
source for the structure of compound P17471. The structure was solved by direct methods 
using SHELXS1 and refined against F2 on all data by full-matrix least squares with 
SHELXL-20161 using established refinement techniques.1All non-hydrogen atoms were 
refined anisotropically. All hydrogen atoms were included into the model at geometrically 
calculated positions and refined using a riding model. The isotropic displacement 
parameters of all hydrogen atoms were fixed to 1.2 times the U value of the atoms they are 
linked to (1.5 times for methyl groups). 
 
For crystal structure determination of Pd/L10 complex: A crystal was mounted on a 
polyimide MiTeGen loop with STP Oil Treatment and placed under a nitrogen stream. Low 
temperature (100K) X-ray data were collected with a Bruker AXS D8 VENTURE KAPPA 
diffractometer running at 50 kV and 1mA (Mo Ka = 0.71073 Å; PHOTON II CPAD 
detector  and Helios focusing multilayer mirror optics). All diffractometer manipulations, 
including data collection, integration, and scaling were carried out using the Bruker 
APEX3 software. An absorption correction was applied using SADABS. The space group 
was determined and the structure solved by intrinsic phasing using XT.  Refinement was 
full-matrix least squares on F2 using XL. All non-hydrogen atoms were refined using 
anisotropic displacement parameters. Hydrogen atoms were placed in idealized positions 
and refined using a riding model. The isotropic displacement parameters of all hydrogen 








A4.2  X-RAY CRYSTAL STRUCTURE ANALYSIS OF ARYLATION PRODUCT 
32ab 
 
Product 32ab was crystallized from EtOAc in hexanes at ambient temperature via slow 
evaporation.  
 
Figure A4.1 X-Ray Coordination of a-Aryl g-Lactam 32ab. 
 
 
 Table A4.1  Crystal Data and Structure Refinement for 32ab. 
Empirical formula  C22 H21 N O2 
Formula weight  331.40 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 6.1796(3) Å a = 90°. 
 b = 7.7424(4) Å b = 90°. 
 c = 34.9981(18) Å g = 90°. 
Volume 1674.48(15) Å3 
Z 4 
Density (calculated) 1.315 Mg/m3 
Absorption coefficient 0.662 mm-1 
F(000) 704 
Crystal size 0.500 x 0.200 x 0.050 mm3 
Theta range for data collection 2.525 to 74.537°. 




Index ranges -7<=h<=7, -9<=k<=9, -43<=l<=43 
Reflections collected 15394 
Independent reflections 3423 [R(int) = 0.0559] 
Completeness to theta = 67.679° 99.9%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7528 and 0.4845 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3423 / 0 / 228 
Goodness-of-fit on F2 1.142 
Final R indices [I>2sigma(I)] R1 = 0.0419, wR2 = 0.1076 
R indices (all data) R1 = 0.0434, wR2 = 0.1083 
Absolute structure parameter 0.17(9) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.215 and -0.302 e.Å-3 




 Table A4.2.  Atomic Coordinates  ( x 104) and Equivalent  Isotropic Displacement 
Parameters (Å2x 103)for 32ab.  U(eq) is Defined as One Third of  the Trace of the 
Orthogonalized Uij Tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O(1) 3102(3) 3420(2) 3552(1) 20(1) 
C(1) 4333(3) 4646(3) 3530(1) 16(1) 
C(2) 6048(3) 5153(3) 3827(1) 18(1) 
C(5) 7930(4) 3889(3) 3763(1) 23(1) 
C(21) 5192(3) 5139(3) 4235(1) 17(1) 
C(22) 6379(3) 4486(3) 4533(1) 19(1) 
C(23) 5648(4) 4624(3) 4918(1) 18(1) 
C(24) 6887(4) 3964(3) 5226(1) 23(1) 
C(25) 6135(4) 4082(3) 5595(1) 27(1) 
C(26) 4144(4) 4895(3) 5669(1) 26(1) 
C(27) 2910(4) 5554(3) 5378(1) 23(1) 
C(28) 3633(4) 5434(3) 4994(1) 19(1) 
C(29) 2412(4) 6077(3) 4681(1) 21(1) 
C(30) 3175(4) 5943(3) 4316(1) 21(1) 
C(3) 6667(4) 6991(3) 3702(1) 22(1) 
C(4) 6306(4) 6988(3) 3270(1) 20(1) 
N(1) 4552(3) 5731(2) 3219(1) 17(1) 
C(11) 3510(3) 5571(3) 2860(1) 17(1) 
C(12) 1606(4) 4621(3) 2809(1) 18(1) 
C(13) 597(3) 4557(3) 2453(1) 18(1) 
C(14) 1476(3) 5434(3) 2142(1) 16(1) 
O(2) 637(3) 5431(2) 1780(1) 21(1) 
C(17) -1408(4) 4619(3) 1726(1) 22(1) 
C(15) 3386(4) 6368(3) 2190(1) 18(1) 
C(16) 4384(4) 6441(3) 2543(1) 18(1) 
________________________________________________________________________________ 




 Table A4.3   Bond lengths [Å] and angles [°] for  32ab 
_____________________________________________________  
O(1)-C(1)  1.219(3) 
C(1)-N(1)  1.382(3) 
C(1)-C(2)  1.535(3) 
C(2)-C(21)  1.525(3) 
C(2)-C(5)  1.537(3) 
C(2)-C(3)  1.537(3) 
C(5)-H(5A)  0.9800 
C(5)-H(5B)  0.9800 
C(5)-H(5C)  0.9800 
C(21)-C(22)  1.372(3) 
C(21)-C(30)  1.421(3) 
C(22)-C(23)  1.423(3) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.418(3) 
C(23)-C(28)  1.420(3) 
C(24)-C(25)  1.375(3) 
C(24)-H(24)  0.9500 
C(25)-C(26)  1.407(4) 
C(25)-H(25)  0.9500 
C(26)-C(27)  1.371(4) 
C(26)-H(26)  0.9500 
C(27)-C(28)  1.418(3) 
C(27)-H(27)  0.9500 
C(28)-C(29)  1.422(3) 
C(29)-C(30)  1.366(3) 
C(29)-H(29)  0.9500 
C(30)-H(30)  0.9500 
C(3)-C(4)  1.527(3) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-N(1)  1.468(3) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
N(1)-C(11)  1.416(3) 




C(11)-C(12)  1.399(3) 
C(11)-C(16)  1.406(3) 
C(12)-C(13)  1.394(3) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.394(3) 
C(13)-H(13)  0.9500 
C(14)-O(2)  1.366(3) 
C(14)-C(15)  1.395(3) 
O(2)-C(17)  1.424(3) 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(15)-C(16)  1.382(3) 
C(15)-H(15)  0.9500 
































































































Symmetry transformations used to generate equivalent atoms:  
  




 Table A4.4   Anisotropic Displacement Parameters  (Å2x 103) for 32ab.  The 
Anisotropic Displacement Factor Exponent Takes the Form:  -2p2[ h2 a*2U11 + ...  
+ 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 20(1)  16(1) 25(1)  2(1) 1(1)  -6(1) 
C(1) 14(1)  14(1) 22(1)  -2(1) 3(1)  3(1) 
C(2) 12(1)  18(1) 25(1)  -2(1) 0(1)  0(1) 
C(5) 16(1)  26(1) 25(1)  -2(1) 3(1)  5(1) 
C(21) 14(1)  14(1) 24(1)  -3(1) 1(1)  -3(1) 
C(22) 13(1)  17(1) 26(1)  -3(1) 2(1)  0(1) 
C(23) 18(1)  12(1) 26(1)  -3(1) 2(1)  -2(1) 
C(24) 23(1)  16(1) 30(1)  -2(1) -2(1)  1(1) 
C(25) 35(1)  20(1) 26(1)  0(1) -3(1)  2(1) 
C(26) 37(1)  15(1) 24(1)  -1(1) 6(1)  -2(1) 
C(27) 22(1)  16(1) 31(1)  -3(1) 8(1)  -2(1) 
C(28) 18(1)  12(1) 27(1)  -2(1) 2(1)  -3(1) 
C(29) 13(1)  18(1) 32(1)  -5(1) 3(1)  2(1) 
C(30) 17(1)  18(1) 27(1)  -2(1) -3(1)  1(1) 
C(3) 19(1)  20(1) 28(1)  -1(1) -1(1)  -7(1) 
C(4) 16(1)  18(1) 27(1)  0(1) -1(1)  -6(1) 
N(1) 14(1)  14(1) 23(1)  1(1) 2(1)  -4(1) 
C(11) 13(1)  12(1) 24(1)  0(1) 2(1)  2(1) 
C(12) 14(1)  16(1) 24(1)  1(1) 4(1)  0(1) 
C(13) 12(1)  15(1) 26(1)  -1(1) 3(1)  -1(1) 
C(14) 12(1)  13(1) 24(1)  -1(1) 1(1)  3(1) 
O(2) 16(1)  23(1) 23(1)  4(1) -2(1)  -2(1) 
C(17) 15(1)  25(1) 27(1)  3(1) -3(1)  -1(1) 
C(15) 15(1)  15(1) 26(1)  3(1) 4(1)  1(1) 
C(16) 12(1)  14(1) 28(1)  2(1) 3(1)  -2(1) 
______________________________________________________________________________ 




 Table A4.5   Hydrogen coordinates ( x 104) and Isotropic  Displacement Parameters 
(Å2x 10 3) for 32ab. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(5A) 9143 4205 3929 34 
H(5B) 8393 3943 3495 34 
H(5C) 7454 2713 3823 34 
H(22) 7718 3929 4482 22 
H(24) 8248 3437 5177 27 
H(25) 6960 3614 5799 32 
H(26) 3646 4989 5925 31 
H(27) 1565 6093 5434 27 
H(29) 1049 6607 4726 25 
H(30) 2340 6397 4111 25 
H(3A) 5734 7860 3828 27 
H(3B) 8198 7243 3764 27 
H(4A) 5871 8146 3178 24 
H(4B) 7629 6621 3133 24 
H(12) 996 4013 3018 22 
H(13) -700 3912 2422 21 
H(17A) -1264 3373 1768 34 
H(17B) -1909 4827 1464 34 
H(17C) -2457 5097 1907 34 
H(15) 4007 6959 1979 22 
H(16) 5680 7088 2572 22 
________________________________________________________________________________ 



















































































A4.3  X-RAY CRYSTAL STRUCTURE  AND ANALYSIS OF Pd/L10 complex 
 
The desired product was crystallized from dioxane at ambient temperature  under N2 
atmosphere.  
 
Figure A4.2 X-Ray Coordination of  Pd/L10 
 
Table A4.7  Crystal Data and Structure Refinement for Pd/L10 
 
Empirical formula  C45 H58 Fe O5 P2 Pd 
Formula weight  903.10 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P1 
Unit cell dimensions a = 11.4377(19) Å a= 102.706(12)° 
 b = 12.9524(19) Å b= 97.356(16)° 
 c = 14.383(3) Å g = 90.123(13)° 
Volume 2060.5(6) Å3 





Density (calculated) 1.456 g/cm3 
Absorption coefficient 0.911 mm-1 
F(000) 940 
Crystal size 0.22 x 0.21 x 0.16 mm3 
Theta range for data collection 2.463 to 60.741°. 
Index ranges -27 £ h £ 27, -31 £ k £ 31, -35 £ l £ 35 
Reflections collected 761601 
Independent reflections 122367 [R(int) = 0.0434] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9961 and 0.9523 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 122367 / 3 / 985 
Goodness-of-fit on F2 1.027 
Final R indices [I>2sigma(I)] R1 = 0.0322, wR2 = 0.0704 
R indices (all data) R1 = 0.0492, wR2 = 0.0788 
Absolute structure parameter [Flack] 0.004(2) 
Extinction coefficient n/a 
Largest diff. peak and hole 4.760 and -2.265 e.Å-3 
 
 
 Table A4.8 Atomic coordinates  ( x 105) and equivalent  isotropic displacement 
parameters (Å2x 104)for Pd/L10.  U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
Pd(1) 66302(2) 76561(2) 13310(2) 98(1) 
Fe(1) 101781(2) 79532(2) 24779(2) 113(1) 
P(1) 77429(2) 92194(2) 18578(2) 107(1) 
P(2) 79432(2) 62950(2) 13324(2) 116(1) 
O(1) 35675(9) 102732(8) 47613(7) 194(1) 
O(2) 47599(9) 54258(7) -3074(7) 185(1) 
O(3) 66651(12) 81266(10) -47409(8) 245(2) 
C(1) 48505(9) 70000(8) 8966(8) 142(1) 




C(2) 48417(9) 81293(8) 11766(8) 133(1) 
C(3) 44752(8) 86701(8) 21062(7) 129(1) 
C(4) 39970(10) 96739(8) 21963(8) 148(1) 
C(5) 36668(10) 102337(9) 30659(8) 162(1) 
C(6) 38383(10) 97917(9) 38721(8) 150(1) 
C(7) 43174(10) 87888(9) 37969(8) 163(1) 
C(8) 46244(10) 82352(9) 29252(8) 156(1) 
C(9) 30681(14) 112850(11) 48511(11) 233(2) 
C(10) 49188(9) 64054(8) -790(8) 143(1) 
C(11) 52127(11) 69958(10) -8035(9) 156(2) 
C(12) 51813(10) 65205(9) -17361(8) 167(2) 
C(13) 55158(10) 69989(9) -24961(8) 165(2) 
C(14) 60938(14) 79891(10) -23061(9) 221(2) 
C(15) 64722(15) 84033(11) -30348(9) 235(2) 
C(16) 62747(12) 78209(10) -39813(9) 192(2) 
C(17) 56621(13) 68470(12) -41961(9) 217(2) 
C(18) 52974(13) 64452(12) -34600(10) 201(2) 
C(19) 72900(20) 91291(14) -45351(13) 328(3) 
C(20) 77475(10) 51844(10) 2496(9) 189(2) 
C(21) 84260(14) 53215(14) -5599(11) 269(3) 
C(22) 80131(18) 41884(11) 6354(15) 318(3) 
C(23) 74330(20) 43240(11) 15504(16) 345(4) 
C(24) 77954(10) 54210(9) 21901(10) 180(2) 
C(25) 69277(15) 57873(12) 29127(12) 252(2) 
C(26) 84142(10) 98172(9) 9735(8) 159(1) 
C(27) 79083(13) 93252(12) -654(9) 224(2) 
C(28) 81897(12) 110239(10) 12363(11) 213(2) 
C(29) 79295(11) 113368(9) 22734(10) 195(2) 
C(30) 70992(9) 104740(8) 24247(8) 149(1) 
C(31) 69132(12) 105680(10) 34682(10) 201(2) 
C(32) 89843(8) 91030(7) 27445(7) 125(1) 
C(33) 101569(10) 95684(9) 29299(9) 169(2) 
C(34) 108213(11) 91287(11) 36489(10) 211(2) 
C(35) 100739(14) 83994(13) 39224(10) 209(2) 
C(36) 89390(10) 83824(9) 33700(8) 156(1) 
C(37) 95133(8) 66319(8) 14991(8) 131(1) 




C(38) 104718(9) 63658(8) 21480(9) 158(1) 
C(39) 115067(9) 69536(9) 20759(10) 184(2) 
C(40) 112081(11) 75730(11) 13823(11) 181(2) 
C(41) 99866(9) 73785(9) 10265(8) 151(1) 
Pd(1B) 33505(2) 19811(2) 86721(2) 97(1) 
Fe(1B) -1861(2) 16576(2) 75190(2) 115(1) 
P(1B) 22117(2) 32635(2) 81434(2) 102(1) 
P(2B) 20536(2) 5905(2) 86561(2) 119(1) 
O(3B) 32914(10) 54630(9) 147589(7) 216(2) 
O(1B) 65209(8) 29095(8) 52638(6) 168(1) 
O(2B) 51746(9) 6078(7) 103341(7) 176(1) 
C(1B) 51319(9) 15755(8) 91206(8) 135(1) 
C(2B) 51356(9) 25618(8) 88273(7) 126(1) 
C(3B) 55273(8) 26435(8) 79057(7) 122(1) 
C(4B) 59970(9) 36052(8) 78095(7) 139(1) 
C(5B) 63509(10) 37319(8) 69447(8) 150(1) 
C(6B) 62243(9) 28821(8) 61512(7) 133(1) 
C(7B) 57586(10) 19113(8) 62318(7) 146(1) 
C(8B) 54175(9) 17930(8) 70964(8) 142(1) 
C(9B) 71124(13) 38421(11) 51718(10) 214(2) 
C(10B) 50331(9) 14694(8) 100937(7) 132(1) 
C(11B) 47387(10) 24269(9) 108040(8) 145(2) 
C(12B) 47741(10) 24182(9) 117387(7) 151(1) 
C(13B) 44527(9) 32752(9) 124988(7) 146(1) 
C(14B) 39291(12) 42022(10) 123235(8) 190(2) 
C(15B) 35415(13) 49582(10) 130555(9) 203(2) 
C(16B) 36820(10) 48005(9) 139918(8) 167(2) 
C(17B) 42476(11) 39065(10) 141926(8) 181(2) 
C(18B) 46209(12) 31602(11) 134546(9) 167(2) 
C(19B) 26642(16) 63661(13) 145818(12) 274(3) 
C(20B) 22290(11) -705(10) 96843(9) 183(2) 
C(21B) 16251(15) 4839(15) 105328(11) 267(3) 
C(22B) 18170(18) -12224(12) 92382(13) 292(3) 
C(23B) 23741(17) -15387(11) 83119(13) 288(3) 
C(24B) 21757(10) -6686(9) 77401(9) 172(2) 
C(25B) 31380(15) -6459(12) 70993(12) 258(2) 




C(26B) 15192(9) 42820(8) 90217(8) 143(1) 
C(27B) 20266(13) 43219(11) 100653(9) 204(2) 
C(28B) 17228(11) 53626(9) 87583(9) 181(2) 
C(29B) 19902(10) 51709(8) 77198(9) 165(2) 
C(30B) 28477(9) 42602(7) 75925(7) 126(1) 
C(31B) 30851(11) 38519(10) 65614(8) 170(2) 
C(32B) 9938(8) 26815(7) 72422(7) 121(1) 
C(33B) -1900(9) 30135(9) 70174(9) 161(2) 
C(34B) -8155(10) 21847(10) 63016(9) 187(2) 
C(35B) -348(12) 13412(11) 60707(10) 171(2) 
C(36B) 10763(9) 16456(8) 66412(7) 135(1) 
C(37B) 4871(9) 8555(8) 85202(8) 134(1) 
C(38B) -5002(9) 2653(8) 79092(9) 157(1) 
C(39B) -15140(10) 9071(10) 79812(10) 184(2) 
C(40B) -11816(12) 18825(11) 86406(11) 187(2) 
C(41B) 454(10) 18537(9) 89766(8) 158(1) 
O(4) 94593(18) 77923(10) 70024(11) 372(3) 
O(5) 92141(13) 56432(10) 60551(11) 329(3) 
C(42) 99870(30) 73967(17) 61717(16) 512(7) 
C(43) 92730(30) 64705(18) 55379(15) 427(5) 
C(44) 86782(15) 60419(12) 68985(14) 280(3) 
C(45) 93548(15) 69988(12) 75181(11) 251(2) 
O(4B) 8282(12) 21933(9) 33615(11) 297(2) 
O(5B) 4502(14) 43546(10) 33786(12) 334(3) 
C(42B) 7350(30) 29334(19) 42100(17) 503(7) 
C(43B) -570(30) 38262(18) 40050(20) 561(8) 
C(44B) 5650(20) 36016(16) 25116(13) 328(3) 
C(45B) 13115(18) 27100(14) 27149(15) 325(3) 
________________________________________________________________________________ 




Table A4.9  Bond lengths [Å] and angles [°] for  Pd/L10 
_____________________________________________________  
Pd(1)-P(1)  2.3154(5) 
Pd(1)-P(2)  2.3185(4) 
Pd(1)-C(1)  2.1655(11) 
Pd(1)-C(2)  2.1351(10) 
Fe(1)-C(32)  2.0300(10) 
Fe(1)-C(33)  2.0508(11) 
Fe(1)-C(34)  2.0606(13) 
Fe(1)-C(35)  2.0494(15) 
Fe(1)-C(36)  2.0296(12) 
Fe(1)-C(37)  2.0370(11) 
Fe(1)-C(38)  2.0445(11) 
Fe(1)-C(39)  2.0552(12) 
Fe(1)-C(40)  2.0616(14) 
Fe(1)-C(41)  2.0392(12) 
P(1)-C(26)  1.8674(11) 
P(1)-C(30)  1.8503(11) 
P(1)-C(32)  1.8130(10) 
P(2)-C(20)  1.8624(12) 
P(2)-C(24)  1.8704(12) 
P(2)-C(37)  1.8203(11) 
O(1)-C(6)  1.3682(14) 
O(1)-C(9)  1.4170(18) 
O(2)-C(10)  1.2455(13) 
O(3)-C(16)  1.3654(17) 
O(3)-C(19)  1.434(2) 
C(1)-H(1)  1.0000 
C(1)-C(2)  1.4296(15) 
C(1)-C(10)  1.4563(16) 
C(2)-H(2)  1.0000 
C(2)-C(3)  1.4789(15) 
C(3)-C(4)  1.3976(14) 
C(3)-C(8)  1.4054(15) 
C(4)-H(4)  0.9500 
C(4)-C(5)  1.3985(15) 




C(5)-H(5)  0.9500 
C(5)-C(6)  1.3947(16) 
C(6)-C(7)  1.3985(16) 
C(7)-H(7)  0.9500 
C(7)-C(8)  1.3884(16) 
C(8)-H(8)  0.9500 
C(9)-H(9A)  0.9800 
C(9)-H(9B)  0.9800 
C(9)-H(9C)  0.9800 
C(10)-C(11)  1.4910(17) 
C(11)-H(11)  0.9500 
C(11)-C(12)  1.3431(17) 
C(12)-H(12)  0.9500 
C(12)-C(13)  1.4591(17) 
C(13)-C(14)  1.3974(17) 
C(13)-C(18)  1.4043(17) 
C(14)-H(14)  0.9500 
C(14)-C(15)  1.3913(19) 
C(15)-H(15)  0.9500 
C(15)-C(16)  1.3936(18) 
C(16)-C(17)  1.395(2) 
C(17)-H(17)  0.9500 
C(17)-C(18)  1.386(2) 
C(18)-H(18)  0.9500 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 
C(19)-H(19C)  0.9800 
C(20)-H(20)  1.0000 
C(20)-C(21)  1.520(2) 
C(20)-C(22)  1.529(2) 
C(21)-H(21A)  0.9800 
C(21)-H(21B)  0.9800 
C(21)-H(21C)  0.9800 
C(22)-H(22A)  0.9900 
C(22)-H(22B)  0.9900 
C(22)-C(23)  1.525(3) 




C(23)-H(23A)  0.9900 
C(23)-H(23B)  0.9900 
C(23)-C(24)  1.537(2) 
C(24)-H(24)  1.0000 
C(24)-C(25)  1.530(2) 
C(25)-H(25A)  0.9800 
C(25)-H(25B)  0.9800 
C(25)-H(25C)  0.9800 
C(26)-H(26)  1.0000 
C(26)-C(27)  1.5270(18) 
C(26)-C(28)  1.5551(18) 
C(27)-H(27A)  0.9800 
C(27)-H(27B)  0.9800 
C(27)-H(27C)  0.9800 
C(28)-H(28A)  0.9900 
C(28)-H(28B)  0.9900 
C(28)-C(29)  1.525(2) 
C(29)-H(29A)  0.9900 
C(29)-H(29B)  0.9900 
C(29)-C(30)  1.5341(16) 
C(30)-H(30)  1.0000 
C(30)-C(31)  1.5211(18) 
C(31)-H(31A)  0.9800 
C(31)-H(31B)  0.9800 
C(31)-H(31C)  0.9800 
C(32)-C(33)  1.4378(15) 
C(32)-C(36)  1.4368(15) 
C(33)-H(33)  0.9500 
C(33)-C(34)  1.4251(17) 
C(34)-H(34)  0.9500 
C(34)-C(35)  1.423(2) 
C(35)-H(35)  0.9500 
C(35)-C(36)  1.4299(18) 
C(36)-H(36)  0.9500 
C(37)-C(38)  1.4397(14) 
C(37)-C(41)  1.4392(15) 




C(38)-H(38)  0.9500 
C(38)-C(39)  1.4332(16) 
C(39)-H(39)  0.9500 
C(39)-C(40)  1.4217(18) 
C(40)-H(40)  0.9500 
C(40)-C(41)  1.4269(17) 
C(41)-H(41)  0.9500 
Pd(1B)-P(1B)  2.3119(4) 
Pd(1B)-P(2B)  2.3252(5) 
Pd(1B)-C(1B)  2.1589(10) 
Pd(1B)-C(2B)  2.1417(11) 
Fe(1B)-C(32B)  2.0251(10) 
Fe(1B)-C(33B)  2.0400(11) 
Fe(1B)-C(34B)  2.0628(12) 
Fe(1B)-C(35B)  2.0625(14) 
Fe(1B)-C(36B)  2.0340(11) 
Fe(1B)-C(37B)  2.0307(11) 
Fe(1B)-C(38B)  2.0471(11) 
Fe(1B)-C(39B)  2.0568(12) 
Fe(1B)-C(40B)  2.0612(14) 
Fe(1B)-C(41B)  2.0380(12) 
P(1B)-C(26B)  1.8685(11) 
P(1B)-C(30B)  1.8486(10) 
P(1B)-C(32B)  1.8144(11) 
P(2B)-C(20B)  1.8553(11) 
P(2B)-C(24B)  1.8756(12) 
P(2B)-C(37B)  1.8190(11) 
O(3B)-C(16B)  1.3655(15) 
O(3B)-C(19B)  1.4269(19) 
O(1B)-C(6B)  1.3698(13) 
O(1B)-C(9B)  1.4226(16) 
O(2B)-C(10B)  1.2439(13) 
C(1B)-H(1B)  1.0000 
C(1B)-C(2B)  1.4309(14) 
C(1B)-C(10B)  1.4545(15) 
C(2B)-H(2B)  1.0000 




C(2B)-C(3B)  1.4773(14) 
C(3B)-C(4B)  1.3970(14) 
C(3B)-C(8B)  1.4079(14) 
C(4B)-H(4B)  0.9500 
C(4B)-C(5B)  1.3986(15) 
C(5B)-H(5B)  0.9500 
C(5B)-C(6B)  1.3927(15) 
C(6B)-C(7B)  1.3983(15) 
C(7B)-H(7B)  0.9500 
C(7B)-C(8B)  1.3892(15) 
C(8B)-H(8B)  0.9500 
C(9B)-H(9BA)  0.9800 
C(9B)-H(9BB)  0.9800 
C(9B)-H(9BC)  0.9800 
C(10B)-C(11B)  1.4926(16) 
C(11B)-H(11B)  0.9500 
C(11B)-C(12B)  1.3423(15) 
C(12B)-H(12B)  0.9500 
C(12B)-C(13B)  1.4605(16) 
C(13B)-C(14B)  1.4005(16) 
C(13B)-C(18B)  1.4042(16) 
C(14B)-H(14B)  0.9500 
C(14B)-C(15B)  1.3898(17) 
C(15B)-H(15B)  0.9500 
C(15B)-C(16B)  1.3953(16) 
C(16B)-C(17B)  1.3947(16) 
C(17B)-H(17B)  0.9500 
C(17B)-C(18B)  1.3820(18) 
C(18B)-H(18B)  0.9500 
C(19B)-H(19D)  0.9800 
C(19B)-H(19E)  0.9800 
C(19B)-H(19F)  0.9800 
C(20B)-H(20B)  1.0000 
C(20B)-C(21B)  1.521(2) 
C(20B)-C(22B)  1.536(2) 
C(21B)-H(21D)  0.9800 




C(21B)-H(21E)  0.9800 
C(21B)-H(21F)  0.9800 
C(22B)-H(22C)  0.9900 
C(22B)-H(22D)  0.9900 
C(22B)-C(23B)  1.526(3) 
C(23B)-H(23C)  0.9900 
C(23B)-H(23D)  0.9900 
C(23B)-C(24B)  1.5359(18) 
C(24B)-H(24B)  1.0000 
C(24B)-C(25B)  1.527(2) 
C(25B)-H(25D)  0.9800 
C(25B)-H(25E)  0.9800 
C(25B)-H(25F)  0.9800 
C(26B)-H(26B)  1.0000 
C(26B)-C(27B)  1.5281(17) 
C(26B)-C(28B)  1.5529(16) 
C(27B)-H(27D)  0.9800 
C(27B)-H(27E)  0.9800 
C(27B)-H(27F)  0.9800 
C(28B)-H(28C)  0.9900 
C(28B)-H(28D)  0.9900 
C(28B)-C(29B)  1.5299(18) 
C(29B)-H(29C)  0.9900 
C(29B)-H(29D)  0.9900 
C(29B)-C(30B)  1.5307(14) 
C(30B)-H(30B)  1.0000 
C(30B)-C(31B)  1.5203(15) 
C(31B)-H(31D)  0.9800 
C(31B)-H(31E)  0.9800 
C(31B)-H(31F)  0.9800 
C(32B)-C(33B)  1.4403(14) 
C(32B)-C(36B)  1.4380(14) 
C(33B)-H(33B)  0.9500 
C(33B)-C(34B)  1.4303(17) 
C(34B)-H(34B)  0.9500 
C(34B)-C(35B)  1.4219(19) 




C(35B)-H(35B)  0.9500 
C(35B)-C(36B)  1.4255(16) 
C(36B)-H(36B)  0.9500 
C(37B)-C(38B)  1.4418(15) 
C(37B)-C(41B)  1.4395(15) 
C(38B)-H(38B)  0.9500 
C(38B)-C(39B)  1.4295(16) 
C(39B)-H(39B)  0.9500 
C(39B)-C(40B)  1.421(2) 
C(40B)-H(40B)  0.9500 
C(40B)-C(41B)  1.4279(18) 
C(41B)-H(41B)  0.9500 
O(4)-C(42)  1.404(3) 
O(4)-C(45)  1.406(2) 
O(5)-C(43)  1.438(3) 
O(5)-C(44)  1.425(2) 
C(42)-H(42A)  0.9900 
C(42)-H(42B)  0.9900 
C(42)-C(43)  1.504(3) 
C(43)-H(43A)  0.9900 
C(43)-H(43B)  0.9900 
C(44)-H(44A)  0.9900 
C(44)-H(44B)  0.9900 
C(44)-C(45)  1.504(2) 
C(45)-H(45A)  0.9900 
C(45)-H(45B)  0.9900 
O(4B)-C(42B)  1.392(3) 
O(4B)-C(45B)  1.422(3) 
O(5B)-C(43B)  1.422(3) 
O(5B)-C(44B)  1.425(2) 
C(42B)-H(42C)  0.9900 
C(42B)-H(42D)  0.9900 
C(42B)-C(43B)  1.526(4) 
C(43B)-H(43C)  0.9900 
C(43B)-H(43D)  0.9900 
C(44B)-H(44C)  0.9900 




C(44B)-H(44D)  0.9900 
C(44B)-C(45B)  1.496(3) 
C(45B)-H(45C)  0.9900 











































































































































































































































































































































































































































































































































































































































































Symmetry transformations used to generate equivalent atoms:  
  
 
Table A4.10   Anisotropic displacement parameters  (Å2x 104) for Pd/L10.  The 
anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 
2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Pd(1) 89(1)  90(1) 115(1)  22(1) 17(1)  3(1) 
Fe(1) 94(1)  107(1) 142(1)  47(1) 3(1)  0(1) 
P(1) 101(1)  91(1) 132(1)  31(1) 16(1)  1(1) 
P(2) 105(1)  95(1) 142(1)  17(1) 16(1)  8(1) 
O(1) 232(4)  193(3) 158(3)  18(2) 69(3)  17(3) 
O(2) 198(3)  130(3) 207(3)  4(2) 16(3)  -28(2) 
O(3) 326(5)  258(4) 162(3)  74(3) 30(3)  34(4) 
C(1) 117(3)  136(3) 167(4)  22(3) 19(3)  -13(2) 
C(2) 114(3)  130(3) 152(3)  26(3) 16(3)  12(2) 
C(3) 111(3)  131(3) 150(3)  35(2) 26(2)  17(2) 
C(4) 157(3)  144(3) 148(3)  36(3) 25(3)  37(3) 
C(5) 176(4)  149(3) 162(3)  31(3) 37(3)  43(3) 
C(6) 149(3)  153(3) 151(3)  26(3) 39(3)  3(3) 




C(7) 175(4)  166(4) 166(3)  60(3) 43(3)  12(3) 
C(8) 165(3)  141(3) 176(4)  54(3) 44(3)  31(3) 
C(9) 272(6)  191(5) 228(5)  -3(4) 95(4)  24(4) 
C(10) 121(3)  129(3) 167(3)  12(3) 5(2)  -9(2) 
C(11) 164(4)  148(4) 147(3)  18(3) 8(3)  2(3) 
C(12) 167(4)  157(3) 161(3)  6(3) 11(3)  -17(3) 
C(13) 173(4)  161(4) 141(3)  6(3) -1(3)  -8(3) 
C(14) 331(6)  171(4) 143(4)  9(3) 17(4)  -52(4) 
C(15) 355(7)  178(4) 162(4)  26(3) 23(4)  -43(4) 
C(16) 226(4)  194(4) 149(4)  40(3) -2(3)  28(3) 
C(17) 232(5)  253(5) 138(4)  1(3) -11(3)  -21(4) 
C(18) 206(5)  215(5) 152(4)  -11(4) -1(4)  -43(4) 
C(19) 539(11)  239(6) 257(6)  115(5) 139(7)  40(6) 
C(20) 146(3)  162(4) 215(4)  -45(3) 17(3)  14(3) 
C(21) 257(6)  302(6) 204(5)  -51(4) 54(4)  20(5) 
C(22) 403(8)  123(4) 416(9)  -13(5) 139(7)  37(5) 
C(23) 475(10)  114(4) 467(10)  35(5) 194(8)  -45(5) 
C(24) 159(4)  150(3) 250(5)  90(3) 24(3)  -3(3) 
C(25) 311(6)  218(5) 269(6)  97(4) 115(5)  -15(4) 
C(26) 144(3)  174(4) 181(4)  84(3) 28(3)  -5(3) 
C(27) 260(5)  266(5) 167(4)  87(4) 36(4)  25(4) 
C(28) 224(5)  163(4) 281(5)  125(4) 10(4)  -33(3) 
C(29) 191(4)  113(3) 275(5)  49(3) 4(4)  -14(3) 
C(30) 139(3)  99(3) 202(4)  25(3) 14(3)  15(2) 
C(31) 205(4)  179(4) 205(4)  4(3) 46(3)  30(3) 
C(32) 117(3)  111(3) 147(3)  32(2) 7(2)  -2(2) 
C(33) 140(3)  125(3) 225(4)  30(3) -17(3)  -21(3) 
C(34) 169(4)  205(4) 221(5)  18(4) -59(3)  -12(3) 
C(35) 238(5)  240(5) 144(4)  58(4) -22(4)  26(4) 
C(36) 168(4)  170(4) 140(3)  54(3) 29(3)  13(3) 
C(37) 113(3)  117(3) 164(3)  34(2) 18(2)  13(2) 
C(38) 123(3)  130(3) 230(4)  69(3) 1(3)  14(2) 
C(39) 109(3)  166(4) 285(5)  74(3) 19(3)  23(3) 
C(40) 129(4)  194(4) 243(5)  74(4) 62(3)  3(3) 
C(41) 144(3)  165(4) 159(3)  56(3) 39(3)  14(3) 
Pd(1B) 89(1)  95(1) 113(1)  34(1) 18(1)  10(1) 




Fe(1B) 86(1)  105(1) 157(1)  40(1) 15(1)  5(1) 
P(1B) 97(1)  91(1) 124(1)  32(1) 17(1)  11(1) 
P(2B) 111(1)  111(1) 146(1)  54(1) 19(1)  3(1) 
O(3B) 257(4)  220(4) 150(3)  0(3) 15(3)  52(3) 
O(1B) 188(3)  197(3) 128(2)  42(2) 40(2)  -1(2) 
O(2B) 204(3)  158(3) 181(3)  77(2) 19(2)  42(2) 
C(1B) 123(3)  146(3) 145(3)  45(3) 24(3)  32(2) 
C(2B) 115(3)  137(3) 129(3)  32(2) 20(2)  2(2) 
C(3B) 106(3)  129(3) 131(3)  28(2) 21(2)  2(2) 
C(4B) 149(3)  133(3) 132(3)  17(2) 25(2)  -21(2) 
C(5B) 164(3)  143(3) 145(3)  27(3) 33(3)  -24(3) 
C(6B) 124(3)  149(3) 129(3)  33(2) 25(2)  9(2) 
C(7B) 162(3)  134(3) 137(3)  14(2) 34(3)  7(3) 
C(8B) 154(3)  123(3) 151(3)  22(3) 38(3)  -3(3) 
C(9B) 226(5)  241(5) 202(4)  90(4) 63(4)  -13(4) 
C(10B) 120(3)  142(3) 141(3)  47(2) 12(2)  20(2) 
C(11B) 151(3)  161(4) 127(3)  41(3) 16(3)  17(3) 
C(12B) 167(3)  162(3) 133(3)  52(3) 22(3)  27(3) 
C(13B) 154(3)  163(3) 126(3)  48(3) 16(2)  21(3) 
C(14B) 267(5)  176(4) 136(3)  56(3) 21(3)  60(3) 
C(15B) 281(5)  178(4) 151(4)  46(3) 15(3)  68(4) 
C(16B) 181(4)  172(4) 137(3)  20(3) 6(3)  21(3) 
C(17B) 204(4)  218(4) 124(3)  49(3) 9(3)  43(3) 
C(18B) 188(4)  191(4) 131(4)  61(3) 13(3)  44(3) 
C(19B) 315(7)  227(5) 255(6)  -3(4) 42(5)  89(5) 
C(20B) 167(4)  216(4) 198(4)  119(4) 13(3)  -6(3) 
C(21B) 276(6)  368(7) 198(5)  130(5) 69(4)  17(5) 
C(22B) 394(8)  196(5) 337(7)  156(5) 70(6)  -23(5) 
C(23B) 394(8)  147(4) 367(7)  122(5) 104(6)  71(5) 
C(24B) 161(4)  126(3) 227(4)  34(3) 30(3)  18(3) 
C(25B) 283(6)  187(5) 318(6)  27(4) 141(5)  57(4) 
C(26B) 140(3)  134(3) 154(3)  20(2) 37(3)  24(2) 
C(27B) 260(5)  204(4) 144(4)  21(3) 40(3)  13(4) 
C(28B) 217(4)  113(3) 210(4)  19(3) 45(3)  44(3) 
C(29B) 184(4)  119(3) 204(4)  60(3) 28(3)  29(3) 
C(30B) 126(3)  107(3) 150(3)  37(2) 25(2)  1(2) 




C(31B) 191(4)  176(4) 156(3)  50(3) 49(3)  -4(3) 
C(32B) 106(3)  113(3) 148(3)  44(2) 8(2)  8(2) 
C(33B) 126(3)  141(3) 227(4)  77(3) 1(3)  21(2) 
C(34B) 143(3)  200(4) 221(4)  86(3) -38(3)  -11(3) 
C(35B) 165(4)  182(4) 156(4)  34(3) -11(3)  -26(3) 
C(36B) 129(3)  132(3) 143(3)  29(2) 21(2)  4(2) 
C(37B) 120(3)  127(3) 169(3)  54(3) 29(2)  1(2) 
C(38B) 124(3)  125(3) 229(4)  54(3) 19(3)  -10(2) 
C(39B) 113(3)  173(4) 283(5)  73(3) 46(3)  -4(3) 
C(40B) 148(4)  184(4) 247(5)  49(4) 91(3)  31(3) 
C(41B) 159(3)  155(4) 171(4)  36(3) 57(3)  15(3) 
O(4) 670(10)  150(4) 315(6)  39(4) 158(6)  -10(5) 
O(5) 367(6)  179(4) 405(7)  -39(4) 94(5)  -10(4) 
C(42) 970(20)  268(8) 317(8)  -2(6) 283(11)  -174(10) 
C(43) 691(16)  319(9) 256(7)  7(6) 99(9)  2(9) 
C(44) 262(6)  189(5) 392(8)  51(5) 77(5)  -18(4) 
C(45) 282(6)  227(5) 242(5)  47(4) 34(4)  -8(4) 
O(4B) 300(5)  154(4) 418(7)  63(4) -24(5)  -24(3) 
O(5B) 446(7)  170(4) 428(7)  99(4) 157(6)  71(4) 
C(42B) 940(20)  322(9) 310(9)  155(7) 178(11)  7(11) 
C(43B) 860(20)  285(8) 670(16)  117(9) 564(16)  157(11) 
C(44B) 411(9)  318(7) 255(6)  102(5) -22(6)  0(6) 




Table A4.11   Hydrogen coordinates ( x 104) and isotropic  displacement 
parameters (Å2x 10 3)for Pd/L10. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1) 4535 6602 1338 17 
H(2) 4622 8493 636 16 
H(4) 3893 9984 1652 18 
H(5) 3329 10909 3107 19 




H(7) 4433 8485 4345 20 
H(8) 4940 7551 2882 19 
H(9A) 2347 11236 4393 35 
H(9B) 3634 11783 4715 35 
H(9C) 2878 11535 5507 35 
H(11) 5428 7727 -600 19 
H(12) 4914 5800 -1919 20 
H(14) 6232 8390 -1662 26 
H(15) 6863 9079 -2888 28 
H(17) 5496 6461 -4844 26 
H(18) 4889 5778 -3611 24 
H(19A) 7570 9244 -5121 49 
H(19B) 7965 9133 -4040 49 
H(19C) 6761 9695 -4303 49 
H(20) 6891 5138 -12 23 
H(21A) 8220 5991 -741 40 
H(21B) 8221 4733 -1117 40 
H(21C) 9275 5329 -344 40 
H(22A) 7683 3550 158 38 
H(22B) 8875 4116 779 38 
H(23A) 7689 3765 1896 41 
H(23B) 6564 4262 1387 41 
H(24) 8590 5372 2556 22 
H(25A) 7238 6440 3364 38 
H(25B) 6823 5236 3268 38 
H(25C) 6166 5921 2569 38 
H(26) 9284 9712 1055 19 
H(27A) 8036 8562 -202 34 
H(27B) 8304 9649 -501 34 
H(27C) 7061 9449 -160 34 
H(28A) 8893 11429 1160 26 
H(28B) 7513 11193 799 26 
H(29A) 7550 12032 2390 23 
H(29B) 8670 11390 2723 23 
H(30) 6314 10532 2047 18 
H(31A) 6419 9969 3517 30 




H(31B) 6523 11231 3697 30 
H(31C) 7678 10565 3862 30 
H(33) 10440 10081 2625 20 
H(34) 11625 9294 3902 25 
H(35) 10291 7994 4390 25 
H(36) 8270 7966 3410 19 
H(38) 10426 5883 2554 19 
H(39) 12263 6933 2431 22 
H(40) 11729 8034 1190 22 
H(41) 9556 7691 555 18 
H(1B) 5460 961 8691 16 
H(2B) 5342 3196 9364 15 
H(4B) 6078 4190 8347 17 
H(5B) 6675 4392 6899 18 
H(7B) 5675 1330 5692 17 
H(8B) 5106 1128 7142 17 
H(9BA) 7262 3768 4505 32 
H(9BB) 7864 3947 5598 32 
H(9BC) 6619 4453 5350 32 
H(11B) 4523 3053 10591 17 
H(12B) 5036 1789 11925 18 
H(14B) 3837 4317 11689 23 
H(15B) 3183 5579 12919 24 
H(17B) 4376 3811 14834 22 
H(18B) 5002 2552 13598 20 
H(19D) 1970 6135 14105 41 
H(19E) 3179 6821 14337 41 
H(19F) 2413 6763 15182 41 
H(20B) 3092 -72 9914 22 
H(21D) 1936 1214 10758 40 
H(21E) 1776 107 11055 40 
H(21F) 774 488 10332 40 
H(22C) 2081 -1687 9682 35 
H(22D) 946 -1278 9098 35 
H(23C) 2014 -2218 7922 35 
H(23D) 3230 -1635 8466 35 




H(24B) 1402 -823 7318 21 
H(25D) 2919 -167 6669 39 
H(25E) 3227 -1361 6717 39 
H(25F) 3886 -395 7501 39 
H(26B) 652 4120 8940 17 
H(27D) 1933 3622 10206 31 
H(27E) 1606 4842 10495 31 
H(27F) 2866 4527 10164 31 
H(28C) 1010 5790 8830 22 
H(28D) 2392 5759 9198 22 
H(29C) 2352 5816 7599 20 
H(29D) 1257 4979 7265 20 
H(30B) 3616 4525 7989 15 
H(31D) 3677 3304 6542 25 
H(31E) 3379 4438 6316 25 
H(31F) 2353 3551 6162 25 
H(33B) -502 3671 7297 19 
H(34B) -1615 2196 6028 22 
H(35B) -220 691 5617 21 
H(36B) 1761 1231 6627 16 
H(38B) -480 -431 7525 19 
H(39B) -2281 714 7645 22 
H(40B) -1686 2452 8825 22 
H(41B) 496 2403 9427 19 
H(42A) 10795 7172 6356 61 
H(42B) 10048 7962 5814 61 
H(43A) 8467 6694 5345 51 
H(43B) 9643 6207 4949 51 
H(44A) 8651 5484 7269 34 
H(44B) 7858 6234 6713 34 
H(45A) 8945 7281 8083 30 
H(45B) 10151 6791 7755 30 
H(42C) 1528 3229 4508 60 
H(42D) 401 2584 4668 60 
H(43C) -850 3533 3704 67 
H(43D) -143 4334 4615 67 




H(44C) 927 3953 2068 39 
H(44D) -226 3319 2194 39 
H(45C) 1371 2192 2105 39 
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Copper-Catalyzed Enantioselective Allylic Alkylation with a g-Butyrolactone-
Derived Silyl Ketene Acetal† 
 
 
3.1  INTRODUCTION, BACKGROUND, AND SYNTHETIC UTILITY 
 
In the Stoltz lab, transition metal-catalyzed allylic alkylation of enolate-derived 
nucleophiles has been a subject of intense investigation. The products formed are valuable 
synthetic intermediates, possessing chirality, as well as carbonyl and alkene functionalities, which 
can be further derivatized.  The most developed system in our group for asymmetric α-alkylation 
is a Pd-catalyzed decarboxylative allylation of enol-carbonates  (Figure 3.1.1.A). Using either (S)-
t-BuPHOX or (S)-(CF3)-t-BuPHOX as a supporting ligand for Pd, excellent yields and 
enantioselectivities have been achieved.1 In order to expand the scope of allylic alkylations and 
access motifs currently inaccessible with Pd catalysis, two more systems using Iridium and Nickel 
 
† This work was performed in collaboration with the Hadt Lab at Caltech.  Additionally, this research has been 
published and adapted with permission from Jette, C. I.; Tong, Z. J.; Hadt, R. G.; Stoltz B. M. Angew. Chem. Int. 
Ed. 2020, 59, 2033–2038. Copyright 2020 Wiley-VCH. Alexander Q. Cusumano is thanked for assistance and 
helpful discussions. 
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were developed.  By exploiting these metals’ different modes of action, substrates that reacted 
poorly under conditions of Pd catalysis could now be successfully employed with a high degree of 
regio- and stereocontrol.    Regarding Iridium, substituted allylic electrophiles were well tolerated, 
allowing for the formation of products with adjacent chiral centers (Figure 3.1.1.B).2  More 
recently, a Nickel catalyst was shown to be effective for 6-membered lactone derived nucleophiles 
to form a-quaternary centers with an allylic alcohol as the electrophile (Figure 3.1.1.C). 3 
 One particular class of nucleophiles that had not yet been used successfully with existing 
methodology are g-butyrolactone-derived anions. g-Butyrolactones comprise an important class of 
compounds predicted to exist in ca. 10% of all natural products.  They can be mono-, bi-, and tri-
substituted, and can also exist in more complex bicyclic or tri-cyclic frameworks. g-Butyrolactone-
containing natural products are also interesting lead structures for new drugs, as they display a 
broad biological profile including antibiotic, antihelmitic, antifungal, antitumor, antiviral, anti-
inflammatory, and cytostatic properties.4  
                                    


















(S)-t-BuPHOX: R= H, Ar = Ph
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 Despite their prevalence in nature and potential utility as precursor materials, the 
development of systems for the functionalization of g-butyrolactones has not reached maturity. 
More specifically, although there are a number of reports on the a-functionalization of substituted 
g-butyrolactones to form chiral quaternary centers, only a limited number of examples have 
demonstrated the construction of chiral a-tertiary g-butyrolactones.5 Some previously disclosed 
strategies for the synthesis of a-allyl g-lactones  include chiral auxiliary-directed alkylation and 






1. LDA, THF, —78 °C
2.
[Pd2(dba)3]•CHCl3 (0.5 mol %)
(R)-BINAP (2 mol %)
LiCl




R = Me,  73% yield, 3:1 dr, 88% ee
































CuBr (5 mol %)
L (10 mol %)
Cs2CO3  (1 equiv)
THF, rt, 12 h
Ph
Me
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subsequent cyclization6 and a Claisen-type rearrangement. 7 However, in both cases the a-allyl 
lactones were obtained in only moderate yield and ee (Figure 3.1.2.A and B). Reports on the 
construction of these molecules via enantioselective a-functionalization remain limited, as the 
potential for racemization of the product necessitates the development of exceptionally mild 
reaction conditions.8 
        One attractive strategy for the synthesis of these molecules is transition metal-catalyzed 
enantioselective allylic alkylation. Since the seminal report by Tsuji,9 transition-metal catalyzed 
allylic alkylation of enolate-derived nucleophiles continues to be a powerful approach for a-
functionalization of carbonyl-containing compounds, as the alkene may be easily converted to a 
diverse array of functional groups. The use of g-butyrolactones in this transformation, however, 
remains underdeveloped.10  More specifically, there is only one example on the use of this 
transformation to produce enantioenriched a-tertiary lactones, which requires the pre-formation 
of the corresponding lithium enolate, and extended reaction times at cryogenic temperatures.10c 
Although the desired product is obtained in moderate diastereoselectivity and good ee when an 
electrophile possessing terminal substitution is used, the ee is extremely low when simple allyl 
carbonate is employed (Figure 3.1.2.C). As part of our ongoing interest in exploring first row 
transition metals in enantioselective catalysis,3,11 we became interested in a system reported by 
Sawamura, wherein a Cu catalyst was used to obtain the desired a-allyl g-butyrolactone in a 
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3.2  INITIAL LIGAND SCREEN 
Table 3.2.1 Preliminary Ligand Screena 
 
 
[a] Reactions were run on 0.1 mmol scale. Yields and l:b ratios were determined by 1HNMR using trimethoxybenzene as an 
internal standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. Using Set-up A (See Materials 



















































































[Cu(MeCN)4]PF6 (10 mol %)
Ligand (12 mol %)
base (1 equiv)
THF, 23 °C, 14 h
O
OTMS












































































































linear (l) branched (b)
L20 L21 L22 L23 L24 L25
L26 L27 L28 L29 L30 L31
L22 L24 L28 L32 L33 L34
L35 L36 L37 L38 L39
L40 L41
(4-CF3-Ph)2
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We commenced our studies into the Cu-catalyzed enantioselective allylic alkylation of silyl 
ketene acetal 41 with allylic phosphate 40a  by initially testing 14 commercially available ligands 
(Table 3.2.1.A), including N-heterocyclic carbenes (L20 and L21), bis-oxazolines (BOX, L22, 
L23, L25, L26), py-BOX (L24),  alkyl and aryl bis-phosphines (L27, L31), and P, N-type ligands 
(L28-30). We generally found that nitrogen ligands such as the gem-dimethyl BOX  (L22, L23) 
and the pyridyl-BOX  (L24) ligands resulted in the highest yields. N-heterocyclic carbenes (L20 
and L21), which are traditionally used in Cu-catalyzed enantioselective allylic alkylation with hard 
nucleophiles resulted in no product formation, highlighting the stark difference in reactivity 
between the present system and traditional Cu-catalyzed enantioselective allylic alkylations.  
Although we found that bisphosphine ligands (L27 and L31) resulted in no reaction, we did 
observe product formation with P,N-type ligands such as the Feringa ligand (L28) and CF3-PHOX 
(L30).  
 It should be noted that this reaction shows a strong preference for the a-product. This 
preference, although slightly influenced by the ligand (i.e. L22 versus L24) could not be reversed 
by changing the identity of the ligand employed. Another surprising result was that the 
enantioselectivity appeared to be independent of the ligand as well; the product was racemic in all 
cases.  This immediately raised concern, as these results indicated that the ligand was having an 
electronic effect on the reaction, which was reflected by the changes in yield and linear:branched 
ratios, but there did not seem to be any steric effect, which would be reflected by the ee. One 
possibility was that the base, Cs2CO3 was too strong, causing epimerization of the newly formed 
stereocenter. Consequently, we re-assessed L22, L24, and L28 using CsOAc, a much milder base 
(Table 3.2.1.B). Unfortunately we found that this did not lead to any significant improvements, as 
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we still did not observe any ee with these ligands. With this new base, however, we chose to 
continue testing commercial ligands, with an aim of examining bulkier ligand classes. 
Unsurprisingly,  phosphine-based ferrocene (L32-35) and Trost (L37) ligands resulted in no 
product formation. Upon examination of bulkier N-based ligands, however, we found that bis-
picolinamide ligand L38 resulted in 10% yield of product in 53% ee.   
 
3.3  CHALLENGES IN THE CONSISTENCY OF THE REACTION OUTCOME 
 
 Having identified an appropriate potential ligand scaffold for this reaction, the steps to 
follow would include the synthesis of various ligand derivatives in order to identify a ligand that 
resulted in product formation in very high yield and ee. However, over the course of continued 
reaction investigation, we noted that when L38 was employed, the outcome was highly variable. 
With an identical set-up, we found that the product was obtained in anywhere from trace amounts 




[a] Reactions were run on 0.1 mmol scale. Yields and l:b ratios were determined by 1HNMR using trimethoxybenzene as 
an internal standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. Using Set-up A (See 
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to 90% yield (Table 3.3.1). These large fluctuations in yield were also accompanied by large 
fluctuations in ee, with the highest ee obtained being 52%.  
Upon closer examination of these results, we noted that in cases where the yield was low, 
the ee was high  (entry 1), and where the ee was low, the yield was high (entry 3).  One possible 
explanation for these results could be minor fluctuations in the metal:ligand ratio, as we had 
previously noted that in the absence of ligand, Cu enabled the formation of product in very high 
yields (Table 3.3.2, entry 1). To probe whether these differences could be attributed to minor 
fluctuations in the metal:ligand ratio, we examined the reaction outcome with 10 mol% Cu in 
combination with varying amounts of L38.  At less than 10 mol% ligand (entries 2-3), we observed 
moderate yields, and 11-12% ee. As the amount of ligand is increased, a drop in reactivity is 
observed, however, this is accompanied with an increase in ee, up to 36% (entry 5). We also noted 
that  the use of a 1:2 metal:ligand ratio (entry 7) resulted in a complete shut-down of reactivity.   
Table 3.3.2. Effect of Metal:Ligand Ratioa 
 
 
[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. Using Set-up A (See Materials 
and Methods).  
 
Ph OP(O)(OEt)2
[Cu(MeCN)4]PF6 (10 mol %)
L38 (mol %)
CsOAc (1 equiv)
THF, 23 °C, 14 h
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Based on these results, we concluded that the fluctuation in reaction outcome could be 
attributed to small differences in the metal:ligand ratio,  and we reasoned that by using very large 
stock solutions of both Cu and the ligand, the fluctuations in quantity could be minimized. Another 
challenge with the present system was due to the low reactivity of hydrocinnamyl phosphate 40a. 




[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. Using Set-up A (See Materials and 
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L38 L42 L43 L44
L45 L46 L47 L48b
L49 L50 L51 L52 L53
43a 41 44a
Ligand:
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Having observed significantly higher reactivities with cinnamyl chloride 43a (Table 3.3.3, L38), 
we chose to continue our optimization with this new electrophile.   
The next step was to assess which part of L38 was critical for high reactivity and 
selectivity, so that the yield and ee’s could be improved. To this end,  we synthesized and tested a  
number of different bis-picolinamide ligands with varying sterics and electronics around the bis-
picolinamide moiety, as well as ligands with a number of different backbones. Suprisingly, we 
noted that all changes made to the ligand led to significant drops in reactivity and the selectivity 
of the reaction, and L38  remained our best performing ligand.   What was most concerning about 
these results was that we did not observe any trends in selectivity that we could use to inspire and 
direct the synthesis of the next set of ligands.  
One possibility could be that we had not yet identified the appropriate Cu source for our 
reaction, so before testing additional ligands, we chose to examine the effect of the Cu source on 
the reaction outcome (Table 3.3.4). As is evident from Table 3.3.4, we found that the yields and 
Table 3.3.4. Cu Source Screena 
 
 
[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. Using Set-up A (See Materials 
and Methods). b. CuBArf was formed by stirring CuCl and NaBArf in THF at room temperature for 2 h.13 
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L38 (12 mol %)
CsOAc (1 equiv)
THF, 23 °C, 14 h
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ee’s were poor in all cases. We found that these poor results were also observed in  our control 
(entry 1), indicating that the reason for these results could be a small change in the set-up of this 
screen. It was noted that the pre-stir (Cu source, combined with L38 and CsOAc in THF), was 
significantly longer in this case, about 45 min, while in the previous screens, the set-up was 
typically about 20 min. One particular explanation could be that in this longer pre-stir, salt 
metathesis was occurring between the different Cu salts and CsOAc. In fact, one salt tested, 
CuBArf  (entry 5), was synthesized by a salt metathesis method, combining NaBArf and CuCl in 
THF at room temperature, and allowing the mixture to stir for 2 h.13  Given that the Cs+ counter-
ion is significantly less coordinating than Na+, we envisioned that in the case of the CsOAc salt 
the counter-ion exchange would likely be much more facile and rapid. Notably, CuOAc (entry 8) 
resulted in very low yields and ee’s.  Interestingly, Cu salts possessing less coordinating counter-
ions (entries 1, 9, and 10) resulted in ee’s very close in range to those observed with Cu(OAc).  
Taking these observations into account, we next removed the CsOAc from the Cu/L38  
pre-stir (Table 3.3.5). Initially, set-up A (entry 1) was being used, resulting in a range of 16-45% 
yield and 9-62% ee for the product. Upon switching to set-up B, which was identical to A except 
that CsOAc was not included in the pre-stir, but was added just prior to the addition of 41, the 
product was obtained in 72% yield and 24% ee (entry 2). Switching to set-up C, in which 41 was 
added before the CsOAc, did not lead to any significant improvements in ee, and led to a drop in 
yield (entry 3). Set-up D, in which the CsOAc and 41 were combined in THF and then added to 
the Cu complex, led to significant drops in both yield and ee (entry 4). To examine the consistency 
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of set-up B, we repeated this same reaction two more times (entries 5 and 6).  For the three separate 
reactions, the yields were within 6% and the ee’s within 4% (entries 2, 5, and 6).    
 Concurrent to these experiments, we were  also examining other aspects of the reaction 
that could lead to inconsistent results,  such as the amount of silyl ketene acetal 41 added. One 
particular concern that we had was that because the final product possessed a potentially 
epimerizable tertiary center, if at any point in the reaction a free lactone enolate was formed, this 
could deprotonate and racemize the stereocenter. For this reason, we anticipated that using only 





[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. See Materials and Methods 
section for details on each reaction set-up. [b] Range is given for 6 different reactions that were set up identically but at 
different times. See Materials and Methods for description of each set-up. 
 
Ph Cl O
OTMS [Cu(MeCN)4]PF6 (10 mol %)
L38 (12 mol %)
CsOAc (1 equiv)
THF, 23 °C, 14 h
Ph O
O


























A. Cu, L38, and CsOAc was combined in THF, stirred for 20-40   min, then the 41 was added, 
the reaction was stirred for 10 min, then 43a was added, and the reaction was allowed to stir 
overnight.
B. Identical to A, but CsOAc was not included in the pre-stir, and was added just prior to the 
addition of 41.
C. Identical to B, but CsOAc was added after the addition of 41.
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the bare minimum amount of silyl ketene acetal 41 and CsOAc could potentially lead to improved  
and consistent results. Using both set-up A and set-up B, we examined how altering the equivalents 
of the silyl ketene acetal would change the reaction outcome (Table 3.4.6). We noted that within 
both set-up A and set-up B, lowering or increasing the equivalents of silyl ketene acetal 41 did not 
result in a significant change in yield (for set up A, entries 1-3, for set-up B, entries 4-6). However, 
with set-up A, we noted that increasing the equivalents of 41 did have a significant effect on the 
ee; with 1.5 equiv, the ee is 32% (entry 1), but when 2 equivalents are used, the ee drops 
significantly to 12 %. In contrast, we found that when set-up B is used, the ee is not so significantly 
affected by the amount of nucleophile added (entries 4-6). Furthermore, besides improving the 
consistency and reducing the sensitivity of the reaction to equivalents of 41, the use of set-up B 
also enabled us to lower the amount of silyl ketene acetal used, as the reaction outcome with 1.5 
equivalents was identical to when 2 equivalents are used.  
 
 




[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. Using Set-up A and B (See 
Materials and Methods). 
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 Although encouraged by the consistency observed with set-up B, the difference between 
the yield and ee obtained with this set up and our initial hit (45% yield and 65% ee, Table 3.3.3) 
indicated that we still did not have a full picture of what was occurring in the pre-stir.  An additional 
part of the reaction set-up we chose to investigate was the time difference between the addition of 
41 and 43a (Table 3.3.7). Because we were first adding silyl ketene acetal 41 to all the reactions 
in the screen, then adding cinnamyl chloride 43a, the time difference between these two additions  
was highly dependent on the size of the screen. For small screens this could be around 5 minutes, 
but for larger screens the time difference between the two additions could be 20 minutes or more. 
To probe this, we examined the reaction outcome at 0, 5, 15, and 30 minute time differences 
between the addition of the two substrates. If the two substrates are added together or within 5 
minutes of each other, the reaction outcome is very similar, with yields over 70% and over 20% 
ee (entries 1 and 2. It should be noted that these results were very similar to those obtained in set-
up B in Table 3.4.5).  If 41 is added and the reaction is allowed to stir for 15 min before the addition 




[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. Using Set-up B (See 
Materials and Methods). 
Ph Cl O
OTMS [Cu(MeCN)4]PF6 (10 mol %)
L38 (12 mol %)
CsOAc (1 equiv)
THF, 23 °C, 14 h
Ph O
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of 43a, the yield drops significantly, down to 33%. However, this is accompanied by a slight boost 
in ee to 30%. If the reaction is allowed to stir for 30 minutes before the addition of 43a, the yield 
and ee both drop significantly (these results look very similar to those obtained in Table 3.3.4, 
entry 1).  These results clearly indicate that the CsOAc and 41 are modifying the catalyst. 
Having identified an additional component to the variability in reaction outcome, we next 
turned to the literature in order to gain a deeper understanding of what could be occurring.  
Although at the time the use of Cu/bis-picolinamide complexes in enantioselective catalysis 
remained unprecedented, there were a handful of reports on the crystal structures of  Cu/L21 and 
other related Cu/bis-picolinamide complexes  by Vagg and coworkers (Figure 3.3.1.A).14  By 
combining Cu(OAc)2 with different bis-picolinamide ligands in hot EtOH, they were able to 
generate Cu complexes bound to the ligand in a tetradentate fashion, with a water ligand at the 
apical position. Notably, the amide nitrogens were deprotonated, presumably by the –OAc counter-
ions.   
Figure 3.3.1. Precedent for Cu/Bis-Picolinamide Complexes and  the Use of L38 in 



























C7H8Mo(CO)3  (10 mol %)
L38 (15 mol %)
NaH (2.1 equiv)
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The use of L38 in enantioselective catalysis had  also been reported by Trost and coworkers 
(Figure 3.3.1.B).15 This ligand, in combination with Mo, proved to be optimal for enantioselective 
allylic alkylations with b-ketoesters. In agreement with Vagg and coworkers, they also found that 
the ligand was deprotonated over the course of the reaction, likely by the NaH base that was 
required to generate the corresponding b-ketoester nucleophile.   
Inspired by these two reports, we decided to probe whether or not the ligand in our active 
Cu complex was deprotonated.  The base we chose was n-BuLi, as it could be titrated, diluted, and 
the byproduct n-butane does not interact with the substrates or catalyst during the reaction.  The 
ligand was fully deprotonated with 24 mol% n-BuLi at –78 °C, and the cold solution of 
deprotonated ligand was added to a vial containing the Cu salt (Figure 3.3.2), the cold mixture was 
allowed to warm to room temperature over 45 min, and the rest of the reaction was then set up 
according to set-up B. With these conditions, we obtained the product in 36% yield and 34% ee. 
Interestingly, these results were very similar to the results obtained in entry 3, Table 3.3.7.  




[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. [b] Using Set-up E (See 
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To further test if the changes in reaction outcome as a function of the time difference 
between the two additions could be attributed to the slow deprotonation of the ligand, we chose to  
set up an identical screen to the one described in Table 3.3.7, but this time with deprotonated ligand 
(Table 3.3.8).   We found that although the reaction outcome was still not fully consistent, the 
results  obtained were now within a smaller range. For the first trial, the results for 0-15 min 
differences (entries 1-3) between the two additions was only 8% and the ee’s were within 3%.  We 
believe that at a 30 min time difference between the two additions (entry 4), significant 
decomposition of the starting material is occurring, and for this reason the results obtained for this 
time point were discarded from the analysis. This improved consistency within the screen was 
extremely important,  as it was an indication that some of the disparity in reaction outcome could 
be attributed to the slow deprotonation of the ligand over the course of the pre-stir.  
To determine whether there was improved consistency across different screens, we set up 
this same set of experiments two more times. We found that the yields for the reaction at a set time 
point across different screens differed by about 12%  in yield,  and 20% ee (for entries 1-3). Most 
importantly, however, we found that for the first time we were able to reproduce our initial hit of 
45% yield and 60% ee (entry 2, trial 2). Although this new set-up was not delivering fully 
consistent results, this last amount of irreproducibility we attributed to the ligand itself; L38 is 
highly flexible, and possesses 6 coordinating atoms. For this reason, Cu could likely bind to L38 
in a number of different ways, leading to a distribution of different Cu/L38 complexes in solution. 
We hypothesized that even the smallest change in reaction set-up  could lead to very significant 
changes in this distribution, and as a result, in the reaction outcome. Because the maximum ee 
achieved with L38 is only 64% (entries 1 and 3, Table 3.4.8), it was clear that we would have to 
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improve the ee through ligand synthesis and design. For this reason, we chose to move forward 
with the set-up described in entry 2 of Table 3.4.8, and start synthesizing and testing new ligand 
derivatives, with a keen eye toward the development of a ligand that would result in a more 
consistent Cu/ligand complex.  
 
3.4  CHIRAL LIGAND IDENTIFICATION 
 
Moving forward, one of the first things we wanted to assess was whether the bis-picolinyl 
moiety was critical for reactivity and selectivity. To this end, we synthesized a number of different 
derivatives that retained the cyclohexyl backbone, but varied in their coordinating atoms (Table 




[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. Using Set-up E (See Materials 
and Methods). This same set of experiments was run 3 separate times, the results for each screen is separate by dashes (/).   
 
Ph Cl O
OTMS [Cu(MeCN)4]PF6 (10 mol %)L38 (12 mol %)
n-BuLi (24 mol %)
CsOAc (1 equiv)
THF, –78 °C to 30 °C,14 h
Ph O
O










 27 / 38 / 33
35 / 45 / 37
35 / 45 / 28
25 / 24 / 35
42 / 64 / 40
45 / 60 / 40
45 / 64 / 50
16 / 72 / 40
time difference between 





trial: 1  /  2  /  3 trial: 1  /  2  /  3
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3.4.1). When mono-picolinyl ligands possessing an adjacent amine (L54) or phosphine (L55) 
group are used, both the yields and ee’s are reduced significantly. Interestingly, benzamide ligand 
L56 performed just as well, and if not slightly better, than L38.  The use of bis-benzamide ligand 
L57, Schiff base ligand L58, and ester ligand L59 all resulted in racemic product, indicating that 
at least one picolinamide moiety is critical for ee.  
In order to determine whether ligand L56 performs better and is more consistent than L38, 
we repeated this reaction a second time, and although the yields are fairly similar, the ee’s are still 
only within 13% of each other (Table 3.4.2, entries 1 and 2). Upon examination of additional Cu 
sources, we found that with CuCl2 and L56, the product is obtained in  a range of of 40-48% yield 





[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. Using Set-up E (See Materials 


























OTMS [Cu(MeCN)4]PF6 (10 mol %)L54–59 (12 mol %)
n-BuLi (0–24 mol %)
CsOAc (1 equiv)
THF, –78 °C to 30 °C,14 h
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and 60-64% ee for three reactions (entries 6-8), indicating that with this Cu source and ligand 
combination, the reaction was finally reproducible.  
 Having identified the last reaction component that contributed to the irreproducibility, we now 
turned our attention to the ee.  Although L56 resulted in the highest ee yet, we wanted to ensure 
that the benzamide moiety was critical for both reactivity and selectivity. To this end, we 
synthesized a number of ligands possessing slightly modified coordinating groups (Table 3.4.3). 
We found that with mono-methylated ligand L60,  we observed a significant drop in ee compared 
to L39. In addition, we tested ligands bearing a mono-imine (L61, L62, L63), an ester moiety 
(L64) and a sulfonamide (L65). The anionic benzamide appears to be especially important for 
stereocontrol, as removing this moiety led to a drastic decrease in ee (L61, L62, L63, L64). In 
comparison, anionic sulfonamide-containing L65 performed most similarly to L56.   
 
Table 3.4.2. Cu source screen with L56a 
 
[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1H NMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. Using Set-up E  and F (See 
Materials and Methods). 
Ph Cl O
OTMS Cu source (10 mol %)L56 (12 mol %)
n-BuLi (24 mol %)
CsOAc (1 equiv)
THF, –78 °C to 30 °C,14 h
Ph O
O































   Having confirmed that the benzamide functional group was critical for ee, we next turned our 
attention to how altering the organic substituents on the ligand affected ee. To this end, we 
synthesized a number of derivatives with varying functional groups on the amide portion of the 
ligand. Generally, we found that the identity of the organic substituent on the amide did have an 
effect on the yield, but not as significant an effect on ee. The reaction outcome seemed to be 
insensitive to the electronics of the functional group at the position para- to the amide (L66 and 
L70, Table 3.4.4), with both electron-donating and withdrawing substituents leading to a similar 
drop in ee. Alkyl substituents at the meta-position led to a significant drop in reactivity, although 
interestingly, the level of ee was retained with L68 but not L69. In a similar vein, we found that 3-
napthylamide (L71) led to a more significant drop in reactivity and selectivity than did the ortho 
Table 3.4.3. Ligand Screena 
 
 
[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an 
internal standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. Using Set-up 
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n-BuLi (12 mol %)
CsOAc (1 equiv)
THF, –78 °C to 30 °C,14 h
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substituted 2-naphthylamide (L72). Interestingly, L67, L68, and L71 all led to identical ee’s as 
L56, however, the yields were all fairly different, with L71 behaving the most like L56. 
Prior to synthesizing a new batch of derivatives with varying substitution around the pyridine, 
we wanted to ensure that we had identified the appropriate ligand backbone for our transformation. 
One particular backbone that we were curious about was the anthracene-diamine backbone (L50, 
Table 3.4.5). Although a chiral bis-picolinyl ligand possessing this backbone had not been 
synthesized before, this backbone did prove to be successful for the Trost bisphosphine ligand, 
which is commonly used in Pd-catalyzed allylic alkylations.16 We envisioned that L50 would have 
significantly different reactivity, as the ANDEN backbone is more rigid (the additional ethylene 
Table 3.4.4. Modification of Benzamide Portion of the Liganda 
 
 
[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
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n-BuLi (24 mol %)
CsOAc (1 equiv)
THF, –78 °C to 30 °C,14 h
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bridge prevents ring-flipping which is commonly observed in cyclohexyl moieties),  and also  more 
bulky. The first time that L50 was tested  was during our initial bis-picolinamide screen (Table 
3.3.3). With our initial conditions, with [Cu(MeCN)4]PF6 and L50, the product is obtained in 26% 
yield and 46% ee (entry 1). Upon switching to set-up F, the product is now obtained in a 75% yield 
and 94% ee (entry 2). However, the second time this reaction was performed, the product was 
obtained in only 55% ee. Having already identified that the bis-picolinyl ligands could be 
detrimental to the reaction consistency, we rapidly synthesized the mono-picolinyl ligand L73. 
When this ligand is used in set-up F, the high yield and ee is restored (entry 4). One of the 
drawbacks of set-up F is that cryogenic temperatures were required for the ligand deprotonation 
step. Gratifyingly, we found that by switching to LiHMDS, the deprotonation could be carried out 
in the glovebox at room temperature (entry 5). With this new set-up G, we found that the reaction 





a. Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. See Materials and Methods 
section for reaction set-up (A, F, or G). b. [Cu(MeCN)4]PF6 was used instead of CuCl2. 
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outcome is consistent, allowing for the formation of the desired product in consistently high yields 
and ee.  
Having identified the appropriate backbone, the final portion of the ligand that we wanted 
to modify was the pyridine ring. To this end, we synthesized a number of ligand derivatives with 
varying substitution around the pyridine ring (Table 3.4.6). Incorporating a methyl substituent at 
the 3- or 6- position of the picolinamide (L74 and L75) both led to slight drops in yield and ee. 
Interestingly, both L74 and L75 seemed to have a very similar effect on the reaction outcome, 
leading to similar yields and identical ee’s. We also tested quinoline (L76) and isoquinoline (L77) 
ligand derivatives. In both cases, we noted a drop in yield and ee relative to L73, however, it was 
more pronounced in the case of the quinoline derivative (L76). Finally, we found that 
incorporating electron-donating or withdrawing groups at the 4-position of the pyridine was 
Table 3.4.6. Modification of the Picolinamidea 
 
 
[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
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CsOAc (1 equiv)
THF, 23 °C to 30 °C,14 h
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detrimental (L78 and L79). Interestingly, the results for both of these ligands were very similar, 
indicating that the drop in reactivity and selectivity may be due to sterics rather than electronics.  
In summary, we identified that the coordinating atoms required for high ee was a picolinyl 
and a benzamide moiety. We also noted that by far the portion of the ligand that had the greatest 
effect on the reaction outcome was the backbone. Modifiying the substituents at the benzamide or 
picolinyl moiety had a small effect, and the yields and ee’s deviated very minimally from those 
obtained with the parent ligands L56 or L73. Generally, we found that the substitution around the 
benzamide had a more significant effect on the yield rather than the ee, and incorporating 
substitution around the picolinyl moiety led to very slight drops in both yield and ee.  Taking these 
observations into account, it became clear that the optimal ligand for our transformation was L73. 
 
3.5  FINAL REACTION OPTIMIZATION 
 Having finally identified the appropriate ligand for this transformation, we next turned our 
attention to examining the last few reaction parameters, including solvent, catalyst loading, 
concentration, Cu source, and the bases used.  
We first examined a number of solvents, including both ethereal and non-ethereal  solvents 
(Table 3.5.1).  Interestingly, we found that polar solvents were critical for reactivity, as toluene 
(entry 4) and MTBE (entry 5) led to very low reactivity. We also noted that ethereal solvents such 
as THF (entry 1) and diethyl ether (entry 3) resulted in the highest ee’s, and polar, non-ethereal  
methylene chloride (entry 2) resulted in a moderate yield, but low ee. These results indicated that  
THF (entry 1) continued to be the best option. 
 




 Next, we examined the catalyst loading and concentration (Table 3.5.2). Gratifyingly, we 
noted that we were able to lower the catalyst loading down to 5 mol% CuCl2, 6 mol% L73,  and 
13 mol% LiHMDS without observing any drops in reactivity or selectivity (entry 2). However, 
lowering the catalyst loading even further to 2.5 mol% Cu, 3 mol% L73, and 6.5 mol% LiHMDS, 
was detrimental to the reaction outcome (entry 3).  Gratifyingly, we found that the reaction is done 
in only 6 hours (entry 4), and by lowering the concentration to 0.042 M, the product is obtained in 
90% yield and 94% ee (entry 5). The use of anhydrous and oxygen-free conditions were necessary 
for achieving high reactivity and selectivity, as running the reaction under air led to significant 
drops in both yield and ee (entry 6). 
 
 
Table 3.5.1. Solvent Screena 
 
 
[A] Conditions: Using Set-up G (See Materials and Methods). The THF was removed via vacuum, and the resulting solid 
was re-suspended in the appropriate solvent. Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR 
using trimethoxybenzene as an internal standard. Enantiomeric excess (ee) was determined by supercritical fluid 
chromatography.  
 








5 < 5 –MTBE 52
Ph Cl O
OTMS CuCl2 (10 mol %)L73 (12 mol %)
LiHMDS (26 mol %)
CsOAc (1 equiv)
solvent (0.08 M), 30 °C, 14 h
Ph O
O










 Having identified the appropriate catalyst loading, concentration, and reaction time, we 
turned our attention to the Cu source, as there were a number of Cu sources that we wanted to re-
examine with these final conditions (Table 3.5.3). Interestingly, we found that CuBr2 (entry 1), 
Cu(OTf)2 (entry 2), and Cu(OTf)•toluene (entry 5) all led to very similar ee’s to those obtained  
with CuCl2   (Table 3.5.2, entry 5). Other Cu(I) sources tested, including CuBr (entry 3),  CuCN 









[a]. Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography.  Using Set-up G (See 
Materials and Methods). 
 
Ph Cl O
OTMS CuCl2 (10 mol %)L73 (12 mol %)
LiHMDS (26 mol %)
CsOAc (1 equiv)
THF (0.08 M), 30 °C, 14 h
Ph O
O






















5 mol % CuCl2, 6 mol% L73,
13 mol % LiHMDS
2.5 mol % CuCl2, 3 mol% L73, 
6.5 mol% LiHMDS
5
5 mol % CuCl2, 6 mol% L73,
13 mol % LiHMDS, after 6 h
5 mol % CuCl2, 6 mol% L73,










Although a more comprehensive base screen was performed at the outset of this 
investigation, we chose to re-examine the effect of the base in our final conditions (Table 3.5.4).   
As in our previous investigations, we found that we do not observe any product when no base is 
used (entry 1). We also found that the nature of the counter-ion was crucial for reactivity, but not 
so much for selectivity; with the less soluble LiOAc base, the product is only obtained in 16% 
yield (entry 2), and with NaOAc (entry 3) or KOAc (entry 4), the product is obtained in moderate 




[a]. Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography.  Using Set-up G (See Materials 
and Methods). 
 













OTMS CuCl2 (5 mol %)L73 (6 mol %)
LiHMDS (13 mol %)
CsOAc (1 equiv)
THF (0.042 M), 30 °C, 4 h
Ph O
O






Table 3.5.4. Base Screena 
 
[a]. Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography. Using Set-up G (See 
Materials and Methods). 
 













OTMS CuCl2 (5 mol %)L73 (6 mol %)
LiHMDS (13 mol %)
base (1 equiv)
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yields, but high ee. Interestingly, with CsF (entry 5), a salt traditionally used to cleave silyl 
enolates,17 no product is observed. With Cs2CO3, we did not observe any product formation (entry 
6).  
We also examined the counter-ion on the catalytic base used (Table 3.5.5), and found that 
with LiHMDS, we still obtain the highest ee’s (entry 1). Interestingly, however, we noted that 
switching to NaHMDS or KHMDS did lead to a significantly faster reaction, and the starting 




3.6 REACTION SCOPE 
 
With optimized conditions in hand, we examined the scope of the electrophile (Table 
3.6.1). We were pleased to find that 2-naphthyl 44c and ortho- methylphenyl (44d) substituents 
were well tolerated. Meta-phenyl substituted electrophiles (44b, 44e) also fared well, and even a  




[a] Reactions were run on 0.1 mmol scale. Yields were determined by 1HNMR using trimethoxybenzene as an internal 
standard. Enantiomeric excess (ee) was determined by supercritical fluid chromatography.   Using Set-up G (See 
Materials and Methods). [b] 6 hours instead  
 








OTMS CuCl2 (5 mol %)L73 (6 mol %)
catalytic base (13 mol %)
CsOAc (1 equiv)
















Table 3.6.1 Scope of the Allylic Chloridea 
                      
 
 
[a] See General Procedure in Materials and Methods section. Isolated yields on 0.2 mmol scale. SFC analysis was used to 
determine ee. [b] Absolute stereochemistry was determined by X-ray diffraction. [c] With 10 mol % CuCl2, 12 mol % L73, and 
26 mol % LiHMDS. [d] Synthesized from a mixture of linear and branched allylic chlorides (see the Materials and Methods 
section for more details). 
 
R Cl O
OTMS CuCl2 (5 mol %)
L73 (6 mol %), LiHMDS (13 mol %)
CsOAc (1 equiv)
THF (0.042 M), 30 °C, 6 h
R O
O
















































43a-r 41 42a, 44a-q
44a
90% yield, 94% ee
44bb
86% yield, 91% ee
44c
84% yield, 91% ee
44d
63% yield, 94% ee
44ed
80% yield, 90% ee
44fd
60% yield, 88% ee
44g
74% yield, 86% ee
44h
90% yield, 93% ee
44i
85% yield, 92% ee
44j
94% yield, 88% ee
44k
77% yield, 90% ee
44ld
83% yield, 90% ee
44mc,d
96% yield, 86% ee
44n
56% yield, 95% ee
44o
71% yield, 90% ee
44p
76% yield, 83% ee
42a




95% yield, 80% ee
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sensitive triflate (44f) and a bulky 3,5-dimethoxy phenyl group (44g) led to products in high yield 
and ee. Electrophiles possessing substituents at the para-phenyl position such as halogens (44i, 
44j, 44k), a trifluoromethyl (44l), and a nitrile (44m) were also well-tolerated. Even heterocyclic 
compounds (44n and 44o), a diene substrate (44p), an aliphatic allylic chloride (42a) and 
unsubstituted allyl chloride (44q) led to product formation in good yields and ee’s.   
 
3.7  DERIVATIZATION OF ALLYL g-BUTYROLACTONE PRODUCTS 
 
 
 In order to demonstrate the synthetic utility of these products, we subjected a-allyl g-
butyrolactone 44a and 44q to a number of transformations (Scheme 3.7.1). Lactone 44a was 




A. DIBAL-H, CH2Cl2, –78 °C, 30 min. B. NaH, triethylphosphonoacetate, THF, 0 °C to 23 °C, 3 h. C. LiAlH4, Et2O, 







































Chapter 3 – Copper-Catalyzed Enantioselective Allylic Alkylation with a g-Butyrolactone-Derived Silyl 
Ketene Acetal 
327 
reduced to the corresponding lactol 45 using DIBAL-H. Lactol 45 was then converted to the 
unsaturated ester, which spontaneously cyclized to the corresponding tetrahydrofuran 46 in high 
yield and high diastereoselectivity. Lactone 44a was also converted to the corresponding chiral 
diol 47 in good yields using lithium aluminum hydride. We also found that 44q could be swiftly 
converted to the corresponding methyl acrylate species 48 via cross metathesis.   
 
3.8  CONCLUSION 
 
  In conclusion, we have developed a Cu-catalyzed enantioselective allylic alkylation with a non-
stabilized enolate-derived nucleophile. Critical to the development of this reaction was the 
identification of a set-up that resulted in a consistent reaction outcome and a novel mono-
picolinamide ligand that led to product formation in high yields (up to 96%) and ee (up to 95%). 
A number of electrophiles with a broad range of functionality were well-tolerated in this reaction, 
including aryl, heteroaryl, and aliphatic allylic chlorides. Future work will focus on gaining a 
deeper understanding of the reaction mechanism and expanding the scope of this reaction to 
include other enolate derived nucleophiles. 
 
3.9  EXPERIMENTAL SECTION 
 
3.9.1  MATERIALS AND METHODS 
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Unless otherwise stated, reactions were performed in flame-dried glassware under an argon 
or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried by passage through 
an activated alumina column under argon. Reaction progress was monitored by thin-layer 
chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC was performed using E. Merck silica 
gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence quenching, p-
anisaldehyde, or KMnO4 staining. ((4,5-dihydrofuran-2-yl)oxy)trimethylsilane (41) was 
synthesized according to a previously reported procedure.18 Silicycle SiliaFlash® P60 Academic 
Silica gel (particle size 40–63 nm) was used for flash chromatography. 1H NMR spectra were 
recorded on a Bruker Avance HD 400 MHz or Varian Mercury 300 MHz spectrometers and are 
reported relative to residual CHCl3 (δ 7.26 ppm). 13C NMR spectra were recorded on a Bruker 
Avance HD 400 MHz spectrometer (101 MHz) and are reported relative to residual CHCl3 (δ 77.16 
ppm) . 19F NMR spectra were recorded on a Varian Mercury 300 MHz spectrometer (282 MHz). 
Data for 1H NMR are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant 
(Hz), integration).  Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad singlet, br d = broad doublet, app 
= apparent.  Data for 13C NMR are reported in terms of chemical shifts (δ ppm). IR spectra were 
obtained using a Perkin Elmer Spectrum BXII spectrometer or Nicolet 6700 FTIR spectrometer 
using thin films deposited on NaCl plates and reported in frequency of absorption (cm–1).  Optical 
rotations were measured with a Jasco P-2000 polarimeter operating on the sodium D-line (589 
nm), using a 100 mm path-length cell and are reported as: [a]DT (concentration in 10 mg/1 mL, 
solvent). Analytical SFC was performed with a Mettler SFC supercritical CO2 analytical 
chromatography system utilizing Chiralpak (AD-H, AS-H or IC) or Chiralcel (OD-H, OJ-H, or 
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OB-H) columns (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, Ltd. High resolution 
mass spectra (HRMS) were obtained from Agilent 6200 Series TOF with an Agilent G1978A 
Multimode source in electrospray ionization (ESI+), atmospheric pressure chemical ionization 
(APCI+), or mixed ionization mode (MM: ESI-APCI+), or obtained from Caltech Mass 
Spectrometry Laboratory. X-Band (9.4 GHz) Continuous-wave(CW) EPR spectra were obtained 
using a Bruker EMX spectrometer with its Bruker Win-EPR software (version 3.0). A vacuum-
insulated quartz liquid nitrogen dewar was inserted into the EPR resonator to obtain all spectra at 
77 K. For optimal sensitivity, all spectra were collected with 0.5 mW microwave power and 
averaged over four scans. UV-Vis-NIR spectra were acquired using Varian Cary 500 Scan 
spectrophotometer with Varian Cary WinUV software (version 4.10 (464)). Samples were loaded 
into 1 cm Starna Cell borosilicate cuvettes enclosed with screw caps. The spectra were collected 
from 300 nm to 1650 nm at a 600 nm/min scan rate and corrected for THF background. IR spectra 
were collected using a Bruker Alpha Platinum ATR spectrometer with OPUS software (version 
7.0.129) stored in a glovebox under N2. An aliquot of sample solution was deposted onto the 
spectrometer to form a thin film, and the spectra were collected over 32 scans. 
 
Reagents were purchased from Sigma-Aldrich, Acros Organics, Strem, or Alfa Aesar and used as 
received unless otherwise stated.  
List of Abbreviations 
ee – enantiomeric excess, SFC – supercritical fluid chromatography, TLC – thin-layer 
chromatography, IPA – isopropanol, MTBE – methyl tert-butyl ether, PE – petroleum ether, 
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DMAP – 4-dimethylaminopyridine, EtOAc – ethyl acetate, LiHMDS – lithium 
bis(trimethylsilyl)amide, NaHMDS – sodium bis(trimethylsilyl)amide, KHMDS – pottassium 
bis(trimethylsilyl)amide, THF – tetrahydrofuran, TMEDA – 1,2-tetramethylethylenediamine. 
        
 




3.9.2.1 Procedures  for the Evaluation of Commercially Available Ligands and 
Synthesized Picolinamide Ligands 
 
Method A: 
n = the number of reactions in the screen. In the glovebox, [Cu(MeCN)4]PF6 (2.33n mg, 0.00625n 
mmol, 0.1 equiv), THF (0.6n mL), and a stir bar were added to a 4-mL vial A. The solution was 
stirred until the Cu had fully dissolved. In a separate 4-mL vial B was added the appropriate ligand 
(0.0075 mmol, 0.12 equiv), and Cs2CO3 (20 mg, 0.0625 mmol, 1.0 equiv) or CsOAc (19.2 mg, 0.1 
mmol, 1 equiv) and a stir bar. The contents of vial A (0.6 mL) was then added to vial B, and 
allowed to stir for 20 min. ((4,5-dihydrofuran-2-yl)oxy)trimethylsilane (44 mg, 0.25 mmol, 2.0 
equiv) was  added to the vial, and the reaction was allowed to stir for 10 min. (E)-diethyl (5-
phenylpent-2-en-1-yl) phosphate (18.65 mg, 0.0625 mmol, 1.0 equiv)  was then added  to the 
reaction, and the reaction was allowed to stir for 14 hours at room temperature  The reaction 
mixture was filtered through a short silica plug eluting with ethyl acetate (5 mL). The eluate was 
concentrated by rotary evaporator and dissolved in CD2Cl2 to determine 1H NMR yield with 
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respect to 1,3,5-trimethoxybenzene. Then, the sample was concentrated and purified by 
preparative TLC (30% EtOAc/hexanes). The purified product was then dissolved in hexanes for 
SFC analysis on a Chiralcel AD column (12% IPA/hexanes, 2.5 mL/min).  
 
Method B:  
 n = the number of reactions in the screen. In the glovebox, [Cu(MeCN)4]PF6 (2.33n mg, 0.00625n 
mmol, 0.1 equiv), THF (0.6n mL), and a stir bar were added to a 4-mL vial A. The solution was 
stirred until the Cu had fully dissolved. In a separate 4-mL vial B was added bis-picolinamide L38 
(0.0075 mmol, 0.12 equiv). The contents of vial A (0.6 mL) was then added to vial B, and allowed 
to stir for 20 min. CsOAc (19.2 mg, 0.1 mmol, 1 equiv)  was added, followed immediately by 
((4,5-dihydrofuran-2-yl)oxy)trimethylsilane  41 (44 mg, 0.25 mmol, 2.0 equiv) and the reaction 
was allowed to stir for 10 min. Cinnamyl chloride 43a (9.53 mg, 0.0625 mmol, 1.0 equiv)  was 
then added  to the reaction, and the reaction was allowed to stir for 14 hours at room temperature.  
The reaction mixture was filtered through a short silica plug eluting with ethyl acetate (5 mL). The 
eluate was concentrated by rotary evaporator and dissolved in CD2Cl2 to determine 1H NMR yield 
with respect to 1,3,5-trimethoxybenzene. Then, the sample was concentrated and purified by 
preparative TLC (30% EtOAc/hexanes). The purified product was then dissolved in hexanes for 
SFC analysis on a Chiralcel AD column (12% IPA/hexanes, 2.5 mL/min).  
 
Method C:  
n = the number of reactions in the screen. In the glovebox, [Cu(MeCN)4]PF6 (2.33n mg, 0.00625n 
mmol, 0.1 equiv), THF (0.6n mL), and a stir bar were added to a 4-mL vial A. The solution was 
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stirred until the Cu had fully dissolved. In a separate 4-mL vial B was added bis-picolinamide L38 
(0.0075 mmol, 0.12 equiv). The contents of vial A (0.6 mL) was then added to vial B, and allowed 
to stir for 20 min. ((4,5-dihydrofuran-2-yl)oxy)trimethylsilane  41 (44 mg, 0.25 mmol, 2.0 equiv) 
was added, followed immediately by CsOAc (19.2 mg, 0.1 mmol, 1 equiv) and the reaction was 
allowed to stir for 10 min. Cinnamyl chloride 43a (9.53 mg, 0.0625 mmol, 1.0 equiv)  was then 
added  to the reaction, and the reaction was allowed to stir for 14 hours at room temperature.  The 
reaction mixture was filtered through a short silica plug eluting with ethyl acetate (5 mL). The 
eluate was concentrated by rotary evaporator and dissolved in CD2Cl2 to determine 1H NMR yield 
with respect to 1,3,5-trimethoxybenzene. Then, the sample was concentrated and purified by 
preparative TLC (30% EtOAc/hexanes). The purified product was then dissolved in hexanes for 
SFC analysis on a Chiralcel AD column (12% IPA/hexanes, 2.5 mL/min).  
 
Method D: 
n = the number of reactions in the screen. In the glovebox, [Cu(MeCN)4]PF6 (2.33n mg, 0.00625n 
mmol, 0.1 equiv), THF (0.6n mL), and a stir bar were added to a 4-mL vial A. The solution was 
stirred until the Cu had fully dissolved. In a separate 4-mL vial B was added bis-picolinamide L38 
(0.0075 mmol, 0.12 equiv). The contents of vial A (0.6 mL) was then added to vial B, and allowed 
to stir for 20 min. In a separate vial, ((4,5-dihydrofuran-2-yl)oxy)trimethylsilane  41 (44 mg, 0.25 
mmol, 2.0 equiv)  in THF (XX) was added, followed immediately by CsOAc (19.2 mg, 0.1 mmol, 
1 equiv), and THF. The Cu/L38 solution is then added to this vial, and the reaction is allowed to 
stir for 10 min.  Cinnamyl chloride 43a (9.53 mg, 0.0625 mmol, 1.0 equiv)  was then added  to the 
reaction, and the reaction was allowed to stir for 14 hours at room temperature.  The reaction 
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mixture was filtered through a short silica plug eluting with ethyl acetate (5 mL). The eluate was 
concentrated by rotary evaporator and dissolved in CD2Cl2 to determine 1H NMR yield with 
respect to 1,3,5-trimethoxybenzene. Then, the sample was concentrated and purified by 
preparative TLC (30% EtOAc/hexanes). The purified product was then dissolved in hexanes for 
SFC analysis on a Chiralcel AD column (12% IPA/hexanes, 2.5 mL/min).  
 
Method E: 
To a flame-dried  4 mL vial charged with Ar and a stir bar was added the desired Ligand 
(0.012n mmol, 0.12 equiv) and THF (0.53n mL). The solution was cooled to –78 °C and n–BuLi 
(174n µL, 0.024n mmol, 0.138 M in THF, 0.24 equiv) was added dropwise. The reaction was 
stirred for 1 h at –78 °C. A solution of [Cu(MeCN)4]PF6 (3.73n mg, 0.01n mmol, 0.10 equiv) in 
THF was added, and the reaction was warmed to room temperature and stirred for 1 h. In the 
glovebox, CsOAc (19.2 mg, 0.1 mmol, 1.0 equiv)  was added to a 4 mL vial containing a stir bar. 
The Cu/L complex in THF was then added (0.8 mL) to the CsOAc followed immediately by the 
silyl ketene acetal 41 (28 mg, 0.15 mmol, 1.5 equiv) in THF (0.8 mL). The resulting solution was 
allowed to stir for 5 min and then cinnamyl chloride 43a (15.3 mg, 0.1 mmol, 1.0 equiv) in THF 
(0.8 mL) was added, and the reaction was allowed to stir for 14 hours at room temperature.  The 
reaction mixture was filtered through a short silica plug eluting with ethyl acetate (10 mL). The 
eluate was concentrated by rotary evaporator and dissolved in CD2Cl2 to determine 1H NMR yield 
with respect to 1,3,5-trimethoxybenzene. Then, the sample was concentrated and purified by 
preparative TLC (30% EtOAc/hexanes). The purified product was then dissolved in diethyl ether 
for SFC analysis on a Chiralpak AD column (12% IPA/hexanes, 2.5 mL/min).  





To a flame-dried 4 mL vial charged with Ar and a stir bar was added the desired Ligand 
(0.012n mmol, 0.12 equiv) and THF (0.63n mL). The solution was cooled to –78 °C and n–BuLi 
(174n mL, 0.024n mmol, 0.138M in THF, 0.24 equiv) was added dropwise. The reaction was 
stirred for 1 h at –78 °C, and then the cold solution was transferred to a flame-dried vial under Ar 
containing CuCl2 (1.34n mg, 0.01n mmol, 0.1 equiv). The resulting mixture was then warmed to 
room temperature. In the glovebox, CsOAc (19.2 mg, 0.1 mmol, 1.0 equiv)  was added to a 4 mL 
vial containing a stir bar. The Cu/L complex in THF made was then added (0.8 mL) to the CsOAc 
followed immediately by the silyl ketene acetal 41 (28 mg, 0.15 mmol, 1.5 equiv) in THF (0.8 
mL). The resulting solution was allowed to stir for 5 min and then cinnamyl chloride 43a (15.3 
mg, 0.1 mmol, 1.0 equiv) in THF (0.8 mL) was added, and the reaction was allowed to stir for 14 
hours at room temperature.  The reaction mixture was filtered through a short silica plug eluting 
with ethyl acetate (10 mL). The eluate was concentrated by rotary evaporator and dissolved in 
CD2Cl2 to determine 1H NMR yield with respect to 1,3,5-trimethoxybenzene. Then, the sample 
was concentrated and purified by preparative TLC (30% EtOAc/hexanes). The purified product 
was then dissolved in diethyl ether for SFC analysis on a Chiralpak AD column (12% IPA/hexanes, 
2.5 mL/min).  
 
Method  G: 
To a 4 mL vial containing CuCl2 (1.34n mg, 0.01n mmol, 0.1 equiv) in the glovebox was 
added a solution of the Ligand (0.012n mmol, 0.12 equiv) in THF (0.4n mL), followed by a 
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solution of LiHMDS (4.35n mg, 0.026n mmol, 0.26 equiv) in THF (0.4n mL). The resulting 
solution was stirred for 1 h at room temperature.  In the glovebox, CsOAc (19.2 mg, 0.1 mmol, 
1.0 equiv)  was added to a 4 mL vial containing a stir bar. The Cu/L complex in THF was then 
added (0.8 mL) to the CsOAc followed immediately by the silyl ketene acetal 41 (28 mg, 0.15 
mmol, 1.5 equiv) in THF (0.8 mL). The resulting solution was allowed to stir for 5 min and then 
cinnamyl chloride 43a (15.3 mg, 0.1 mmol, 1.0 equiv) in THF (0.8 mL) was added, and the reaction 
was allowed to stir for 14 hours at room temperature.  The reaction mixture was filtered through a 
short silica plug eluting with ethyl acetate (10 mL). The eluate was concentrated by rotary 
evaporator and dissolved in CD2Cl2 to determine 1H NMR yield with respect to 1,3,5-
trimethoxybenzene. Then, the sample was concentrated and purified by preparative TLC (30% 
EtOAc/hexanes). The purified product was then dissolved in diethyl ether for SFC analysis on a 
Chiralpak AD column (12% IPA/hexanes, 2.5 mL/min).  
 
3.9.2.2  Synthesis of Chiral Picolinamide Ligands 
 
Preparation of Known Ligands: Previously reported methods were used to prepare  L4319, L4620, 
L4821, L4922, L5122, L5523, L5624, L5725, L5826, L6527, L7124 
 
General Procedure 1: Synthesis of Cyclohexylbispicolinamide Ligands 
 




N,N'-((1R,2R)-cyclohexane-1,2-diyl)bis(isoquinoline-1-carboxamide) (L44): To a solution of 
isoquinoline-1-carboxylic acid (204.1 mg, 1.18 mmol, 2.5 equiv) in THF (0.87 mL) was added 
carbonyl diimidazole (183 mg, 1.13 mmol, 2.4 equiv). The resultant mixture was allowed to stir 
for 1 h at room temperature, or until the solution turned clear. (1R,2R)-cyclohexane-1,2-diamine 
(54 mg, 0.47 mmol, 1.0 equiv) was added, and the reaction was allowed to stir overnight. The 
reaction mixture was diluted with water and stirred for 1 h. The aqueous layer was extracted with 
methylene chloride three times, and the resulting organic layers were dried over Na2SO4 and 
concentrated. Product L44 was purified by column chromatography to provide a white solid (120 
mg, 0.28 mmol, 60% yield); 1H NMR (500 MHz, CDCl3) δ 9.24 (d, J = 9.8 Hz, 2H), 8.45 (d, J = 
5.6 Hz, 2H), 8.38 (d, J = 8.1 Hz, 2H), 7.77 – 7.67 (m, 4H), 7.56 (ddd, J = 8.2, 6.8, 1.2 Hz, 2H), 
7.44 – 7.35 (m, 2H), 4.16 (t, J = 8.4 Hz, 2H), 2.33 (d, J = 12.0 Hz, 2H), 1.91 (d, J = 6.7 Hz, 2H), 
1.63 – 1.49 (m, 4H). 
 
N,N'-((1R,2R)-cyclohexane-1,2-diyl)bis(4-(trifluoromethyl)picolinamide) (L45):  Product L45 
was prepared according to the General Procedure 1 and 4-(trifluoromethyl)picolinic acid. Product 
L45 was purified by column chromatography to provide a white solid (147 mg, 0.32 mmol, 60% 
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2H), 7.58 (d, J = 5.0 Hz, 2H), 4.16 – 3.99 (m, 2H), 2.21 (d, J = 7.4 Hz, 2H), 1.98 – 1.71 (m, 3H), 
1.63 – 1.36 (m, 4H); δ 13C NMR (126 MHz, CDCl3) δ 163.3, 151.2, 149.4, 140.2, 139.9, 139.7, 
139.4, 123.7, 121.8, 121.7, 121.5, 118.3, 118.3, 118.3, 118.2, 77.4, 76.9, 53.7, 32.6, 24.9; 19F NMR 
(282 MHz, CDCl3) δ –64.90.	
 
	
N,N'-((1R,2R)-cyclohexane-1,2-diyl)bis(5-(trifluoromethyl)picolinamide) (L47): Product L47 
was prepared according to the General Procedure 1 and 4-(trifluoromethyl)picolinic acid. Product 
L47 was purified by column chromatography to provide a white solid (276 mg, 0.6 mmol, 60% 
yield);  1H NMR (300 MHz, CDCl3) δ 8.76 (s, 2H), 8.21 (t, J = 8.1 Hz, 4H), 7.99 (dd, J = 8.2, 2.4 




N,N'-((11S,12S)-9,10-dihydro-9,10-ethanoanthracene-11,12-diyl)dipicolinamide (L50):  
Product L50 was prepared according to the General Procedure 1 and  (11S,12S)-9,10-dihydro-
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provide a white solid; 1H NMR (300 MHz, CDCl3) δ 8.43 (ddd, J = 4.8, 1.7, 0.9 Hz, 2H), 8.14 (dt, 
J = 7.8, 1.1 Hz, 2H), 7.91 (d, J = 8.3 Hz, 2H), 7.79 (td, J = 7.7, 1.8 Hz, 2H), 7.50 – 7.43 (m, 2H), 
7.41 – 7.31 (m, 4H), 7.28 – 7.16 (m, 5H), 4.53 (d, J = 3.0 Hz, 2H), 4.38 – 4.30 (m, 2H). 
 
 
N-((1S,2S)-2-(dimethylamino)cyclohexyl)picolinamide (L54): To a solution of picolinic acid 
(308 mg, 2.5 mmol, 1.25 equiv) in THF (3.33 mL) was added carbonyl diimidazole (389 mg, 2.5 
mmol, 1.2 equiv). The resultant mixture was allowed to stir for 1 h at room temperature, or until 
the solution turned clear. (1S,2S)-N1,N1-dimethylcyclohexane-1,2-diamine (285 mg, 2.0 mmol, 1.0 
equiv) was added, and the reaction was stirred overnight. The reaction mixture was diluted with 
water and allowed to stir for 1 h. The aqueous layer was extracted with methylene chloride three 
times, and the resulting organic layers were dried over Na2SO4 and concentrated. Product L54 was 
purified by column chromatography to provide a white solid (247 mg, 1.0 mmol, 50% yield); 
[a]D25 74.79 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.56 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H), 
8.29 (s, 1H), 8.18 (dt, J = 7.8, 1.1 Hz, 1H), 7.81 (td, J = 7.7, 1.8 Hz, 1H), 7.39 (ddd, J = 7.5, 4.8, 
1.2 Hz, 1H), 3.80 (tdd, J = 10.7, 6.6, 4.0 Hz, 1H), 2.47 (dddd, J = 11.7, 9.8, 7.3, 3.9 Hz, 2H), 2.26 
(s, 6H), 1.96 – 1.77 (m, 2H), 1.70 (dtd, J = 13.0, 3.3, 1.8 Hz, 1H), 1.45 – 1.12 (m, 4H); 13C NMR 
(101 MHz, CDCl3) δ 164.3, 150.7, 148.2, 137.3, 125.9, 122.2, 66.6, 51.0, 40.3, 33.0, 25.4, 25.0, 
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1339, 1270, 1189, 1153, 1084, 1044, 1032, 997, 866, 844, 782, 750, 700, 671, 620 cm–1; HRMS 
(MM) m/z calc’d for C14H22N3O [M+H]+: 248.1757, found 248.1753. 
 
 
(1S,2S)-cyclohexane-1,2-diyl dipicolinate (L59): To a solution of picolinic acid (345 mg, 2.8 
mmol, 2.5 equiv) in THF (1.87 mL) was added carbonyl diimidazole (435 mg, 2.68 mmol, 2.4 
equiv). The resultant mixture was allowed to stir for 1 h at room temperature, or until the solution 
turned clear. (1S,2S)-cyclohexane-1,2-diol (130 mg, 1.12 mmol, 1.0 equiv) was added, and the 
reaction was allowed to stir overnight. The reaction mixture was diluted with water and stirred for 
1 h. The aqueous layer was extracted with methylene chloride three times, and the resulting organic 
layers were dried over Na2SO4 and concentrated. Product L59 was purified by column 
chromatography to provide a white solid (189 mg, 0.58 mmol, 52% yield); [a]D25 –78.88 (c 0.80, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.69 (ddd, J = 4.7, 1.7, 0.9 Hz, 2H), 8.00 (dt, J = 7.9, 1.1 
Hz, 2H), 7.74 (td, J = 7.8, 1.8 Hz, 2H), 7.38 (ddd, J = 7.6, 4.7, 1.2 Hz, 2H), 5.45 – 5.27 (m, 2H), 
2.35 – 2.25 (m, 2H), 1.93 – 1.78 (m, 2H), 1.75 – 1.56 (m, 2H), 1.58 – 1.39 (m, 2H); 13C NMR (101 
MHz, CDCl3) δ 164.3, 150.1, 147.9, 137.1, 126.9, 125.2, 75.4, 30.5, 23.8; IR (Neat Film, NaCl) 
2940, 2868, 1740, 1716, 1582, 1437, 1325, 1304, 1280, 1224, 1157, 1128, 1087, 1045, 1028, 992, 
918, 845, 821, 747, 706, 674, 664, 619 cm–1; HRMS (MM) m/z calc’d for C18H19N2O4 













N-((1S,2S)-2-(((E)-pyridin-2-ylmethylene)amino)cyclohexyl)benzamide (L62): To a solution 
of N-((1S,2S)-2-aminocyclohexyl)benzamide (109 mg, 0.5 mmol, 1.0 equiv)  in MeOH (2.5 mL) 
at 0°C was added pyridine-2-carboxaldehyde (59 mg, 0.55mmol, 1.1 equiv) in MeOH (2.5 mL)  
dropwise. The resulting mixture was warmed to room temperature, and concentrated by rotary 
evaporator and high-vac to afford L62; 1H NMR (300 MHz, CDCl3) δ 8.58 (d, J = 4.9 Hz, 1H), 
8.42 (s, 1H), 8.01 (d, J = 7.8 Hz, 1H), 7.69 (t, J = 8.6 Hz, 1H), 7.63 – 7.51 (m, 2H), 7.47 – 7.26 
(m, 5H), 5.79 (d, J = 15.5 Hz, 1H), 4.24 (d, J = 9.1 Hz, 1H), 3.33 – 3.17 (m, 1H), 2.23 (s, 1H), 
1.87 (d, J = 5.2 Hz, 3H), 1.58 – 1.31 (m, 3H).	
 
Synthesis of (1S,2S)-2-(picolinamido)cyclohexyl benzoate (L64): 
























1. CDI (1.20 equiv), THF, 1 h, 23 °C
2. SI9 (1 equiv)
OH
O




 To a solution of picolinic acid (616 mg, 5.0 mmol, 1.1 equiv) in THF (12 mL) was added 
carbonyl diimidazole (811 mg, 5.0 mmol, 1.1 equiv). The resultant mixture was allowed to stir for 
1 h at room temperature, or until the solution turned clear.  The solution was then diluted with THF 
(84 mL) and added slowly to a solution of (1S,2S)-2-aminocyclohexan-1-ol (576 mg, 5.0 mmol, 
1.0 equiv) in THF (100 mL) via a dropping funnel. The reaction was allowed to stir at room 
temperature overnight. The crude reaction mixture was then concentrated by rotary evaporator and 
purified by short silica plug (2% MeOH in EtOAc) to afford SI9 (925 mg, 4.2 mmol, 84% yield).  
 To a solution of benzoic acid (269 mg, 2.2 mmol, 1.1 equiv) in THF (6.1 mL) was added 
carbonyl diimidazole (357 mg, 2.2 mmol, 1.1 equiv). The resultant mixture was allowed to stir for 
1 h at room temperature, or until the solution turned clear. N-((1S,2S)-2-
hydroxycyclohexyl)picolinamide (SI9, 414 mg, 2.0 mmol, 1.0 equiv) was added, and the reaction 
was allowed to stir overnight. The reaction mixture was diluted with water and allowed to stir for 
1 h. The aqueous layer was extracted with methylene chloride three times, and the resulting organic 
layers were dried over Na2SO4 and concentrated. Product L64 was purified by column 
chromatography to provide a white solid (189 mg, 0.59 mmol 30% yield);  [a]D25 – 92.02 (c 0.80, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ  8.48 (ddd, J = 4.8, 1.7, 0.9 Hz, 1H), 8.16 – 8.07 (m, 2H), 
8.01 – 7.94 (m, 2H), 7.75 (td, J = 7.7, 1.7 Hz, 1H), 7.50 – 7.44 (m, 1H), 7.39 – 7.30 (m, 3H), 5.01 
(td, J = 10.4, 4.4 Hz, 1H), 4.31 (dddd, J = 13.8, 9.6, 7.4, 4.5 Hz, 1H), 2.28 – 2.13 (m, 2H), 1.90 – 
1.72 (m, 2H), 1.68 – 1.57 (m, 1H), 1.55 – 1.36 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 166.7, 
164.1, 149.8, 148.1, 137.3, 132.9, 130.4, 129.8, 128.3, 126.1, 122.2, 75.7, 52.1, 32.1, 31.2, 24.5, 
24.2; IR (Neat Film, NaCl) 3345, 2938, 2860, 1710, 1671, 1568, 1522, 1450, 1319, 1272, 1114, 
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N-((1S,2S)-2-aminocyclohexyl)picolinamide (SI10): To a solution of picolinic acid (1.23 g, 10.0 
mmol, 1.0 equiv) in THF (25 mL) was added carbonyl diimidazole (1.62 g, 10.0 mmol, 1.0 equiv). 
The resultant mixture was stirred for 1 h at room temperature.  The reaction was then diluted with 
THF (170 mL) and added slowly to a solution of (1S,2S)-cyclohexane-1,2-diamine (1.14 g, 10.0 
mmol, 1.0 equiv) in THF (200 mL) via a dropping funnel. The reaction was allowed to stir  at 
room temperature overnight. The crude reaction mixture was then concentrated by rotary 
evaporator and purified by column chromatography(3:1 ethyl acetate: MeOH to flush out 
imidazole, then 1% Et3N to solvent mixture to elute product) to afford SI10 (1.36 g, 6.2 mmol,  
62% yield); [a] D25 136.06 (c 0.80, CHCl3);  1H NMR (400 MHz, CDCl3) 8.55 (ddd, J = 4.8, 1.7, 
0.9 Hz, 1H), 8.20 (dt, J = 7.8, 1.1 Hz, 1H), 7.97 (d, J = 9.4 Hz, 1H), 7.85 (td, J = 7.7, 1.7 Hz, 1H), 
7.42 (ddd, J = 7.6, 4.8, 1.2 Hz, 1H), 3.72 (dtd, J = 11.0, 9.6, 4.0 Hz, 1H), 2.60 – 2.52 (m, 1H), 2.04 
(ddt, J = 12.7, 9.3, 3.1 Hz, 2H), 1.77 (dq, J = 9.1, 2.5 Hz, 2H), 1.66 (s, 2H), 1.47 – 1.16 (m, 4H); 
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25.3; IR (Neat Film, NaCl) 3341, 3312, 2929, 2858, 1700, 1590, 1568, 1520, 1448, 1434, 1465, 
1326, 1288, 1252, 1147, 1162, 1089, 1027, 997, 923, 906, 853, 821, 753, 692, 680, 620 cm–1; 
HRMS (MM) m/z calc’d for C12H18N3O [M+H]+: 220.1444, found 220.1434. 
 
N-((1S,2S)-2-(((E)-benzylidene)amino)cyclohexyl)picolinamide (L61): To a solution of SI10 
(219 mg, 1.0 mmol, 1.0 equiv)  in MeOH (5 mL) at 0°C was added benzaldehyde (112 uL, 1.1 
mmoL, 1.1 equiv) in MeOH (5 mL)  dropwise. The resulting mixture was warmed to room 
temperature, and concentrated by rotary evaporator and high-vac to afford L61 (257 mg, 0.83 
mmol, 83% yield); [a] D25 128.30 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.44 (ddd, J = 
4.7, 1.7, 0.9 Hz, 1H), 8.29 (s, 1H), 8.09 (dt, J = 7.8, 1.1 Hz, 1H), 7.92 – 7.83 (m, 1H), 7.73 (td, J 
= 7.7, 1.7 Hz, 1H), 7.67 – 7.61 (m, 2H), 7.36 – 7.28 (m, 4H), 4.19 (dtd, J = 10.4, 9.1, 4.1 Hz, 1H), 
3.27 (td, J = 9.6, 5.0 Hz, 1H), 2.31 – 2.17 (m, 1H), 1.93 – 1.72 (m, 4H), 1.61 – 1.32 (m, 3H); 13C 
NMR (101 MHz, CDCl3) δ 163.6, 160.3, 150.2, 147.9, 137.3, 136.4, 130.5, 128.5, 128.3, 126.0, 
122.3, 53.2, 33.5, 31.7, 24.9, 24.3; IR (Neat Film, NaCl) 3379, 2932, 2855, 2673, 1643, 1590, 
1568, 1519, 1464, 1450, 1434, 1293, 1156, 1042, 998, 752, 695, 680 cm–1; HRMS (MM) m/z 
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N-((1S,2S)-2-(((E)-pyridin-2-ylmethylene)amino)cyclohexyl)picolinamide (L63): To a 
solution of SI10 (219 mg, 1.0 mmol, 1.0 equiv)  in MeOH (5 mL) at 0°C was added pyridine-2-
carboxaldehyde (112 uL, 1.1 mmoL, 1.1 equiv) in MeOH (5 mL)  dropwise. The resulting 
mixture was warmed to room temperature, and concentrated by rotary evaporator and high-vac to 
afford L63 (257 mg, 0.84 mmol, 76% yield); 1H NMR (400 MHz, CDCl3) δ 8.49 (d, J = 34.9 Hz, 
2H), 8.36 (s, 1H), 8.11 – 8.03 (m, 1H), 7.99 (d, J = 10.4 Hz, 1H), 7.87 (d, J = 10.1 Hz, 1H), 7.78 
– 7.70 (m, 1H), 7.70 – 7.59 (m, 1H), 7.36 – 7.29 (m, 1H), 7.26 – 7.18 (m, 1H), 4.36 – 4.19 (m, 
1H), 3.42 – 3.21 (m, 1H), 2.23 (d, J = 12.3 Hz, 1H), 1.86 (d, J = 9.3 Hz, 6H), 1.65 – 1.36 (m, 
3H); 13C NMR (101 MHz, CDCl3) δ 164.3, 160.1, 154.4, 151.1, 149.2 147.1, 137.3, 134.3, 
126.8, 124.7, 122.2, 121.3, 69.1, 56.2, 35.2, 29.9, 27.3, 23.4.  
 
 
General Procedure 2: Synthesis of Cyclohexylpicolinamide Ligands 
 
 
N-((1S,2S)-2-pivalamidocyclohexyl)picolinamide (L67): To a solution of pivalic acid (56.2 mg, 
0.55 mmol, 1.1 equiv) in THF (1.0 mL) was added carbonyl diimidazole (89.2 mg, 0.55 mmol, 1.1 
equiv). The resultant mixture was stirred for 1 h at room temperature. N-((1S,2S)-2-
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was allowed to stir overnight. The reaction mixture was then  diluted with water and allowed to 
stir for 1 h. The aqueous layer was extracted with methylene chloride three times, and the resulting 
organic layers were dried over Na2SO4 and concentrated. The product was purified by column 
chromatography to provide a white solid (82.2 mg, 0.27 mmol, 54% yield); [a]D25 36.82 (c 0.80, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.54 (ddd, J = 4.7, 1.7, 0.9 Hz, 1H), 8.14 (dt, J = 7.8, 1.1 
Hz, 1H), 8.08 (d, J = 9.0 Hz, 1H), 7.82 (td, J = 7.7, 1.7 Hz, 1H), 7.41 (ddd, J = 7.6, 4.7, 1.2 Hz, 
1H), 6.36 (d, J = 7.6 Hz, 1H), 3.93 (tdd, J = 11.3, 9.0, 4.0 Hz, 1H), 3.73 (tdd, J = 11.2, 7.6, 4.0 Hz, 
1H), 2.18 – 2.04 (m, 2H), 1.86 – 1.71 (m, 2H), 1.54 – 1.34 (m, 3H), 1.29 – 1.15 (m, 1H), 1.01 (s, 
9H); 13C NMR (101 MHz, CDCl3) δ 178.7, 165.2, 149.5, 148.4, 137.4, 126.4, 122.2, 55.0, 52.5, 
38.6, 32.7, 32.4, 27.5, 25.2, 24.7; IR (Neat Film, NaCl) 3354, 2935, 2858,1740, 1715, 1655, 1590, 
1570, 1525, 1434, 1398, 1364, 1322, 1289, 1244, 1202, 1129, 1087, 1044, 997, 820, 750, 692, 620 
cm–1; HRMS (MM) m/z calc’d for C17H26N3O2 [M+H]+: 304.2020, found 304.2008. 
 
 
N-((1S,2S)-2-(4-methoxybenzamido)cyclohexyl)picolinamide (L66): Product L66 was 
prepared according to the General Procedure 2 and 4-methoxybenzaldehyde and SI10. The product 
was purified by column chromatography to provide a white solid (106 mg, 0.3 mmol, 60% yield); 
[a]D25 120.32 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.52 (ddd, J = 4.8, 1.7, 0.9 Hz, 1H), 
8.20 – 8.06 (m, 2H), 7.79 (td, J = 7.7, 1.7 Hz, 1H), 7.76 – 7.70 (m, 2H), 7.39 (ddd, J = 7.6, 4.8, 1.2 
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(tdd, J = 10.9, 7.1, 4.0 Hz, 1H), 3.80 (s, 3H), 2.37 (dq, J = 12.6, 2.3 Hz, 1H), 2.16 – 2.07 (m, 1H), 
1.92 – 1.74 (m, 2H), 1.57 (qd, J = 12.4, 3.7 Hz, 1H), 1.44 (ddt, J = 12.2, 9.9, 3.2 Hz, 2H), 1.37 – 
1.21 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 166.8, 165.8, 162.0, 149.4, 148.3, 137.5, 128.9, 
126.9, 126.5, 122.3, 113.7, 56.5, 55.5, 52.4, 32.7, 32.3, 25.2, 24.6; IR (Neat Film, NaCl) 3316, 
2933, 2856, 1656, 1607, 1569, 1507, 1527, 1465, 1330, 1302, 1255, 1178, 1146, 1109, 1092, 1028, 




N-((1S,2S)-2-(3,5-di-tert-butylbenzamido)cyclohexyl)picolinamide (L68): Product L68 was 
prepared according to General Procedure 2 from SI10 and 3,5-di-tert-butylbenzoic acid. The 
product was purified by column chromatography to provide a white solid (66.7 mg, 0.15 mmol,  
31% yield);  [a]D25 37.12 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.53 (ddd, J = 4.7, 1.7, 
0.9 Hz, 1H), 8.23 – 8.15 (m, 2H), 7.80 (td, J = 7.7, 1.7 Hz, 1H), 7.62 (d, J = 1.8 Hz, 2H), 7.48 (t, 
J = 1.8 Hz, 1H), 7.39 (ddd, J = 7.6, 4.8, 1.2 Hz, 1H), 7.29 (d, J = 7.1 Hz, 1H), 4.07 (dddd, J = 11.7, 
10.8, 8.8, 4.0 Hz, 1H), 3.89 (tdd, J = 10.9, 7.1, 4.0 Hz, 1H), 2.42 (ddt, J = 12.1, 4.9, 2.6 Hz, 1H), 
2.12 (ddp, J = 12.4, 5.2, 2.6, 2.0 Hz, 1H), 1.93 – 1.73 (m, 2H), 1.59 (qd, J = 12.4, 3.7 Hz, 1H), 
1.45 (ddt, J = 17.1, 11.8, 6.1 Hz, 2H), 1.32 (s, 19H); 13C NMR (101 MHz, CDCl3) δ 168.1, 165.6, 
151.1, 149.4, 148.3, 137.3, 134.0, 126.5, 125.2, 122.4, 121.5, 56.7, 52.3, 35.1, 32.6, 32.4, 31.5, 
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1334, 1264, 1249, 1147, 1097, 998, 888, 820, 750, 706, 612 cm–1; HRMS (MM) m/z calc’d for 
C27H38N3O2 [M+H]+: 436.2959, found 436.2939. 
 
 
N-((1S,2S)-2-(3-methylbenzamido)cyclohexyl)picolinamide (L69): Product L69 was prepared 
according to General Procedure 2  from SI10 and 3-methylbenzoic acid. The product was purified 
by column chromatography to provide a white solid (94.2 mg, 76% yield); [a]D25 75.30 (c 0.80, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.52 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H), 8.18 (d, J = 8.8 Hz, 
1H), 8.13 (dt, J = 7.8, 1.1 Hz, 1H), 7.79 (td, J = 7.7, 1.7 Hz, 1H), 7.56 (dp, J = 1.6, 0.7 Hz, 1H), 
7.55 – 7.50 (m, 1H), 7.39 (ddd, J = 7.6, 4.8, 1.3 Hz, 1H), 7.25 – 7.15 (m, 3H), 4.12 – 4.01 (m, 1H), 
3.92 (tdd, J = 11.0, 7.3, 4.0 Hz, 1H), 2.40 – 2.30 (m, 4H), 2.13 (ddt, J = 12.8, 4.1, 2.7 Hz, 1H), 
1.92 – 1.76 (m, 2H), 1.64 – 1.49 (m, 1H), 1.48 – 1.40 (m, 2H), 1.39 – 1.23 (m, 1H); 13C NMR (101 
MHz, CDCl3) δ 167.6, 165.7, 149.4, 148.4, 138.2, 137.4, 134.5, 132.0, 128.4, 128.0, 126.5, 124.1, 
122.3, 56.3, 52.5, 32.6, 32.3, 25.2, 24.6, 21.5; IR (Neat Film, NaCl) 3304, 3055, 2933, 2857, 1655, 
1641, 1606, 1587, 1528, 1485, 1464, 1434, 1328, 1289, 1250, 1216, 1145, 1093, 1043, 998, 936, 












N-((1S,2S)-2-(4-(trifluoromethyl)benzamido)cyclohexyl)picolinamide (L70): Product L70 
was prepared according to General Procedure 2  from SI10 and 4-(trifluoromethyl)benzoic acid. 
The product was purified by column chromatography to provide an off-white solid (117 mg, 0.3 
mmol, 60% yield). 1H NMR (400 MHz, CDCl3) δ 1H NMR (300 MHz, CDCl3) δ 8.54 (ddd, J = 
4.8, 1.7, 0.9 Hz, 1H), 8.22 – 8.11 (m, 2H), 7.89 (d, J = 8.1 Hz, 2H), 7.83 (td, J = 7.7, 1.7 Hz, 1H), 
7.64 (d, J = 8.1 Hz, 2H), 7.54 (d, J = 6.5 Hz, 1H), 7.42 (ddd, J = 7.6, 4.8, 1.2 Hz, 1H), 4.17 – 4.00 
(m, 1H), 3.95 – 3.81 (m, 1H), 2.41 (d, J = 13.0 Hz, 1H), 2.13 (d, J = 12.8 Hz, 1H), 1.96 – 1.77 (m, 




N-((1S,2S)-2-(2-naphthamido)cyclohexyl)picolinamide (L72): Product L72 was prepared 
according to General Procedure 2  from SI10 and 2-naphthoic acid. The product was purified by 
column chromatography to provide an off-white solid (150 mg, 73% yield); 1H NMR (400 MHz, 
CDCl3) δ 9.24 (dq, J = 8.8, 1.0 Hz, 1H), 8.57 (ddd, J = 4.8, 1.8, 0.9 Hz, 1H), 8.43 (dd, J = 12.3, 
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7.73 – 7.65 (m, 2H), 7.60 (ddd, J = 8.2, 6.8, 1.2 Hz, 1H), 7.44 (ddd, J = 8.4, 6.8, 1.3 Hz, 1H), 7.33 
(ddd, J = 7.6, 4.8, 1.3 Hz, 1H), 4.16 (tdd, J = 10.9, 8.6, 3.9 Hz, 1H), 4.05 (tdd, J = 10.7, 8.6, 4.1 
Hz, 1H), 2.33 – 2.20 (m, 2H), 1.93 – 1.80 (m, 2H), 1.60 – 1.40 (m, 4H);	13C NMR (101 MHz, 
CDCl3) δ 166.7, 164.7, 150.0, 149.0, 148.2, 140.5, 137.3, 137.1, 130.3, 128.2, 127.7, 126.8, 126.8, 
126.0, 124.1, 122.2, 54.1, 53.2, 32.8, 32.6, 25.1, 25.0; IR (Neat Film, NaCl) 3310, 3053, 3007,  
2934, 1661, 1522, 1381, 1154, 998, 833, 747, 665, cm–1.	
  
 
N-((11S,12S)-12-amino-9,10-dihydro-9,10-ethanoanthracen-11-yl)benzamide (SI11):  To a 
solution of benzoic acid (1.04 g, 8.5 mmol) in THF (21 mL) was added carbonyl diimidazole (1.38 
g, 8.5 mmol). The resultant mixture was allowed to stir for 1 h at room temperature, or until the 
solution turned clear.  The solution was then diluted with THF (142 mL) and added slowly to a 
solution of (11S,12S)-9,10-dihydro-9,10-ethanoanthracene-11,12-diamine (1.14 g, 10.0 mmol) in 
THF (170 mL) via a dropping funnel. The reaction was allowed to stir  at room temperature 
overnight. The crude reaction mixture was then concentrated by rotary evaporator and purified by 
column chromatography (9:1 ethyl acetate: MeOH) to afford SI11 (1.7 g, 5.1 mmol, 60% yield, 
co-eluted with imidazole, used without further purification); [a]D25 30.33 (c 0.80, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 7.59 – 7.56 (m, 2H), 7.49 – 7.45 (m, 1H), 7.41 – 7.34 (m, 6H), 7.23 – 7.17 











Chapter 3 – Copper-Catalyzed Enantioselective Allylic Alkylation with a g-Butyrolactone-Derived Silyl 
Ketene Acetal 
350 
2.97 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 167.7, 142.4, 140.3, 139.2, 138.7, 134.2, 131.8, 128.8, 
127.2, 126.9, 126.7, 126.4, 125.3, 124.9, 124.8, 61.1, 60.2, 52.1, 49.1; IR (Neat Film, NaCl) 3119, 
2922, 2838, 2697, 2608, 1960, 1918, 1826, 1638, 1602, 1578, 1542, 1535, 1485, 1466, 1445, 1379, 
1326, 1294, 1256, 1228, 1141, 1116, 1095, 1063, 1026, 1000, 931, 866, 826, 751, 720, 664 cm–1; 
HRMS (MM) m/z calc’d for C23H21N2O [M+H]+: 341.1648, found 341.1649. 
 




To a solution of picolinic acid (378 mg, 3.07 mmol) in THF (4.65 mL) was added carbonyl 
diimidazole (498 mg, 3.07 mmol). The resultant mixture was stirred for 1 h at room temperature. 
N-((11S,12S)-12-amino-9,10-dihydro-9,10-ethanoanthracen-11-yl)benzamide (SI11, 950 mg, 
2.79 mmol) was added, and the reaction was allowed to stir overnight. The reaction mixture was 
then diluted with water and allowed to stir for 1 h. The aqueous layer was extracted with methylene 
chloride three times, and the resulting organic layers were dried over Na2SO4 and concentrated. 
Product L73 was purified by column chromatography to provide a white solid (747 mg, 1.68 
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4.8, 1.7, 0.9 Hz, 1H), 8.06 (dt, J = 7.8, 1.1 Hz, 1H), 7.92 (d, J = 8.7 Hz, 1H), 7.78 (td, J = 7.7, 1.7 
Hz, 1H), 7.62 – 7.57 (m, 2H), 7.51 – 7.39 (m, 3H), 7.39 – 7.30 (m, 5H), 7.25 – 7.14 (m, 4H), 6.10 
(d, J = 7.7 Hz, 1H), 4.63 (d, J = 2.6 Hz, 1H), 4.49 (d, J = 2.6 Hz, 1H), 4.36 – 4.29 (m, 2H); 13C 
NMR (101 MHz, CDCl3) δ 167.4, 164.2, 149.3, 148.2, 141.2, 139.2, 138.7, 137.3, 134.3, 131.7, 
128.6, 127.11, 127.07, 127.07, 127.01, 126.97, 126.91, 126.4, 126.0, 125.9, 125.1, 124.9, 122.3, 
57.8, 56.9, 49.6, 49.4; IR (Neat Film, NaCl) 3360, 3006, 1652, 1569, 1517, 1489, 1465, 1434, 
1327, 1293, 1146, 998, 748, 716 cm–1; HRMS (MM) m/z calc’d for C29H24N3O2 [M+H]+: 






methylpicolinamide (L74): Product L74 was prepared according to General Procedure 3  from 
SI11 and 6-methylpicolinic acid . The product was purified by column chromatography to provide 
a white solid (150 mg, 0.33 mmol, 65% yield); [a]D25 171.86 (c 0.80, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 7.97 (d, J = 8.6 Hz, 1H), 7.87 (dt, J = 7.7, 0.9 Hz, 1H), 7.66 (t, J = 7.7 Hz, 1H), 7.63 – 
7.58 (m, 2H), 7.52 – 7.47 (m, 1H), 7.46 – 7.40 (m, 2H), 7.39 – 7.31 (m, 4H), 7.29 – 7.16 (m, 5H), 
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2.45 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 167.4, 164.3, 157.3, 148.6, 141.2, 139.2, 138.8, 137.5, 
134.3, 131.7, 128.6, 127.1, 127.0, 126.9, 126.8, 126.1, 126.0, 125.9, 125.2, 124.9, 119.3, 57.9, 
56.7, 49.7, 49.4, 24.3;  IR (Neat Film, NaCl) 3328, 3022, 1654, 1595, 1578, 1521, 1489, 1455, 
1376, 1312, 1328, 1292, 1258, 1227, 1116, 1084, 1026, 995, 820, 804, 757, 716, 691, 664, 638 





methylpicolinamide (L75): Product L75 was prepared according to General Procedure 3  from 
SI11 and 3-methylpicolinic acid . The product was purified by column chromatography to provide 
a white solid (148 mg, 0.3 mmol, 64% yield); [a]D25 165.82 (c 0.80, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 8.26 (d, J = 4.5 Hz, 1H), 8.07 (d, J = 8.8 Hz, 1H), 7.64 – 7.58 (m, 2H), 7.53 (ddd, J = 
7.8, 1.6, 0.8 Hz, 1H), 7.50 – 7.42 (m, 3H), 7.40 – 7.31 (m, 4H), 7.25 – 7.14 (m, 5H), 5.98 (d, J = 
8.0 Hz, 1H), 4.61 (d, J = 2.8 Hz, 1H), 4.50 (d, J = 2.7 Hz, 1H), 4.34 – 4.28 (m, 1H), 4.23 (ddd, J 
= 8.8, 3.7, 2.8 Hz, 1H), 2.68 (s, 3H);  13C NMR (101 MHz, CDCl3) δ 167.4, 165.8, 146.6, 145.6, 
141.4, 141.1, 140.9, 139.2, 138.9, 135.5, 134.3, 131.7, 128.7, 127.1, 127.0, 126.9, 126.0, 125.0, 
124.9, 57.7, 57.0, 53.6, 49.6, 49.5, 20.6; IR (Neat Film, NaCl) 3327, 3046, 2956, 1654, 1602, 1579, 
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carboxamide (L76): Product L76 was prepared according to General Procedure 3  from SI11 and 
quinoline-2-carboxylic acid (174 mg, 0.35 mmol, 70% yield); [a]D25 221.25 (c 0.80, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 8.26 (dd, J = 8.6, 0.8 Hz, 1H), 8.17 (d, J = 8.5 Hz, 1H), 8.15 (s, 1H), 
7.98 – 7.92 (m, 1H), 7.87 – 7.81 (m, 1H), 7.73 (ddd, J = 8.4, 6.9, 1.4 Hz, 1H), 7.65 – 7.56 (m, 3H), 
7.55 – 7.51 (m, 1H), 7.49 – 7.44 (m, 1H), 7.41 (ddd, J = 7.6, 6.2, 1.8 Hz, 2H), 7.39 – 7.16 (m, 7H), 
6.13 (d, J = 7.4 Hz, 1H), 4.67 (d, J = 2.5 Hz, 1H), 4.54 (d, J = 2.5 Hz, 1H), 4.40 (ddt, J = 9.2, 3.5, 
1.6 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 167.4, 164.3, 149.1, 146.5, 141.1, 139.2, 138.8, 137.5, 
134.3, 131.7, 130.2, 130.0, 129.4, 128.6, 128.1, 127.7, 127.2, 127.1, 127.0, 126.02, 125.95, 125.2, 
124.9, 118.8, 57.9, 56.9, 49.7, 49.4; IR (Neat Film, NaCl) 3329, 3022, 1654, 1579, 1525, 1499, 
1427, 1328, 1211, 1145, 1113, 1026, 904, 844, 794, 750, 715, 674, 638 cm–1; HRMS (MM) m/z 












carboxamide (L77): Product L77 was prepared according to General Procedure 3  from SI11 and 
isoquinoline-1-carboxylic acid (173 mg, 69% yield); [a]D25 142.51 (c 0.80, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 9.52 – 9.48 (m, 1H), 8.34 (d, J = 5.5 Hz, 1H), 8.17 (d, J = 8.5 Hz, 1H), 7.81 (dt, J 
= 8.4, 0.8 Hz, 1H), 7.74 (dd, J = 5.6, 1.0 Hz, 1H), 7.69 (ddd, J = 8.2, 6.8, 1.4 Hz, 1H), 7.64 (ddt, J 
= 6.9, 3.7, 1.9 Hz, 3H), 7.49 (dd, J = 7.1, 1.4 Hz, 2H), 7.47 – 7.42 (m, 1H), 7.41 – 7.32 (m, 4H), 
7.28 – 7.16 (m, 4H), 6.08 (d, J = 7.7 Hz, 1H), 4.65 (d, J = 2.7 Hz, 1H), 4.58 (d, J = 2.7 Hz, 1H), 
4.36 (dddd, J = 12.1, 8.6, 3.6, 2.8 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 167.4, 166.0, 147.4, 
141.4, 141.1, 140.3, 139.2, 138.9, 137.5, 134.4, 131.7, 130.6, 128.8, 128.7, 127.7, 127.10, 127.07, 
127.05, 127.0, 126.9, 126.0, 125.1, 124.9, 124.6, 57.8, 57.2, 49.6, 49.5; IR (Neat Film, NaCl) 3328, 
3054, 3022, 2952, 1650, 1602, 1582, 1510, 1489, 1466, 1383, 1325, 1292, 1260, 1222, 1144, 1110, 
1024, 878, 834, 812, 800, 756, 715, 637, 619 cm–1; HRMS (MM) m/z calc’d for C33H26N3O2 
[M+H]+:496.2020, found 496.2014. 
 
N-((11S,12S)-12-benzamido-9,10-dihydro-9,10-ethanoanthracen-11-yl)-4-
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SI11 and 4-methoxypicolinic acid (174 mg, 0.37 mmol, 70% yield); [a]D25 134.97 (c 0.80, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 8.22 (dd, J = 5.6, 0.5 Hz, 1H), 7.94 (d, J = 8.6 Hz, 1H), 7.64 – 7.58 
(m, 3H), 7.50 – 7.40 (m, 3H), 7.39 – 7.31 (m, 4H), 7.28 – 7.14  (m, 4H), 6.86 (dd, J = 5.7, 2.6 Hz, 
1H), 6.12 (d, J = 7.6 Hz, 1H), 4.63 (d, J = 2.6 Hz, 1H), 4.47 (d, J = 2.5 Hz, 1H), 4.31 (dtd, J = 
10.4, 6.3, 3.1 Hz, 2H), 3.84 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 167.4, 166.9, 164.2, 151.3, 
149.4, 141.3, 141.1, 139.2, 138.7, 134.3, 131.7, 128.6, 127.12, 127.09, 127.0, 126.0, 125.1, 124.9, 
113.1, 107.6, 57.9, 56.9, 55.6, 49.6, 49.4; IR (Neat Film, NaCl) 3328, 2926, 1654,1599, 1579, 
1566, 1518, 1489, 1308, 1257, 1226, 1138, 1030, 994, 849, 804, 784, 761, 716, 640 cm–1; HRMS 




(trifluoromethyl)picolinamide (L79): Product L79 was prepared according to General Procedure 
3  from SI11 and 4-(Trifluoromethyl)pyridine-2-carboxylic acid . The product was purified by 
column chromatography to provide a white solid (107.1 mg, 0.21 mmol, 42% yield); [a]D25 143.66 
(c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.62 (dt, J = 5.0, 0.8 Hz, 1H), 8.28 (dt, J = 1.6, 0.7 
Hz, 1H), 7.84 (d, J = 8.7 Hz, 1H), 7.62 – 7.56 (m, 3H), 7.51 – 7.40 (m, 3H), 7.38 – 7.30 (m, 4H), 
7.29 – 7.15 (m, 4H), 6.13 (d, J = 7.9 Hz, 1H), 4.60 (d, J = 2.6 Hz, 1H), 4.49 (d, J = 2.6 Hz, 1H), 
4.39 – 4.32 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 167.4, 162.8, 150.8, 149.3, 141.1, 139.9 (q, J 
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(d, J = 18.6 Hz), 124.0, 124.0, 121.9 (d, J = 3.7 Hz), 121.2, 121.2, 118.6 – 118.2 (m), 57.7, 57.1, 
49.5 (d, J = 12.8 Hz); 19F NMR (282 MHz, CDCl3) δ –64.86; IR (Neat Film, NaCl) 3312, 3069, 
1654, 1610, 1580, 1524, 1488, 1411, 1331, 1293, 1265, 1228, 1173, 1141, 1116, 1080, 1026, 857, 
842, 797, 752, 720, 699, 665, 639 cm–1; HRMS (MM) m/z calc’d for C30H23F3N3O2 [M+H]+: 




3.9.2.3  Synthesis of Allylic Chloride Electrophiles 
 
General Procedure  4: Synthesis of Aryl-Substituted Allylic Chlorides (43b-d, 43g, 43h, 43j-m, 




(E)-2-(3-chloroprop-1-en-1-yl)naphthalene (43b):  (E)-3-(naphthalen-2-yl)prop-2-en-1-ol  (553 
mg, 3.0 mmol, 1.0 equiv) was dissolved in methylene chloride (6 mL, 0.5 M). Then, thionyl 
chloride (326  µL, 4.5 mmol, 1.2 equiv) was added dropwise. The reaction was allowed to stir for 
2 h at 0 °C,  then quenched with saturated aqueous NaHCO3 solution (6 mL) and allowed to warm 
to room temperature. The aqueous layer was extracted with methylene chloride three times, and 




0 °C, 2 h
Cl
43b
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suspended in hexanes (10 mL) and washed with water 4 times. The hexanes layer was then dried 
with Na2SO4   and concentrated to afford the desired allylic chloride 43b as a white solid (339 mg, 
1.68 mmol, 56% yield); 1H NMR (500 MHz, CDCl3) δ 7.91 – 7.83 (m, 3H), 7.83 – 7.79 (m, 1H), 
7.65 (dd, J = 8.6, 1.7 Hz, 1H), 7.57 – 7.47 (m, 2H), 6.88 (dtd, J = 15.6, 1.2, 0.6 Hz, 1H), 6.51 (dt, 




(E)-1-(3-chloroprop-1-en-1-yl)naphthalene (43c): 994 mg, 4.9 mmol, 77% yield;  1H NMR (300 
MHz, CDCl3) δ 8.19 – 8.02 (m, 1H), 7.96 – 7.77 (m, 2H), 7.62 (dt, J = 7.3, 1.0 Hz, 1H), 7.59 – 
7.38 (m, 4H), 6.37 (dtd, J = 15.1, 7.1, 0.8 Hz, 1H), 4.36 (dt, J = 7.1, 1.1 Hz, 2H); All 
characterization data match those reported.28 
 
 
(E)-1-(3-chloroprop-1-en-1-yl)-2-methylbenzene (43d): 274 mg, 1.64 mmol, 55% yield; 1H 
NMR (500 MHz, CDCl3) δ 7.50 – 7.38 (m, 1H), 7.22 – 7.12 (m, 3H), 6.88 (dt, J = 15.5, 1.2 Hz, 
1H), 6.22 (dt, J = 15.4, 7.2 Hz, 1H), 4.28 (dd, J = 7.2, 1.2 Hz, 2H), 2.37 (s, 3H); All characterization 











(E)-1-(3-chloroprop-1-en-1-yl)-3,5-dimethoxybenzene (43g): 106 mg, 0.5 mmol,  22% yield; 
1H NMR (500 MHz, CDCl3) δ 7.02 (dt, J = 1.5, 0.8 Hz, 2H), 6.93 (tt, J = 1.7, 0.8 Hz, 1H), 6.66 – 
6.54 (m, 1H), 6.30 (dt, J = 15.6, 7.2 Hz, 1H), 4.24 (dd, J = 7.3, 1.2 Hz, 2H), 2.31 (t, J = 0.7 Hz, 
6H); All characterization data match those reported.30 
 
 
(E)-1-(3-chloroprop-1-en-1-yl)-4-methylbenzene (43h): 442 mg, 2.65 mmol, 88% yield; 1H 
NMR (500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.18 – 7.11 (m, 2H), 6.63 (dd, J = 15.6, 1.1 Hz, 
1H), 6.27 (dt, J = 15.6, 7.2 Hz, 1H), 4.25 (dd, J = 7.3, 1.2 Hz, 2H), 2.35 (s, 3H); All characterization 
data match those reported.32 
 
 
(E)-1-chloro-4-(3-chloroprop-1-en-1-yl)benzene (43j): 609 mg, 3.25 mmol, 81% yield; 1H NMR 
(300 MHz, CDCl3) δ 7.31 (d, J = 1.1 Hz, 4H), 6.61 (dt, J = 15.7, 1.3 Hz, 1H), 6.30 (dt, J = 15.6, 
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(E)-1-bromo-4-(3-chloroprop-1-en-1-yl)benzene (43k): 579 mg, 2.5 mmol,  50% yield; 1H 
NMR (300 MHz, CDCl3) δ 7.55 – 7.38 (m, 2H), 7.26 (s, 2H), 6.60 (d, J = 15.7 Hz, 1H), 6.31 (dt, 




(E)-1-(3-chloroprop-1-en-1-yl)-4-(trifluoromethyl)benzene (43ll) and 1-(1-chloroallyl)-4-
(trifluoromethyl)benzene (43lb): 405 mg, 1.8 mmol, 61% yield, 43ll:43lb = 83:17 (inseparable 
mixture); 43ll:  1H NMR (300 MHz, CDCl3) δ 7.73 – 7.39 (m, 5H), 6.70 (d, J = 15.7 Hz, 1H), 6.41 
(dt, J = 15.5, 7.0 Hz, 1H), 4.25 (dd, J = 7.0, 1.3 Hz, 2H). 43lb: 1H NMR (300 MHz, CDCl3) δ 7.70 




(E)-4-(3-chloroprop-1-en-1-yl)benzonitrile (43ml) and 4-(1-chloroallyl)benzonitrile (43mb): 
Isolated as an inseparable mixture of constitutional isomers 1ml and 1mb  (210 mg, 1.18 mmol, 
56% yield, 43ml:43mb = 59:42, 43m = 86:15, E:Z); 1H NMR (400 MHz, CDCl3) 43ml: δ 7.70 – 
7.58 (m, 2H), 7.55 – 7.44 (m, 2H), 6.72 – 6.56 (m, 1H), 6.43 (dt, J = 15.7, 6.9 Hz, 1H), 4.25 (dd, 
J = 6.9, 1.2 Hz, 2H); 43mb: δ 7.70 – 7.58 (m, 2H), 7.55 – 7.44 (m, 2H), 6.11 (ddd, J = 17.1, 10.1, 
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Hz, 1H); 43ml and 43mb: 13C NMR (101 MHz, CDCl3) δ, 140.5, 136.6, 134.8, 132.6, 132.6, 
132.2, 129.3, 128.9, 128.3, 127.3, 118.8, 118.5, 118.3, 112.3, 111.6, 77.2, 57.4, 44.7, 25.2;  IR 
(Neat Film, NaCl) 3042, 2956, 2357, 2227, 1921, 1654, 1606, 1504, 1439, 1412, 1333, 1303, 1250, 
1215, 1177, 1156, 1109, 1075, 1017, 969, 936, 834, 811, 760, 722, 688, 672 cm–1; HRMS (MM) 
m/z calc’d for C10H9ClN [M+H]+: 178.0418, found 178.0422. 
 
 
((1E,3E)-5-chloropenta-1,3-dien-1-yl)benzene (43p): 1.32 g, 7.4 mmol, 92% yield;  1H NMR 
(300 MHz, CDCl3) δ 7.26 (m, 5H), 6.78 (dd, J = 15.6, 10.4 Hz, 1H), 6.60 (d, J = 15.7 Hz, 1H), 
6.46 (dd, J = 14.9, 10.3 Hz, 1H), 5.92 (dt, J = 14.8, 7.4 Hz, 1H), 4.18 (dd, J = 7.3, 1.1 Hz, 2H); All 
characterization data match those reported.34 
 
 
(E)-1-(3-chloroprop-1-en-1-yl)-3-methylbenzene (43el) and 1-(1-chloroallyl)-3-
methylbenzene (43eb): 513 mg, 71% yield. To a solution of (E)-3-(m-tolyl)prop-2-en-1-ol (640 
mg, 4.32 mmol, 1.0 equiv) in anhydrous Et2O (4.3 mL, 1 M) at 0° C  under a nitrogen atmosphere 
was added thionyl chloride (0.38 mL, 5.2 mmol, 1.2 equiv). Stirring was continued at 0° C for 6 
hours. The reaction was then diluted with Et2O and washed with saturated aqueous NaHCO3, 
followed by brine. The organic layer was dried over anhydrous sodium sulfate, filtered, and solvent 
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EtOAc/hexanes) to yield the title compound colorless oil (513 mg, 3.08 mmol, 71% yield, 
43el:43eb= 9:1); 1H NMR (500 MHz, CDCl3) 43el:  d 7.26– 7.20 (m, 3H), 7.11 (d, J = 7.2 Hz, 
1H), 6.64 (d, J = 15.4 Hz, 1H), 6.32 (dt, J = 15.4, 7.2 Hz, 1H), 4.26 (d, J = 7.2 Hz, 2H), 2.37 (s, 
3H); 43eb: d 7.28 (d, J = 7.5 Hz, 1H), 7.26 – 7.20 (m, 3H), 7.14 (d, J = 7.6 Hz, 1H), 6.21 (ddd, J 
= 17.2, 10.1, 7.2 Hz, 1H), 5.44 (d, J = 7.2 Hz, 1H), 5.36 (d, J = 16.8 Hz, 1H), 5.25 (d, J = 10.1 Hz, 
1H), 2.39 (s, 3H); 1el and 1eb: 13C NMR (125 MHz, CDCl3)   140.1, 138.6, 138.4, 137.9, 136.0, 
134.4, 129.3, 129.2, 128.7, 128.2, 127.5, 124.8, 124.6,  124.0, 116.9, 63.8,  45.7, 21.5; IR (Neat 
Film, NaCl) 3033, 2952, 2921, 2860, 1651, 1604, 1486, 1439, 1251, 964, 778 cm-1; HRMS (MM) 
m/z calc’d for C10H12 [M–Cl-]+: 131.0861, found 131.0858. 
 
 
(E)-1-(3-chloroprop-1-en-1-yl)-4-fluorobenzene (43i): ):  1-(4-fluorophenyl)prop-2-en-1-ol  
(750 mg, 4.92 mmol, 1.0 equiv) was dissolved in methylene chloride (6 mL, 0.5 M). Then, thionyl 
chloride (428  µL, 5.9 mmol, 1.2 equiv) was added dropwise. The reaction was allowed to stir for 
2 h at 0 °C,  then quenched with saturated aqueous NaHCO3 solution (6 mL) and allowed to warm 
to room temperature. The aqueous layer was extracted with methylene chloride three times, and 
the resulting organic layers were dried over Na2SO4 and concentrated.  The crude oil was then re-
suspended in hexanes (10 mL) and washed with water 4 times. The hexanes layer was then dried 
with Na2SO4  and concentrated by rotary evaporator. The crude product was purified by column 
chromatography (100% hexanes) to afford the desired allylic chloride 43i as a white solid (420 
mg, 2.46 mmol, 50% yield). 1H NMR (400 MHz, CDCl3) δ 7.43 – 7.31 (m, 2H), 7.12 – 6.95 (m, 
SOCl2 (1.2 equiv)
CH2Cl2 (0.5 M)
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2H), 6.62 (dt, J = 15.6, 1.2 Hz, 1H), 6.24 (dtd, J = 15.6, 7.2, 0.6 Hz, 1H), 4.23 (dd, J = 7.2, 1.2 Hz, 
2H); 13C NMR (101 MHz, CDCl3) δ 164.1, 161.6, 133.1, 132.2, 128.4, 124.8, 115.9, 115.7, 45.5; 
19F NMR (282 MHz, CDCl3) δ –113.30; IR (Neat Film, NaCl) 3043, 2361, 1602, 1508, 1300, 
1234, 1158, 966, 814 cm–1; HRMS (MM) m/z calc’d for C9H8ClF [M]+: 170.0299, found 170.0299 
 
 
(E)-3-(2,3-dihydrobenzofuran-5-yl)prop-2-en-1-ol (SI4): To a solution of ethyl (E)-3-(2,3-
dihydrobenzofuran-5-yl)acrylate (2.40 g, 11.0 mmol, 1.0 equiv) in anhydrous DCM (37 mL, 0.3 
M) under nitrogen atmosphere at -78° C was dropwise added neat DIBAL-H (4.37 mL, 24.2 mmol, 
2.20 equiv). The reaction was then allowed to warm to room temperature and stirring was 
continued for 12 hours. Upon completion, the reaction was cooled to 0° C and EtOAc (10 mL) 
was slowly added. The reaction was then diluted with Et2O and a saturated aqueous solution of 
Rochelle’s salt (ca. 150 mL) was added. Stirring was continued at room temperature for 1 hour. 
The biphasic mixture was then extracted with EtOAc (3x). The combined organic layers were dried 
over anhydrous sodium sulfate, filtered, and solvent was removed in vacuo to yield the crude 
product as a colorless solid (1.66 g, 9.42 mmol, 86% yield). The crude alcohol was isolated in 
good purity and used directly in the next step. 1H NMR (400 MHz, CDCl3) d 7.27 (s, 1H), 7.13 
(dd, J = 8.2, 1.4 Hz, 1H), 6.73 (d, J = 8.2 Hz, 1H), 6.54 (d, J = 15.8 Hz, 1H), 6.20 (dt, J = 15.8, 
6.0 Hz, 1H), 4.58 (t, J = 8.7 Hz, 2H), 4.29 (dd, J = 6.0, 1.4 Hz, 2H), 3.20 (t, J = 8.7 Hz, 2H), 1.48 
(s, 1H); 13C NMR (100 MHz, CDCl3) d 160.1, 131.6, 129.6, 127.6, 127.1, 125.7, 122.9, 109.4, 
O
OEt
O DIBAL-H (2.2 equiv)
CH2Cl2 (0.5 M)
–78 °C to 23°C, 12 h O
OH
SI12
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71.6, 64.2, 29.7; IR (Neat Film, NaCl) 3291, 2914, 2889, 2861, 1610, 1490, 1243, 1218, 1106, 
1086, 970; HRMS (MM) m/z calc’d for C11H11O [M–OH-]+: 159.0804, found 159.0804. 
 
 
(E)-5-(3-chloroprop-1-en-1-yl)-2,3-dihydrobenzofuran (43n):  To a solution of (E)-3-(2,3-
dihydrobenzofuran-5-yl)prop-2-en-1-ol (600 mg, 3.40 mmol, 1.0 equiv) in anhydrous Et2O (4.3 
mL, 1 M) at 0° C  under a nitrogen atmosphere was added thionyl chloride (0.30 mL, 4.1 mmol, 
1.2 equiv). Stirring was continued at 0° C for 12 hours. The reaction was then diluted with Et2O 
and washed with saturated aqueous NaHCO3, followed by brine. The organic layer was dried over 
anhydrous sodium sulfate, filtered, and solvent was removed in vacuo to yield the crude product 
as a tan amorphous solid (350 mg, 1.80 mmol, 53% yield). The crude allyl chloride was stored 
cold under nitrogen and used directly in the next reaction, as it was unstable to silica and neutral 
alumina (50 mg, 0.26 mmol,  51% yield). 1H NMR (400 MHz, CD2Cl2) δ 7.26 (d, J = 1.3 Hz, 1H), 
7.10 (d, J = 10.0 Hz, 1H), 6.67 (d, J = 8.2 Hz, 1H), 6.56 (d, J = 15.6 Hz, 1H), 6.19 – 6.07 (m, 1H), 
4.53 (t, J = 8.7 Hz, 3H), 4.21 (d, J = 7.4 Hz, 2H), 3.16 (t, J = 8.7 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 160.5, 134.4, 128.8, 127.7, 127.5, 123.1, 122.1, 109.4, 71.6, 46.2, 29.7; IR (Neat Film, 
NaCl) 2960, 2894, 1646, 1611, 1492, 1440, 1246, 1102, 982, 808 cm-1; HRMS (MM) m/z calc’d 
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3-(1-hydroxyallyl)phenyl trifluoromethanesulfonate (SI13): To a solution of 3-formylphenyl 
trifluoromethanesulfonate(635 mg, 2.5 mmol, 1.0 equiv) in THF (6.6 mL, 0.38 M)  at –78°C was 
added vinylmagnesium bromide (2.53 mL, 2.53 mmol, 1M solution in THF) slowly. The reaction 
was allowed to stir for 4 h at –78 °C, then quenched with saturated aqueous NH4Cl solution (6 
mL) and allowed to warm to room temperature. The aqueous layer was extracted with methylene 
chloride three times, and the resulting organic layers were dried over Na2SO4 and concentrated. 
The crude allylic alcohol was purified by column chromatography to afford a yellow oil (542 mg, 
1.92 mmol, 77% yield). 1H NMR (400 MHz, CDCl3) δ 7.41 – 7.30 (m, 2H), 7.25 (s, 1H), 7.15 – 
7.10 (m, 1H), 6.03 – 5.81 (m, 1H), 5.31 (d, J = 18.3 Hz, 1H), 5.19 (d, J = 11.2 Hz, 2H), 2.00 (d, J 
= 3.6 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 149.9, 145.7, 139.5, 130.4, 126.3, 123.7 – 114.1 (q, 
J = 320.7 Hz), 120.5, 119.3, 116.7, 114.1, 74.6; 19F NMR (282 MHz, CDCl3) δ –72.93; IR (Neat 
Film, NaCl) 3573, 3358, 3087, 2878, 1614, 1583, 1485, 1425, 1249, 1208, 1141, 1035, 990, 960, 
912, 841, 96, 775, 753, 696, 657, 666 cm–1; HRMS (MM) m/z calc’d for C10H8F3O3S [M–OH-]+: 
265.0141, found 265.0146. 
 
General Procedure 5: Synthesis of Allylic Chlorides 43f, 43n, and 43o. 
 
 
3-(1-chloroallyl)phenyl trifluoromethanesulfonate(43fl) and (E)-3-(3-chloroprop-1-en-1-
yl)phenyl trifluoromethanesulfonate (43fb):  N-chlorosuccinamide (150 mg, 1.125 mmol, 1.5 
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1.39 mmol, 1.85 equiv) was added slowly and the resulting suspension was cooled to –10 °C. 3-
(1-hydroxyallyl)phenyl trifluoromethanesulfonate (SI13,  211mg, 0.75 mmol, 1.0 equiv) in 
dichloromethane (1.5 mL) was then added slowly. The reaction was warmed to 0 °C and allowed 
to stir for 3 h. Upon consumption of the starting material, the reaction was quenched with ice-cold 
water, and extracted with diethyl ether four times. The combined extracts were then rinsed with 
water and brine, and dried over Na2SO4. The resulting crude oil was purified by column 
chromatography to afford (E)-3-(3-chloroprop-1-en-1-yl)phenyl trifluoromethanesulfonate (43fl)  
3-(1-chloroallyl)phenyl trifluoromethanesulfonate (43fb) and in an inseparable mixture (112 mg, 
50% yield, 43fl:43fb = 60:40, 43fl = 86:14 E/Z); 1H NMR (300 MHz, CDCl3) 43fl:  δ 7.50 –7.12 
(m, 4H), 6.12 (ddd, J = 17.0, 10.1, 7.1 Hz, 1H), 5.46 (dt, J = 7.2, 1.1 Hz, 1H), 5.40 – 5.27 (m, 2H), 
4.60 (s, 1H); 43fb: δ 7.50 –7.12 (m, 4H), 6.66 (dt, J = 15.7, 1.2 Hz, 1H), 6.44 – 6.32 (m, 1H), 4.24 
(dd, J = 7.0, 1.2 Hz, 2H); 43fl and 43fb: 13C NMR (101 MHz, CDCl3) δ 150.0, 149.7, 143.0, 138.8, 
136.8, 133.7, 132.0, 130.7, 130.6, 128.5, 127.8, 127.5, 126.7, 121.6, 121.4, 120.8, 120.7, 120.4, 
119.4, 118.3, 117.3, 61.9, 57.5, 44.8, 44.7, 25.3; 19F NMR (282 MHz, CDCl3) δ –72.86 (m); IR 
(Neat Film, NaCl) 2916, 2849, 1611, 1576, 1487, 1422, 1247, 1215, 1140, 1120, 962, 908, 886, 
847, 787, 680 cm–1; HRMS (MM) m/z calc’d for C10H8ClF3SO3 [M]*+: 299.9835, found 299.9846. 
 
 
(E)-3-(3-chloroprop-1-en-1-yl)thiophene(43o): Synthesized from (E)-3-(thiophen-3-yl)prop-2-
en-1-ol according to General Procedure 5, and used without further purification (286 mg, 1.84 
mmol, 48% yield); 1H NMR (400 MHz, CDCl3) δ 7.29 (ddd, J = 5.0, 3.0, 0.6 Hz, 1H), 7.24 – 7.19 
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1.2 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 138.7, 128.5, 126.5, 125.1, 124.9, 123.6, 45.7; IR 
(Neat Film, NaCl) 3736, 3103, 2952, 1650, 1417, 1293, 1247, 1150, 1074, 961, 865, 768 cm–1; 
HRMS (MM) m/z calc’d for C7H7S [M–Cl-]+: 123.0268, found 123.0260.  
 
 
(E)-(5-chloropent-3-en-1-yl)benzene (40b): Compound 40b was prepared from the 
corresponding allylic alcohol according to a previously reported procedure.29 1H NMR (500 MHz, 
CDCl3) δ 7.30 (td, J = 7.4, 1.4 Hz, 2H), 7.24 – 7.16 (m, 3H), 5.82 (dtd, J = 14.5, 6.6, 1.2 Hz, 1H), 
5.66 (dddq, J = 15.4, 7.1, 6.2, 1.3 Hz, 1H), 4.04 (dt, J = 7.1, 1.0 Hz, 2H), 2.72 (dd, J = 8.7, 7.0 Hz, 
2H), 2.47 – 2.33 (m, 2H); All characterization data match those reported.29 
 
3.9.2.4 Procedure for  Cu-Catalyzed Allylic Alkylation Reactions 
 
 
n = number of reactions.  To a 4 mL vial containing CuCl2 (1.34n mg, 0.01n mmol, 0.05 equiv) in 
the glovebox was added a solution of the L73 (5.2n mg, 0.012n mmol, 0.06 equiv) in THF (0.8n 




OTMS CuCl2 (5 mol %)
L73 (6 mol %), LiHMDS (13 mol%)
CsOAc (1 equiv)





N L7340b, 43a-q 41 42a, 44a-q
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The resulting solution was stirred for 1 h at room temperature. This solution (1.6 mL) was then 
transferred to a vial containing CsOAc, followed by silyl ketene acetal 41 (47.5 mg, 0.3 mmol, 1.5 
equiv) in THF (1.6 mL). The mixture was allowed to stir for 5 min, then allyl chloride (30.4 mg, 
0.2 mmol, 1 equiv) in THF (1.6 mL) was added and the reaction was allowed to stir for 6 h at 30 
°C. The reaction was then quenched with sat. NH4Cl solution and a few drops of TMEDA, and the 
aqueous layer was extracted five times with ethyl acetate. The combined organic extracts were 
dried with Na2SO4, and concentrated by rotary evaporator. The crude oil was then purified by 
column chromatography to afford the desired product. 
3.9.2.5 Spectroscopic Data for Products from Catalytic Reactions 
Please note that the absolute configuration was determined only for compound 44ba via x-ray 




       
(S)-3-cinnamyldihydrofuran-2(3H)-one (44a): Product 44a was purified by column 
chromatography (25% EtOAc in hexanes) to provide a white solid (36.4 mg,0.18 mmol, 90% 
yield); 94% ee; [a]D25 46.62 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.38 – 7.28 (m, 4H), 
7.26 – 7.20 (m, 1H), 6.49 (dt, J = 15.7, 1.4 Hz, 1H), 6.29 – 6.08 (m, 1H), 4.35 (td, J = 8.8, 3.1 Hz, 
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13C NMR (101 MHz, CDCl3) δ 178.9, 137.0, 133.2, 128.7, 127.6, 126.3, 125.9, 66.8, 39.4, 33.7, 
27.9; IR (Neat Film, NaCl) 3057, 3027, 2988, 2936, 2906, 1770, 1480, 1436, 1378, 1314, 1294, 
1251, 1208, 1190, 1164, 1074, 1021, 988, 966, 812, 798, 751, 705, 695, 681, 671, 622 cm–1; HRMS 
(MM) m/z calc’d for C13H15O2 [M+H]+: 203.1067, found 203.1064; SFC Conditions: 15% IPA, 
2.5 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): major = 4.70, minor = 5.02. 
 
 
(S,E)-3-(3-(naphthalen-2-yl)allyl)dihydrofuran-2(3H)-one (44b): Product 44b was purified by 
column chromatography (25% EtOAc in hexanes) to provide a white solid (43.4 mg, 0.17 mmol, 
86% yield); 91% ee; [a]D25 32.53 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.87 – 7.75 (m, 
3H), 7.70 (d, J = 1.7 Hz, 1H), 7.57 (dd, J = 8.6, 1.8 Hz, 1H), 7.51 – 7.39 (m, 2H), 6.65 (dd, J = 
15.8, 1.6 Hz, 1H), 6.30 (dt, J = 15.7, 7.1 Hz, 1H), 4.35 (td, J = 8.8, 3.0 Hz, 1H), 4.22 (td, J = 9.3, 
6.8 Hz, 1H), 2.90 – 2.68 (m, 2H), 2.62 – 2.28 (m, 2H), 2.08 (dtd, J = 12.7, 9.7, 8.6 Hz, 1H); 13C 
NMR (101 MHz, CDCl3) δ 178.9, 134.5, 133.7, 133.2, 133.0, 128.3, 128.0, 127.8, 126.4, 126.3, 
126.0, 125.9, 123.5, 66.7, 39.4, 33.8, 28.0; IR (Neat Film, NaCl)  2905, 1767, 1452, 1374, 1154, 
1020, 964, 866, 821, 753, 668 cm–1; HRMS (MM) m/z calc’d for C17H17O2 [M+H]+: 253.1223, 
found 253.1232; SFC Conditions: 35% IPA, 3.5 mL/min, Chiralcel OD-H column, λ = 254 nm, tR 
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(S,E)-3-(3-(naphthalen-1-yl)allyl)dihydrofuran-2(3H)-one (44c): Product 44c was purified by 
column chromatography (25% EtOAc in hexanes) to provide a colorless solid (42.4 mg, 0.17 
mmol, 84% yield); 91% ee; [a]D25 29.405 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 8.15 – 
8.04 (m, 1H), 7.91 – 7.82 (m, 1H), 7.78 (dt, J = 8.1, 1.0 Hz, 1H), 7.59 – 7.39 (m, 4H), 7.22 (s, 1H), 
6.19 (dt, J = 15.5, 7.2 Hz, 1H), 4.38 (td, J = 8.8, 3.1 Hz, 1H), 4.24 (td, J = 9.3, 6.9 Hz, 1H), 2.95 
– 2.74 (m, 2H), 2.58 (dddd, J = 13.9, 8.4, 7.3, 1.4 Hz, 1H), 2.45 (dddd, J = 12.7, 8.7, 6.9, 3.1 Hz, 
1H), 2.14 (dtd, J = 12.7, 9.7, 8.5 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 178.9, 134.9, 133.7, 
131.1, 130.5, 129.3, 128.7, 128.0, 126.2, 125.9, 125.7, 123.9, 123.8, 66.8, 39.5, 34.1, 28.0; IR 
(Neat Film, NaCl) 3746, 2909, 2358, 1769, 1508, 1374, 1153, 1023, 969, 777 cm–1; HRMS (MM) 
m/z calc’d for C17H17O2 [M+H]+: 253.1223, found 253.1221; SFC Conditions: 25% IPA, 2.5 
mL/min, Chiralcel OD-H column, λ = 210 nm, tR (min): major = 10.39, minor = 11.48. 
 
 
(S,E)-3-(3-(o-tolyl)allyl)dihydrofuran-2(3H)-one (44d): Product 44d was purified by column 
chromatography (25% EtOAc in hexanes) to provide a colorless oil (27.2 mg, 0.13 mmol, 63% 
yield); 94% ee; [a]D25 26.0 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.26 (s, 2H), 7.11 (s, 
2H), 6.45 (d, J = 15.7 Hz, 1H), 6.17 – 6.05 (m, 1H), 4.38 – 4.30 (m, 1H), 4.26 – 4.17 (m, 1H), 2.80 
– 2.67 (m, 2H), 2.51 – 2.35 (m, 2H), 2.33 (s, 3H), 2.05 (t, J = 9.5 Hz, 1H). 13C NMR (101 MHz, 
CDCl3) δ 131.1, 130.4, 127.5, 127.3, 126.2, 125.7, 66.7, 39.5, 34.0, 27.9, 20.0; IR (Neat Film, 
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m/z calc’d for C14H17O2 [M+H]+: 217.1223, found 217.1221; SFC Conditions: 20% IPA, 2.5 
mL/min, Chiralcel OD-H column, λ = 254 nm, tR (min): major = 5.05, minor = 5.73. 
 
 
(S,E)-3-(3-(m-tolyl)allyl)dihydrofuran-2(3H)-one (44e): Compound 44e was purified by 
column chromatography (30% EtOAc/hexanes) to afford the title compound as a colorless oil (38.3 
mg, 0.18 mmol, 88% yield); 90% ee; [a]D23 31.6 (c 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) d 
7.22 – 7.14 (m, 3H), 7.05 (d, J = 7.4 Hz, 1H), 6.46 (d, J = 15.7 Hz, 1H), 6.16 (dt, J = 15.8, 7.2 Hz, 
1H), 4.34 (td, J = 8.8, 3.1 Hz, 1H), 4.21 (td, J = 9.3, 6.9 Hz, 1H), 2.78 – 2.69 (m, 2H), 2.50 – 2.36 
(m, 2H), 2.34 (s, 3H), 2.11 – 2.00 (m, 1H); 13C NMR (100 MHz, CDCl3) d 179.0, 137.4, 134.3, 
133.0, 129.4, 126.2, 124.8, 66.8, 39.5, 33.7, 27.9, 21.3; IR (Neat Film, NaCl) 2911, 1769, 1602, 
1486, 1454, 1374, 1152, 1022, 968, 775 cm-1; HRMS (MM) m/z calc’d for C14H17O2 [M+H]+: 
217.1223, found 217.1227; SFC Conditions: 15% IPA, 2.5 mL/min, Chiralcel OD-H column, l = 




(44f): Product 44f was purified by column chromatography (25% EtOAc in hexanes) to provide a 
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(400 MHz, CDCl3) δ 7.44 – 7.32 (m, 2H), 7.24 – 7.20 (m, 1H), 7.12 (dt, J = 7.2, 2.3 Hz, 1H), 6.48 
(dt, J = 15.8, 1.4 Hz, 1H), 6.25 (dt, J = 15.8, 7.1 Hz, 1H), 4.36 (td, J = 8.9, 2.8 Hz, 1H), 4.23 (td, 
J = 9.4, 6.8 Hz, 1H), 2.85 – 2.68 (m, 2H), 2.54 – 2.35 (m, 2H), 2.12 – 1.97 (m, 1H); 13C NMR (101 
MHz, CDCl3) δ 178.6, 150.0, 139.8, 131.2, 130.5, 128.9, 126.2, 120.0, 118.9, 118.8 (q, J = 320.7 
Hz), 66.7, 39.2, 33.6, 28.1; 19F NMR (282 MHz, CDCl3) δ -72.94; IR (Neat Film, NaCl) 2912, 
2356, 1770, 1654, 1609, 1573, 1486, 1421, 1248, 1214, 1141, 1118, 1023, 960, 904, 884, 848, 
786, 736, 683, 658, 606 cm–1; HRMS (MM) m/z calc’d for C14H14F3O2S [M+H]+: 351.0509, found 
351.0508; SFC Conditions: 5% IPA, 2.5 mL/min, Chiralcel OJ-H column, λ = 254 nm, tR (min): 
minor = 6.9, major = 7.2. 
 
 
(S,E)-3-(3-(3,5-dimethoxyphenyl)allyl)dihydrofuran-2(3H)-one (44g): Product 44g was 
purified by column chromatography (25% EtOAc in hexanes) to provide a colorless oil (38.8 mg,  
0.15 mmol, 74% yield); 80% ee; [a]D25 30.71 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ  6.98 
(d, J = 1.5 Hz, 2H), 6.92 – 6.85 (m, 1H), 6.49 – 6.38 (m, 1H), 6.14 (dt, J = 15.7, 7.1 Hz, 1H), 4.34 
(td, J = 8.8, 3.1 Hz, 1H), 4.21 (td, J = 9.3, 6.9 Hz, 1H), 2.73 (dddd, J = 12.0, 10.4, 6.7, 3.6 Hz, 
2H), 2.52 – 2.24 (m, 8H), 2.16 – 2.00 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 179.0, 138.2, 136.9, 
133.3, 129.4, 129.3, 125.5, 124.2, 66.7, 39.4, 33.7, 27.9; IR (Neat Film, NaCl) 2914, 1768, 1600, 
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263.1278, found 263.1268; SFC Conditions: 15% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 
254 nm, tR (min): major = 5.50, minor = 6.85. 
 
 
(S,E)-3-(3-(p-tolyl)allyl)dihydrofuran-2(3H)-one (44da): Product 44da was purified by column 
chromatography (25% EtOAc in hexanes) to provide a colorless oil (38.9 mg, 0.18 mmol,  90% 
yield); 93% ee; [a]D25 38.205 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.26 (d, J = 7.9 Hz,  
2H), 7.12 (d, J = 7.9 Hz, 2H), 6.49 – 6.42 (m, 1H), 6.11 (dt, J = 15.7, 7.2 Hz, 1H), 4.34 (td, J = 
8.8, 3.1 Hz, 1H), 4.21 (td, J = 9.2, 6.9 Hz, 1H), 2.82 – 2.66 (m, 2H), 2.52 – 2.30 (m, 5H), 2.05 
(dtd, J = 12.6, 9.6, 8.5 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 179.0, 137.4, 134.2, 132.9, 129.4, 
126.2, 124.8, 66.7, 39.4, 33.7, 27.9, 21.3; IR (Neat Film, NaCl) 2919, 1770, 1513, 1454, 1373, 
1152, 1020, 972, 823, 680 cm–1; HRMS (MM) m/z calc’d for C14H17O2 [M+H]+: 217.1223, found 
217.1224; SFC Conditions: 10% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): 
major = 7.90, minor = 8.41. 
 
 
(S,E)-3-(3-(4-fluorophenyl)allyl)dihydrofuran-2(3H)-one (44i): Product 44i was purified by 
column chromatography (25% EtOAc in hexanes) to provide a colorless oil (37.3 mg, 0.17 mmol, 
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2H), 7.05 – 6.94 (m, 2H), 6.44 (dt, J = 15.8, 1.4 Hz, 1H), 6.08 (dt, J = 15.7, 7.1 Hz, 1H), 4.35 (td, 
J = 8.8, 3.0 Hz, 1H), 4.22 (td, J = 9.3, 6.9 Hz, 1H), 2.79 – 2.66 (m, 2H), 2.51 – 2.33 (m, 2H), 2.05 
(dtd, J = 12.7, 9.6, 8.5 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 178.8, 163.5, 161.1, 133.2 (d, J = 
3.3 Hz), 131.9, 127.8 (d, J = 8.0 Hz), 126.0 – 125.1 (m), 115.6 (d, J = 21.6 Hz), 66.7, 39.4, 33.6, 
28.0; 19F NMR (282 MHz, CDCl3) δ -114.71 (tt, J = 8.5, 5.3 Hz); IR (Neat Film, NaCl) 3734, 
2910, 2358, 1769, 1601, 1508, 1456, 1374, 1226, 1157, 1023, 970, 838 cm–1; HRMS (MM) m/z 
calc’d for C13H14FO2 [M+H]+: 219.0972, found 219.0974; SFC Conditions: 15% IPA, 2.5 mL/min, 
Chiralpak OD-H column, λ = 280 nm, tR (min): major = 5.10, minor = 5.57. 
 
 
(S,E)-3-(3-(4-chlorophenyl)allyl)dihydrofuran-2(3H)-one (44j): Product 44j was purified by 
column chromatography (25% EtOAc in hexanes) to provide a colorless oil (44.4 mg, 0.19 mmol,  
94% yield); 88% ee; [a]D25 32.55 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.26 (s, 4H), 
6.43 (dt, J = 15.7, 1.4 Hz, 1H), 6.14 (dt, J = 15.8, 7.1 Hz, 1H), 4.34 (td, J = 8.8, 3.0 Hz, 1H), 4.21 
(td, J = 9.3, 6.8 Hz, 1H), 2.84 – 2.67 (m, 2H), 2.53 – 2.31 (m, 2H), 2.04 (dtd, J = 12.7, 9.7, 8.5 Hz, 
1H); 13C NMR (101 MHz, CDCl3) δ 178.8, 135.5, 133.2, 131.9, 128.8, 127.5, 126.7, 66.7, 39.3, 
33.6, 28.0; IR (Neat Film, NaCl) 2910, 1770, 1490, 1454, 1405, 1375, 1326, 1154, 1091, 1023, 
970, 830 cm–1; HRMS (MM) m/z calc’d for C13H14ClO2 [M+H]+: 237.0667, found 237.0682; SFC 
Conditions: 20% IPA, 2.5 mL/min, Chiralcel aOD-H column, λ = 254 nm, tR (min): major = 5..30, 










(S,E)-3-(3-(4-bromophenyl)allyl)dihydrofuran-2(3H)-one (44k): Product 44k was purified by 
column chromatography (25% EtOAc in hexanes) to provide a colorless oil (43.5 mg, 0.154 mmol, 
77% yield); 90% ee; [a]D25 13.95 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ  7.45 – 7.38 (m, 
2H), 7.24 – 7.17 (m, 2H), 6.42 (dd, J = 15.7, 1.5 Hz, 1H), 6.17 (dt, J = 15.8, 7.1 Hz, 1H), 4.34 (td, 
J = 8.8, 3.0 Hz, 1H), 4.21 (td, J = 9.3, 6.8 Hz, 1H), 2.85 – 2.62 (m, 2H), 2.53 – 2.30 (m, 2H), 2.04 
(dtd, J = 12.7, 9.7, 8.6 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 178.7, 135.9, 132.0, 131.8, 127.8, 
126.8, 121.3, 66.7, 39.3, 33.6, 28.0; IR (Neat Film, NaCl) 2910, 1769, 1487, 1454, 1401, 1375, 
1260, 1156, 1072, 1023, 969, 799, 707 cm–1; HRMS (MM) m/z calc’d for C13H14BrO2 [M+H]+: 
281.0172, found 281.0175; SFC Conditions: 20% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 
254 nm, tR (min): major = 6.34, major = 7.18. 
 
 
(S,E)-3-(3-(4-(trifluoromethyl)phenyl)allyl)dihydrofuran-2(3H)-one (44l): Product 44l was 
purified by column chromatography (25% EtOAc in hexanes) to provide a colorless oil (44.9 mg, 
0.17 mmol,  83% yield); 90% ee; [a]D25 30.89 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.55 
(d, J = 8.2 Hz, 2H), 7.44 (d, J = 8.1 Hz, 2H), 6.52 (dd, J = 15.9, 1.7 Hz, 1H), 6.29 (dt, J = 15.8, 
7.1 Hz, 1H), 4.36 (td, J = 8.8, 2.9 Hz, 1H), 4.22 (td, J = 9.4, 6.8 Hz, 1H), 2.84 – 2.68 (m, 2H), 2.56 
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131.8, 129.3 (q, J = 32.3 Hz), 126.4, 125.5 (q, J = 3.8 Hz), 122.9, 66.7, 39.2, 33.7, 28.0; 19F NMR 
(282 MHz, CDCl3) δ -62.50; IR (Neat Film, NaCl) 2914, ,1770, 1614, 1414, 1376, 1326, 1157, 
1119, 1067, 1018, 970, 834, 682 cm–1; HRMS (MM) m/z calc’d for C14H14F3O2 [M+H]+: 271.0940, 
found 271.0945; SFC Conditions: 10% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 210 nm, tR 
(min): major= 5.32, major = 5.86. 
 
 
(S,E)-4-(3-(2-oxotetrahydrofuran-3-yl)prop-1-en-1-yl)benzonitrile (44m): Product 44m was 
synthesized according to the General Procedure, but with a doubled catalyst loading (10 mol% 
CuCl2, 12 mol%, L73, 26 mol% LiHMDS). The crude product was purified by column 
chromatography (40% EtOAc in hexanes) to provide a colorless oil (43.6 mg, 0.19 mmol, 96% 
yield, 98:2 E:Z); 86% ee; [a]D25 48.79 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.61 – 7.55 
(m, 2H), 7.46 – 7.39 (m, 2H), 6.50 (dd, J = 15.8, 1.5 Hz, 1H), 6.33 (dt, J = 15.8, 7.0 Hz, 1H), 4.40 
– 4.31 (m, 1H), 4.22 (td, J = 9.4, 6.7 Hz, 1H), 2.85 – 2.68 (m, 2H), 2.56 – 2.35 (m, 2H), 2.13 – 
1.96 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 178.5, 141.4, 132.5, 131.6, 130.2, 126.8, 119.0, 
110.8, 66.7, 39.2, 33.7, 28.1; IR (Neat Film, NaCl) 3432, 2924, 2224, 1766, 1604, 1375, 1156, 
1021, 970, 837 cm–1; HRMS (MM) m/z calc’d for C14H14NO2 [M+H]+: 228.1019, found 228.1020; 
SFC Conditions: 25% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 280 nm, tR (min): major = 










(S,E)-3-(3-(2,3-dihydrobenzofuran-5-yl)allyl)dihydrofuran-2(3H)-one (44n): Compound 44n 
was purified by flash column chromatography (40% EtOAc/hexanes) to afford the title compound 
as a colorless amorphous solid (27.6 mg, 0.11 mmol, 56% yield); 95% ee; [a]D23 35.0 (c 1.00, 
CHCl3); 1H NMR (400 MHz, CDCl3) d 7.24 (s, 1H), 7.08 (dd, J = 8.2, 1.4 Hz, 1H), 6.71 (d, J = 
8.2 Hz, 1H), 6.41 (d, J = 15.7 Hz, 1H), 5.98 (dt, J = 15.7, 7.2 Hz, 1H), 4.56 (t, J = 8.7 Hz, 2H), 
4.33 (td, J = 8.8, 3.2 Hz, 1H), 4.21 (td, J = 9.2, 6.9 Hz, 1H), 3.19 (t, J = 8.6 Hz, 2H), 2.75 – 2.67 
(m, 2H), 2.47 – 2.41 (m, 2H), 2.39 – 2.33 (m, 2H), 2.05 (dtd, J = 12.9, 9.5, 8.6 Hz, 1H); 13C NMR 
(100 MHz, CDCl3)   179.0, 159.9, 132.9, 129.9, 127.6, 126.7, 122.9, 122.5, 109.3, 71.5, 66.8, 
39.5, 33.7, 29.7, 27.8; IR (Neat Film, NaCl) 2912, 1764, 1608, 1491, 1374, 1244, 1150, 1022, 980 
cm-1; HRMS (MM) m/z calc’d for C15H17O3 [M+H]+: 245.1172, found 245.1171; SFC Conditions: 
20% IPA, 2.5 mL/min, Chiralcel OD-H column, l = 210 nm, tR (min): minor = 6.93, major = 6.05. 
 
 
(S,E)-3-(3-(thiophen-3-yl)allyl)dihydrofuran-2(3H)-one (44o): Product 44o was purified by 
column chromatography (25% EtOAc in hexanes) to provide a colorless oil (29.6 mg, 0.142 mmol, 
71% yield); 90% ee; [a]D25 45.11 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.26 (s, 1H), 
7.18 (dd, J = 5.0, 1.4 Hz, 1H), 7.10 (dd, J = 3.0, 1.3 Hz, 1H), 6.49 (dd, J = 15.8, 1.6 Hz, 1H), 6.09 
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2H), 2.14 – 1.97 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 178.9, 139.7, 127.4, 126.2, 125.8, 125.0, 
121.7, 66.7, 39.4, 33.6, 27.9; IR (Neat Film, NaCl) 3098, 2994, 2909, 1766, 1482, 1454, 1374, 
1201, 1183, 1151, 1094, 1022, 967, 862, 832, 772, 696, 673, 616 cm–1; HRMS (MM) m/z calc’d 
for C11H13O2S [M+H]+: 209.0631, found 209.0637; SFC Conditions: 20% IPA, 2.5 mL/min, 
Chiralcel OD-H column, λ = 254 nm, tR (min): major = 4.76, major = 5.32. 
 
 
(S)-3-((2E,4E)-5-phenylpenta-2,4-dien-1-yl)dihydrofuran-2(3H)-one (44p): Product 44p was 
purified by column chromatography (25% EtOAc in hexanes) to provide a colorless oil (34.7 mg, 
0.152 mmol, 76% yield); 83% ee; [a]D25  34.815 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
7.41 – 7.35 (m, 2H), 7.31 (dd, J = 8.5, 6.8 Hz, 2H), 7.25 – 7.19 (m, 1H), 6.75 (ddd, J = 15.7, 10.4, 
0.8 Hz, 1H), 6.50 (d, J = 15.7 Hz, 1H), 6.30 (ddq, J = 15.2, 10.4, 1.1 Hz, 1H), 5.85 – 5.69 (m, 1H), 
4.35 (td, J = 8.8, 3.1 Hz, 1H), 4.21 (td, J = 9.3, 6.9 Hz, 1H), 2.75 – 2.62 (m, 2H), 2.44 – 2.33 (m, 
2H), 2.03 (dtd, J = 12.8, 9.6, 8.5 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 178.9, 137.3, 133.7, 
131.8, 130.2, 128.7, 128.5, 127.6, 126.4, 66.7, 39.4, 33.5, 28.0; IR (Neat Film, NaCl) 3748, 3671, 
3022, 2910, 2358, 1769, 1684, 1652, 1595, 1558, 1540, 1506, 1489, 1448, 1374, 1309, 1157, 1023, 
992, 749, 693, 668, 625  cm–1; HRMS (MM) m/z calc’d for C15H17O2 [M+H]+: 229.1223, found 
2229.1227; SFC Conditions: 20% IPA, 2.5 mL/min, Chiralcel OD-H column, λ = 280 nm, tR (min): 
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(S,E)-3-(5-phenylpent-2-en-1-yl)dihydrofuran-2(3H)-one (42a): Product 42a was purified by 
column chromatography (25% EtOAc in hexanes) to provide a colorless oil (44.4 mg, 0.19 mmol, 
96% yield); 87% ee; [a]D25 20.90 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.26 (m, 2H), 
7.21 – 7.14 (m, 3H), 5.55 (dtt, J = 14.8, 6.7, 1.3 Hz, 1H), 5.36 (dtt, J = 15.3, 6.9, 1.4 Hz, 1H), 4.24 
(td, J = 8.8, 3.3 Hz, 1H), 4.15 (td, J = 9.1, 6.9 Hz, 1H), 2.68 (dd, J = 8.4, 6.9 Hz, 2H), 2.62 – 2.44 
(m, 2H), 2.42 – 2.29 (m, 2H), 2.28 – 2.14 (m, 2H), 1.87 (dtd, J = 12.8, 9.5, 8.6 Hz, 1H); 13C NMR 
(101 MHz, CDCl3) δ 179.2, 141.8, 133.1, 128.6, 128.4, 126.6, 125.9, 66.7, 39.3, 35.8, 34.3, 33.2, 
27.6; IR (Neat Film, NaCl) 3520, 2918, 1770, 1602, 1496, 1454, 1374, 1297, 1251, 1209, 1171, 
1149, 1084, 1024, 972, 906, 843, 748, 701, 666 cm–1; HRMS (MM) m/z calc’d for C15H19O2 
[M+H]+: 231.1384, found 231.1384; SFC Conditions: 10% IPA, 2.5 mL/min, Chiralpak AD-H 
column, λ = 210 nm, tR (min): major = 5.84, major = 6.29. 
 
 
(S)-3-allyldihydrofuran-2(3H)-one (44r): Product 44r was synthesized according to the General 
Procedure, but with a doubled catalyst loading (10 mol% CuCl2, 12 mol%, L73, 26 mol% 
LiHMDS). The crude product was purified by column chromatography (25% EtOAc in hexanes) 
to provide a colorless oil (24.2 mg, 96% yield, 80% ee); 1H NMR (300 MHz, CDCl3) δ 5.78 (ddt, 
J = 16.9, 10.1, 6.9 Hz, 1H), 5.20 – 5.05 (m, 2H), 4.38 – 4.28 (m, 1H), 4.20 (td, J = 9.2, 6.9 Hz, 
1H), 2.71 – 2.53 (m, 2H), 2.43 – 2.18 (m, 2H), 2.08 – 1.91 (m, 1H). All characterization data match 
those reported.9c The purified product was converted to the corresponding methyl acrylate species 








3.9.2.6 Procedures and Spectroscopic Data for Product Transformations 
 
(2S,3S)-3-cinnamyltetrahydrofuran-2-ol (45): Adapted from a previously reported procedure.35  
To a solution of lactone (12.4 mg, 0.061 mmol, 1.0 equiv) in dichloromethane (0.4 mL) at –78 °C 
was added diisobutylaluminium hydride (12 µL, 0.067 mmol, 1.1 equiv) in dichloromethane (2.2 
mL) dropwise.  The reaction was allowed to stir for 30 min at –78 °C. The reaction was quenched 
slowly with MeOH, and then saturated aqueous potassium tartrate solution was added and the 
reaction was allowed to warm to room temperature. After 2 h, the layers were separated, and the 
aqueous layer was extracted 3 times with diethyl ether. The organic layers were combined, washed 
with brine, dried over sodium sulfate, and concentrated. The crude product was purified by column 
chromatography to afford product 45 as a white solid (11.9 mg, 0.058 mmol, 95 % yield, 68:32 
anti:syn); [a]D25 4.20 (c 0.75, CHCl3); major, anti:  1H NMR (400 MHz, CDCl3) δ 7.31 – 7.20 
(m, 4H), 7.17 – 7.11 (m, 1H), 6.39 – 6.33 (m, 1H), 6.15 – 6.07 (m, 1H), 5.19 (d, J = 1.5 Hz, 1H), 
4.00 (td, J = 8.0, 6.6 Hz, 1H), 3.91 (td, J = 8.1, 5.5 Hz, 1H), 2.45 (dtd, J = 14.2, 7.1, 1.4 Hz, 1H), 
2.34 – 2.18 (m, 3H), 2.18 – 2.06 (m, 1H), 1.65 – 1.55 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 
137.5, 131.8, 128.67, 128.66, 127.3, 126.2, 102.7, 67.1, 46.1, 35.8, 29.7. minor, syn: 1H NMR 
(400 MHz, CDCl3) δ 7.31 – 7.20 (m, 4H), 7.17 – 7.11 (m, 1H), 6.43 – 6.38 (m, 1H), 6.24 – 6.16 
(m, 1H), 5.30 (d, J = 4.4 Hz, 1H), 4.06 (ddd, J = 9.3, 8.2, 2.7 Hz, 1H), 3.78 (ddd, J = 9.4, 8.2, 7.3 
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1H), 1.76 (tt, J = 11.8, 9.2 Hz, 1H), 1.64 – 1.45 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 137.7, 
131.1, 128.7, 128.1, 127.2, 126.1,  98.4, 67.4, 44.7,  32.2,  28.8. major, anti and minor, syn: IR 
(Neat Film, NaCl) 3390, 3024, 2936, 2892, 1598, 1494, 1500, 1266, 1119, 1015, 967, 912, 744, 
694 cm–1; HRMS (MM) m/z calc’d for C13H15O [M-OH-]+: 187.1117, found 187.1119. 
 
 
ethyl 2-((2R,3S)-3-cinnamyltetrahydrofuran-2-yl)acetate (46): In a flame-dried round bottom 
flask under argon was added NaH (3.5 mg, 0.0874 mmol, 1.5 equiv) and THF (0.3 mL). To the 
resulting suspension was added triethyl phosphonoacetate (17.3 µL, 0.0874 mmol, 1.5 equiv) 
slowly. After 30 min, the reaction was cooled to 0 °C and lactol 45 (11.9 mg, 0.058 mmol, 1.0 
equiv) in THF (0.6 mL) was added slowly. The reaction was allowed to warm to room temperature 
overnight. The reaction was subsequently quenched with saturated aqueous NaHCO3, and 
extracted with ethyl acetate three times. The organic layers were then combined, dried over 
Na2SO4, and concentrated. The crude oil was purified by column chromatography to afford product 
46 (13.4 mg, 0.049 mmol,  84% yield, 95:5 anti:syn); 93% ee; [a]D25 18.74 (c 0.75, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 7.38 – 7.27 (m, 4H), 7.24 – 7.18 (m, 1H), 6.47 – 6.39 (m, 1H), 6.18 
(dt, J = 15.8, 7.2 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 3.99 (ddd, J = 7.9, 6.6, 4.8 Hz, 1H), 3.92 – 
3.81 (m, 2H), 2.64 – 2.46 (m, 2H), 2.40 (dddd, J = 14.1, 7.1, 5.7, 1.4 Hz, 1H), 2.25 (dddd, J = 14.0, 
8.4, 7.1, 1.4 Hz, 1H), 2.18 – 1.97 (m, 2H), 1.76 – 1.64 (m, 1H), 1.25 (t, J = 7.1 Hz, 3H); 13C NMR 
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36.3, 32.1, 14.3; IR (Neat Film, NaCl) 3058, 3024, 2978, 2936, 2873, 1736, 1598, 1478, 1495, 
1449, 1368, 1302, 1261, 1204, 1158, 1070, 1032, 967, 843, 805, 746, 694, 670, 652  cm–1; HRMS 
(MM) m/z calc’d for C17H23O3 [M+H]+: 275.1642, found 275.1649. Please note that the NMR data 
listed is for the major diastereomer. SFC Conditions: 15% IPA, 2.5 mL/min, Chiralcel OJ-H 
column, λ = 254 nm, tR (min): minor= 3.07, major= 3.39. 
 
Stereochemical Assignment: 
             
 
 
(S)-2-cinnamylbutane-1,4-diol (47): Product 6 was synthesized according to a slightly modified, 
previously reported procedure.36 To a suspension of lithium aluminum hydride (3.57 mg, 0.094 
mmol, 1.0 equiv) in diethyl ether (0.5 mL) was added a solution of lactone 44a (19.0 mg, 0.094 
mmol, 1.0 equiv) in diethyl ether (0.4 mL), maintaining reflux. Then, the reaction was heated to 
40 °C and refluxed for 3 h. The reaction was then quenched by sequentially adding methanol, 
water, and 2M HCl. Then, brine was added and the aqueous layer was extracted five times with 
ethyl acetate. The crude diol was then purified by column chromatography to afford the desired 
product 47 as a clear oil (18.4 mg, 0.089 mmol, 95% yield); 94% ee  [a]D25 –10.61 (c 0.75, CHCl3); 
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(dt, J = 15.8, 7.3 Hz, 1H), 3.78 (ddd, J = 10.8, 6.4, 4.5 Hz, 1H), 3.72 – 3.44 (m, 5H), 2.31 – 2.13 
(m, 2H), 1.90 – 1.68 (m, 2H), 1.60 (dtd, J = 14.5, 8.0, 4.4 Hz, 1H);  13C NMR (101 MHz, CDCl3) 
δ 137.5, 131.9, 128.6, 127.2, 126.1, 66.0, 61.1, 39.7, 35.6; IR (Neat Film, NaCl) 3322, 3080, 3058, 
3024, 2921, 1754, 1598, 1494, 1448, 1053, 967, 742, 694, 661 cm–1; HRMS (MM) m/z calc’d for 
C13H19O2 [M+H]+: 207.1380, found 207.1383. SFC Conditions: 25% IPA, 2.5 mL/min, Chiralcel 
OD-H column, λ = 254 nm, tR (min): minor = 3.64, major= 4.04. 
 
 
methyl (S,E)-4-(2-oxotetrahydrofuran-3-yl)but-2-enoate (48): Adapted from a previously 
reported procedure.37  To a solution of lactone 44q (12.1 mg, 0.096 mmol, 1.0 equiv)  and methyl 
acrylate (86 uL, 0.96 mmol, 1.0 equiv)  in dichloromethane (0.7 mL) was added Grubbs II catalyst 
(4.8 mg, 0.00576 mmol, 6 mol%). The reaction was sealed and heated to 40 °C for 3 h. The crude 
reaction mixture was filtered with a small pad of SiO2, and concentrated. The resulting crude oil 
was then purified by column chromatography to afford product 48 as a yellow oil (16.8 mg, 0.091 
mmol, 95% yield); 80% ee  [a]D25 19.52 (c 0.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 6.91 (dt, J 
= 15.4, 7.2 Hz, 1H), 5.93 (dt, J = 15.6, 1.5 Hz, 1H), 4.37 (td, J = 8.9, 2.5 Hz, 1H), 4.28 – 4.17 (m, 
1H), 3.74 (s, 3H), 2.85 – 2.66 (m, 2H), 2.46 – 2.34 (m, 2H), 2.06 – 1.91 (m, 1H); 13C NMR (101 
MHz, CDCl3) δ 178.1, 166.5, 144.6, 123.8, 77.2, 66.6, 51.8, 38.5, 32.9, 28.3; IR (Neat Film, NaCl) 
2954, 1764, 1719, 1656, 1438, 1376, 1277, 1155, 1022, 988, 702 cm–1; HRMS (MM) m/z calc’d 
for C19H12O4+ [M+H]+: 185.0808, found 185.0812. SFC Conditions: 25% IPA, 2.5 mL/min, 










3.10  OTHER POTENTIAL PRODUCT TRANSFORMATIONS 
 
In addition to the product transformations reported above, there are a number of other 




Furthermore, chiral lactols such as 45 can also be converted to acyclic molecules 
possessing propargylic stereocenters (Org. Lett. 2012, 14, 3648–3651.) or allylic stereocenters (J. 
Am. Chem. Soc. 2017, 139, 13272–13275.) without loss of enantiomeric excess. In addition, the 
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high levels of enantiomeric excess can also be retained under mild lactone ring opening reactions. 
Zhang and coworkers (ACIE, 2013, 5807–5812.) reported a ring opening with a Weinreb amide 
and subsequent addition of ethylmagnesum bromide to form a-chiral ketones with full retention 
of enantiomeric excess. Koert and coworkers also demonstrate that an a-chiral g-butyrolactone 
can undergo ring opening of the lactone with HBr without loss of stereochemistry: Chem. Eur. J. 
2013, 19, 7423–7436. For an example with HCl, see: Helv. Chem. Acta, 1979, 62, 474–480.  
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Challenging Substrates in Cu-Catalyzed Enantioselective Allylic Alkylation 
with Silyl Ketene Acetals† 
 
 
A5.1   INTRODUCTION  
 
 Although we found that our developed conditions for the Cu-catalyzed enantioselective 
allylic alkylation of a g-butyrolactone-derived silyl ketene acetal were fairly robust and tolerant of 
a wide range of reactivity on the electrophile component, some substrates proved to be very 
challenging. Below are allylic electrophiles  that resulted in poor reactivity, selectivity, or both. In 
addition, we examined additional nucleophiles in order to understand why the optimized system 
is limited to g-butyrolactones.   
 
A5.2   LIMITATIONS IN THE ALLYLIC CHLORIDE ELECTROPHILE  
  
 
†  This work was performed in collaboration with the Hadt Lab at Caltech.  Additionally, this research has been 
published and adapted with permission from Jette, C. I.; Tong, Z. J.; Hadt, R. G.; Stoltz B. M. Angew. Chem. Int. 
Ed. 2020, 59, 2033–2038. Copyright 2020 Wiley-VCH. Alexander Q. Cusumano is thanked for assistance and 
helpful discussions. 
 
Appendix 5 – Challenging Substrates in Cu-Catalyzed Enantioselective Allylic Alkylation with Silyl Ketene 
Acetals  
389 
 Although we were able to tolerate a wide range of functionality on the electrophile, a 
number of limitations were noted. The use of electrophiles possessing a large degree of steric 
bulk at the a-position  resulted in the formation of products in moderate yields and low ee. This 
type of behavior was noted with a-a-disubstituted electrophiles, such as 43s discussed in 
Chapter 4 (Scheme 4.7.1), as well as a-monosubstituted electrophiles possessing very bulky 
substituents. Electrophiles possessing substituents such as a pendant silyl ether (55a, Table 
A5.2.1), an alkyl silane (55e), and 3,5-di-tert-butylphenyl (55f) resulted in moderate to high 
yields, but racemic product. In addition,  we found that with a geraniol derivative (55d) we 
observed similar behavior to 43s. In the case of an electrophile possessing a pendant ethyl ester 
(55b), we also observed low ee. Because we previously noted that  substitution at the b-position 
does not seem to have a significant effect on the overall reaction outcome (Chapter 4, Scheme 
Table A5.2.1. Bulky Allylic Electrophilesa 
 
 
[a] Isolated yields on 0.2 mmol scale. SFC analysis was used to determine ee. See Chapter 3 for reaction set-up. 
 
R Cl O
OTMS CuCl2 (5 mol %)L73 (6 mol %)
LiHMDS (13 mol%)
CsOAc (1 equiv)
THF (0.042 M), 30 °C, 6 h
R O
O
























90% yield, 40% ee 80% yield, 5% ee
O
O







Appendix 5 – Challenging Substrates in Cu-Catalyzed Enantioselective Allylic Alkylation with Silyl Ketene 
Acetals  
390 
4.7.1), the low ee could likely be attributed to a competitive 1,4-addition pathway, rather than 
sterics. Finally, in the case of the allylic electrophile possessing a phthalamide (55c), we 
obtained the product in both low yield and low ee.  
 Allylic electrophiles possessing functionality that can competitively bind to the Cu 
catalyst,  such as an  indole, amide, or ether  generally resulted in lower reactivity and ee’s 
(Table A5.2.2, 55g-i). We did note, however, that in a handful of cases the ee and yield could be 
improved by doubling the catalyst loading (55g and 55i). Interestingly, in the case of 55h, 
although we did see a significant improvement in the ee when the catalyst loading was doubled, 
the yield remained constant. It should be noted that this strategy was also implemented to 
improve the results for the p-nitrile substrate (44m) in Table 3.7.1, Chapter 3.  




[a] Isolated yields on 0.2 mmol scale. See Chapter 3 for reaction set-up. SFC analysis was used to determine ee. [b] With 10 mol% 





with 5 mol% Cu: 76% yield, 66% ee













with 5 mol% Cu: 40% yield, 57% ee
with 10 mol% Cu:b 38% yield, 74% ee
55g 55h 55i
R Cl O
OTMS CuCl2 (5 mol %)L73 (6 mol %)
LiHMDS (13 mol%)
CsOAc (1 equiv)
THF (0.042 M), 30 °C, 6 h
R O
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 We also tested allylic electrophiles possessing internal chlorides (Table A5.2.3). Although 
the yields were high, the products were obtained in approximately a 1:1 mixture of diastereomers 
(55k and 55j). In their initial disclosure, Sawamura and coworkers reported that this reaction was 
not stereoablative, and when a chiral electrophile is used, chiral product is formed.1 These results 
are in agreement with their observations. 
We also examined electrophiles possessing two reactive chlorides (54l and 54m, Table 
A5.2.4). We noted that in these cases, only the bis-addition product was isolated and no mono-
addition products were observed. We also tested a cinnamyl electrophile possessing a sensitive 
aldehyde group at the para-position on the aryl ring, and found that the g-butyrolactone nucleophile 
added to both the allylic chloride and the aldehyde (55n). Interestingly, we noted that the silyl 








[a] Isolated yields on 0.2 mmol scale. See Chapter 3 for reaction set-up. SFC analysis was used to determine 
ee.  
 














13% yield, 1:1 dr
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L73 (6 mol %), LiHMDS (13 mol%)
41 (1.5 equiv), CsOAc (1 equiv)
THF (0.042 M), 30 °C, 6 h
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41 (1.5 equiv), CsOAc (1 equiv)
THF (0.042 M), 30 °C, 6 hCl
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A5.3  LIMITATIONS IN THE NUCLEOPHILE 
 
 In addition to the g-butyrolactone-derived silyl ketene acetal, a number of different silyl 
enolates were also tested in our final conditions. We have noted that our conditions are specific to 
this nucleophile, and poor reactivity and selectivity has been observed with other silyl enolates 
under a number of conditions.  











47% conversion of cinnamyl chloride
no aldehyde product observed
36% conversion of cinnamyl chloride






43% conversion of cinnamyl chloride
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THF (0.042 M), 30 °C, 6 h
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THF (0.042 M), 30 °C, 6 h
CuCl2 (5 mol %)
L73 (6 mol %), LiHMDS (13 mol%)
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THF (0.042 M), 30 °C, 6 h





Our first investigations into other silyl ketene acetals included an a-methyl g-butyrolactone 
(56),  d-valerolactone (57),  and  thiolactone (58) derived silyl ketene acetals,  a silyl ketene aminal 
(59), and two ketone derived silyl enolates of differing ring sizes (60 and 61). Unfortunately, with 
our final set of conditions, we obtained very small quantities of the desired products (entries 1, 4, 
8, 9, and 11), with the best-performing nucleophile being thiolactone 58 (entry 7).   




[a]. Reactions were run on 0.1 mmol scale. Yields and l:b ratios were determined by 1HNMR using trimethoxybenzene as an 










CuCl2 (10 mol %)
L73 (12 mol %)
LiHMDS (26 mol%)
CsOAc (1 equiv)
THF, temp, 14 h
Ph Nu



















1 56 30 Cl 13 7 –
2 70 Cl 22 10 556
3 30 Br 27 29 1056
4 30 Cl 9 0 –57
5 70 Cl 22 0 –57
6 30 Br 0 0 –57
58
7 30 Cl 27 0 –58
8 30 Cl 8 0 –59
9 30 Cl 0 0 –60
10 30 Br 16 14 –60
11 30 Cl 0 0 –61
12 30 Br 14 18 –61
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At elevated temperatures, the yields for the product derived from the a-methyl g-
butyrolactone 56 and d-valerolactone 57 improved slightly (entries 2 and 3). In the case of the d-
valerolactone, the linear product continued to be the major isomer. However, when  a-methyl g-
butyrolactone is used as the nucleophile, the corresponding product is obtained as a mixture of 
linear and branched isomers, and the ee of the linear product is low (entry 2). 
We found that by switching to the more reactive cinnamyl bromide, we were able to obtain 
the desired product in low to moderate yields with 56 (entry 3), 60 (entry 9), and 61 (entry 10). 
Interestingly, with these nucleophiles, the products were obtained in roughly a 1:1 mixture of linear 
and branched isomers. Upon closer examination of the results obtained with a-methyl g-
butyrolactone 56, we did note that the ee of the linear product 63 was still low and the branched 
product  64 was obtained in 56:44 dr (Scheme A5.3.1). We also obtained 40% yield of the a-
bromo lactone 65,  which may be an indication that a radical pathway is operative under these 








[a] Reactions were run on 0.1 mmol scale. Yields and l:b ratios were determined by 1HNMR using trimethoxybenzene 
as an internal standard. Products were isolated by Prep TLC.  Enantiomeric excess (ee) was determined by supercritical 
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 There were also a number of nucleophiles that did not result in any product, regardless of 
the conditions employed (68-72, Table A5.3.3.A).  It should be noted that with methyl-3-
methylbutanoate-derived silyl ketene acetal 69, the characteristic color change from green to 
yellow at the start of the reaction did not occur, and the reaction mixture remained green over the 
course of the entire reaction. With silyl furan 70, a color change from green to red was noted 
instead. In both of these cases, perhaps the lack of product formation could be attributed to the 
inability of these silyl ketene acetals to coordinate and successively reduce the Cu catalyst to the 
corresponding starting Cu(I) complex (See Chapter 4).  
Generally, one possible explanation for the lack of reactivity being observed with all 
nucleophiles may be due to the large steric bulk of L73, which  may prevent coordination and 
subsequent allylic alkylation with larger nucleophiles.  Interestingly, in the absence of ligand,  
some of these nucleophiles  allowed for the formation of product in moderate to good yields (Table 
A5.3.4.B). The one exception to this is methyl 3-phenylpropanoate-derived silyl ketene acetal (67),  
which allows for the formation of the corresponding product in very similar yield to what was 
observed in the presence of ligand (see Scheme A5.4.1).   





A5.4  ACYCLIC NUCLEOPHILES AND BICYCLO[2.2.2]OCTANE BACKBONE 
 
In addition to examining cyclic nucleophiles, we also examined acyclic silyl ketene acetals 
in our reaction. Gratifyingly, we found that with methyl 3-phenylpropanoate-derived silyl ketene 
acetal, the corresponding product was obtained in over 40% yield with either the primarily E or Z 
nucleophile (66, Scheme A5.4.1.A). We did find that the silyl ketene acetal geometry did have an 





[a] Reactions were run on 0.1 mmol scale. Yields and l:b ratios were determined by 1HNMR using trimethoxybenzene 
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effect on the ee; with the E nucleophile the product obtained is racemic, however, with the Z 
nucleophile, the product is obtained in 20% ee.   
The low level of reactivity we were observing with ligand L73 with nucleophiles other 
than the very small and highly reactive g-butyrolactone-derived silyl ketene acetal 41 prompted us 
to investigate ligands with alternate backbones. When mono-picolinyl ligands possessing 
backbones such as  diphenylethylene and cyclohexyl  were used, no product was observed with 
66.  With L80, which possesses a bicyclo[2.2.2]octane backbone, the desired  acyclic a-benzyl 
product 67 is obtained in 56% yield and 85% ee. Although this backbone is significantly less bulky 
than L73, the large bite angle between the two amides is still retained, which we believe may be 





[a] Reactions were run on 0.1 mmol scale. E/Z ratios of 66 were determined by 1H NMR analysis. Yields and l:b ratios 
were determined by 1H NMR using trimethoxybenzene as an internal standard.  Enantiomeric excess (ee) was 
determined by supercritical fluid chromatography. See Chapter 3 for reaction set-up. [b] The primarily Z silyl ketene 
acetal that was used in this experiment was used in slight excess (1.8 equiv), as it was isolated with a large amount of 
both the a-silyl product and recovered starting material. The purity of the reagent was determined to be close to 50% 














CuCl2 (10 mol %)
L80 (12 mol %)
LiHMDS (26 mol%)
CsOAc (1 equiv)







E/Z: 88:12 56% yield, 85% ee










CuCl2 (10 mol %)
L73 (12 mol %)
LiHMDS (26 mol%)
CsOAc (1 equiv)
THF, temp, 14 h
43a 66 67
E/Z: 88:12 47% yield, 5% ee
E/Z: 23:73 45% yield, 20% ee
1.5 equiv
A. Acyclic Silyl Ketene Acetals with L73
B. Acyclic Silyl Ketene Acetals with L80
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critical for reactivity.  In addition, although in the case of L73, the E/Z ratio  of the silyl ketene 
acetal does appear to influence the ee of the product, when L80 is used, nearly identical results are 
obtained with either the E or Z silyl ketene acetal.  
Intrigued by the success of L80 with 66, we evaluated additional nucleophiles in 
combination with this ligand (Scheme A5.4.2). With the g-butyrolactone-derived silyl ketene 
acetal, the corresponding product  was formed in 65% yield and 76% ee, indicating that the bulkier 
ANDEN backbone is important for the high yields and ee’s in our original conditions ((–)-44a). 
With a d-valerolactone-derived nucleophile and an a-isopropyl derived nucleophile, very small 
amounts of desired product were formed (75 and 77). Interestingly, with the a,a-dimethyl-derived 
acyclic nucleophile, the desired product is formed in 25%.  
 
 




[a] Reactions were run on 0.1 mmol scale. Yields and l:b ratios were determined by 1H NMR using trimethoxybenzene as an 











[a] Reactions were run on 0.1 mmol scale. Yields and l:b ratios were determined by 1HNMR using trimethoxybenzene 
as an internal standard.  Enantiomeric excess (ee) was determined by supercritical fluid chromatography. See Chapter 3 
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A5.5  COPPER-CATALYZED ALLYLIC ALKYLATION WITH SILYL ENOL ETHERS 
 
 Given the large difference in pKa between a lactone and a ketone, we were curious to see 
if we could observe Cu-catalyzed allylic alkylations with silyl enol ethers, either under our 
conditions or under slightly modified conditions. Given that the cyclopentanone-derived silyl enol 
ether 60 was most similar in size to g-butyrolactone 41, we believed that the difference in reactivity 
between these two nucleophiles could largely be attributed to electronics.   As was described in 
A5.2.1, although we did not observe any product when 60 was exposed to our final set of reaction 
conditions at 30 °C or at 70 °C (entries 1 and 2, Table A5.5.1), we did note that with a more 
reactive cinnamyl bromide nucleophile, a small amount of both the linear and branched product 
isomers is observed (entry 3).  Using these results as our starting point, we aimed to understand 
why these nucleophiles were unreactive and how the reaction conditions needed to be modified in 
order for a-allyl ketone products to be observed.  





  One of the first things that we chose to assess was whether or not we had identified the 
appropriate ligand for this transformation. One particular difference that we noted between the 
reactivity profiles of the silyl ketene acetals and the silyl enol ethers was that in the case of  silyl 
enol ether 60, no product is observed when Cu is used in the absence of ligand. Consequently, we 
believed that a different set of chelating atoms may be required on the ligand in order to observe 
product formation. To this end, we tested 16 commercially available ligands in the Cu catalyzed 
allylic alkylation using silyl enol ethers. Interestingly, the only ligand to result in product formation 
was SIMES-leucinol (L21, Table A5.5.2), a ligand that led to an unreactive Cu catalyst in our 
allylic alkylation with the g-butyrolactone-derived silyl ketene acetal. However, the product was 
formed in only 13% yield, which was less than what we  had observed with cinnamyl bromides in 
our initial conditions (Table A5.5.2, entry 1). Given that little to no reactivity was being observed 
with a large variety of ligands, we concluded that the low level of reactivity was not due to an 




[a] Reactions were run on 0.1 mmol scale. Yields and l:b ratios were determined by 1HNMR using trimethoxybenzene 
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unfavorable coordination environment around the Cu, but could be due to another aspect of the 
reaction. To gain a deeper understanding of what was occuring, we ran a number of controls with 
L21 as the ligand.  
 Gratifyingly, we noted that in the absence of Cu, no allylic alkylation product was being 
formed, indicating that the small amount of product being observed with both L73 and L21 was 
formed via a Cu-mediated reaction (entry 2). Interestingly, when silyl enol ether 60 is omitted from 
the transformation, cinnamyl acetate (80) is obtained in a 23% yield after only 2 h (entry 3). To  
determine whether or not this was Cu-mediated, we ran an additional control, this time omitting 
both 60 and the Cu catalyst, and found that no cinnamyl acetate product is formed, indicating that 
the formation of 80 is Cu-mediated.  





[a] Reactions were run on 0.1 mmol scale. Yields and l:b ratios were determined by 1HNMR using trimethoxybenzene 











CuCl (10 mol %)
L21 (12 mol %)
CsOAc (1 equiv)
THF, 30 °C, 2 h
Ph
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The observation of a Cu-catalyzed cinnamyl acetate formation was not only intriguing, but 
also offered some insight into the reaction.  We currently believe that the Cu-catalyzed allylic 
alkylation of a g-butyrolactone-derived silyl ketene acetal proceeds via an inner-sphere pathway, 
involving an initial enantiodetermining transmetalation of the silyl ketene acetal 41 to form a Cu(I) 
enolate (C), followed by oxidative addition into the allylic electrophile (D), and a fast reductive 
elimination to form the desired product (Scheme A5.5.1, see Chapter 4 for more details).  Taking 
this mechanistic hypothesis into account, we initially envisioned that when silyl enol ethers are 
used, the oxidative addition step could be more challenging, as the Cu(I) enolate generated would 
be less electron-rich than its corresponding lactone counterpart, and consequently, much less prone 
to undergo oxidative addition. The Cu-mediated formation of cinnamyl acetate could be an 
indication that the difference in electronics between the two  Cu(I) enolates may not be the reason 
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no a-allyl ketone is formed,  as product formation is observed under identical conditions with an 
even less electron-rich nucleophile, CsOAc.2  It is interesting to note that in the presence of 60 
(entry 1), the cinnamyl acetate yield is only 2%, indicating that 60 could be slowing down the rate 
of cinnamyl acetate formation via competitive binding to the Cu catalyst.  One possible explanation 
for this behavior could be that the silyl enol ethers are binding to Cu, but that CsOAc is not a strong 
enough base to generate the required Cu enolate. For this reason, we tested a number of different 
bases in this transformation. Gratifyingly, we found that with TBAT, the desired product is 
obtained in 44% yield, albeit in < 5% ee. We also noted that in the absence of Cu, 60 still reacts 
with 43a, but in this case, the O-alkylation product is the major species (Scheme A5.5.3).  
 
A5.6   CONCLUSION 
In conclusion, we have observed a number of limitatons in both the electrophile and 
nucleophile in our enantioselective Cu-catalyzed allylic alkylation. With regards to the 
electrophile, we noted that allylic chlorides possessing either  a-,a- disubstitution or very bulky 
a-substituents result in very low ee’s, although the yields are generally moderate. In addition, we 




[a] Reactions were run on 0.1 mmol scale. Yields and linear:branched ratios were determined by 1HNMR using 




[Cu(MeCN)4]PF6 (10 mol %)
L21 (12 mol %),
TBAT (1 equiv)
THF, 30 °C, 12 h






44% yield, < 5% ee none
10 % yield 29% yield
43a 60 78 81
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noted that electrophiles possessing functional groups that can coordinate to the Cu catalyst result 
in both lower yields and ee, although the results can be slightly improved by doubling the catalyst 
loading. Internal allylic chlorides react favorably, but the resulting products were obtained in low 
diastereoselectivity. Furthermore, if two reactive sites are present on the allylic chloride, di-
substitution products are favored, and no mono-substitution is observed. 
 With respect to the nucleophile, we found that our current conditions are specific to the g-
butyrolactone-derived silyl ketene acetal. Other nucleophiles, including larger cyclic or acyclic 
silyl ketene acetals, silyl ketene aminals, silyl thioketene acetals, and silyl enol ethers result in very 
low formation of the corresponding products. Strategies such as increasing the temperature or 
switching to the more reactive cinnamyl bromides led to only slight improvements in the yield, 
and the ee’s are low in all cases. One possible explanation for the lack of reactivity observed with 
other silyl ketene acetals is that L73 may be too bulky, preventing the coordination of larger 
nucleophiles. To this end, we synthesized and tested a ligand possessing a bicyclo[2.2.2]octane 
backbone (L80) and found that this ligand enables the accommodation of larger nucleophiles.  
Promising reactivity was obtained with larger, acyclic nucleophiles using this backbone.  
 Finally, we also investigated the reaction of a cyclopentanone-derived silyl enol ether (60). 
With this nucleophile, we found that both L73 and SIMES-leucinol (L21) lead to product 
formation, albeit in low yields. We found that one possible explanation for the lack of reactivity 
observed with silyl enol ethers may be attributed to the CsOAc base used, as it may not be reactive 
enough to cleave the silyl enol ether. Switching to a more reactive base, TBAT, led to higher yields 
of the desired product.  
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A5.7    REFERENCES AND NOTES 
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2. This statement holds true if we assume that the Cu-mediated cinnamyl acetate formation 



































































































































































































































































































































































































































































































































































































































A6.8 Infrared spectrum (Thin Film, NaCl) of compound L54 
 






            
            
            























































































            















































A6.11 Infrared spectrum (Thin Film, NaCl) of compound L59 
 




























































































































































































            
            
            
            
            
            
            
            
            
            
            
            

































A6.15 Infrared spectrum (Thin Film, NaCl) of compound L64 
 























































































































            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
        
A6.18 Infrared spectrum (Thin Film, NaCl) of compound SI10 
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A6.21 Infrared spectrum (Thin Film, NaCl) of compound L61 
 
 
































































            















































































































































            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            


























































            
            




            
    
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
             
A6.26 Infrared spectrum (Thin Film, NaCl) of compound L67 
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A6.29 Infrared spectrum (Thin Film, NaCl) of compound L66 
 
A6.30 13C NMR (100 MHz, CDCl3) of compound L66 
 


























            
            
            
            
            




















































































A6.32 Infrared spectrum (Thin Film, NaCl) of compound L68 
 
A6.33 13C NMR (100 MHz, CDCl3) of compound L68 
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A6.35 Infrared spectrum (Thin Film, NaCl) of compound L69  
































































































































































































































































































































































































































































































A6.41 Infrared spectrum (Thin Film, NaCl) of compound SI11 
 













































































































































A6.44 Infrared spectrum (Thin Film, NaCl) of compound L73 
 
 




































           


































































            








































A6.48  13C NMR (100 MHz, CDCl3) of compound L74 
 
A6.47  Infrared spectrum (Thin Film, NaCl) of compound L74 
 














































A6.50  Infrared spectrum (Thin Film, NaCl) of compound L75 
 
A6.51  13C NMR (100 MHz, CDCl3) of compound L75 
 












            
            
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           











































































            
            
   
   
   
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
A6.53 Infrared spectrum (Thin Film, NaCl) of compound L76 
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A6.57  13C NMR (100 MHz, CDCl3) of compound L77 
 
 
A6.56 Infrared spectrum (Thin Film, NaCl) of compound L77 
 
 











































































































































A6.59 Infrared spectrum (Thin Film, NaCl) of compound L78 
 
















































































































































A6.62 Infrared spectrum (Thin Film, NaCl) of compound L79 
 

























     
 
A6.64  19F NMR (282 MHz, CDCl3) of compound L79 
 






Spectra for Substrates and Products Synthesized in Chapter 3: 
Copper-Catalyzed Enantioselective Allylic Alkylation with a  










































































































            
            
            
            
            
            
            
            
            
            
            
            



































A7.2 Infrared spectrum (Thin Film, NaCl) of compound 43m 
 










            
            
            






























































































            







































A7.5 Infrared spectrum (Thin Film, NaCl) of compound 43e 
 














































































































A7.8 Infrared spectrum (Thin Film, NaCl) of compound 43i 
 





            
            
            
     
 
  
A7.10 19F NMR (282 MHz, CDCl3) of compound 43i 


































































































A7.12 Infrared spectrum (Thin Film, NaCl) of compound SI12 
 











































A7.15 Infrared spectrum (Thin Film, NaCl) of compound 43n 
 





























































A7.18 Infrared spectrum (Thin Film, NaCl) of compound SI13 
 





A7.20 19F NMR (282 MHz, CDCl3) of compound SI13 


























































A7.22 Infrared spectrum (Thin Film, NaCl) of compound 43f 
 




            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
   
   
   
            
            
            

















A7.24 19F NMR (282 MHz, CDCl3) of compound 43f 












































A7.26 Infrared spectrum (Thin Film, NaCl) of compound 43o 
 




























































































            
            
            
            
            
            
            
            
            
            
            
            










A7.29 Infrared spectrum (Thin Film, NaCl) of compound 44a 
 






















































































































            






















A7.32 Infrared spectrum (Thin Film, NaCl) of compound 44b 
 


































           














































































































A7.35 Infrared spectrum (Thin Film, NaCl) of compound 44c 
 

























            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            







































            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            




























A7.38 Infrared spectrum (Thin Film, NaCl) of compound 44d 
 




























           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
            
            
            
            
            
            
            
            
            
            
            
            







































            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            




            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            






A7.41 Infrared spectrum (Thin Film, NaCl) of compound 44e 
 




            




















            
            
            
            
          
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            







































            
         
            
            
            
            
            
            












































A7.44 Infrared spectrum (Thin Film, NaCl) of compound 44f 
 
 






















            
            
            






















































































            
            
            
            

















A7.49 13C NMR (100 MHz, CDCl3) of compound 44g 
 
A7.48 Infrared spectrum (Thin Film, NaCl) of compound 44g 
 













































































































































A7.51 Infrared spectrum (Thin Film, NaCl) of compound 44h 
 



























































































































A7.54 Infrared spectrum (Thin Film, NaCl) of compound 44i 
 









































































































































































































A7.58 Infrared spectrum (Thin Film, NaCl) of compound 44j 
 







































































































































     






A7.61 Infrared spectrum (Thin Film, NaCl) of compound 44k 
 

































































































A7.64 Infrared spectrum (Thin Film, NaCl) of compound 44l 
 















































































           


























            

























































































A7.68 Infrared spectrum (Thin Film, NaCl) of compound 44m 
 
A7.69 13C NMR (100 MHz, CDCl3) of compound 44m 
 























            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            











































A7.71 Infrared spectrum (Thin Film, NaCl) of compound 44n 
 
A7.72 13C NMR (100 MHz, CDCl3) of compound 44n 
 






            



















































































            
            
            
            
            
            
            
            
            
            


































A7.75 13C NMR (100 MHz, CDCl3) of compound 44o 
 
 
A7.74 Infrared spectrum (Thin Film, NaCl) of compound 44o 
 








            
            
            
            
            
            
            
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
            
            
            
            
            
            
            
            
            
            















































            
            
            
            
            
            
            
            
            
            
            
            
            
            




            
       
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            




A7.77 Infrared spectrum (Thin Film, NaCl) of compound 44p 
 




            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            













































































            
            
            
            




































A7.80 Infrared spectrum (Thin Film, NaCl) of compound 42a 
 


























































































            
            
            
            
            
            
            
            
            
            
            
            







































A7.83 Infrared spectrum (Thin Film, NaCl) of compound 45 
 
































































































A7.86 Infrared spectrum (Thin Film, NaCl) of compound 46 
 






            
            
            




















































































            
















































A7.89 Infrared spectrum (Thin Film, NaCl) of compound 47 
 

































































































A7.92 Infrared spectrum (Thin Film, NaCl) of compound 48 
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A8.1  GENERAL EXPERIMENTAL 
For crystal structure determination of 44b A crystal was mounted on a polyimide MiTeGen 
loop with STP Oil Treatment and placed under a nitrogen stream. Low temperature (200K; there 
were crystal issues at lower temperatures) X-ray data were collected with a Bruker AXS D8 
VENTURE KAPPA diffractometer running at 50 kV and 1mA (Cu Ka = 1.54178 Å; PHOTON II 
CPAD detector and Helios focusing multilayer mirror optics). All diffractometer manipulations, 
including data collection, integration, and scaling were carried out using the Bruker APEX3 
software. An absorption correction was applied using TWINABS. The space group was 
determined and the structure solved by intrinsic phasing using XT.  Refinement was full-matrix 
least squares on F2 using XL. All non-hydrogen atoms were refined using anisotropic displacement 
parameters. Hydrogen atoms were placed in idealized positions and refined using a riding model. 
The water molecule was refined as a rigid body. The isotropic displacement parameters of all 
hydrogen atoms were fixed at 1.2 times (1.5 times for methyl groups) the Ueq value of the bonded 
atom.  
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Figure A8.1 X-Ray Coordination of a-Allyl g-Butyrolactone 44b. 
 
 Table A8.1  Crystal Data and Structure Refinement for 44b. 
Empirical formula  C17 H16 O2 
Formula weight  252.30 
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P 1 21 1 
Unit cell dimensions a = 6.9377(5) Å a= 90° 
 b = 7.1431(5) Å b= 98.260(5)° 
 c = 13.2770(10) Å g = 90° 
Volume 651.14(8) Å3 
Z 2 
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Density (calculated) 1.287 g/cm3 
Absorption coefficient 0.659 mm-1 
F(000) 268 
Crystal size 0.32 x 0.17 x 0.05 mm3 
Theta range for data collection 3.364 to 80.143°. 
Index ranges -8 £ h £ 8, -9 £ k £ 9, -16 £ l £ 16 
Reflections collected 2467 
Independent reflections 2467 [R(int) = ?] 
Completeness to theta = 67.679° 97.1 %  
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2467 / 1 / 173 
Goodness-of-fit on F2 1.115 
Final R indices [I>2sigma(I)] R1 = 0.0339, wR2 = 0.0996 
R indices (all data) R1 = 0.0349, wR2 = 0.1006 
Absolute structure parameter [Flack] -0.13(13) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.163 and -0.178 e.Å-3 
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Table A8.2.  Atomic Coordinates  ( x 105) and Equivalent  Isotropic Displacement Parameters (Å2x 104) for 
44b.  U(eq) is Defined as One Third of  the Trace of the Orthogonalized Uij Tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O(1) -94170(30) -49190(30) -37017(12) 254(4) 
O(2) -113080(30) -46280(30) -51927(13) 277(5) 
C(1) -27370(40) -55580(30) -77985(18) 207(5) 
C(2) -13460(40) -59970(40) -83901(18) 206(5) 
C(3) -16470(40) -56390(30) -94593(18) 200(5) 
C(4) -2330(50) -60820(40) -100900(20) 242(6) 
C(5) -5780(50) -57100(40) -111190(20) 274(6) 
C(6) -23470(50) -48680(40) -115498(17) 280(6) 
C(7) -37520(40) -44350(40) -109595(18) 245(6) 
C(8) -34350(40) -48180(40) -98950(17) 211(5) 
C(9) -48730(40) -44210(40) -92670(17) 206(5) 
C(10) -45640(40) -47770(40) -82329(17) 207(5) 
C(11) -61220(40) -43810(40) -76283(19) 220(5) 
C(12) -59920(40) -43400(40) -66160(20) 235(6) 
C(13) -76880(40) -38650(40) -60750(20) 255(6) 
C(14) -78040(40) -50900(40) -51425(18) 219(5) 
C(15) -63020(40) -47120(50) -42066(19) 296(6) 
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C(16) -73710(50) -53270(40) -33449(19) 308(7) 





Table A8.3 Bond lengths [Å] and angles [°] for 44b 
_____________________________________________________  
O(1)-C(16)  1.459(3) 
O(1)-C(17)  1.346(3) 
O(2)-C(17)  1.203(3) 
C(1)-H(1)  0.9500 
C(1)-C(2)  1.366(4) 
C(1)-C(10)  1.428(4) 
C(2)-H(2)  0.9500 
C(2)-C(3)  1.428(3) 
C(3)-C(4)  1.415(4) 
C(3)-C(8)  1.418(4) 
C(4)-H(4)  0.9500 
C(4)-C(5)  1.378(4) 
C(5)-H(5)  0.9500 
C(5)-C(6)  1.412(5) 
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C(6)-H(6)  0.9500 
C(6)-C(7)  1.371(4) 
C(7)-H(7)  0.9500 
C(7)-C(8)  1.425(3) 
C(8)-C(9)  1.418(4) 
C(9)-H(9)  0.9500 
C(9)-C(10)  1.383(3) 
C(10)-C(11)  1.463(4) 
C(11)-H(11)  0.9500 
C(11)-C(12)  1.334(4) 
C(12)-H(12)  0.9500 
C(12)-C(13)  1.503(4) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(13)-C(14)  1.527(4) 
C(14)-H(14)  1.0000 
C(14)-C(15)  1.527(3) 
C(14)-C(17)  1.512(4) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
C(15)-C(16)  1.515(4) 
C(16)-H(16A)  0.9900 
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_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
Table A8.4 Anisotropic Displacement Parameters  (Å2x 104) for 44b.  The Anisotropic 
Displacement Factor Exponent Takes the Form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 237(10)  304(10) 222(7)  -1(7) 39(7)  23(10) 
O(2) 185(9)  358(12) 291(8)  41(8) 43(7)  -7(9) 
C(1) 218(14)  191(12) 202(9)  1(9) -1(10)  -17(11) 
C(2) 193(13)  173(11) 240(10)  12(9) -9(9)  10(11) 
C(3) 229(13)  149(11) 220(10)  -11(9) 27(10)  -30(11) 
C(4) 271(15)  187(11) 273(11)  -19(9) 56(11)  1(13) 
C(5) 354(17)  215(13) 270(11)  -49(10) 101(11)  -33(13) 
C(6) 407(17)  224(12) 207(10)  -11(10) 33(10)  -57(15) 
C(7) 302(15)  186(12) 229(10)  10(9) -28(10)  -25(12) 
C(8) 257(14)  146(10) 221(10)  -9(9) 10(10)  -37(12) 
C(9) 192(11)  151(11) 259(11)  14(9) -21(10)  7(10) 
C(10) 206(12)  166(11) 247(10)  -1(10) 29(10)  -30(13) 
C(11) 167(12)  195(12) 297(11)  39(9) 25(9)  6(11) 
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C(12) 187(13)  232(13) 296(11)  27(10) 66(10)  13(12) 
C(13) 207(12)  264(14) 305(12)  25(10) 71(11)  18(12) 
C(14) 161(13)  227(12) 276(11)  -4(10) 50(10)  18(12) 
C(15) 200(13)  356(16) 318(11)  4(13) -11(10)  18(13) 
C(16) 293(16)  357(16) 254(11)  12(10) -30(11)  67(13) 
C(17) 234(13)  191(11) 225(10)  2(10) 41(9)  -32(14) 
______________________________________________________________________________  
 
 Table A8.5  Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) for 44b. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1) -2486 -5777 -7086 25 
H(2) -158 -6549 -8085 25 
H(4) 964 -6640 -9803 29 
H(5) 375 -6021 -11538 33 
H(6) -2566 -4599 -12258 34 
H(7) -4940 -3878 -11261 29 
H(9) -6080 -3897 -9565 25 
H(11) -7369 -4124 -7999 26 
H(12) -4775 -4622 -6220 28 
Appendix 8 – X-Ray Crystallography Reports Relevant to Chapter 3 530 
H(13A) -8909 -4007 -6556 31 
H(13B) -7583 -2538 -5859 31 
H(14) -7687 -6429 -5344 26 
H(15A) -5105 -5459 -4223 36 
H(15B) -5956 -3368 -4150 36 
H(16A) -7178 -6681 -3207 37 
H(16B) -6908 -4620 -2715 37 
________________________________________________________________________________ 
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Mechanistic Investigations for Cu-Catalyzed Enantioselective Allylic Alkylation 
with a g-Butyrolactone-Derived Silyl Ketene Acetal† 
 
4.1  INTRODUCTION 
Having developed a ligand and final set of conditions that enabled the Cu-catalyzed 
enantioselective allylic alkylation with a g-butyrolactone silyl ketene acetal (Figure 4.1.1), our next 
goal was to gain a deeper understanding of the reaction mechanism, with an aim of elucidating 
how the ligand is imparting chirality on the substrate. Furthermore, because of the significant 
challenges we faced with nucleophiles other than the g-butyrolactone silyl ketene acetal (see 
Appendix 5), we hoped that this deeper understanding of the mechanism would enable us to expand 
the scope of the nucleophile as well.  
 
† This work was performed in collaboration with the Hadt Lab at Caltech.  Additionally, this research has been 
published and adapted with permission from Jette, C. I.; Tong, Z. J.; Hadt, R. G.; Stoltz B. M. Angew. Chem. Int. Ed. 
2020, 59, 2033–2038. Copyright 2020 Wiley-VCH. 
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4.2  OVERVIEW ON MECHANISMS FOR CU-CATALYZED ALLYLIC 
ALKYLATIONS  
 Although Cu as a catalyst in allylic substitutions with softer, enolate-derived nucleophiles 
(pka < 30) remains underexplored, the use of Cu with hard, organometallic nucleophiles (pka > 
40), such as organomagnesium, dialkylzinc, trialkylaluminum, organolithium, and organoboron 
reagents  is well precedented.1 This transformation was first reported by Corey and coworkers in 
19672, and has been extensively developed over the course of 50 years. Traditionally these 
reactions are optimized for the branched SN2’ products, allowing for the opportunity to set a new 
chiral center on the allyl products (g, SN2’, Figure 4.2.1.A). Chiral ligands traditionally used 
include phosphoramidites, ferrocene ligands, amino acid-derived ligands, and N-heterocyclic 
carbenes.3  
Initially, a ligated Cu (I) species (A) will undergo transmetalation, generating an 
organocuprate species (B). This organocuprate can then coordinate to the allylic electrophile, 
Figure 4.1.1. Final Conditions for Cu-Catalyzed Allylic Alkylations with a g-




OTMS CuCl2 (5 mol %)L56 (6 mol %)
LiHMDS (13 mol %)
CsOAc (1 equiv)
THF (0.042 M), 30 °C, 6 h
Ph O
O







Chapter 4 – Mechanistic Investigations for Cu-Catalyzed Enantioselective Allylic Alkylation with a  




forming p-allyl complex C. Upon oxidative addition, it is believed that the branched s-allyl species 
D forms first, which can either undergo reductive elimination to form the g-product, or isomerize 
to  p-allyl complex E. p-Allyl complex E is believed to be in equilibrium with both s-allyl complex 
F  and branched s-allyl species D, and if D is formed, reductive elimination from the s-allyl 
complex F is possible, allowing for formation of the linear, SN2 product. 
Although a number of different strategies have been implemented in order to access either 
product preferentially, the oldest and most studied method involves the modification of the X 
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group, a non-transferrable ligand on  Cu. If  X is electron deficient, such as CN or Cl, fast reductive 
elimination to the g-product is believed to be favored.3 If the X group is more electron-rich, such 
as an alkyl or alkoxy group, isomerization to the p-allyl species E is favored.  Consequently, a 
mixture of both the g and a products is formed. Under these conditions, other parameters such as 
the solvent,  leaving group,  and temperature can be modified in order to favor the formation of 
the a-product.1,3,4  An alternative theory  based on DFT calculations states that when X=CN, there 
is an orbital dissymmetry in the HOMO of the cuprate which favors formation of a [s+p] allyl 
complex with R3 proximal to the benzylic position of the allyl group, allowing for reductive 
elimination at this position. When X = alkyl, the symmetrical HOMO of the cuprate allows for 
either formation of the linear or branched product.4 Despite the significant effort made toward 
understanding the role these non-transferrable ligands play in this transformation, modern reports 
now rely on the influence of sterics and the presence of chelating groups on the auxiliary ligand 
(Ln) to control the site selectivity.5  
Because the use of Cu in allylic alkylations with softer, enolate derived nucleophiles (pka 
< 30) remains underdeveloped, one of the challenges associated with the development of this 
transformation is that the mechanism was not well understood.  Although the inner sphere allylic 
alkylation with Cu is well precedented (Figure 4.2.1.B),  a number of different reaction pathways  
could logically be expected for the present reaction. One possibility is that Cu could be functioning 
as a Lewis Acid for the activation of enolate-type nucleophiles, a pathway that has been implicated 
twice before in the enantioselective allylic alkylation of b-ketoester nucleophiles (Figure 4.2.2).6,7 
Although in both the present case and in these reports the reaction is hypothesized to proceed 
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through an enolate nucleophile, b-ketoesters significantly differ both sterically and electronically 
from g-butyrolactones, and for this reason, it was unclear whether both types of species would 
undergo alkylation via a similar pathway.8 
Outer-sphere allylic alkylation pathways, in which Cu exclusively activates the 
electrophile could also be operative (Figure 4.2.3). This mechanism is more common when softer 
nucleophiles are used in combination with metals such as Ir and Pd.1  In an outer sphere 
mechanism, the metal will oxidatively insert into the allylic electrophile to form a  metal p-allyl 
species, which then can undergo nucleophilic attack to form the desired product and regenerate the 
transition metal catalyst.9   





1. CsI (2 equiv)
    BF3•OEt2 (2 equiv)
    MeCN, 23 °C, 30 min
    then i-Pr2NEt (4 equiv)
2. Cu(OTf)2 (10 mol %)
    L1 (12 mol%)
    4A MS, CH2Cl2
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Figure 4.2.3. Outer-Sphere Allylic Alkylation Mechanism9 
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4.3  INVESTIGATIONS INTO A RADICAL MECHANISM 
 One of the first possible mechanisms we explored was the radical mechanism.  Given that 
carbon-centered radicals can be generated from the corresponding silyl ketene acetals by an 
oxidative process involving Cu(II),10 a radical mechanism for alkylation of the g-butyrolactone-
derived silyl ketene acetal seemed plausible. For this reason, a couple of experiments were carried 
out in order to determine if a radical mechanism was operative.  
Early on in the investigation, we performed a reaction in the presence of TEMPO. We 
found that the yield was comparable to what was observed without TEMPO, and no TEMPO-
substrate adducts were observed by 1H NMR or GC-MS (Scheme 4.3.1).  
Another possibility could be that the reaction proceeds through an allylic radical 
intermediate. If this is the case, a benzylic radical should be just as viable an intermediate as an 
allylic radical, as determined by their bond dissociation energies (Scheme  4.3.2.A).11  However, 
no reaction occurred when benzyl chloride was used as the electrophile instead of cinnamyl 
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chloride in either our starting or final conditions (Figure 4.3.2.B).  Furthermore, this experiment 
also served to demonstrate that the alkene was a crucial component of the electrophile, and it was 
not simply the activated nature of the allylic leaving group that was leading to product formation 
via  a mechanism involving a Cu Lewis Acid activation of the nucleophile. 
 
4.4  CHARACTERIZATION OF THE STARTING COPPER/L73 COMPLEX 
With preliminary evidence suggesting that both a radical mechanism and a Lewis acid 
mechanism were unlikely, we next turned our attention to the characterization of the starting Cu 
complex, with a goal of  understanding  how the Cu complex was activating either the electrophile 
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(outer-sphere mechanism) or the nucleophile and electrophile (inner sphere mechanism), and how 
enantioinduction may be occurring.  
 Given the novelty of the Cu/L73 complex, we chose to examine it using continuous wave (CW) 
X-band electron paramagnetic resonance (EPR), UV-vis spectroscopies, and density functional 
theory (DFT) calculations. Although the single x-ray diffraction crystal structure of a planar CuII 
complex with a tetradentate, deprotonated L38 has been reported,12 it was unclear how exclusion 
of one of the pyridine moieties and the presence of a large, bulky backbone would affect the 
binding mode of the ligand. For this reason, we aimed to determine whether our best performing 
ligand L73 coordinates through the two amide nitrogens, or if it adopts an alternative binding mode 
through the benzamide oxygen, similarly to the previously disclosed Mo/L38 complex.13 
Figure 4.4.1. Absorption Spectrum of L73•CuCl2 
 
Chapter 4 – Mechanistic Investigations for Cu-Catalyzed Enantioselective Allylic Alkylation with a  




 One challenge with Cu in catalysis is its propensity to form higher order aggregates.14 
Consequently, we wanted to ensure that the observed catalytic activity could be attributed to a 
monomeric Cu complex prior to performing any DFT calculations. Given the thermal instability 
of the Cu(II) catalyst (which also prevented structural determination by techniques such as X-ray 
crystallography), we chose EPR and electronic absorption spectroscopies for the quantification of 
monomeric Cu(II) species in the reaction.  
Three batches of L73•CuCl2 were prepared independently and diluted to 2.1 mM in Cu, 
which is the concentration of Cu in the final reaction conditions  (See Materials and Methods). An 
aliquot of the sample was loaded into a 4.0 mm standard quartz Norell EPR tube and immediately 
immersed in liquid nitrogen to avoid sample decomposition (rapid freezing also ameliorates the 
adverse effect from the non-glassiness of THF, as we found that preparing the complex in the 
glassy 2-MeTHF solvent led to a yellow solution with a different EPR spectrum. See Figure S2). 
2 mL of the same solution of each sample was then loaded into a 1 cm borosilicate cuvette to 
obtain its absorption spectrum. All three samples afforded a green solution with low intensity d-d 
transitions ranging from 560 to 1400 nm, (Figure 4.3.1), albeit small variations exist. As a result, 
we estimate a 5% error associated with the concentrations of the anolyte (± 0.1 mM). 
The three L73•CuCl2 samples show a double integrated intensity of 3.00*105, 2.87*105, 
and 2.68*105. This resulted in an averaged concentration of 1.81 mM with a standard deviation of 
0.1 mM. Moreover, combining various sources of error with standard error of regression, standard 
error of the slope, and standard error of the intercept resulted in a 6 % error associated with the 
calibration method described herein. Adding calibration error and the standard deviation in 
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quadrature, we report the average concentration of monomeric, divalent copper in L73•CuCl2 to 
be 1.81 (± 0.14) mM. 
These three different batches of L73•CuCl2  were further diluted down with acetonitrile for 
ESI-MS. In negative ion mode, we found 577.0364 m/z, which was consistent with  the calculated 
m/z for C29H22Cl2CuN3O2 [M+H]– = 577.0385. We also found that the isotope patterns observed 
were consistent with the ionization of the fully deprotonated [L73•CuCl2]2– species. It was 
interesting to note that the Cl- ions remained bound to Cu after coordination of the ligand, 
indicating that they may be playing a role in the generation of a consistent complex (see Chapter 
3, Table 3.5.2). 
With some preliminary characterization data in hand, our next focus was to determine 
whether the L73 was bound to Cu via the benzamide nitrogen or the benzamide oxygen. Because  
we were limited to a non-glassy solvent for EPR, it was impossible to determine the fine coupling 
structure, and thus we were not able to establish the binding mode using this technique.  We also 
attempted to use FTIR, but the  Cu-O and Cu-N bonds cannot be directly observed through IR, and 
although the carbonyl peaks  and the bending modes could be used to obtain structural information, 
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4.5 LIGAND COORDINATION GEOMETRY: DFT CALCULATIONS 
Given the challenges we faced with a large variety of experimental techniques, we turned 
to DFT calculations in order to determine the binding mode of the ligand. We found that DFT 
calculations indicate that L73 preferentially binds to Cu in a tridentate fashion, via Npyridine, 
Npicolinamide, and Obenzamide atoms (L73NNO•CuCl2, Table 4.5.1, entry 1). Regardless of the level of 
theory employed, the alternative tridentate binding mode via the benzamide nitrogen 
(L73NNN•CuCl2) is disfavored by 14-23 kcal/mol (entry 2 and Tables 4.11.1 and 4.11.2). This large 
Table 4.5.1. DFT Calculations on L73 and L73•CuCl2a 
 
[a] Obtained using B3LYP density functional with 38% Hartree-Fock exchange. [b] Ligand coordination geometry 
was obtained by removing CuCl2 from the optimized geometry of the corresponding complex. 
L73NNO•CuCl2 L73NNN•CuCl2
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energy difference renders the thermal  population of the O–bound enolate unlikely; for this reason, 
we postulate that only one conformer of the pre-catalyst accounts for the observed asymmetric 
catalytic activity.  To further probe the origin for this binding preference, we performed single-
point calculations on L73 in the absence of CuCl2 (entries 3-5). Interestingly, we found that the 
energy gap between the two conformations L73NNO and L73NNN is still retained (entries 4 and 5), 
implying that ligand sterics affect the binding preference and tune the metal coordination 
geometry. As demonstrated by the geometry index τ4’,15 the two sp3 ring carbons C1 and C2 
exhibit a stronger deviation from the ideal tetrahedral geometry (τ4’ = 1) in L73NNN relative to 
L73NNO.  
In order to gain a better understanding for why L73 performed better than L56, we 
performed an identical analysis on L56•CuCl2 (Table 4.5.2).  We found that with L56, the NNO 
Table 4.5.2. DFT Calculations on L56 and L56•CuCl2a 
 
[a] Obtained using B3LYP density functional with 38% Hartree-Fock exchange. [b] Ligand coordination 
geometry was obtained by removing CuCl2 from the optimized geometry of the corresponding complex. 
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binding conformation is still preferred. Even though with L56 the  energy difference between the 
two conformations is reduced,  this energy difference  is still too large for the population of both 
binding modes.  
4.6 REDUCTION OF COPPER(II) TO COPPER(I) 
 Throughout our reaction screening, we consistently noted that both Cu(I) and Cu(II) sources 
could be used, regardless of the reaction conditions employed. Because our reaction conditions 
were somewhat reducing, we hypothesized that when a Cu(II) source is used, a reduction to Cu(I) 
could be occurring at the start of the reaction. In the final conditions, a color change from green to 
Figure 4.6.1. Room Temperature UV-vis and 77 K X-band EPR (inset) Spectroscopic 
Monitoring of the Reaction of 5 mol % of L73•CuCl2  with Silyl Ketene Acetal 41 
 
Chapter 4 – Mechanistic Investigations for Cu-Catalyzed Enantioselective Allylic Alkylation with a  




yellow does occur within 5 minutes of the addition of silyl ketene acetal 41 and CsOAc to 
L73•CuCl2, indicating that a significant change at Cu is occurring. 
 In order to confirm the occurrence of an oxidation state change, we monitored the change at Cu 
upon addition of silyl ketene acetal 41 and CsOAc using UV-vis and EPR.  In agreement with the 
above observations, we noted that the characteristic d-d transitions and 77 K X-band EPR signal 
of the starting L73•CuCl2 complex disappear at the start of the reaction, signifying the CuII 
precatalyst is reduced to a CuI complex (Figure 4.6.1).  
Interestingly, we noted that the reduction occurs even in the absence of CsOAc, indicating 
the silyl ketene acetal 41 is the reductant.15   Using EPR we quantified the amount of monomeric, 
divalent Cu after the addition of 1.5 equiv of 41  to 5 mol% L73•CuCl2, and found that the 
concentration  of Cu(II) remaining in solution was 0.29 (+/- 0.02) mM, only 16% of the total 
amount of Cu(II)  present at the start of the reaction (see Section 4.3).  It should be noted that this 
reduction occurs only in the presence of a large excess of silyl ketene acetal 41 relative to Cu. In 
Figure 4.6.2. UV-Vis-NIR: Observation of Intermediate During Reduction 
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addition, with less than 30 equivalents of 41 relative to Cu, incomplete consumption of the Cu(II) 
is observed.   
From the UV-Vis monitoring of the initial reduction,  we were also able to  detect a new 
on pathway reaction intermediate. The addition of 7.6 equivalents of 41 (relative to L73•CuCl2) 
resulted in both a decrease in Cu(II) signals and a change in the EPR spectrum and the d-d 
transitions in the 600-800 nm region (Figure 4.6.2). The further characterization of this 
intermediate will be reported in a follow up study. 
For insight into the mechanism for the reduction of the starting Cu(II) complex, we turned 
to the literature. There are a number of reports on the radical coupling of enolates using CuCl2 as 
the oxidant, which led us to postulate a similar mechanism for the reduction of CuCl2 by 41 
(Scheme 4.6.1).16 Although to our knowledge,  no reports on the use of silyl enolates in this type 
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of transformation exist in the literature, we envision that a chloride assisted cleavage of  the silyl 
enolate could lead to an intermediate (C, Scheme 4.5.1)  that is commonly postulated in related 
reports.   
Initially, ligand substitution by the electron-rich olefin of the silyl ketene acetal may lead 
to complex B. The displaced chloride anion can then attack the silyl group, allowing for the 
formation of a Cu enolate C. This Cu enolate can then react with an additional Cu enolate to afford 
the lactone dimer 97 and 2 equivalents of the corresponding Cu(I) salt D. Another likely 
mechanism also involves a bimolecular pathway, but rather than reacting with a second equivalent 
of C, the Cu enolate could also react with A to form the a-chlorolactone.17  Given the low  
molecular weight of both 97 and 98, we have not isolated either at this time, and for this reason, 
neither mechanism can be ruled out.  
 Having confirmed  that a reduction is occurring at the start of the reaction, another question 
that had to be answered was whether or not the binding mode of the ligand is retained after the 
reduction. To this end, we performed DFT calculations on a number of possible intermediates. We 
found that, although the energy differences between the two binding modes may change slightly, 
the NNO binding mode is still preferred for a number of different Cu complexes. 
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4.7  FTIR: ADDITIONAL STRUCTURAL INSIGHT FOR COPPER(I)  
Having identified that the starting Cu(II) complex is reduced to a Cu(I) complex at the start 
of the reaction, our next goal was to identify whether  a Cu(I) enolate was being formed, as this 
would be a direct indication of  whether an inner-sphere or outer-sphere alkylation pathway is 
operative.  
It should be noted that while NMR was not useful for the characterization of the Cu(II) 
precatalyst, we tried to use 1H NMR, 13C NMR, 7Li NMR, and FTIR to gain structural insight on 
the Cu(I) catalyst. However, the 1H NMR was extremely messy, as 30 equivalents of the silyl 
ketene acetal 41 relative to Cu are required to fully reduce the catalyst (Figure 4.7.1). As a 
Table 4.6.1. Steric Preference for L73NNO Coordination Across Different Possible 
Intermediates 
 
[a] This structure failed to converge; dissociation of the chloride was energetically favorable during the optimization 
cycles. [b] The benzamide moiety dissociated in the optimized structure, resulting in a T-shaped Cu complex with a 
bidentate L73 ligand.  
 


























-3997.8647 -3997.8289 0.0358 22.5
-3537.3202 -3537.2842 0.0360 22.7
-3076.6231 -3076.6029 0.0202 12.7
n.a. n.a. n.a. n.a.
-3537.2750 n.a.b n.a. n.a.
-3076.7185 3076.681 0.0375 23.6
-3998.0902 -3998.0591 0.0311 19.5
-3537.3972 -3537.3682 0.0290 18.3
-3076.6523 -3076.6288 0.0235 14.8
n.a. n.a. n.a. n.a.
-3537.4968 n.a.b n.a. n.a.
-3076.7939 -3076.7650 0.0289 18.2
with solvent correction
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consequence, the alkyl region of the spectrum is congested by the very large silyl ketene acetal 
peaks. In the aryl region of the 1H NMR, we observed a large amount of broadened resonances 
with full width at half-maximum (FWHM) of around 10 Hz, which is indicative of dynamic 
behavior. As a result, no conclusions could be drawn about the binding mode from the 1H NMR 
alone. Given this dynamic movement, we believed that even if we had been able to access our 
Cu(I) active catalyst cleanly using an alternative method, it would be nearly impossible to discern 
the binding mode, or any other structural features of the complex from the 1H NMR data.   
 In addition to 1H NMR, we also collected a 13C NMR spectrum of the Cu(I) form of the 
complex. Unfortunately, not all 13C signals were cleanly resolved, particularly the sp2 carbonyl 
carbons, and the alpha carbons of interest (See A9.1). In the  7Li NMR spectrum, we did observe 
that the addition of silyl ketene acetal to the Cu(II) pre-catalyst resulted in a change of less than 
Figure 4.7.1: 1HNMR (400 MHz, THF-d8) Spectrum of L73•CuCl2 + 30 equivalents of 
41 
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0.5 ppm in the lithium spectrum, however, no further structural elucidations could be made (See 
A9.2 and A9.3).  
From the FTIR we were able to gain some insight into the  structural changes that were 
occurring upon exposure of the starting Cu(II) complex to 41.  Compared to that of the free ligand, 
the pyridine ring bending mode shifted from 748 to 756 cm-1, indicating the coordination of 
pyridine to copper center (See A6.32 for IR of free L73).18 For L73•CuCl2  (Figure 4.7.2, blue 
trace), we consistently noted high transmittance. Upon addition of silyl ketene acetal 41, we 
observed the reappearance of amide bands at 1683, 1669, and 1646 cm-1. The pyridine remained 
bound to the copper center as the ring bending mode occurred at 755 cm-1. Interestingly, we 
observed an intense ring C-H bend from the phenyl moiety. These results suggest that the 
benzamide moiety may have dissociated upon addition of silyl ketene acetal 41. 
A carbonyl band was also observed at 1774 cm-1, which could be attributed to a Cu(I) 
enolate, as it is 4 cm—1  away from where the g-butyrolactone carbonyl stretch is observed. 
Figure 4.7.2: FTIR Spectrum of L73•CuCl2 + 30 equivalents of 41 
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However, although a large excess of silyl ketene acetal is added to the starting precatalyst in order 
to reduce it down to Cu(I), we observe no peaks that correspond with the silyl ketene acetal or free 
g-butyrolactone. One  likely explanation is that because these experiments  were performed on a 
dry sample, perhaps the g-butyrolactone and silyl ketene acetal evaporated prior to spectrum 
acquisition.  
Although we do not have any conclusive data that indicates that a Cu(I) enolate is being 
formed or that it is the species that undergoes oxidative addition into the cinnamyl chloride, we do 
have some evidence that indicates this may be likely.  The first is that controls run in the absence 
of Cu result in little to no product formation. Even when cinnamyl bromide is used, only a small 
amount of product is observed. We believe that this may be an indication that CsOAc is not a 
strong enough base to cleave the silyl ketene acetal without the assistance of the Cu catalyst. 
Furthermore, when the analogous lithium or zinc enolates are used as nucleophiles, or when other 
salts that are designed to cleave silyl enolates such as TBAT and CsF are used, no product is 
observed, indicating that a free enolate may not be the reactive species.   
In addition, the present conditions for silyl ketene acetal cleavage are similar to those 
developed by Zhou and coworkers for the Pd-catalyzed enantioselective a-arylation (Figure 
4.7.3.A). On the basis of DFT calculations, they propose a  mechanism for their transformation 
that involves a reductive elimination step from an aryl Pd(II) enolate (D, Figure 4.7.3.B).19  
Furthermore, in their DFT calculations,  they found that a C-bound Pd enolate was consistently 
favored over an O-bound Pd enolate by 15 kcal/mol (we observe similar results, see Figure 4.7.4). 
After modeling a number of different transmetallation mechanisms, they found that the only one 
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that allows for exclusive formation of a C-bound enolate involves  external acetate cleavage of a 
silyl ketene acetal bound to Pd through the electron-rich olefin (C, Scheme 4.7.3.B). Although 
Zhou and coworkers have no experimental evidence to confirm that silyl enolates  bind to transition 
metal complexes in this manner, in our own control reactions run during the investigation of silyl 
enol ether nucleophiles (see Section A5.4), we did observe some reactivity that could be explained 
by coordination of a silyl enolate to the Cu catalyst.  
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Having concluded that the formation of a Cu(I) enolate is likely, we performed DFT 
calculations in order to establish which enolate geometry is preferred. In agreement with Zhou and 
coworkers, we found that a C-bound Cu enolate is significantly favored over an O-bound enolate. 
Interestingly, we noted that the two C-bound enolate enantiomers are very close in energy, with 
the disfavored  (R)-enantiomer slightly lower in energy than the desired (S)-enantiomer (Table  
4.7.4).20   
 
4.8  IMPORTANCE OF OLEFIN GEOMETRY  
Another equally important question we hoped to answer is to what extent the Cu is 
interacting with the electrophile. One unique characteristic of our reaction was that the product 
was consistently formed in high linear:branched ratios.21  From our investigation, it appears that 
this is regardless of the Cu source, ligand, leaving group, solvent, and base used.  This high 
Table 4.7.1.  Energetic Preference for C-bound Enolate 
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linear:branched selectivity, which is uncommon in traditional Cu-catalyzed allylic alkylations, 
could be explained in a number of ways: the first is that the reaction is going through a pathway 
that involves direct SN2 with a Cu(I) enolate, which we deemed unlikely from our experiments 
with benzyl chloride, but could not yet rule out.  The second explanation is that this high selectivity 
for the linear product is a consequence of the nucleophile used.  The g-butyrolactone silyl ketene 
acetal  significantly differs both in size and electronics from nucleophiles used in traditional Cu-
catalyzed allylic alkylations, which are typically unbranched organometallic nucleophiles. If the 
reaction is going through an inner-sphere mode of attack, perhaps the large size of this nucleophile 
could be consistently preventing the formation of the branched products, or may alter the geometry 
of the HOMO on Cu in such a way that consistently favors formation of the linear product.22   
Finally,  another possibility is that by chance we did not test any ligands that could afford the 
branched product in high yields. One of the more common ways to direct the site selectivity is 
through the presence of chelating groups on the ligands. These modifications have been 
extensively made on NHC’s ligands, but unfortunately those ligands resulted in no product 
formation in the present conditions.   
 Because the product distribution did not resemble that of  traditional Cu-catalyzed allylic 
alkylations, we hoped to further probe to what extent Cu interacts with the electrophile, as this 
would be a good indication of whether an inner-sphere mechanism was operative, or an alternate 
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mechanism needed to be considered. To this end,  we took a closer look at the effect of the 
electrophile olefin geometry on the reaction outcome. Interestingly, we found that although 
trisubstituted olefin 43r (Scheme 4.8.1) led to the desired product 44r in good selectivity and yield, 
the product formed from a-,a-substituted olefin 43s was obtained in significantly lower yield and 
ee. Intrigued by this result, we exposed Z-olefin substrate 43t to our reaction conditions. 
Interestingly, we obtained the corresponding Z-olefin product 44t in good yield, but in only 
moderate ee. Furthermore, we also noted that even when a mixture of linear and branched 
electrophiles is used, only the linear product is obtained (44u). Taking these results into account, 
Scheme 4.8.1 Importance of Olefin Substitution Patterna 
 




90% yield, 88% ee
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and also considering that other electrophiles such as benzyl or phenethyl chloride result in no 
product formation, we believe  that SN2 of a Cu enolate is an unlikely pathway, and the reaction 
may be proceeding through a CuIII[s+p] allyl species.4,5a 
 
4.9  PROPOSED CATALYTIC CYCLE 
Taking all this mechanistic insight into account, we propose that the reaction follows an 
inner sphere CuI-CuIII catalytic cycle as shown in Scheme 4.9.1. We believe that the catalytic cycle 
commences with coordination of the electron-rich olefin of the silyl ketene acetal to CuI  bis-
amidate complex A, forming B. The Si-O bond is then cleaved via outer sphere attack by the 
acetate anion2d to afford the desired C-bound Cu enolate C.  We envision that this could be the 
enantiodetermining step, during which the lithium counter-ion may assist through electrostatic 
interactions, preventing rotation of the silyl ketene acetal.  Dissociation of the benzamide then 
allows for the coordination and subsequent oxidative addition of the allyl chloride, generating 
CuIII[s+p] species D.23 The sterically encumbered CuIII species can then undergo reductive 
elimination to generate the desired a-allyl g-butyrolactone and the starting CuI species A.  
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4.10  CONCLUSION 
We have performed a preliminary investigation into the reaction mechanism, with the goal 
of being able to expand this reaction protocol to other silyl enolate nucleophiles. Although the use 
of experimental techniques for the determination of the binding mode of the ligand proved 
unsuccessful, from DFT calculations we were able to identify that the NNO binding mode of the 
ligand was significantly preferred, and this preference seemed to be a consequence of the ligand 
itself. Furthermore, using UV-vis and EPR spectroscopic techniques, we were able to show that 
the starting Cu(II) complex was reduced to Cu(I) over the course of the pre-stir, and that the 
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reducing agent is the silyl ketene acetal 41. On the basis of  these experiments and further examples 
of similar reactivity in the literature, we proposed a bimolecular, radical mechanism for the 
reduction of the Cu catalyst. Although we do not have conclusive evidence that suggests that a 
Cu(I) enolate may be the reactive species, on the basis of some results we obtained during reaction 
screening, as well as FTIR data, and due to the similarity between our conditions and the Pd-
catalyzed a-arylation conditions reported by Zhou,19  we conclude that a Cu enolate is likely to be 
the active species. Finally, upon examination of the effect of the electrophile olefin geometry on 
the reaction outcome, we noted that a CuIII[s+p] species that has been implicated in previous Cu-
catalyzed allylic alkylation reports is a likely intermediate.  For these reasons, we have proposed 
an inner-sphere pathway for bond formation. Future work will focus on the elucidation of the final 
intermediate prior to C-C bond formation (D in Scheme 4.9.1),  as this should allow for additional 
insight into how the ligand sterics and electronics influence the reactivity and selectivity of the Cu 
catalyst, and also contribute to the ongoing debate in the literature about the viability of  d8 CuIII 
species.24 
One very interesting aspect of the reaction mechanism is that previously reported Cu-
catalyzed allylic alkylations set the stereocenter on the electrophile, not the nucleophile. To our 
knowledge, this is the first time that a prochiral nucleophile is used in a Cu-catalyzed allylic 
alkylation involving an inner-sphere type pathway. We believe that this difference is also reflected 
in the ligand screen (See Chapter 3), as ligands typically used for this type of transformation did 
not lead to selective product formation.  As a consequence, a novel ligand scaffold with a new 
backbone was required to enable the formation of the desired product in high yield and ee.  We 
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are currently using this mechanistic insight to help us design the next generation of ligands with 
the aim of accommodating bulkier silyl ketene acetals (See Section A5.4).  
 
4.11  EXPERIMENTAL SECTION 
4.11.1  MATERIALS AND METHODS 
Unless otherwise stated, reactions were performed in flame-dried glassware under an argon 
or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried by passage through 
an activated alumina column under argon. Reaction progress was monitored by thin-layer 
chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC was performed using E. Merck silica 
gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence quenching, p-
anisaldehyde, or KMnO4 staining. ((4,5-dihydrofuran-2-yl)oxy)trimethylsilane (41) was 
synthesized according to a previously reported procedure.25  L73 was synthesized according to the 
procedure in Chapter 3.  Silicycle SiliaFlash® P60 Academic Silica gel (particle size 40–63 nm) 
was used for flash chromatography. 1H NMR spectra were recorded on a Bruker Avance HD 400 
MHz or Varian Mercury 300 MHz spectrometers and are reported relative to residual CHCl3 (δ 
7.26 ppm). 13C NMR spectra were recorded on a Bruker Avance HD 400 MHz spectrometer (101 
MHz) and are reported relative to residual CHCl3 (δ 77.16 ppm) or THF (δ 68.03). 19F NMR 
spectra were recorded on a Varian Mercury 300 MHz spectrometer (282 MHz). Data for 1H NMR 
are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration).  
Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, 
sept = septuplet, m = multiplet, br s = broad singlet, br d = broad doublet, app = apparent.  Data 
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for 13C NMR are reported in terms of chemical shifts (δ ppm). IR spectra were obtained using a 
Perkin Elmer Spectrum BXII spectrometer or Nicolet 6700 FTIR spectrometer using thin films 
deposited on NaCl plates and reported in frequency of absorption (cm–1).  Optical rotations were 
measured with a Jasco P-2000 polarimeter operating on the sodium D-line (589 nm), using a 100 
mm path-length cell and are reported as: [a]DT (concentration in 10 mg/1 mL, solvent). Analytical 
SFC was performed with a Mettler SFC supercritical CO2 analytical chromatography system 
utilizing Chiralpak (AD-H, AS-H or IC) or Chiralcel (OD-H, OJ-H, or OB-H) columns (4.6 mm x 
25 cm) obtained from Daicel Chemical Industries, Ltd.. High resolution mass spectra (HRMS) 
wereobtained from Agilent 6200 Series TOF with an Agilent G1978A Multimode source in 
electrospray ionization (ESI+), atmospheric pressure chemical ionization (APCI+), or mixed 
ionization mode (MM: ESI-APCI+), or obtained from Caltech mass spectrometry laboratory. X-
Band (9.4 GHz) Continuous-wave(CW) EPR spectra were obtained using a Bruker EMX 
spectrometer with its Bruker Win-EPR software (version 3.0). A vacuum-insulated quartz liquid 
nitrogen dewar was inserted into the EPR resonator to obtain all spectra at 77 K. For optimal 
sensitivity, all spectra were collected with 0.5 mW microwave power and averaged over four scans. 
UV-Vis-NIR spectra were acquired using Varian Cary 500 Scan spectrophotometer with Varian 
Cary WinUV software(version 4.10(464)). Samples were loaded into 1 cm Starna Cell borosilicate 
cuvettes enclosed with screw caps. The spectra were collected from 300 nm to 1650 nm at a 600 
nm/min scan rate and corrected for THF background. IR spectra were collected using a Bruker 
Alpha Platinum ATR spectrometer with OPUS software (version 7.0.129) stored in a glovebox 
under N2. An aliquot of sample solution was deposted onto the spectrometer to form a thin film, 
and the spectra were collected over 32 scans 
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All calculations were performed using the ORCA 4.1.2 package.26 Unless otherwise 
specified, the spectroscopically calibrated Becke3-Lee-Yang-Parr density functional with 38% 
exact Hartree-Fock exchange (B3(38HF)LYP was employed, similar to that reported by Solomon 
and coworkers.27 All atoms were described with the def2-TZVP basis set. Calculations were 
performed with the finest available grid (Grid7) and the chain of sphere approximation (RIJCOSX) 
for two-electron integrals on the corresponding finest auxiliary integration grid (GRIDX9) for the 
RI/J auxiliary basis set. Gas-phase geometries were optimized with tight convergence criteria (ΔE 
≤ 1*10-8 Hartree). Frequency calculations were used to confirm optimized structures represented 
local minima on the potential energy surfaces. To approximate solvent effects, single point energy 
calculations were performed on gas-phase optimized geometries using a conductor-like polarizable 
continuum model for THF. In all cases, counter ions were excluded from calculations.   
Reagents were purchased from Sigma-Aldrich, Acros Organics, Strem, or Alfa Aesar and used as 
received unless otherwise stated.  
List of Abbreviations 
ee – enantiomeric excess, SFC – supercritical fluid chromatography, TLC – thin-layer 
chromatography, IPA – isopropanol, MTBE – methyl tert-butyl ether, PE – petroleum ether, 
DMAP – 4-dimethylaminopyridine, EtOAc – ethyl acetate, LiHMDS – lithium 
bis(trimethylsilyl)amide, NaHMDS – sodium bis(trimethylsilyl)amide, KHMDS – pottassium 
bis(trimethylsilyl)amide, THF – tetrahydrofuran, TMEDA – 1,2-tetramethylethylenediamine. 
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4.11.2  EXPERIMENTAL PROCEDURES AND SPECTROSCOPIC DATA 
 
4.11.2.1  Preparation of L73•CuCl2 in THF for UV-vis, EPR, and HRMS 
To a 4 mL vial containing CuCl2 (1.34n mg, 0.01n mmol, 0.1 equiv) in the glovebox was 
added a solution of the L73 (0.012n mmol, 0.12 equiv) in THF (0.4n mL), followed by a solution 
of LiHMDS (4.35n mg, 0.026n mmol, 0.26 equiv) in THF (0.4n mL). The resulting solution was 
stirred for 1 h at room temperature. The Cu/L73 solution was then diluted to the appropriate 
concentration (2.1 mM), or was added to a vial containing  silyl ketene acetal 41 (28 mg, 0.15 
mmol, 1.5 equiv) in THF (0.8 mL), and then diluted to 2.1 mM and allowed to stir for 10 min or 
until a color change has been observed. For the experiments containing both  CsOAc and 41, the 
Cu/L complex solution was added to a vial containing  CsOAc (19.2 mg, 0.1 mmol, 1.0 equiv), 
followed immediately by the silyl ketene acetal 41 (28 mg, 0.15 mmol, 1.5 equiv) in THF (0.8 
mL), and the resulting solution was diluted down to 2.1 mM.  For ESI-MS (negative ion mode), 
the resulting solutions were diluted down even further in acetonitrile. HRMS (MM) m/z calc’d for 
C29H22Cl2CuN3O2 [M+H]- = 577.0385, found 577.0364. 
4.11.2.2 Spin Quantification Experiment 
50.0(2) mg of CuSO4•5H2O (0.2 mmol) was added to a 20 mL scintillation vial and 
dissolved in ca. 3 mL of 20% glycerol 80% water mixture. The solution was then transferred to a 
10 mL volumetric flask and diluted accordingly to afford a 20 mM stock solution; calibration 
standards were then prepared from the stock solution. Briefly, the 1 mM and the 2 mM calibration 
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standard were prepared directly from the stock solution. The remaining standards were prepared 
by diluting the 1 mM or 2 mM solution once more using volumetric pipettes and volumetric flasks 
of varying sizes. The error associated with concentration is estimated to be ≤ 2%. Given its 
relatively small size compared to other sources of error, we have excluded this random error from 
further consideration and have assumed the concentration to be absolute.  
77K X-band EPR spectra were then obtained on a variety of samples with variable CuII 
concentrations at 0.5 mW microwave power. A linear baseline correction was performed on the 
resulting EPR spectra to give a zero baseline. Double integration was performed from 260 to 340 
mT. The end point of integration was chosen to minimize any higher-order baseline contribution; 
we found this results in a 2% definition error to the double integrated intensity of the analyte. 
Moreover, we collected multiple spectra for a selected number of samples by first removing the 
sample dewar from the EPR resonator and then collecting a new set of spectra. We estimate 
Figure 4.11.1. Calibration Curve for Spin Quantification 
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instrument variations and the operator errors contribute 3000 to the total integrated intensity. The 
calibration curve and relevant statistics have been reported in Figure 4.11.1. 
An aliquot of the sample was loaded into a 4.0 mm standard quartz Norell EPR tube and 
immediately immersed in liquid nitrogen to avoid sample decomposition. Rapid freezing also 
ameliorates the adverse effect from the non-glassiness of THF, as we found preparing the complex 
in the glassy 2-MeTHF solvent led to a yellow solution with a different EPR spectrum (Figure 
4.10.2). 2 mL of the same solution of each sample was then loaded into a 1 cm borosilicate cuvette 
to obtain its absorption spectrum. All three samples gave optical spectra similar to that reported 
herein (Figure S4) and the manuscript, albeit small variations exist. As a result, we estimate a 5% 
error associated with the concentrations of the analyte (± 0.1 mM). Three L73•CuCl2 samples give 
Figure 4.11.2. 77 K EPR Spectrum of L73•CuCl2 in 2-MeTHF 
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double integrated intensity of 3.00 *105, 2.87*105, and 2.68*105. The averaged concentration was 
1.81 mM with a standard deviation of 0.1 mM.  
 
4.11.2.3  Supporting Computational Results 
 
To understand how variations in the optimized geometry affected single point energy calculations, 
we re-optimized the B3(38HF)LYP-optimized geometry (Geometry B) with the B3(0HF)LYP 
density functional (Figure 4.11.3). The resulting structures (Geometry A) show increased 
deviation from a trigonal bipyramidal geometry (τ5 = 1) towards square pyramidal geometry (τ5 = 
0, Table 4.11.1). 
Figure 4.11.3.Hartree-Fock dependence on L73NNO•CuCl2 (left) versus L73NNN•CuCl2 
(right) geometrya  
 
 
[a] Geometry A (grid): B3(0HF)LYP optimized geometry; Geometry B (filled): B3(38HF)LYP optimized geometry 
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Using the two optimized structures, we examined the Hartree-Fock dependence on the 
energy difference between L73NNO•CuCl2 and L73NNN•CuCl2 (ΔE ≡ ENNN - ENNO, Table 4.11.2). 
Despite L73NNO•CuCl2 exhibiting a modest structural variation between different functionals, the 
energy difference between NNO vs. NNN coordination between the different geometries remains 
relatively small (entries 1 and 6, or entries 2 and 8). Additionally, within the same geometry, 
increasing the amount of Hartree-Fock exchange increases the energy gap between NNO/NNN 
coordination (entries 1 and 2; entries 3-5, or entries 5-8); this observation is maintained for 
calculations with solvent correction (entries 9-11, or entries 11-14). Solvent correction also 
Table 4.11.1. Effects of Levels of Theory on the Optimized Geometry of L73•CuCl2 
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reduces the energy separation between the two coordination modes. As discussed in the 
manuscript, similar energy differences between L73NNO and L73NNN are observed upon removal 
of CuIICl2, suggesting electronic differences between Cu-O and Cu-N bonding do not play a major 
role in determining the ligand binding and are likely secondary to steric contributions. Indeed, by 
comparing both electronic energy and Gibbs free energy, we found steric contributions 
enforce L73NNO coordination mode for a series of possible copper intermediates (Table S3). 
 
4.11.2.4 Synthesis of Allylic Chloride Electrophiles 
General Procedure: Synthesis of Allylic Chlorides (43r, 43s, 43u).  
 
(E)-(3-chloro-2-methylprop-1-en-1-yl)benzene (43r):  (E)-2-methyl-3-phenylprop-2-en-1-ol 
(1.03 g, 6.98 mmol, 1.0 equiv) was dissolved in methylene chloride (14 mL, 0.5 M). Then, thionyl 
chloride (610 µL,  8.4 mmol, 1.2 equiv) was added dropwise. The reaction was allowed to stir for 
2 h at 0 °C,  then quenched with saturated aqueous NaHCO3 solution (6 mL) and allowed to warm 
to room temperature. The aqueous layer was extracted with methylene chloride three times, and 
the resulting organic layers were dried over Na2SO4 and concentrated.  The crude oil was then re-
suspended in hexanes (10 mL) and washed with water 4 times. The hexanes layer was then dried 
with Na2SO4   and concentrated to afford the desired allylic chloride 43r as a white solid (1.14 g, 
6.84 mmol, 98% yield); 1H NMR (300 MHz, CDCl3) δ 7.26 (s, 6H), 6.56 (s, 1H), 4.16 (t, J = 2.0 
Hz, 2H), 1.96 (q, J = 2.2, 1.8 Hz, 3H); All characterization data match those reported.28 
SOCl2 (1.2 equiv)
CH2Cl2 (0.5 M)
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(E)-(4-chlorobut-2-en-2-yl)benzene (1t): 883 mg, 5.29 mmol,  76% yield; 1H NMR (300 MHz, 
CDCl3) δ 7.45 – 7.26 (m, 6H), 6.00 (tq, J = 8.0, 1.4 Hz, 1H), 4.29 (d, J = 8.0 Hz, 2H), 2.15 (d, J = 
1.5 Hz, 3H); All characterization data match those reported.28 
 
 
(E)-(3-chloroprop-1-en-1-yl)cyclohexane(43ul) and (1-chloroallyl)cyclohexane (43ub): 
Isolated as an inseparable mixture of constitutional isomers 43ul and 43ub (623 mg, 3.9 mmol, 
78% yield, 43ul:43ub = 1:2.8); 1H NMR (400 MHz, CDCl3)  43ul: 5.71 ( ddt, J = 15.3, 6.5, 1.0 
Hz, 1H), 5.55 ( dtd, J = 15.3, 7.0, 1.3 Hz, 1H), 4.03 (dt, J = 7.0, 0.8 Hz, 2H), 1.93 (m, 1H), 1.83 – 
1.56 (m, 5H), 1.33 – 0.95 (m, 5H); 43ub: δ 5.88 (ddd, J = 16.9, 10.1, 8.9 Hz, 1H), 5.31 – 5.09 (m, 
2H), 4.17 (dd, J = 8.9, 6.4 Hz, 1H), 1.93 (ddt, J = 12.8, 3.6, 1.8 Hz, 1H), 1.83 – 1.56 (m, 5H), 1.33 
– 0.95 (m, 5H); 43ul and 43ub: 13C NMR (101 MHz, CDCl3) δ 141.9, 137.5, 123.6, 117.2, 69.4, 
46.0, 44.5, 40.3, 32.6, 29.8, 29.6, 26.4, 26.2, 26.14, 26.07, 26.05; δ IR (Neat Film, NaCl) 3084, 
2926, 2853, 1641, 1450, 1419, 1300, 1249, 1197, 987, 968, 926, 891, 780, 756, 688 cm–1; HRMS 
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(Z)-(3-chloroprop-1-en-1-yl)benzene (43t): Compound 43t was prepared from the corresponding 
allylic alcohol according to a previously reported procedure (Z:E=97:3). 1H NMR (300 MHz, 
CDCl3) δ 7.44 – 7.35 (m, 2H), 7.34 – 7.27 (m, 3H), 6.67 (d, J = 11.4 Hz, 1H), 5.98 – 5.85 (m, 1H), 
4.32 – 4.25 (m, 2H); All characterization data match those reported.29 
 
4.11.2.5 Procedure for Cu-Catalyzed Allylic Alkylation Reaction 
 
n = number of reactions.  To a 4 mL vial containing CuCl2 (1.34n mg, 0.01n mmol, 0.05 equiv) in 
the glovebox was added a solution of the L73 (5.2n mg, 0.012n mmol, 0.06 equiv) in THF (0.8n 
mL), followed by a solution of LiHMDS (4.35n mg, 0.026n mmol, 0.13 equiv) in THF (0.8n mL). 
The resulting solution was stirred for 1 h at room temperature. This solution (1.6 mL) was then 
transferred to a vial containing CsOAc, followed by silyl ketene acetal 41 (47.5 mg, 0.3 mmol, 1.5 
equiv) in THF (1.6 mL). The mixture was allowed to stir for 5 min, then allyl chloride (30.4 mg, 
0.2 mmol, 1 equiv) in THF (1.6 mL) was added and the reaction was allowed to stir for 6 h at 30 
°C. The reaction was then quenched with sat. NH4Cl solution and a few drops of TMEDA, and the 
aqueous layer was extracted five times with ethyl acetate. The combined organic extracts were 
dried with Na2SO4, and concentrated by rotary evaporator. The crude oil was then purified by 
column chromatography to afford the desired product. 
 
R Cl O
OTMS CuCl2 (5 mol %)
L73 (6 mol %), LiHMDS (13 mol%)
CsOAc (1 equiv)





N L7343r-u 41 44r-u
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4.11.2.6 Spectroscopic Data for Products from Catalytic Reactions 
Please note that the absolute configuration was determined only for compound 44b via x-ray 
crystallographic analysis (See Appendix 8). The absolute configuration for all other products has 
been inferred by analogy.  
  
 
(S,E)-3-(2-methyl-3-phenylallyl)dihydrofuran-2(3H)-one (44r): Product 44r was purified by 
column chromatography (25% EtOAc in hexanes) to provide a colorless oil (37.6 mg, 0.17 mmol, 
87% yield); 89% ee; [a]D25 57.81 (c 0.80, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.30 (m, 
2H), 7.26 – 7.17 (m, 3H), 6.34 (s, 1H), 4.38 (td, J = 8.8, 3.2 Hz, 1H), 4.24 (td, J = 9.2, 6.9 Hz, 1H), 
2.91 – 2.74 (m, 2H), 2.38 (dddd, J = 12.8, 8.5, 6.9, 3.3 Hz, 1H), 2.32 – 2.20 (m, 1H), 2.13 – 1.96 
(m, 1H), 1.89 (d, J = 1.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 179.4, 179.10, 137.8, 135.4, 
128.9, 128.3, 127.6, 126.5, 66.7, 41.5, 38.1, 28.4, 17.6; IR (Neat Film, NaCl) 2912, 1768, 1490, 
1442, 1373, 1205, 1178, 1149, 1022, 958, 920, 746, 700, 668 cm–1; HRMS (MM) m/z calc’d for 
C14H17O2 [M+H]+: 217.1223, found 217.1224; SFC Conditions: 20% IPA, 2.5 mL/min, Chiralcel 
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(E)-3-(3-phenylbut-2-en-1-yl)dihydrofuran-2(3H)-one (44s): Product 44s was purified by 
column chromatography (20% EtOAc in hexanes) to provide a colorless oil (28.1 mg, 0.13 mmol, 
65% yield, 20:1 E:Z); 5% ee; 1H NMR (400 MHz, CDCl3) δ 7.41 – 7.28 (m, 4H), 7.26 (m, 1H), 
5.73 (tq, J = 7.5, 1.5 Hz, 1H), 4.36 (td, J = 8.8, 3.0 Hz, 1H), 4.21 (td, J = 9.3, 6.8 Hz, 1H), 2.83 – 
2.65 (m, 2H), 2.52 – 2.33 (m, 2H), 2.13 – 1.95 (m, 4H); 13C NMR (101 MHz, CDCl3) δ 179.1, 
143.5, 138.0, 128.4, 127.2, 125.8, 123.6, 66.7, 39.6, 29.3, 28.2, 16.3; IR (Neat Film, NaCl)2922, 
2855, 1760, 1597, 1494, 1456, 1374, 1311, 1203, 1182, 1149, 1068, 1022, 960, 760, 696, 676, 
666; HRMS (MM) m/z calc’d for C15H17O2 [M+H]+: 217.1223, found 217.1223; SFC Conditions: 
10% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): minor = 5.09, major = 5.54. 
 
(S,Z)-3-(3-phenylallyl)dihydrofuran-2(3H)-one (44t): Product 44t was purified by column 
chromatography (25% EtOAc in hexanes) to provide a colorless oil (34.0 mg, 0.17 mmol, 84% 
yield); 73% ee; [a]D25 53.19 (c 0.80, CHCl3); Z isomer (for E isomer, see data for 3a): 1H NMR 
(400 MHz, CDCl3) δ 7.38 – 7.29 (m, 2H), 7.26 (m, 3H), 6.59 (dt, J = 11.7, 1.9 Hz, 1H), 5.64 (dt, 
J = 11.5, 7.2 Hz, 1H), 4.31 (td, J = 8.8, 3.0 Hz, 1H), 4.19 (td, J = 9.3, 6.8 Hz, 1H), 2.90 (dddd, J = 
15.0, 6.8, 4.5, 1.9 Hz, 1H), 2.68 (dtd, J = 9.9, 8.7, 4.4 Hz, 1H), 2.57 (dddd, J = 14.9, 9.0, 7.3, 1.7 
Hz, 1H), 2.37 (dddd, J = 12.8, 8.7, 6.8, 2.9 Hz, 1H), 1.94 (dtd, J = 12.8, 9.8, 8.5 Hz, 1H); 13C NMR 
(101 MHz, CDCl3) δ 178.9, 137.0, 131.9, 128.8, 128.5, 128.1, 127.1, 66.7, 39.6, 29.0, 28.2; IR 
(Neat Film, NaCl) 3016, 2912, 1766, 1598, 1494, 1448, 1374, 1308, 1208, 1150, 1074, 1023, 967, 
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(S,E)-3-(3-cyclohexylallyl)dihydrofuran-2(3H)-one (44u): Product 44u was purified by column 
chromatography (25% EtOAc in hexanes) to provide a colorless oil (37.3 mg, 0.18 mmol, 90% 
yield); 87% ee; [a]D25 16.32 (c 0.60, CHCl3); 1H NMR (400 MHz, CDCl3) δ 5.48 (dd, J = 15.4, 
6.7 Hz, 1H), 5.37 – 5.26 (m, 1H), 4.30 (td, J = 8.8, 3.5 Hz, 1H), 4.19 (td, J = 9.1, 7.0 Hz, 1H), 2.59 
(qd, J = 9.0, 4.4 Hz, 1H), 2.50 (ddd, J = 14.2, 6.8, 4.5 Hz, 1H), 2.32 (dddd, J = 12.5, 8.9, 7.0, 3.5 
Hz, 1H), 2.20 (dt, J = 14.8, 7.8 Hz, 1H), 2.05 – 1.86 (m, 2H), 1.67 (dddt, J = 19.5, 15.5, 8.6, 4.0 
Hz, 5H), 1.31 – 0.96 (m, 5H); 13C NMR (101 MHz, CDCl3) δ, 179.2, 140.3, 123.0, 66.8, 40.8, 
39.4, 33.4, 33.2, 27.7, 26.3, 26.1; IR (Neat Film, NaCl) 2923, 2850, 1773, 1483, 1448, 1375, 1300, 
1258, 1202, 1180, 1157, 1024, 971, 894, 706, 663 cm–1; HRMS (MM) m/z calc’d for C13H21O2 
[M+H]+: 209.1536, found 209.1537; SFC Conditions: 10% IPA, 2.5 mL/min, Chiralpak AD-H 
column, λ = 210 nm, tR (min): major = 3.32, minor = 3.53. 
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A9.5 Infrared spectrum (Thin Film, NaCl) of compound 43u 
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 A9.8 Infrared spectrum (Thin Film, NaCl) of compound 44r 
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A9.11 Infrared spectrum (Thin Film, NaCl) of compound 44s 
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A9.14 Infrared spectrum (Thin Film, NaCl) of compound 44t 
 































































































































A9.17 Infrared spectrum (Thin Film, NaCl) of compound 44u 
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A10.1   COORDINATES FOR B3(0HF)LYP OPTIMIZED L73NNO•CuCl2 
 
  C   5.84649546244608      3.80009699351144      0.35677478540613 
  C   5.20628526966995      3.54427414304280     -0.85151136053620 
  H   4.43843795031227      2.76843330873990     -0.90835413876220 
  C   5.57245233271477      4.26132049922000     -1.99597840840474 
  H   5.08426380468348      4.04912827253866     -2.95002940226531 
  C   6.58444927880399      5.21979523225337     -1.92845268989370 
  H   6.88761810191443      5.75689867271473     -2.83024296532060 
  C   7.23429840965186      5.47277190941920     -0.71554445088301 
  H   8.04419813809433      6.20414098150249     -0.66273787952742 
  C   6.86219041994545      4.77025442858758      0.42717089475257 
  C   5.30496521823870      4.16228481163829      2.70241434681085 
  C   4.20464883302810      4.21555948924984      3.55410647567852 
  H   3.45746943449329      3.41864977965394      3.52367912547705 
  C   4.06813515504421      5.28043398840012      4.45448458800090 
  H   3.20513152189289      5.32041239151633      5.12396366085001 
  C   5.04030065361813      6.28168666930179      4.50798361184927 
  H   4.93656590251965      7.10682345399245      5.21717236619432 
  C   6.15553774358018      6.22433546221199      3.66163260937201 
  H   6.93145199137887      6.99208727144098      3.71326637429685 
  C   6.28537861380839      5.17385945461384      2.75570481662866 
  C   5.61451361883679      3.09732596931170      1.67624322562103 
  H   4.83689219573620      2.32362262990335      1.62166420560046 
  C   7.44128734641475      4.93417225745630      1.81153173151597 
  H   8.21660734850250      5.70542260472605      1.87895308012207 
  C   6.99020539493881      2.42161896893882      2.05109037797509 
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  C   8.04681470655706      3.54298665525527      2.30301787644251 
  N   9.34198340358532      3.20559310556420      1.74624823044713 
  N   6.81198664777545      1.53718192569435      3.18054367626867 
  H   7.31744573425189      1.87555501800638      1.14618124200731 
  H   8.15806025707222      3.65619677241761      3.39720925522048 
  C   10.35608981540664      4.04107966120902      1.98321306435662 
  O   10.32879068814233      5.15956749600066      2.57251240964311 
  C   11.67870186598739      3.53497846343068      1.46931752768328 
  C   12.81219652818755      4.35577804506283      1.45892617339345 
  C   12.88123982953077      1.75127822478929      0.59599020617176 
  C   14.01311177792603      3.83665616689550      0.98446690292745 
  H   12.70289569921495      5.37436890327597      1.83253919876009 
  C   14.05101744738914      2.50967213035211      0.54380980371241 
  H   12.81813121858895      0.70170982238844      0.28734594617472 
  H   14.91375003066435      4.45627132189672      0.95763838319354 
  H   14.97379228418060      2.06315202979394      0.16745155915373 
  N   11.72791642775386      2.25967329706688      1.04816085785147 
  C   7.76953333849433      0.65613759361462      3.36999766425075 
  O   8.85789374960608      0.46005013518106      2.71217330596226 
  C   7.56202451529443     -0.29073674850832      4.53447474624347 
  C   6.49076757713324     -0.14352330098897      5.42867366583204 
  C   8.46271336951653     -1.34796709344498      4.73296718314431 
  C   6.32332472641905     -1.02850528256569      6.49414479241306 
  H   5.80337216894331      0.68535771923953      5.25350485451498 
  C   8.29242956768574     -2.23803661039940      5.79595166187977 
  H   9.28675271813469     -1.44242311159463      4.02310413232512 
  C   7.22426313412840     -2.08342462544594      6.68408353157662 
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  H   5.48512663311003     -0.89645921870251      7.18457801423826 
  H   9.00045801111915     -3.06021158385933      5.93278558227576 
  H   7.09364084620980     -2.77780189712960      7.51863447158090 
  Cu  9.78120858103308      1.32888903607831      1.03240081285816 
  Cl  8.81554460742632      1.66004498732765     -1.12698476570414 
  Cl  10.77685195326325     -0.77597868178764      0.56658305264232 
 
A10.2   COORDINATES FOR B3(0HF)LYP OPTIMIZED B3(0HF)LYP L73NNN•CuCl2 
 
  C   -2.86181484528682     -3.58940008954456      1.95054375745875 
  C   -3.31349561668561     -3.69892806317600      3.26250890510869 
  H   -4.13201981424364     -3.06402295850537      3.60957023087454 
  C   -2.69166078877141     -4.59997873554681      4.13703540534236 
  H   -3.03977202382283     -4.68112858726659      5.16951055772232 
  C   -1.61450006587853     -5.37333267302338      3.70063026890984 
  H   -1.11918665003785     -6.05923485469390      4.39211883046056 
  C   -1.15401417694491     -5.25930197698310      2.38244463344789 
  H   -0.29497713299160     -5.84023114359128      2.03926924108307 
  C   -1.78033160369459     -4.37729609827755      1.50634650947363 
  C   -3.75173736489797     -3.46521827440768     -0.30282559372406 
  C   -4.97750369229859     -3.45829869736675     -0.96435677423204 
  H   -5.75890544455049     -2.76349384916088     -0.64721581442237 
  C   -5.20152493383831     -4.33602636614491     -2.03381041432141 
  H   -6.16297769083989     -4.32618806709272     -2.55283331174731 
  C   -4.19794824599778     -5.21690234943456     -2.44008383027092 
  H   -4.37365180775356     -5.89846280196543     -3.27601398450806 
  C   -2.95831455020654     -5.21994771719559     -1.78496612231822 
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  H   -2.16174467701921     -5.89328943504955     -2.11177768958318 
  C   -2.73457961553729     -4.35083735592329     -0.72127916470769 
  C   -3.37331706245782     -2.62165160380954      0.89614157692924 
  H   -4.20993714530172     -2.01936063426353      1.26309702517890 
  C   -1.43861634905272     -4.16617112198962      0.04697374420373 
  H   -0.61530612865887     -4.80049980067353     -0.29977462931757 
  C   -2.06870834057739     -1.74653729845357      0.60823164693850 
  C   -1.12654857996390     -2.64169144200025     -0.23329153273700 
  N   0.17807677174764     -2.07369500144812     -0.07939931260257 
  N   -2.09369454295182     -0.46650754392405     -0.09469085132616 
  H   -1.58270398413108     -1.62011890928101      1.59414633634100 
  H   -1.42476319348728     -2.47473829499704     -1.28631421994704 
  C   1.35017636433688     -2.68913092021165     -0.13436395652539 
  O   1.62217792878584     -3.91633192589262     -0.26140901416013 
  C   2.46882463684969     -1.67935675525097     -0.01466482661331 
  C   3.80702569585218     -2.06782406847755      0.08881457473474 
  C   3.04753423417500      0.57234335209120      0.08034955842634 
  C   4.78601910284615     -1.08485112427463      0.20200902682291 
  H   4.02479659050468     -3.13652980921024      0.07731692490857 
  C   4.40177120154489      0.25960948036649      0.19958080239680 
  H   2.65834052547137      1.59364133141025      0.04256709356220 
  H   5.84049892387173     -1.35945818433587      0.29304536329919 
  H   5.13794677710420      1.06064536626853      0.28872484545744 
  N   2.11506484582269     -0.38003878037524     -0.02380140843529 
  C   -3.02514947327033      0.48548434128828      0.13683851027035 
  O   -3.21524042877017      1.48258008233778     -0.58726858437059 
  C   -3.93226547087433      0.42024079169482      1.36293991576418 
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  C   -5.32290435103615      0.52628181281700      1.21086131984595 
  C   -3.39013801733346      0.38169637034138      2.65723336046604 
  C   -6.16566520360415      0.54758700487333      2.32232049749550 
  C   -4.23537416878162      0.43692714636742      3.76952438980982 
  H   -2.29879871680153      0.32988609081922      2.78194031834153 
  C   -5.62265894532815      0.50431892619841      3.61216165872487 
  H   -7.24940273261483      0.60899672948706      2.18616275181731 
  H   -3.79882607853386      0.42200923800630      4.77175867899157 
  H   -6.27834421558201      0.53067053223428      4.48680812861745 
  Cu  0.03617643535316     -0.05242231160071     -0.01913595566441 
  Cl  0.18202321645312      0.27002263103041      2.57231415549656 
  Cl  0.29325881017386      2.02731557064579     -0.99523340875897 
  H   -5.72956104448254      0.60579524254171      0.20004752957136 
 
A10.3   COORDINATES FOR B3(38HF)LYP OPTIMIZED L73NNO•CuCl2 
 
  C      5.996110782131    3.901206403957    0.452079601878 
  C      5.423486805078    3.679827078564   -0.786061411137 
  H      4.667520217538    2.920436572539   -0.904396692789 
  C      5.839428879551    4.428986077828   -1.882956965284 
  H      5.399476923526    4.253036574871   -2.851016388804 
  C      6.831735664453    5.384431642849   -1.735752036232 
  H      7.163768223835    5.951501965469   -2.590124163908 
  C      7.414576303946    5.602299341489   -0.490743626918 
  H      8.200673516229    6.330040744673   -0.376741521911 
  C      6.993777917947    4.867261840308    0.602015616610 
  C      5.332116417736    4.195442603273    2.771842483688 
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  C      4.189952214415    4.228420058479    3.549276556945 
  H      3.452856064764    3.447771617348    3.456712372216 
  C      4.003114019401    5.262696013321    4.461957736775 
  H      3.114280724597    5.286917391230    5.071525355996 
  C      4.963659331499    6.252329528748    4.597542301981 
  H      4.821097874227    7.048346639473    5.310476614833 
  C      6.118926140900    6.214766956788    3.821485434612 
  H      6.875332932452    6.974013361780    3.935563307494 
  C      6.300724842810    5.192942761987    2.907440975164 
  C      5.701703622593    3.161820372109    1.736566102369 
  H      4.938984917382    2.402224595939    1.617074970074 
  C      7.504965252742    4.987214850609    2.017555170105 
  H      8.243515277002    5.763153761470    2.130243426082 
  C      7.051091178732    2.487207621378    2.159542821071 
  C      8.108184864734    3.596027330405    2.468159587946 
  N      9.388220838187    3.236459144108    1.885942503798 
  N      6.821977544490    1.589070334148    3.263889240509 
  H      7.405838448457    1.949687548234    1.284158346282 
  H      8.208910724937    3.659528248118    3.549920834187 
  C     10.361555359048    4.121037817158    1.850408640231 
  O     10.399565897214    5.302062669248    2.245415300616 
  C     11.608868581047    3.583798199216    1.172962636089 
  C     12.662071242279    4.426011550783    0.835823368586 
  C     12.700918451362    1.759832401351    0.284878185249 
  C     13.758218129810    3.891235217255    0.188377419153 
  H     12.584116608080    5.465348971456    1.092656241391 
  C     13.780532506528    2.533894554776   -0.098888455296 
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  H     12.647574982173    0.703386050431    0.099431046553 
  H     14.587726990705    4.521367067434   -0.090838439002 
  H     14.616384137745    2.079333196417   -0.601273669208 
  N     11.651231278595    2.285805536168    0.900400206884 
  C      7.627405417897    0.581479742613    3.340901878820 
  O      8.605258220891    0.274703870437    2.579248858236 
  C      7.379616572659   -0.398956292953    4.463387474823 
  C      6.188345145551   -0.405767353400    5.184974754904 
  C      8.369197171738   -1.322048044660    4.791669699835 
  C      5.982790318877   -1.321928298980    6.204409970181 
  H      5.438004240614    0.320923913183    4.931620045610 
  C      8.166026280491   -2.233333149044    5.818485765358 
  H      9.293690860245   -1.295770003667    4.242240757041 
  C      6.972684656387   -2.242128143675    6.525988503078 
  H      5.052373773028   -1.317837679978    6.750566413328 
  H      8.945645435044   -2.935109870487    6.066962597461 
  H      6.815759858662   -2.953772317392    7.321352582794 
  Cu    10.066149178894    1.192064170598    1.672139645038 
  Cl     9.898255811504   -0.030829863250   -0.484324121440 
  Cl    11.773634426644    0.232647107470    3.284474140053 
 
 
A10.4   COORDINATES FOR B3(38HF)LYP OPTIMIZED L73NNN•CuCl2 
 
  C      5.945807246296    3.107202192485    1.502335399784 
  C      5.047563103218    2.379285222991    0.746343080120 
  H      4.570427748968    1.509381540430    1.165978116224 
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  C      4.782768893749    2.760492505325   -0.566855568440 
  H      4.086869742328    2.189559730583   -1.159765933959 
  C      5.427200654394    3.855577495917   -1.117654468486 
  H      5.233426104196    4.137075308720   -2.139949337469 
  C      6.336557647805    4.587245397077   -0.357878209749 
  H      6.854912142272    5.428320936185   -0.787303785004 
  C      6.589595534335    4.219687578302    0.949683852854 
  C      6.131121302581    4.048341019032    3.724889537997 
  C      5.400164393550    4.130523241191    4.894877378511 
  H      4.996481378647    3.236411831315    5.340407106897 
  C      5.191444046219    5.368653903605    5.498534273740 
  H      4.623686673517    5.430533231572    6.412629514348 
  C      5.716271662029    6.516700127011    4.929825554562 
  H      5.556653039856    7.473481866126    5.400121563219 
  C      6.462717046995    6.436264224317    3.755789016043 
  H      6.889172175177    7.325900480823    3.321613355388 
  C      6.667487660645    5.209672483760    3.155039839766 
  C      6.399315341173    2.796223001674    2.917976233572 
  H      5.886576934930    1.938280165358    3.320996928774 
  C      7.505536128462    4.928401115723    1.922440944151 
  H      7.964320073348    5.810445406169    1.504147969042 
  C      7.954403720473    2.549268354511    2.717750668989 
  C      8.585918378494    3.940571494812    2.491939698213 
  N      9.839124011004    3.694359168249    1.839109493965 
  N      8.807338169448    1.905572387920    3.705421189512 
  H      8.024697362767    2.020819248718    1.769417397151 
  H      8.820775248370    4.324926197443    3.483186188373 
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  C     10.503389077773    4.531301676875    1.086118307732 
  O     10.198189428818    5.659984750505    0.656210430818 
  C     11.861068479588    3.961185481642    0.711618004369 
  C     12.675513079510    4.584082690324   -0.225750385992 
  C     13.412394622472    2.298779074916    1.057406317120 
  C     13.898658859848    4.013502710789   -0.523691904981 
  H     12.324679512827    5.488339757776   -0.686782941406 
  C     14.278308649264    2.848471185087    0.126380041060 
  H     13.646137485181    1.408922428976    1.614059182886 
  H     14.550361235383    4.468644478482   -1.252684116163 
  H     15.221910040494    2.373013912293   -0.078326749282 
  N     12.240182639866    2.848804009728    1.332770866814 
  C      8.440267134508    0.839528182969    4.427295430888 
  O      9.018245504531    0.445770563139    5.437324187872 
  C      7.248873356043   -0.027316676101    4.019906417854 
  C      6.262057443613   -0.328586452190    4.955173371299 
  C      7.192197665405   -0.629234895493    2.765958784198 
  C      5.213160011470   -1.176432268797    4.636283690487 
  C      6.155472554838   -1.500582048909    2.456242301259 
  H      7.973801751575   -0.434211589525    2.048418465465 
  C      5.156086357629   -1.768394043887    3.380474480416 
  H      4.447866698088   -1.386497338331    5.367167713507 
  H      6.133377765647   -1.970328285775    1.486261451803 
  H      4.347359112124   -2.437036387966    3.131266526377 
  Cu    10.699039502479    2.038456173134    2.682684332339 
  Cl    10.285273616349    0.175760174498    0.885400531079 
  Cl    12.394853006098    1.330995784988    4.155710819502 
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  H      6.336071843333    0.102080093511    5.939177444591 
 
A10.5   COORDINATES FOR L73NNO•CuIICl 
 
  C   -2.29864477597556     -3.58731153675347      1.77943236012319 
  C   -2.82269583769079     -3.37374726294824      3.03998455660984 
  H   -3.82701029132694     -2.99987819926119      3.15365994361713 
  C   -2.04382217012108     -3.63643097880283      4.16309273863349 
  H   -2.44938709680332     -3.47113707563367      5.14708218916788 
  C   -0.74692298206639     -4.10027993433679      4.01747265080046 
  H   -0.14471943208168     -4.29563690410795      4.88889274827863 
  C   -0.21644932181507     -4.30882108586799      2.74781533841623 
  H   0.79471489534926     -4.66283531029266      2.63394162469672 
  C   -0.99152935467057     -4.05639183543934      1.63151164098629 
  C   -2.92616304079229     -4.59253312440871     -0.34787032253630 
  C   -3.99252998395378     -5.24887761103317     -0.93220535133589 
  H   -4.98690011244504     -4.84233849291993     -0.85200224855454 
  C   -3.77399110614694     -6.43152970026845     -1.63192819871353 
  H   -4.60366358941286     -6.94577359969880     -2.08758384224271 
  C   -2.49249588495234     -6.94476882736923     -1.75022120629525 
  H   -2.32665399997289     -7.85839849088098     -2.29624914443834 
  C   -1.41639760879049     -6.27895395106108     -1.17106628532963 
  H   -0.41716709085784     -6.66816822521432     -1.27472182824629 
  C   -1.63499603747155     -5.10971688084549     -0.46705376849506 
  C   -2.97568433355135     -3.31376200277411      0.45453102760618 
  H   -3.98244513790593     -2.93275597138695      0.56820717352760 
  C   -0.58203704396480     -4.24267793578932      0.18890515346645 
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  H   0.41133384563383     -4.64878477147106      0.08119199247920 
  C   -2.08213664190885     -2.23680469153504     -0.24391464833591 
  C   -0.69289486801510     -2.86368139642553     -0.56354513184782 
  N   0.36692221042153     -1.91060487263126     -0.27209249000565 
  N   -2.74488671788774     -1.68898054010092     -1.39664796206734 
  H   -1.92507385203720     -1.46753634974589      0.51266858341727 
  H   -0.67044085044108     -3.10180276561733     -1.62326886176089 
  C   1.61955311932614     -2.25366741023266     -0.53235408887348 
  O   2.06711077336694     -3.31925298554036     -0.96323800365650 
  C   2.60760856798099     -1.14397787826392     -0.22228376371913 
  C   3.97615308261379     -1.35609408712208     -0.28371544611937 
  C   2.90837451973131      1.05351522885967      0.41418631597412 
  C   4.82331858165214     -0.30769085546144      0.02477240521091 
  H   4.33110696729582     -2.32767490524341     -0.57037334143926 
  C   4.28461501589137      0.91909299177955      0.38289724643908 
  H   2.41814557422152      1.97082534856068      0.68889633040352 
  H   5.89124760642107     -0.44269173167419     -0.01149432966664 
  H   4.91174677501937      1.75596858370341      0.63248208332725 
  N   2.10277170126038      0.04132210337837      0.11467101328793 
  C   -2.37582879730922     -0.52053814375877     -1.78782641323640 
  O   -1.46101898064543      0.24497554741815     -1.29610585003924 
  C   -3.11450898600925      0.06644339211880     -2.96387258960770 
  C   -4.02929985388284     -0.69122830042472     -3.69234886863277 
  C   -2.89323795160488      1.38779504640400     -3.33956362463047 
  C   -4.70476365630797     -0.14058928061053     -4.76836571349237 
  H   -4.19563938467940     -1.71056298780792     -3.39723873440266 
  C   -3.57487013768014      1.94217056885130     -4.41367458322156 
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  H   -2.18860338374280      1.96971076043692     -2.77500200180587 
  C   -4.48177831719301      1.18070328920468     -5.13378625825837 
  H   -5.40618613494452     -0.74153548567637     -5.32354383684020 
  H   -3.39621849738451      2.96901671045815     -4.68697043539714 
  H   -5.00942180853932      1.60952082777139     -5.96974728801084 
  Cu  0.00545942313146      0.03655931315095     -0.03965192972256 
  Cl  -0.28504383133412      1.95596010134205      1.17118492250833 
 
 
A10.6  COORDINATES FOR OPTIMIZED L73NNN•CuIICl 
 
  C   -2.67185294410575     -3.74581222287031      2.27453108077461 
  C   -3.06931575738793     -4.00680042709489      3.57075494299466 
  H   -3.85283283661694     -3.42301690421306      4.02475060338536 
  C   -2.44696427070843     -5.02422576005257      4.29087815398733 
  H   -2.75709711908311     -5.23194717409296      5.30120386403083 
  C   -1.42813430987645     -5.76236113702235      3.71373496104396 
  H   -0.94449163867816     -6.54376649568084      4.27550935977981 
  C   -1.02642601628321     -5.49888791856164      2.40634789512476 
  H   -0.23330135470357     -6.07244219795091      1.95630174673321 
  C   -1.64935923084263     -4.49834593975350      1.68629527124923 
  C   -3.67620047050665     -3.32978927002081      0.11029168476090 
  C   -4.93438904848705     -3.22853467283452     -0.45162681167076 
  H   -5.66770831297295     -2.57033422044106     -0.01772958358513 
  C   -5.24879805049901     -3.97862314473308     -1.58212535973805 
  H   -6.22918838658975     -3.89903972405887     -2.02092519099521 
  C   -4.30597925933208     -4.82308220599138     -2.14256666248858 
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  H   -4.55227533313058     -5.40063297156872     -3.01777090162448 
  C   -3.03510616038500     -4.92350226480484     -1.58163903098343 
  H   -2.29517931073666     -5.56889437375397     -2.02497590232605 
  C   -2.72405800242955     -4.18318233648698     -0.45871876215824 
  C   -3.19733433828898     -2.63765330556285      1.37296965781113 
  H   -3.98105212788972     -2.07504395579334      1.85200522688830 
  C   -1.37881342875729     -4.12312322347919      0.24477697211078 
  H   -0.62792313081405     -4.74000932181240     -0.22437534130799 
  C   -1.88435689353236     -1.79458326295217      1.12280910524273 
  C   -1.03118645221682     -2.60090085502976      0.11739951231122 
  N   0.30838694415626     -2.08461968010786      0.25108598639121 
  N   -1.78029546455593     -0.41340313864540      0.67150373471262 
  H   -1.36075712172097     -1.85292610834637      2.07517741854809 
  H   -1.37890988953541     -2.31732238050960     -0.87382880519817 
  C   1.36228541049567     -2.59636894857824     -0.35229231815807 
  O   1.50853957696851     -3.68260724759085     -0.91832485949395 
  C   2.53962646111336     -1.63387775496380     -0.30910533605580 
  C   3.81354985730786     -2.03008832926891     -0.68427614359350 
  C   3.26036113364100      0.51485504577369      0.11645395624669 
  C   4.83704758674355     -1.10073859128611     -0.64404672622021 
  H   3.96189719260342     -3.04571688746704     -0.99932859282961 
  C   4.55970985896924      0.19511287882489     -0.23732534069413 
  H   2.97425539484856      1.49598298558185      0.45250357309007 
  H   5.83823789261706     -1.38071008537193     -0.92593362169702 
  H   5.32816923871985      0.94588790427340     -0.19266721377797 
  N   2.28240123289376     -0.38212605980402      0.07595832739248 
  C   -2.71847730778715      0.51898098152497      0.50689799815197 
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  O   -2.56871367798798      1.51898702453799     -0.19044973788906 
  C   -4.03443593177107      0.44742844671305      1.26041577357980 
  C   -5.24136554653843      0.55181179946546      0.57772811326328 
  C   -4.05237383008002      0.41938367955050      2.65065822638565 
  C   -6.44299044229318      0.58749772257501      1.26718321993916 
  C   -5.25219109321234      0.48092815102599      3.34480420258158 
  H   -3.12023946706383      0.36316250169373      3.18617000573214 
  C   -6.45308284645493      0.55366168059024      2.65513333200770 
  H   -7.37120452041003      0.65398758736066      0.72400953807077 
  H   -5.24837804999414      0.47341100328718      4.42210527636135 
  H   -7.38594719995050      0.59301863852258      3.19223464585292 
  Cu  0.21651555259459     -0.12009121619230      0.61690785022554 
  Cl  0.57798473507685      1.85486886433973      1.68666971388371 
  H   -5.22714264053895      0.61480449310846     -0.49617888216012 
 
 
A10.7   COORDINATES FOR B3(38HF)LYP OPTIMIZED L73NNO•CuII 
 
  C   -2.20003181308295     -3.58141656281122      1.72980578537622 
  C   -2.67251170659025     -3.32934361995174      3.00377026270975 
  H   -3.65591359556593     -2.91314199726360      3.14714153117363 
  C   -1.87098971763960     -3.62252535064683      4.10300206477360 
  H   -2.23843218764835     -3.43739157413717      5.09778572469613 
  C   -0.60472885349447     -4.15426671431079      3.92095403156063 
  H   0.01014429537774     -4.38120756723473      4.77502647253295 
  C   -0.12555478797295     -4.40083663195002      2.63802094037041 
  H   0.85921862355543     -4.81268939171241      2.49498406884499 
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  C   -0.92463819970519     -4.11743024259730      1.54629262543712 
  C   -2.94843043643592     -4.57526577975780     -0.37245965740370 
  C   -4.06470273752915     -5.18299709654796     -0.91404887189210 
  H   -5.03702631259909     -4.73460921049958     -0.79845355355437 
  C   -3.92333181310996     -6.37800899044153     -1.61145150210578 
  H   -4.79034393207008     -6.85805299664567     -2.03173251753519 
  C   -2.67177324850753     -6.95136003451505     -1.76889581398402 
  H   -2.56837538446065     -7.87653817592666     -2.30931737160675 
  C   -1.54664585676470     -6.33459504332720     -1.23180905092176 
  H   -0.57266114891930     -6.77667149151174     -1.35935545109566 
  C   -1.68930246370151     -5.15184006919893     -0.53090993496102 
  C   -2.90990145117784     -3.29237928857963      0.42404050890372 
  H   -3.89223274381092     -2.86194530566553      0.56900861377191 
  C   -0.57288230085670     -4.34005592152370      0.09276203433866 
  H   0.39279395308010     -4.80035695194838     -0.03644132355909 
  C   -1.99116872518845     -2.26654016195671     -0.31114534129391 
  C   -0.63105525125306     -2.96525398377875     -0.66173371988612 
  N   0.45743031916393     -2.03320732958847     -0.39268444586219 
  N   -2.65985303741974     -1.70343671898111     -1.45599565401705 
  H   -1.77193108833925     -1.49552044742968      0.42502180056979 
  H   -0.63676619703201     -3.19458136098921     -1.72334536542498 
  C   1.73964875486623     -2.37516859188164     -0.30482491546319 
  O   2.26931544120965     -3.47421997074102     -0.37510151615855 
  C   2.63921675571763     -1.16737232385632     -0.06047826351092 
  C   3.98549359402577     -1.32291769224592      0.21520771533571 
  C   2.82458726791228      1.13839920818660      0.07415845626445 
  C   4.75829236692057     -0.19740682099372      0.43401954533157 
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  H   4.38533721484551     -2.31849452626147      0.24810355662654 
  C   4.17026196068306      1.05707520385749      0.36420599559831 
  H   2.32462731462718      2.08817264814794      0.00175098668223 
  H   5.80691102448398     -0.29282059461052      0.65509180478838 
  H   4.73792988943775      1.95444641929036      0.52676516329813 
  N   2.08197747370914      0.04895001015435     -0.12963616758980 
  C   -2.38026237370951     -0.51969701087638     -1.83089173672265 
  O   -1.45887734719449      0.27194819262574     -1.29910429532263 
  C   -3.14223687384816      0.08706140518041     -2.96493622302119 
  C   -4.10197125440388     -0.65855221916302     -3.64773822626402 
  C   -2.90811808646545      1.40123975467590     -3.35825987913847 
  C   -4.80645494248210     -0.10082703218331     -4.69919236048530 
  H   -4.27923478681439     -1.67272432397950     -3.34256440711676 
  C   -3.61883922526160      1.96110733073748     -4.40929938514995 
  H   -2.17228141772684      1.98245601859803     -2.83508662686981 
  C   -4.56854236773557      1.21205950384504     -5.08402657095423 
  H   -5.54198295941802     -0.68935272415562     -5.22020137225018 
  H   -3.42922109092542      2.98029966851652     -4.69969007390780 
  H   -5.11895823834202      1.64476885602404     -5.90174351264737 
  Cu  0.17604730958700     -0.14376904246234     -0.62959785630831 
 
 
A10.8   COORDINATES FOR  L73NNN•CuII 
 
  C   -2.90318100304892     -4.04187347603220      2.19279641678500 
  C   -3.43224597195278     -4.21500019194389      3.45547496775815 
  H   -4.33047239074837     -3.69585626757540      3.74635026585597 
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  C   -2.80050152735493     -5.07225340945572      4.35371756449165 
  H   -3.21387802184112     -5.21561855231104      5.33712409383720 
  C   -1.64459487311139     -5.73714474850710      3.98487905118704 
  H   -1.15773145023167     -6.39620176274622      4.68274479983594 
  C   -1.11101586726088     -5.56349403496826      2.71018792596241 
  H   -0.21492486551599     -6.08700092463947      2.42261744005074 
  C   -1.73976663101980     -4.72237149031189      1.81376322258851 
  C   -3.66783794025881     -3.96824659412816     -0.10932323330323 
  C   -4.85066999411354     -4.05839146980725     -0.81560233252799 
  H   -5.69268093792478     -3.44268697291398     -0.54638598721093 
  C   -4.95294883793043     -4.95566383313711     -1.87561062147900 
  H   -5.87494413320613     -5.03078410799399     -2.42577521292581 
  C   -3.87499669398461     -5.75218373650055     -2.21956779631602 
  H   -3.95906603840380     -6.44660912599990     -3.03764224164616 
  C   -2.67773412637193     -5.65736455624890     -1.51402774648951 
  H   -1.83532892866394     -6.26826261087565     -1.79137604796745 
  C   -2.57726148631347     -4.77116309201715     -0.46135775574593 
  C   -3.41731083907104     -3.10064990339184      1.11016042281603 
  H   -4.30212046811460     -2.56017773124244      1.41502948388522 
  C   -1.33511692554216     -4.48224757634928      0.37126910851063 
  H   -0.47650928065942     -5.06131454805896      0.06678262997375 
  C   -2.16838673712002     -2.16765167506992      0.91485047812034 
  C   -1.13548443761153     -2.95786258611577      0.08145676006216 
  N   0.11995411109486     -2.23676257039328      0.21655665056979 
  N   -2.17161671907831     -0.84510807693456      0.30499775616023 
  H   -1.74230760277207     -2.05447263764764      1.90822936158648 
  H   -1.43469032156489     -2.83867945125013     -0.95722037027923 
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  C   1.30645248003891     -2.61868450782261     -0.22937550736211 
  O   1.72481266768451     -3.72826392233376     -0.52904493366089 
  C   2.24389625581416     -1.41375432032406     -0.36970737814576 
  C   3.60280590063494     -1.58662884526604     -0.56153422258532 
  C   2.46830251578818      0.88739894169005     -0.50034493605655 
  C   4.40784362560222     -0.47182062664978     -0.71226648727216 
  H   3.98923080997298     -2.58783529342751     -0.59284793896670 
  C   3.83374457711137      0.78951945906383     -0.68142874387569 
  H   1.97303513488029      1.84229239152896     -0.47701023952611 
  H   5.46862260681872     -0.58239008953801     -0.85547390655256 
  H   4.42438410191922      1.67936605971361     -0.79856615456059 
  N   1.69588131192471     -0.18648062121858     -0.34647240344066 
  C   -2.46551583024016      0.37461579828894      0.71092455436005 
  O   -1.64509702377751      1.26904750227492      0.32015253843435 
  C   -3.63949027180550      0.80332462945583      1.51922278543182 
  C   -4.24460638875893      2.02169045903534      1.21638377685715 
  C   -4.12070145052607      0.05395995676199      2.58754968631844 
  C   -5.33248012092667      2.46313910631366      1.94820962829467 
  C   -5.19359008117886      0.51114862682058      3.33656885915325 
  H   -3.64610175919175     -0.86991844350673      2.85876148343815 
  C   -5.80839268776599      1.70969518715661      3.01187870375128 
  H   -5.80297358826453      3.39752926907079      1.69617701802922 
  H   -5.54643989461316     -0.06796325241184      4.17204157937704 
  H   -6.64799805141629      2.05833567634167      3.58782336868797 
  Cu  -0.31170000498584     -0.35176161313300     -0.03318021507640 
  H   -3.85339977604248      2.61130699768284      0.40774012180214 
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A10.9   COORDINATES FOR  L73NNO•CuICl 
 
  C   -2.28511132202420      3.73106744047687     -2.57793739170622 
  C   -2.39692691199541      3.66956531834250     -3.95412848911881 
  H   -3.24045965866246      3.17254451525446     -4.40571339663531 
  C   -1.40898721629852      4.23588797086717     -4.75494130483988 
  H   -1.49100725985927      4.18172274331999     -5.82837663154526 
  C   -0.31180894655980      4.84954839097590     -4.17322248951257 
  H   0.46103117168344      5.27208352875719     -4.79463299835095 
  C   -0.19516284237603      4.90578496221842     -2.78728505753373 
  H   0.66652382536033      5.36718290382750     -2.33373700537810 
  C   -1.18072705865316      4.35409621774475     -1.98997316704677 
  C   -3.64181048810671      4.25668757882339     -0.63363748124919 
  C   -4.92884619416002      4.64443446107470     -0.31192066909744 
  H   -5.76966693672577      4.11839391695666     -0.73355170857326 
  C   -5.13525635856397      5.70053981303235      0.57183479645403 
  H   -6.13946180915865      5.99967616047978      0.82643029490338 
  C   -4.05269867748719      6.35618381183642      1.13635467082542 
  H   -4.21394358381062      7.16697410881638      1.82871961929167 
  C   -2.75528380363397      5.96148103241855      0.82020028897557 
  H   -1.91079228883584      6.45426827078866      1.27347160847765 
  C   -2.54947094691458      4.92097937610948     -0.06716610830456 
  C   -3.23185645117395      3.13865241610797     -1.56168527552451 
  H   -4.08230398263132      2.64656539081825     -2.01729226841549 
  C   -1.21941910157753      4.33904710162747     -0.48211065865156 
  H   -0.38322307078077      4.84857203936841     -0.02799636658566 
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  C   -2.39370870058853      2.08821872551069     -0.74641813212193 
  C   -1.25945112942135      2.83767818776711      0.01872406193722 
  N   0.01500638741678      2.15065459183480     -0.08090034336732 
  N   -3.27681420874644      1.32783691980640      0.10086755185853 
  H   -1.91027542744034      1.45109961033817     -1.48582206058455 
  H   -1.55328518483392      2.89618175828730      1.06339200362918 
  C   0.95392335767021      2.58855299680780      0.72636464783328 
  O   0.93395899351823      3.57120729499236      1.50449865728361 
  C   2.25115138398183      1.79396718571410      0.69061630121334 
  C   3.42404954900810      2.35948179761651      1.19388496325031 
  C   3.36438276901313     -0.13171730250597      0.12405218221461 
  C   4.59574584885197      1.63047914461443      1.14054027045911 
  H   3.37457880233114      3.34742162456042      1.61168644211115 
  C   4.57448939446976      0.35523835994555      0.59030640829246 
  H   3.28078382634560     -1.10503614531384     -0.33291432186937 
  H   5.51682508050836      2.04839035382704      1.51620780394193 
  H   5.46674700972483     -0.24455596503711      0.52253403092397 
  N   2.24025391919386      0.56636459832514      0.18551794967972 
  C   -2.89965438935129      0.10702992770664      0.36895968012663 
  O   -1.86032909766683     -0.51206883511571      0.02163431313980 
  C   -3.88911486631854     -0.68208902430769      1.22013658562349 
  C   -5.04574157311707     -0.11013407031261      1.74807891120075 
  C   -3.63828064635801     -2.02527801700893      1.48725876501040 
  C   -5.92441037403382     -0.85859555559479      2.51626235739870 
  H   -5.22975544939440      0.92817094607774      1.54057159359127 
  C   -4.51826705324332     -2.77937030975318      2.25169333677175 
  H   -2.74011544158371     -2.45206456926334      1.07822263013634 
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  C   -5.66682038853332     -2.20031734969847      2.77177835993231 
  H   -6.81234921532667     -0.39590496061548      2.91885286465497 
  H   -4.30593203390408     -3.81966999387641      2.44360443499005 
  H   -6.35070177591196     -2.78320671101246      3.36880078122371 
  Cu  0.15965166358524      0.21642433159637     -0.97694695047009 
  Cl  0.98588480910045     -1.29740452595581     -2.55736746487380 
 
 
A10.10   COORDINATES FOR OPTIMIZED L73NNN•CuICl 
 
  C   -2.89027943273917     -3.65764678352983      1.86190462355790 
  C   -3.27799145774849     -3.79508533198864      3.18229823475140 
  H   -4.18892765309442     -3.33391757112034      3.52722822055543 
  C   -2.47922933921401     -4.51290739052547      4.06731572347038 
  H   -2.77566837429579     -4.61014886407740      5.09896586236411 
  C   -1.29386290465066     -5.08112637001851      3.63074741711613 
  H   -0.66809950980957     -5.62135632777768      4.32240954914178 
  C   -0.89612628217139     -4.93316689910695      2.30510643008433 
  H   0.03652196405351     -5.35616916874674      1.96884037372430 
  C   -1.69097200752835     -4.22545802379161      1.42308754192795 
  C   -3.81022994367113     -3.83763329000184     -0.37885132925086 
  C   -4.99902928356614     -4.13285956396533     -1.01925791707625 
  H   -5.91200969855846     -3.65487059521556     -0.70537109975801 
  C   -5.00898163291902     -5.02880964726112     -2.08416723669392 
  H   -5.93583381105901     -5.25312413734126     -2.58733670427332 
  C   -3.82906712296715     -5.61709318072916     -2.51102589133925 
  H   -3.83750389662130     -6.30220927411718     -3.34368262503297 
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  C   -2.62868375229376     -5.31105125883293     -1.87561282341467 
  H   -1.70470917277514     -5.74726456355136     -2.21912653798744 
  C   -2.62099725731705     -4.42976441581986     -0.81062234060020 
  C   -3.61185708091566     -2.89388339286628      0.78047801500128 
  H   -4.54183101686132     -2.46375684996518      1.12852882632215 
  C   -1.41308490146772     -3.96032160785722     -0.03628412132904 
  H   -0.49848736153647     -4.41963188369138     -0.38422830753224 
  C   -2.63581868694982     -1.72947842923079      0.30408612608387 
  C   -1.34219897894930     -2.39970077274101     -0.25663709032529 
  N   -0.09460776849807     -1.84535694560422      0.27225071593212 
  N   -3.24618054035965     -0.90693751227617     -0.70247647194598 
  H   -2.36150731329199     -1.20618482306832      1.21824228043870 
  H   -1.36165049698173     -2.24684781703526     -1.32715678262604 
  C   0.95515494757272     -2.06133282952991     -0.50095010669386 
  O   1.01148991021516     -2.70111273589372     -1.56807031228103 
  C   2.27609101672677     -1.45164069034885     -0.03806577092779 
  C   3.39993616919129     -1.55894733184259     -0.85890534632165 
  C   3.48243905794942     -0.30062999858052      1.54149810766304 
  C   4.59175172552359     -1.00228643659773     -0.43857192786997 
  H   3.29648376656803     -2.07281685289083     -1.79536544590811 
  C   4.64389635975096     -0.35669229489746      0.78985332017502 
  H   3.45367230949712      0.18522951235672      2.50444874215599 
  H   5.47219298006359     -1.06826029927680     -1.05793358217433 
  H   5.55363709267580      0.08975021709485      1.15419207052752 
  N   2.34033124073953     -0.83179571972908      1.13285904999391 
  C   -4.03969376216117      0.09568561176922     -0.42166943647970 
  O   -4.66125077508372      0.77815621611317     -1.26881390648136 
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  C   -4.32477978188978      0.54931625757369      1.01615222449665 
  C   -5.64284735665062      0.53466072663341      1.47582660641364 
  C   -3.34796307349947      1.05601382518796      1.86835494687795 
  C   -5.96918496128681      0.98782207033849      2.74342785091478 
  C   -3.66819670620413      1.51942779827209      3.13813199129166 
  H   -2.32230035133471      1.08391454719673      1.54646263703077 
  C   -4.97983929504762      1.48435425494733      3.58446425606429 
  H   -6.99553593821708      0.95773863527934      3.07680179545669 
  H   -2.88079243365650      1.87759776263851      3.77943421089528 
  H   -5.22842341816728      1.83215998899678      4.57454334160896 
  Cu  0.13942063367543     -0.92049698419207      2.03744876013629 
  Cl  0.25952373276251      0.08526378649440      4.03135416966742 
  H   -6.41316952095481      0.18132332874144      0.81138889848157 
 
 
A10.11  COORDINATES FOR OPTIMIZED L73NNO•CuI 
 
  C   -2.26607830177772      3.84840594541677     -2.51485661046162 
  C   -2.35205781243868      3.77737367032772     -3.89245368058958 
  H   -3.16580365084757      3.24482179143088     -4.35743927888943 
  C   -1.38021203258064      4.39160823379520     -4.67756412355062 
  H   -1.44681000296832      4.34015970097817     -5.75166342357540 
  C   -0.32617337505139      5.06285475590569     -4.07969657086398 
  H   0.42803400581208      5.53207527104171     -4.68944294251359 
  C   -0.23587257876524      5.12995228593644     -2.69230663346010 
  H   0.58834896324131      5.64310773149735     -2.22560605543039 
  C   -1.20572248530227      4.52947860672319     -1.91148172155414 
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  C   -3.68091073040540      4.29309588898663     -0.58435777470112 
  C   -4.99284712777604      4.60585405260877     -0.28370168613419 
  H   -5.79683446376194      4.03672048001798     -0.72021023158543 
  C   -5.27047122295612      5.65062621111583      0.59282130640122 
  H   -6.29277697263455      5.89526378309787      0.82902799480762 
  C   -4.23560851288812      6.37018792114708      1.16809115644150 
  H   -4.45328777718457      7.17548387183302      1.84990113366513 
  C   -2.91354145351555      6.05120896371530      0.87200449559254 
  H   -2.10698099735127      6.60097713072602      1.32833313514942 
  C   -2.63743225585573      5.01952760656335     -0.00595586106725 
  C   -3.19728963456280      3.20367888432414     -1.51221406466061 
  H   -4.01212219548290      2.66852646577478     -1.98375751929999 
  C   -1.26754121740357      4.51634986531738     -0.40238827657162 
  H   -0.46600209460068      5.07418616947586      0.05764624026166 
  C   -2.30041911825567      2.20360602870315     -0.70417328808121 
  C   -1.23242543768345      3.02278213725117      0.09445617918861 
  N   0.04022974983659      2.34760549116649     -0.00726197661616 
  N   -3.12197020020294      1.34345598913872      0.11114655201166 
  H   -1.75235914247502      1.63163591052737     -1.44879713389807 
  H   -1.54446531272270      3.05227777366298      1.13683401322458 
  C   1.11809359878266      2.81716523192603      0.56340325437011 
  O   1.33880662777686      3.88624888477986      1.15922931277800 
  C   2.29582952822734      1.84163422447313      0.44744082857580 
  C   3.58328406048176      2.28273521302633      0.73376585089207 
  C   3.08570843499959     -0.27738258591983      0.00457186225753 
  C   4.64248234669974      1.40374266856188      0.63054743459315 
  H   3.70422466693801      3.30619642717129      1.03414899225863 
Appendix 10 – Coordinates for Optimized Geometries Relevant to Chapter 4 614 
  C   4.39315394301642      0.09166455890008      0.25559529931168 
  H   2.84247619421291     -1.28812695787111     -0.27530316677604 
  H   5.64728659000912      1.73025702188774      0.84088658041859 
  H   5.18486100411556     -0.63089110587110      0.16624604778192 
  N   2.06222525216131      0.56976329430659      0.09491174681475 
  C   -2.79190302280291      0.10656241240133      0.26427112424038 
  O   -1.75470917442183     -0.53404229036675     -0.16543830676096 
  C   -3.77068589427325     -0.74239704346286      1.04663017742525 
  C   -4.92337851112514     -0.19695462211894      1.60965526410857 
  C   -3.52927991845903     -2.10210054851298      1.22029102021348 
  C   -5.80722351112708     -0.98896337186852      2.32325014992627 
  H   -5.10336987405111      0.85354944365655      1.47629211212505 
  C   -4.41660151748437     -2.89874916330598      1.93068945899396 
  H   -2.63788279175477     -2.51872836832637      0.78950683064733 
  C   -5.55949843413810     -2.34613742420694      2.48652335685437 
  H   -6.69122562807580     -0.54802276682174      2.75424585232823 
  H   -4.21265846673506     -3.95021323666061      2.05200525238463 
  H   -6.24802818782155     -2.96214805315068      3.04130775846618 
  Cu  0.02558085140960      0.25081057916660     -0.18507209546837 
 
 
A10.12   COORDINATES FOR OPTIMIZED L73NNN•CuI 
 
  C   -2.90781129124592     -3.68046865675812      2.13164834635104 
  C   -3.46035747886549     -3.82065378319546      3.38984152479710 
  H   -4.27745436770137     -3.18815854855292      3.69462714512012 
  C   -2.94985087797712     -4.77635431742260      4.26541256348064 
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  H   -3.38141027011127     -4.88916859673130      5.24608626475853 
  C   -1.88718271262363     -5.57582522469807      3.87980291619148 
  H   -1.49039839919948     -6.30989656857782      4.56124261548890 
  C   -1.32982625116660     -5.43476800885337      2.61144811426673 
  H   -0.50264613123690     -6.05638808194214      2.31085060144345 
  C   -1.84070588466859     -4.49472782702951      1.73686569660659 
  C   -3.62631387091864     -3.43629787997717     -0.17193905515669 
  C   -4.79552260478670     -3.35342687986923     -0.90377195027406 
  H   -5.56363751274495     -2.65449244304425     -0.61693963154380 
  C   -4.97700358320674     -4.17489637845732     -2.01355959189677 
  H   -5.88815317801540     -4.11058089052533     -2.58461685225351 
  C   -3.98832493733641     -5.07033753415306     -2.38490531219769 
  H   -4.12970406139996     -5.70238114862981     -3.24579905701514 
  C   -2.80588653768993     -5.15120968815544     -1.65352534211520 
  H   -2.02750420447906     -5.83301311067909     -1.95315690561643 
  C   -2.62851631577805     -4.34129599935583     -0.54908949140439 
  C   -3.29501325645231     -2.65334646886807      1.08142256983360 
  H   -4.12447084248195     -2.04688873137428      1.40600722094273 
  C   -1.38967270098707     -4.24064621559159      0.31770897504466 
  H   -0.59479146686010     -4.89690781516964     -0.00621144266850 
  C   -1.95371407971483     -1.82710957778720      0.91605120623941 
  C   -0.97195483384726     -2.73600791447806      0.12600287452467 
  N   0.36195944831228     -2.28574355522053      0.41584244325957 
  N   -1.89407443279824     -0.49498034100695      0.31203484701908 
  H   -1.54716107908181     -1.76324214929581      1.92346562280588 
  H   -1.16030606218252     -2.54403857936095     -0.92956458229663 
  C   1.36407780174846     -2.63751474885840     -0.34690762686901 
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  O   1.53840160926782     -3.60217243784438     -1.10945226856254 
  C   2.47815693927773     -1.58459803152473     -0.31865720008314 
  C   3.81536017185770     -1.94177274375556     -0.44468708212917 
  C   3.04494803615624      0.65242577966787     -0.30517768723389 
  C   4.78385163386447     -0.95928812732132     -0.46415229144450 
  H   4.05532762476149     -2.98497944611403     -0.53309425981839 
  C   4.39375112772911      0.37099922389786     -0.39307014220096 
  H   2.69401822844662      1.66957514012908     -0.27208312200388 
  H   5.82652302714565     -1.21902459896298     -0.54060853851793 
  H   5.11169272791813      1.17139319063058     -0.41632018437782 
  N   2.10748555917640     -0.29438288993679     -0.26031436273015 
  C   -2.69938534261749      0.53290964760177      0.54081627432254 
  O   -2.54787429567852      1.64877670388144      0.02462768426344 
  C   -3.88363870891324      0.45147874366222      1.48884965059238 
  C   -5.17238068873012      0.66827855644842      1.00893602975712 
  C   -3.70460995718364      0.28538872333586      2.85770078614459 
  C   -6.25705324149071      0.68531391095161      1.87011196431455 
  C   -4.78673272079972      0.32465593510361      3.72604441478805 
  H   -2.71414431579864      0.12571355352052      3.24753035146751 
  C   -6.06897331945761      0.51560378304089      3.23562744782018 
  H   -7.24907500265285      0.84062753581404      1.47899902234991 
  H   -4.62669551863065      0.20225096264092      4.78448593509709 
  H   -6.91068593675811      0.53681644206987      3.90731135536042 
  Cu  0.05382852343182     -0.14354025469507     -0.01337905713486 
  H   -5.31361006582430      0.83208917237764     -0.04513933590688 
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A10.13   COORDINATES FOR  Relaxed L732- 
 
  C   -1.50980226084915     -3.62116911105623      2.72615860314258 
  C   -1.68340799356656     -3.35860169562684      4.07323134827566 
  H   -2.59483981702770     -2.89582078173036      4.41589570582876 
  C   -0.67460272951149     -3.67842775539011      4.97826380108572 
  H   -0.80887890248065     -3.47176667409105      6.02843777746346 
  C   0.50615731833735     -4.24796831889832      4.52847145142283 
  H   1.29320272857669     -4.48162267860238      5.22792426735532 
  C   0.68669722033739     -4.50121342513615      3.17134393436695 
  H   1.61434478656440     -4.91963513040380      2.81674460300411 
  C   -0.31759423511593     -4.19425697240955      2.27206048157501 
  C   -2.70156566335182     -4.58789816231023      0.84738635268309 
  C   -3.91766838169115     -5.17282443811878      0.54584575846410 
  H   -4.83244588091537     -4.70326056560895      0.86848478893298 
  C   -3.95820982278705     -6.35366684773445     -0.19122442266858 
  H   -4.90795562694109     -6.80556946444191     -0.43014987186307 
  C   -2.78148982925926     -6.93835136380692     -0.63216536929142 
  H   -2.81433403966444     -7.84727986952626     -1.21215658252973 
  C   -1.55577679165536     -6.34613404076767     -0.33785773842845 
  H   -0.63938107398957     -6.78643853051787     -0.69659752740514 
  C   -1.51383810284546     -5.17956003763884      0.40443987255748 
  C   -2.47781918369340     -3.30887238560186      1.61442782916270 
  H   -3.39401883773722     -2.85918950452032      1.96935068259883 
  C   -0.28538345053009     -4.38980303622759      0.77679664141039 
  H   0.62898944866872     -4.84780259174546      0.42676330454808 
  C   -1.73914522626712     -2.28860317440128      0.64874203888385 
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  C   -0.44890857328055     -2.96687850633627      0.09548401043282 
  N   0.72920556642948     -2.15321921208103      0.29823579186393 
  N   -2.61190882184876     -1.84170064435282     -0.41271153494271 
  H   -1.43091139768558     -1.45903658966913      1.27942782633752 
  H   -0.60922271938651     -3.16705888891441     -0.96086661376087 
  C   1.75959584368178     -2.46914083420471     -0.42755916220803 
  O   1.92057331092540     -3.39500780489706     -1.27345384596586 
  C   2.97079546861827     -1.54876963249551     -0.26513410139782 
  C   3.86403878420004     -1.45870114093756     -1.34356549190996 
  C   4.27070786604539     -0.10161446457716      0.94302848545016 
  C   4.96893118827598     -0.63980154186559     -1.25597108824262 
  H   3.65092338169721     -2.05001610006941     -2.21395593853973 
  C   5.19008931231989      0.06455297620416     -0.07864517959414 
  H   4.41027948854706      0.41788458259362      1.88207479459363 
  H   5.65275565563666     -0.55037331279288     -2.08629436119444 
  H   6.04202779533599      0.71281006179979      0.04598876149418 
  N   3.19357471421462     -0.87111089682644      0.86235775416589 
  C   -3.56813982398621     -1.02036339169791     -0.07138394523836 
  O   -3.88291616298300     -0.56480491561861      1.06007486553971 
  C   -4.43227795829112     -0.56017595905553     -1.24635941704756 
  C   -4.20528533029771     -0.98435972663075     -2.55558137309629 
  C   -5.48918755058185      0.31696887307395     -1.01666631786900 
  C   -5.00829167357217     -0.54539041526907     -3.59691360457047 
  H   -3.38646937086661     -1.66017318741823     -2.72330818578493 
  C   -6.29587989103031      0.76037098089488     -2.05670395926556 
  H   -5.65164591230094      0.63674086353243     -0.00258438488795 
  C   -6.06052465872253      0.33105903039748     -3.35482759008372 
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  H   -4.81384611131610     -0.88559736658161     -4.60243093631265 
  H   -7.10852515135652      1.44178532949650     -1.85442854067287 
  H   -6.68425261702601      0.67323531461210     -4.16612444786781 
 
 
A10.14   COORDINATES FOR  OPTIMIZED L73NNO•CuICl2 
 
  C   -1.88649399072427     -4.53976587870486      2.72782702458312 
  C   -0.48502919218565     -4.96273143383004      2.29651665997950 
  C   -2.60957767751661     -3.83892335299510      1.58055982065353 
  H   -3.58686011847290     -3.48675161120067      1.90305806781028 
  C   0.28976427158957     -3.77235621100259      1.73538735644610 
  H   1.26968359034699     -4.08962189454434      1.39906726459391 
  C   -1.84233868045315     -2.64064507693845      0.99367500047383 
  C   -0.42922470969714     -3.07470977893471      0.55858215990898 
  N   0.38526453982909     -1.95020106834930      0.10681484430566 
  N   -2.65520472354931     -2.11624193856780     -0.08479163398959 
  H   -1.71582830179127     -1.89204001542938      1.77830956690188 
  H   -0.53451455147409     -3.79687133952208     -0.25273293351979 
  C   1.51524845379303     -2.26617867092129     -0.49021403928215 
  O   1.93239589309772     -3.37945538892417     -0.86185988470177 
  C   2.45570217672732     -1.08760735333184     -0.65005818896021 
  C   3.73530007896181     -1.25254046842614     -1.16927483846763 
  C   2.84654520408443      1.14245305295259     -0.22293690936261 
  C   4.58521739725218     -0.16464431524358     -1.19375216366386 
  H   4.01813164360290     -2.22644198901454     -1.52131203435920 
  C   4.14105189590896      1.05483861916263     -0.70169472022958 
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  H   2.42627709034077      2.05689723007802      0.15012019239676 
  H   5.58531039457651     -0.26229344136905     -1.58609690994936 
  H   4.77492842567471      1.92433018057947     -0.69857243628480 
  N   2.03970466333009      0.09065491166226     -0.20401763430390 
  C   -2.63949209190348     -0.84368653704707     -0.27413716383796 
  O   -1.92762930555714      0.04377885271604      0.32629898886650 
  C   -3.62396557968075     -0.30519946887745     -1.28944853028947 
  C   -4.66017203078304     -1.09359718917730     -1.78784907790013 
  C   -3.51437470703289      1.01109161178586     -1.72939339011029 
  C   -5.57120124940920     -0.57933678354885     -2.69656113473524 
  H   -4.72813359538719     -2.11105213764763     -1.44794437447946 
  C   -4.42406966182256      1.52388305977081     -2.64482815089316 
  H   -2.69487219185000      1.60709594915265     -1.36959751293908 
  C   -5.45847652661991      0.73680000423998     -3.12857076686367 
  H   -6.36918996640720     -1.20323485507527     -3.06893287170665 
  H   -4.31490741111953      2.54130716570057     -2.98448676374390 
  H   -6.16488115798038      1.13909367321711     -3.83820252523004 
  Cu  0.01909162342559      0.13210409542787      0.29598271739894 
  Cl  0.53003247806746      1.12867232642933      2.53340096521830 
  Cl  -0.02448529228963      2.04531022952820     -1.48380698797233 
  H   -2.79105969100433     -4.54963642477851      0.77417492347649 
  H   -1.80747696782295     -3.86155059313215      3.57779979579056 
  H   -2.46355384808443     -5.40171293652907      3.06841272461078 
  H   0.05822973811298     -5.40233740540651      3.13442247193106 
  H   -0.56184481854012     -5.73958788732545      1.53407610626102 
  H   0.43746562043702     -3.03186067960819      2.51976273816863 
 
Appendix 10 – Coordinates for Optimized Geometries Relevant to Chapter 4 621 
A10.15   COORDINATES FOR L73NNN•CuICl2 
 
  C   -3.76732416474454     -3.71903771504974      0.26022618571144 
  C   -2.61658187688120     -4.60644859180410     -0.21469754664906 
  C   -3.60694782979964     -2.26678821888084     -0.20264441539727 
  H   -3.68277482667684     -2.20866762798681     -1.28895220465478 
  C   -1.25178465110627     -3.99904447860014      0.11835164743162 
  H   -0.45521570109036     -4.59890565448462     -0.30195208161755 
  C   -2.24629530223693     -1.68543165988688      0.22370912199325 
  C   -1.15022211164922     -2.56431298082626     -0.42163233272824 
  N   0.12440223323475     -1.92014578193149     -0.21116236530148 
  N   -2.00785683649429     -0.29943004248951     -0.17598668695174 
  H   -2.14736952632392     -1.81768815136154      1.30398632767587 
  H   -1.35072310877546     -2.59844951674723     -1.49810335255874 
  C   1.25843510044054     -2.45977826095302     -0.58182027903736 
  O   1.49655260402214     -3.55353998939383     -1.12906104098198 
  C   2.43565505057576     -1.55751825805794     -0.25857075520056 
  C   3.74568142010302     -2.00890648370203     -0.36671023945065 
  C   3.13638402600041      0.51626879222276      0.44952541240640 
  C   4.77312179065858     -1.14665601501045     -0.03423661219095 
  H   3.91210916797015     -3.01476357909475     -0.70409995785489 
  C   4.46800484807159      0.14010710363604      0.38526213113985 
  H   2.82148223420132      1.50254831046559      0.74113575364067 
  H   5.80011290818702     -1.47022894561147     -0.09977294786994 
  H   5.23938764713039      0.84061850816170      0.65512144005093 
  N   2.15802636391888     -0.31856077442172      0.13407174997778 
  C   -2.93457666107770      0.65516082596400      0.03051920320034 
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  O   -3.05064817024354      1.67270765378880     -0.64519364060163 
  C   -3.91311500159120      0.56516838045517      1.20506844334957 
  C   -5.25526814690576      0.88225535682735      1.00759587024009 
  C   -3.47209468875868      0.29096002472273      2.49647125204633 
  C   -6.15091949888211      0.88833498947134      2.06444857576535 
  C   -4.36595059422270      0.32208866027987      3.56034788757997 
  H   -2.42833930157959      0.08359970908513      2.67648919329414 
  C   -5.70678210522904      0.60731598007666      3.35111906140889 
  H   -7.18958757288823      1.12373624523693      1.89010999598464 
  H   -4.00294410746271      0.12442947695904      4.55588016078229 
  H   -6.39750745430310      0.62123993196946      4.17977189907866 
  Cu  0.00288195582255      0.04525948537972      0.20110302065726 
  Cl  0.14067032411241     -0.22517690517628      2.97018365237010 
  Cl  0.38576165541683      2.33076864844883     -0.18709649686925 
  H   -5.58112081369467      1.13616600092855      0.01343965998913 
  H   -2.68994898598036     -4.73757389770071     -1.29547683260359 
  H   -4.72164391333099     -4.11899551253384     -0.08651717263661 
  H   -1.10631027618951     -3.97387418479918      1.19735172142107 
  H   -2.70362062989036     -5.60241578674092      0.22224302342695 
  H   -4.42149746723664     -1.67783298496365      0.19921720503885 








Palladium-Catalyzed  Enantioselective Vinylation  




A11.1   INTRODUCTION AND BACKGROUND 
 
Nitrogen heterocycles are ubiquitous structural motifs that can be found across all areas and 
applications of organic chemistry.  A particularly important subgroup of these compounds are the 
pyrrolidinones along with their saturated counterparts the pyrrolidines, with both occuring widely 
in nature,1,2 possessing a wide range of biological and pharmacological properties,3 and finding 
use in functional materials4 and catalysis.5  For these reasons, the development of enantioselective 
approaches to functionalized five-membered nitrogen-containing heterocycles is a topic of great 
interest for the synthesis of natural products and other small molecules.   
 
 Our group has a long-standing interest in the stereoselective synthesis of five-membered 
N-heterocyclic building blocks, having developed methods for both enantioselective allylic 
alkylation,6 enantioselective a-acylation,7  and more recently, a-arylation of g-lactams.8 In our a-
 
† This research was performed in collaboration with visiting graduate student Shunya Sakurai.  This  research has 
been published and adapted with permission from Jette, C. I. Geibel, I.; Bachman, S.; Hayashi, M.; Sakurai, S.; 
Shimizu, H.; Morgan, J. B.; Stoltz, B. M.  Angew. Chem. Int. Ed. 2019, 58, 4297–4301. Copyright 2019 Wiley-VCH. 
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arylation protocol, a-quaternary g-lactams can be smoothly afforded from the corresponding aryl 
bromides or chlorides in the presence of a Pd catalyst (Figure A11.1.1.A). Given the importance 
of  b-g-unsaturated carbonyls in bioactive compounds,9 as well as the diversity of methods in the 
literature for alkene functionalization, we envisioned that the extension of our a-arylation method 
to also include vinyl electrophiles would be of great synthetic value.   
Although there are numerous reports on the a-vinylation of carbonyl derivatives such as 
ketones, esters, and nitriles,10 there are few reports on the synthesis of vinyl g-lactams, and to our 
knowledge, no reports on the enantioselective variant. One strategy for the synthesis of these 
Figure A11.1.1. a-Arylation of Lactams and Previously Reported Methods for the 
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compounds is the Pd-catalyzed decarboxylative carbonylation approach, which converts cyclic 
carbamates to the corresponding unsubstituted a-vinyl lactams (Figure A11.1.1.B).11  To our 
knowledge, there is only one report of a direct a-vinylation approach of a cyclic amide, however 
the scope of this reaction is limited to oxindoles (Figure A11.1.1.C).12  Given the large pKa 
difference between g-lactams and oxindoles, it is unsurprising that these scaffolds should exhibit 
significant differences in their reactivity profiles. One critical challenge in the development of 
enantioselective a-vinylation of g-lactams is that as a result of their enolates’ high reactivity, direct 
a-vinylation (via addition/elimination) may occur in the absence of a Pd catalyst. Uncatalyzed 
direct vinylation may be detrimental to the selectivity of the reaction, resulting in significant 
challenges associated with retention of olefin geometry and generation of enantioenriched product.  
In order to circumvent these challenges, a Pd-catalyst that generates the desired a-vinyl product 
significantly faster than the unwanted background reaction will have to be identified. Herein, we 
Table A11.2.1 Initial Hit and Temperature Screen with 2-Chloropropenea 
 
 
[a] Conditions: See Section A11.6, 0.1 mmol scale. [b] Yields determined by 1HNMR analysis of the crude reaction 
mixture using 1,3,5–trimethoxybenzene as a standard. [c] Determined by chiral SFC analysis of the isolated product. 









L10 ( 7.5 mol%)
LiHMDS (1.5 equiv)







1.5 equiv 1.0 equiv
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report our progress toward the development of an enantioselective a-vinylation of g-lactams 
(Figure A11.1.1.D). 
  
A11.2   PRELIMINARY INVESTIGATIONS 
We first exposed 2-chloropropene (100a) to PMP-lactam 30a using our optimized 
conditions for the enantioselective a-arylation (Table A11.2.1). At 80 °C, we obtained the product 
in  23% yield and 82% ee (entry 1). Interestingly, we noted that although in the arylation conditions 
higher temperatures are required for efficient product formation, in this case the yields increase 
slightly at lower temperatures. At 50 °C, we obtained the product in 47% yield and a slightly higher 
86% ee (entry 3). As the temperature is lowered even further, however, a drop in yield is observed, 
and at 23 °C, no product is formed (entries 4 and 5). 
 Using our previously developed conditions for the a-arylation of g-lactams using aryl 
bromides, we examined the analogous 2-bromopropene in our reaction conditions. At 80 °C, we 
found that only a trace amount of product was formed (entry 1, Table A11.2.2). When the reaction 




[a] Conditions: See Section A11.6, 0.1 mmol scale. [b] Yields determined by 1HNMR analysis of the crude reaction 
mixture using 1,3,5–trimethoxybenzene as a standard. [c] Determined by chiral SFC analysis of the isolated 









L10 ( 7.5 mol%)
NaHMDS (1.5 equiv)







1.5 equiv 1.0 equiv
30a 102a 101aa
*

















627 Appendix 11- Palladium-Catalyzed Enantioselective Vinylation of g-Lactams and g-Butyrolactones 
 
 
temperature is lowered to 23 °C,  the desired product is formed in 20% yield. Given the greater 
amount of reactivity observed with 2-chloropropene, we chose to move ahead with these 
conditions.   
A11.3   REACTION OPTIMIZATION 
During the course of optimization we noted that an alternative Pd source, Pd2(dba)3 resulted 
in higher enantioselectivity, and that the lactam nucleophile could be used as the limiting reagent 
without leading to a significant change in reaction outcome (Table A11.3.1). Given that the vinyl 
chloride is the least precious of the two coupling partners, we chose to switch to conditions in 
which the electrophile is used in excess. We also noted that the boiling point of 2-chloropropene 
is 30 °C, which we believed could be affecting the reaction consistency, as this was leading to 
significant challenges in the accurate weighing of this reagent. For this reason, we switched the 
electrophile to isocrotyl chloride which we found to be significantly less reactive, and only a small 
Table A11.3.1. Temperature Screen with Isocrotyl Chloridea 
 
[a] Conditions: See Section A11.6, 0.1 mmol scale. [b] Yields determined by 1HNMR analysis of the crude reaction mixture 
using 1,3,5–trimethoxybenzene as a standard. [c] Determined by chiral SFC analysis of the isolated product. PMP = p-






Pd2(dba)3 (2.5 mol %)
L10 (7.5 mol %)
LiHMDS (1.0 equiv)






1.0 equiv 1.5 equiv
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amount of product was observed at all temperatures up to 80 °C after 15 h (Table A11.3.1, entries 
1-4). However, if the reaction time is extended to 24 h, the product is obtained in 43% yield and 
93% ee at 80 °C (entry 5). The higher temperature required could be due either to a slower 
transmetalation to the more sterically hindered Pd(II)-vinyl complex, or a slower O– to C–bound 
enolate isomerization (see Figure 2.2.1 for plausible mechanism).  Nevertheless, we were pleased 
to see product formation using isocrotyl chloride under slightly modified conditions, and chose to 
continue the optimization with this electrophile.   
 The importance of the lactam protecting group on  the reaction outcome was also examined 
(Table A11.3.2), and it was noted that the p-methoxyphenyl N-protecting group (30a, Table 
A11.3.1, entry 5) was optimal; switching to a bulkier aryl group (101bb), or altering the electronics 
(101db and 101eb) resulted in significant drops in reactivity.  
We next turned our attention to the Pd source. We noted that Pd(dba)2 (entry 1, Table 
A11.3.3), performed very similarly to Pd2(dba)3, however, all other Pd(0) precatalysts led to 
Table A11.3.2. Effect of the N-Protecting Groupa 
 
 
[a] Conditions: See Section A11.6, 0.1 mmol scale. Yields determined by 1HNMR analysis of the crude reaction 






Pd2(dba)3 (2.5 mol %)
L10 (7.5 mol %)
LiHMDS (1.0 equiv)
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significant drops in reactivity (entries 3–6). Increasing the catalyst loading also led to a significant 
decrease in yield (entry 2).  
 
  
Having examined a number of parameters without observing any significant changes in 
reactivity, we chose to go back and examine additional ligands in order to ensure that we had 
identified the optimal ligand for this transformation. Similar to what we found in the arylation, the 
ferrocene ligands led to the most reactive complexes, and ferrocelanes continued to stand out as 
the optimal class. We also noted that  Me-ferrocelane (L10) seemed to be optimal, and although 
Et-ferrocelane did lead to a slight boost in ee, this was accompanied by a drop in reactivity.  It 
should be noted that in all these reactions, an excess of LiHMDS (1.5 equiv) was used, as in 
concurrent experiments we had noted that this led to a modest increase in reactivity.  
 




[a] Conditions: 0.1 mmol scale. See A11.6. [b] Yields determined by 1HNMR analysis of the crude reaction mixture using 
1,3,5–trimethoxybenzene as a standard. [c] Determined by chiral SFC analysis of the isolated product. PMP = p-
methoxyphenyl. dba = dibenzylideneacetone, dm-dba = 3,5,3’,5’–dimethoxydibenzylideneacetone. [d] with 10 mol% 















4 (TMEDA)PdMe2 11 58
5 (ƞ3-allyl)PdCp 12 73




Pd source (5 mol %)
L10 (7.5 mol %)
LiHMDS (1.0 equiv)






























[a] 0.1 mmol scale, See A11.6. Yields determined by 1H NMR analysis of the crude reaction mixture using 1,3,5–
trimethoxybenzene as a standard.  Enantiomeric excess (ee) was determined by chiral SFC analysis of the isolated 




































 4% yield, –%ee
SL-J001-1 (JosiPhos)
47% yield, –47% ee
SL-M001-2 (MandyPhos)











 5% yield, –%ee
(R,R)-Me-DuPhos
 5% yield, –%ee
(R)-MOP











dioxane (0.1 M), 80 ºC, 24 h
0.2 mmol scale, 1 dram vial
+















R = Me: 53% yield, 89% ee
R = Et: 45% yield, 92% ee
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We  next decided to take a deeper look at the reaction in order to see if we could understand 
why we never observed yields above 50%.  When 1 equivalent of LiCl  is added at the start of the 
reaction, only a negligible amount of product is observed (Table A11.3.5, entry 1). This result 
suggests that in the presence of excess Cl anions, Pd may remain in an anionic state which could 
result in a significantly less viable catalyst for this reaction.13 This prompted the investigation into 
different solvents, as we envisioned that a less polar solvent might encourage the LiCl to precipitate 
from the solution. However, with less polar solvents (entries 3-5), a significant drop in both 
reactivity and ee is observed. In addition, the use of electrophiles other than vinyl chlorides, such 
as vinyl triflates and bromides also led to negligible amounts of product.  
 
By reverting the stoichiometry back to excess lactam and base, we were able to slightly 
improve the yield (entry 1, Table A11.3.6). However, we found that the isolated yield was 
significantly lower than that determined using 1H NMR and an internal standard. By extending the 




[a] Conditions: See Section A11.6, 0.1 mmol scale. [b] Yields determined by 1HNMR analysis of the crude reaction 
mixture using 1,3,5–trimethoxybenzene as a standard. [c] Determined by chiral SFC analysis of the isolated product. 
PMP = p-methoxyphenyl. dba = dibenzylideneacetone. 
 







 equiv LiCl solvent
dioxane
dioxane
3 0 23 831:1 dioxane/toluene
4 0 30 84toluene




Pd2(dba)3 (2.5 mol %)
L10 (7.5 mol %)
LiHMDS (1.0 equiv)
solvent (0.1 M) 
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reaction time  to 48 h, we were able to improve the outcome of the reaction slightly, and with these 
conditions, the product is obtained in 56% isolated yield and 88% ee (entry 2). Increasing the 
reaction concentration to [0.2 M] did lead to a 10% drop in yield (entry 4), and decreasing the 
concentration did not lead to any significant improvements (entry 3).  Gratifyingly, the temperature 
can be lowered by 10 °C without significantly altering the reaction outcome (entry 5).  
 
 
A11.4   PRELIMINARY RESULTS WITH g-BUTYROLACTONES AND VINYL 
BROMIDES 
 
  Our initial success in the Pd-catalyzed a-vinylation of g-lactams prompted the 
examination of  g-butyrolactones substrates in this reaction. Interestingly, we found that the g-
butyrolactones, in combination with LiHMDS and isocrotyl chloride, led to very little product 




[a] Isolated yields on 0.2 mmol scale, See Section A11.6 for set-up. [b] ee was determined by supercritical fluid 
chromatography [c] Results from a separate run in parentheses, yield determined by 1H NMR using 
trimethoxybenzene as an internal standard. 
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formation (entries 1 and 2, Table A11.4.1). When isocrotyl bromide and NaHMDS are used, the 
desired a-vinyl g-butyrolactone is obtained in moderate yield and excellent ee at 50 °C (entry 4). 
We found that the reaction yield can be improved by increasing the temperature to 80 °C, however 
this is accompanied by a slight decrease in ee (entry 5). 
 
 
A11.5  CONCLUSION 
We have initiated the development of  a protocol for the enantioselective a-vinylation of 
g-lactams and g-lactones. Starting from the conditions developed for the enantioselective a-
arylation, we examined the effect of the electrophile, protecting group, Pd source, ligand, and 
reactant stoichiometry on the reaction outcome. We found that the yields could not be improved 
beyond 50%, and control experiments indicate that the reason for this may be that LiCl is poisoning 
the Pd catalyst. Future work will focus on examining different strategies for sequestering the Cl 




[a] Conditions: See Section 5.6, 0.1 mmol scale. [b] Yields determined by 1HNMR analysis of the crude reaction 
mixture using 1,3,5–trimethoxybenzene as a standard. [c] Determined by chiral SFC analysis of the isolated 







Pd(dba)2 (5 mol %)
L10 (7.5 mol %)
base (1.0 eq.)
dioxane (0.1 M), temp, 24 h
+
1.0 equiv 1.5 equiv
56 100b or 102b 103
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anions in solution as well as determining the origin of enantioselectivity (enantioselective 
transmetalation vs. equilibration of diastereomeric L*-Pd-enolates). In addition, we have also 
obtained some promising preliminary results using g-butyrolactones as nucleophiles. Interestingly, 
we noted that the reaction conditions that result in the highest yield and ee are highly dependent 
on the nucleophile; with the g-lactams, we found that the conditions developed for vinyl chlorides 
worked best, and with g-butyrolactones, we found that the conditions developed for vinyl bromides 
gave the optimal results. 
 
A11.6  REPRESENTATIVE PROCEDURE FOR PALLADIUM-CATALYZED a-
VINYLATION OF g-LACTAMS AND g-BUTYROLACTONES 
 
 
In a nitrogen-filled glovebox, to an oven-dried 4 mL vial equipped with a stir bar was added 
1,1′-Bis[(2S,5S)-2,5-dimethylphospholano]ferrocene L10 (6.2 mg, 15 µmol, 0.075 equiv)  and 
Pd(dba)2 (5.8 mg, 10 µmol, 0.05 equiv), and dioxane (0.4 mL). The vial was capped with a PTFE-
lined septum cap and stirred at 40 °C. After 20 minutes, the mixture was cooled to ambient 
temperature and the corresponding vinyl chloride (0.2 mmol, 1.0 equiv) was added. A solution of 
protected lactam 30a (61.6 mg, 0.3 mmol, 1.5 equiv) and LiHMDS (50 mg, 0.3 mmol, 1.5 equiv) 




Pd(dba)2 (5 mol %)
L10 (7.5 mol %)
LiHMDS (1.0 equiv)
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70 °C for 48 h, unless otherwise noted. The solution was cooled to ambient temperature, quenched 
with saturated NH4Cl solution, and extracted with EtOAc five times. The combined organic layers 
were dried over Na2SO4 and concentrated. The crude reaction mixture was purified by silica gel 
flash chromatography (33% EtOAc in hexanes)  to furnish product 101ab (28.7 mg, 0.17 mmol, 
55% yield); 87% ee; 1H NMR (500 MHz, CDCl3) δ  7.59 – 7.50 (m, 2H), 6.96 – 6.85 (m, 2H), 
5.55 – 5.40 (m, 1H), 3.80 (s, 3H), 3.79 – 3.68 (m, 2H), 2.28 (dt, J = 12.5, 8.2 Hz, 1H), 2.17 (ddd, 
J = 12.4, 7.4, 3.7 Hz, 1H), 1.75 (d, J = 1.4 Hz, 3H), 1.69 (d, J = 1.2 Hz, 3H), 1.36 (s, 3H); δ 13C 
NMR (126 MHz, CDCl3) δ 177.76, 156.50, 134.54, 133.78, 129.86, 122.32, 114.10, 55.19, 48.75, 
45.71, 33.21, 29.82, 27.04, 25.47, 20.33; SFC Conditions: 10% IPA, 2.5 mL/min, Chiralcel OD-
H column, λ = 254 nm, tR (min): minor = 9.96, major = 10.52. 
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Nickel-Catalyzed Enantioselective Allylic Alkylation of Lactones and Lactams 
with Unactivated Allylic Alcohols† 
 
 
A12.1  INTRODUCTION, BACKGROUND, AND SYNTHETIC UTILITY 
 
Since the seminal report in 1965 by Tsuji,1 transition metal-catalyzed allylic alkylation has 
emerged as one of the most powerful methods for the construction of stereocenters.2 In particular, 
with the use of prochiral nucleophiles that proceed through tetrasubstituted enolates, the transition 
metal-catalyzed enantioselective allylic alkylation has proven to be a formidable strategy for 
accessing chiral quaternary stereocenters in catalytic enantioselective fashion.3 Although this 
transformation has been studied for more than 50 years,4 the use of α-substituted lactones or 
lactams as prochiral nucleophiles remains significantly under-developed.5,6 
As part of our ongoing research program directed at the development of new strategies for 
constructing quaternary stereocenters,7 we were drawn to the α-acyl lactones and lactams, as we 
envisioned that the α-acyl substituent would provide an additional functional handle for further 
synthetic manipulations. In addition, lactone products could also provide access to acyclic 
 
† This research was performed with Aurapat Ngamnithiporn and Shoshana Bachman, both alumni in the Stoltz 
group, as well as Dr. Scott Virgil, director of the Caltech Center for Catalysis and Chemical Synthesis. This research 
has been published and adapted with permission from Ngaminithiporn, A.; Jette, C. I.; Virgil S. C.;  Stoltz, B. M. 
Chem. Sci. 2018, 9, 2547. Published by The Royal Society of Chemistry. 
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quaternary stereocenters via ring-opening reactions,8 and reduction of the lactam products would 
enable direct access to functionalized piperidine rings, the most prevalent nitrogenous heterocycle 
in drug molecules.9 However, to the best of our knowledge, there has been only one report of a 
transition metal-catalyzed enantioselective allylic alkylation of monocyclic α-acyl lactone or 
lactam prochiral nucleophiles to furnish products bearing a quaternary stereocenter.Error! Bookmark 
not defined.d  
Recently, Cossy disclosed a palladium-catalyzed decarboxylative enantioselective allylic 
alkylation of enol carbonates derived from γ-butyrolactones (Scheme A12.1.1.A). Various enol 
carbonates can be used to obtain diverse α-acyl quaternary butyrolactones in moderate to high 
levels of enantioselectivity. Nonetheless, the limited electrophile scope and challenging 
nucleophile synthesis limits the practicality of this transformation. 
Scheme A12.1.1. Metal-Catalyzed Enantioselective Allylic Alkylations (AA) of a-Acyl 



































• Inexpensive catalyst and commercially available ligand
functional handle
diverse substitution
• Easily accessible substrates
• Substrates require low yielding, multistep synthesis
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To address this limitation, we chose to investigate the enantioselective allylic alkylation of 
α-acyl lactones and lactams by using an inexpensive transition metal catalyst and easily accessible 
prochiral nucleophiles. Mashima’s recent report on nickel-catalyzed enantioselective allylic 
alkylation of β-keto esters with allyl alcohol prompted us to probe nickel in our system.10,11 
Furthermore, we anticipated that an intermolecular allylic alkylation would simplify the substrate 
synthesis and provide a more convergent approach to these α-quaternary products.12 Herein, we 
report the first example of nickel-catalyzed intermolecular enantioselective allylic alkylation using 
easily accessible α-acyl lactones and lactams as prochiral nucleophiles in conjunction with allylic 
alcohols as electrophilic coupling partners (Scheme A12.1.1.B). 
 
 
A12.2  REACTION OPTIMIZATION 
Our studies commenced with an investigation of the enantioselective allylic alkylation 
between α-ethoxycarbonyl lactone 120a and allyl alcohol (121a) using Ni(COD)2 and (R)-BINAP 
in diethyl ether at 0 °C. Although the α-quaternary lactone product 122aa was obtained in good 
yield, only moderate enantioselectivity was achieved.13 Seeking to improve the enantioselectivity, 
we elected to survey a wide variety of commercially available ligand scaffolds. Chiral 
bisphosphine ligands were discovered to exhibit superior enantioselectivity to other classes of 
ligands, including those commonly used in asymmetric allylic alkylations such as 
phosphinooxazolines (PHOX) or C2-asymmetric ligands pioneered by the Trost group.14 In the 
presence of Ni(COD)2 (10 mol %) and chiral bisphosphine ligands L90–L93 (12 mol %), the 
reaction proceeds with moderate levels of enantioselectivity (Table A12.2.1, entries 1–4). The 
highest enantiomeric excess (ee) was achieved with (R)-P-phos (L93), which delivers α-quaternary 
lactone 122aa in 82% yield and 82% ee (entry 4). Decreasing the catalyst loading to 5 mol % 
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requires an exceedingly long reaction time (entry 5). An examination of different temperatures 
revealed that decreasing the temperature improves ee (entries 6–7), albeit with slightly diminished 
yields. Prolonged reaction time (48 h) at –10 °C affords product 122aa in 80% yield and 85% ee 
(entry 8). Importantly, a control experiment performed in the absence of the chiral ligand shows 




A12.3  SCOPE OF THE NUCLEOPHILE AND ELECTROPHILE 




[a] Conditions: 120a (0.1 mmol), 121a (0.1 mmol), Ni(COD)2 (10 mol %), ligand (12 mol %) in Et2O (1.0 mL). [b] Yields 
determined by 1H NMR of crude reaction mixture using 1,3,5-trimethoxybenzene as a standard. [c] Determined by chiral 
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[a] Reactions performed on 0.2 mmol. [b] Yield of isolated product. [c] Reaction performed at –10 °C. [d] Determined by 
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With the optimized reaction conditions in hand, we examined the scope of this asymmetric 
transformation (Table A12.3.1). The reaction of α-methoxycarbonyl lactone 120b, possessing a 
smaller alkyl group at the ester fragment, with allyl alcohol (121a) provides α-quaternary lactone 
122ba in comparable yield and ee to the allylated product 122aa. Bicyclic lactone 120c could also 
be used to furnish product 122ca in slightly diminished yield and enantioselectivity. With respect 
to the electrophile scope, reactions between lactone 120a with various substituted allyl alcohols 
proceed with good ee (78–90% ee) at increased temperature (10 °C). Although a trend in 
enantioselectivity was not observed, we found that the electronic nature of the aryl substituent does 
affect the reactivity. 
Electrophiles containing electron rich aryl substituents provide the corresponding products 
in greater yields than their electron-deficient counterparts (122ac–122ag). Furthermore, we found 
that para- and meta-substituted aryl rings exhibit higher reactivity as compared to the ortho-
substituted aryl ring (122ac, 122ah–ai vs. 122aj). Apart from the aryl-substituted electrophiles, 




[a] Reactions performed on 0.2 mmol. [b] Yield of isolated product. [c] Determined by chiral SFC analysis. [d] 
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we were pleased to find that heteroaryl substitution is also well-tolerated (122ak–122al). The 
reaction with an aliphatic electrophile affords product 122am in slightly diminished yield and ee. 
In addition, an alkenyl-substituted electrophile fares well under our reaction conditions, delivering 
product 122an in an excellent 91% yield and 88% ee. 
At this stage, we questioned whether we could leverage this transformation to include 
nitrogen-containing lactam nucleophiles. To our delight, under slightly modified reaction 
conditions using the same chiral bisphosphine ligand L93, α-ester lactams 123a–123b furnish 
products 124aa–124ba in good yields and with even higher enantioselectivity as compared to their 
lactone counterparts (Table A12.3.2). Examination of different protecting groups revealed that the 
benzoyl-protecting group is optimal.15,16 Reaction of α-ethoxycarbonyl benzoyl-protected lactam 
123a with branched cinnamyl alcohol affords linear product 124ab in 74% yield and 90% ee.  
In order to gain mechanistic insights into this transformation, we compared the results from 
reactions using linear and branched cinnamyl alcohols (Table A12.3.3). Only the linear product 




[a] Reactions performed on 0.1 mmol scale [b] Yields determined by 1H NMR of crude reaction mixture using 
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was detected, indicating that a nickel π-allyl is likely an intermediate in the catalytic cycle.17 While 
additional studies are needed to establish the full reaction mechanism and stereocontrolling factors 
in the process, the ability of this catalyst combination to access a single product from two 
electrophilic coupling partners highlights its flexibility in potential synthetic applications. 
 
A12.4  PRODUCT TRANSFORMATIONS 
 
 
To demonstrate the synthetic utility of the α-quaternary products, we performed a number 
of product transformations on both α-quaternary lactone 122aa (Scheme A12.4.1) and lactam 
124aa (Scheme A12.4.2). Selective reduction of the lactone functionality in 122aa provides diol 
125 in 88% yield. Additionally, vinyl Grignard addition into lactone 122aa affords enone 126 in 
67% yield with no erosion of enantioselectivity. These enantioenriched acyclic products 125 and 
126 bearing a quaternary stereocenter are envisioned to be useful chiral building blocks as they 




[a] NaBH4, CeCl3×7H2O, THF/MeOH, 0°C, 88% yield. [b] Vinyl–magnesium bromide, THF, –78 °C, 67% yield, 86% 
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contain multiple functional handles for further manipulations. For example, enantioenriched 
spirocycle 127 can be accessed via ring-closing metathesis followed by lactonization of enone 126. 
 
We also performed experiments to probe the reactivity of our α-quaternary lactam products 
(Scheme A12.4.2). Reduction of lactam 124aa with lithium aluminium hydride delivers chiral 
piperidine derivative 128, which is of potential value to medicinal chemists.9 Use of the aldehyde 
selective Wacker procedure18 affords aldehyde 129 in 75% yield. Lastly, cleavage of the benzoyl 
protecting group under basic conditions provides unprotected lactam 130 in 84% yield.  
 
A12.5  CONCLUSION 
 
In summary, we have developed the first nickel-catalyzed enantioselective allylic 
alkylation of α-substituted lactones and lactams with free allylic alcohols. Utilizing a commercially 
available chiral bisphosphine ligand, α-quaternary lactones and lactams can be constructed in good 
yield (up to 91% yield) and with high enantiomeric excess (up to 90% ee). A broad range of 
functional groups are compatible with the reaction conditions.  A number of product 




[a] LAH, Et2O, 65 °C, 80% yield; [b] CuCl×H2O (12 mol %), PdCl2(PhCN)2 (12 mol %), AgNO2 (6 mol %), t-BuOH, 




























Appendix 12- Nickel-Catalyzed Enantioselective Allylic Alkylation of Lactones and Lactams with 
Unactivated Allylic Alcohols 
647 
derivatizations showed the synthetic utility of this methodology for constructing small chiral 
building blocks with multiple functional handles. Future work to further elucidate the mechanism 
of this transformation is underway and will be reported in due course.  
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[a] Conditions: lactam (0.1 mmol), alcohol (0.1 mmol), Ni(COD)2 (10 mol %), ligand (12 mol %) for 48 h. 
[b] Yields determined by 1H NMR of crude reaction mixture using trimethoxybenzene as a standard.
[c] Determined by chiral SFC analysis. [d] 5 mol % Ni(COD)2 and 6 mol % L96 were used. [e] Reaction 
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17.  For previous reports that also proposed a nickel π-allyl intermediate in the catalytic cycle, 
see  ref 10, 11a and b. 
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